text,title,id,project_number,terms,administration,organization,mechanism,year,award_amount,cong_dist,score
"Substance Abuse Continuing Care through Mobile Assessment and Messaging. DESCRIPTION (provided by applicant): This Phase I SBIR application entitled ""Substance Abuse Continuing Care through Mobile Assessment and Messaging"" is designed to create a low cost, continuous care decision support text messaging intervention to increase treatment adherence, decrease drop-out and prevent the recurrence of problem drug use during and following professionally facilitated addiction treatment. Based on the high drop-out rates during treatment and relapse rates following treatment, it has been proposed that addiction should be treated similarly to other chronic illnesses that require long-term intensive monitoring and care. Recent research on adaptive phone-based continuing care interventions supports the use of a chronic care addictions treatment model both for those attempting to change illicit substance abuse and society as a whole. There is an emerging literature on the use of text messaging and ecological momentary assessment through mobile phones for low cost automated disease management of chronic illnesses like asthma and diabetes. Text messaging is ideally suited to addiction continuous care because the mobile phone is capable of providing low cost adaptive monitoring and feedback wherever and whenever relapse is most likely to occur. The proposed study is designed to develop the content, structure, programming and user interface of an automated interactive drug treatment continuous care text messaging intervention that can be modulated by the severity of symptoms during and following substance abuse treatment. The intervention will include web-based assessment, ecological momentary assessment (EMA), adaptive supportive messaging based on assessment results and counselor/social network alerts. The intervention is designed to both retain persons in treatment and help them sustain long-term change following treatment. We will obtain outside feedback and review of the preliminary intervention through focus groups with a heterogeneous group of clients enrolled in substance abuse treatment. Thought leaders with expertise in addiction, continuous care, text messaging and ecological momentary assessment will help develop the core content and features of the intervention. Specific content and programming benchmarks for success will determine Phase II feasibility. If successful this messaging program has the potential to significantly improve outcomes for the 2.2 million chronic illicit substance users who seek treatment each year without the financial burden and/or time commitment needed to implement traditional counselor based continuing care interventions. Additionally, the program can be used by clients of private addiction specialists and could be adapted to reach substance abusers in earlier stages of change as a stepped care intervention. Despite the emerging literature on the importance and effectiveness of continuing care  interventions for drug abuse, few treatment programs implement these strategies into care  due to lack of resources and financial incentive. We propose to create a low cost adaptive  continuing care text messaging support and monitoring program through the mobile phone  to help reduce drug abuse treatment drop-out and relapse among illicit drug users  attempting to change. If study aims are achieved, the proposed intervention could be easily  disseminated to providers, improve long-term psychosocial and health outcomes for  substance users and reduce overall healthcare costs related to substance abuse.",Substance Abuse Continuing Care through Mobile Assessment and Messaging.,7998538,R43DA029359,"['Professional counselor ', ' Counselor ', ' Car Phone ', ' Mobile Phones ', ' Provider ', ' Diabetes Mellitus ', ' diabetes ', ' Effectiveness ', ' prevent ', ' preventing ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Environment ', ' Symptoms ', ' Caring ', ' Social Network ', ' Data ', ' Enrollment ', ' enroll ', ' Small Business Innovation Research Grant ', ' Small Business Innovation Research ', ' SBIRS (R43/44) ', ' SBIR ', ' Monitor ', ' Principal Investigator ', ' Text ', ' Development ', ' developmental ', ' Expenditure ', ' Feedback ', ' Focus Groups ', ' Stimulus Generalization ', ' base ', ' Goals ', ' improved ', ' Health ', ' Health behavior ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Chronic ', ' Clinical ', ' Phase ', ' Ensure ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Literature ', ' Long-Term Care ', ' extended care ', ' Fostering ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Drug usage ', ' drug use ', ' Marketing ', ' Memory ', ' substance abuse treatment ', ' substance abuse therapy ', ' Motivation ', ' Persons ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Therapeutic ', ' Staging ', ' Drug user ', ' Recurrence ', ' Recurrent ', ' Relapse ', ' Research ', ' Resources ', ' Research Resources ', ' Running ', ' Smoking ', ' Societies ', ' Knowledge ', ' Disease Management ', ' Disorder Management ', ' programs ', ' Substance Addiction ', ' Substance Dependence ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Technology ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Asthma ', ' Bronchial Asthma ', ' United States Substance Abuse and Mental Health Services Administration ', ' Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Body Weight decreased ', ' wt-loss ', ' body weight loss ', ' Weight Reduction ', ' Weight Loss ', ' Frequencies (time pattern) ', ' Frequency ', ' Severities ', ' System ', ' LOINC Axis 4 System ', ' Back ', ' Dorsum ', ' Behavioral Research ', ' Benchmarking ', ' Best Practice Analysis ', ' psychosocial ', ' meetings ', ' data management ', ' success ', ' Structure ', ' treatment program ', ' Reporting ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' disorder later incidence prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Illicit Drugs ', ' Chronic Disease ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Modeling ', ' Specialist ', ' Decision Support Systems ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Client ', ' cost ', ' design ', ' designing ', ' Outcome ', ' Chronic Care ', ' substance abuser ', ' Abstinence ', ' volunteer ', ' addiction ', ' addictive disorder ', ' prototype ', ' treatment adherence ', ' financial incentive ', ' Secure ', ' Drops ', ' ']",NIDA,"MOBILE HEALTH INTERVENTIONS, LLC",R43,2010,119348,NY-07,0.017403396847928156
"Towards Automatically Discovering Adverse Drug Effects from User Generated Conten    DESCRIPTION (provided by applicant): The ADE Discoverer is an initiative to harvest adverse drug effects (ADEs) casually reported in forum discussions, user reviews, and other social media. Initially, the Discoverer will focus on a limited number of health-care related websites; however, as Phase I progresses there will be a focus on implementing techniques of automatic pattern recognition to allow structured data extraction from additional unknown websites. Once relevant social media is extracted, the Discoverer must then identify any occurrences of adverse drug effects. This is particularly challenging in forum discussions, where members are often discussing well known side effects, or their distinct experiences with multiple drugs in the context of a single post. In order to recognize which adverse effect terms were actually experienced as the result of the commenter taking a drug, a series of machine-learning algorithm based classifiers have been proposed. The classifiers will create classification models based on training data provided by the manual identification of ADEs over thousands of human reviewed posts. In Phase I and beyond, a constant focus will be on improving the ability to recognize human-experienced ADEs in social media. The side effects that pass through the classification filter will be correlated with FDA-reported side effects in order to power the ADE Search and Analysis Workbench. Using the interactive ADE Workbench, researchers will be able to quickly gain the insights necessary to make informed decisions about medications. Publicly available components of the workbench include: total side effect reports by drug, drill-down functionality to view raw, relevant social media and medical reports, and a drug comparison application to compare similar drugs effectiveness and likelihood of side effects side-by-side.      PUBLIC HEALTH RELEVANCE: In the 2010 Omnibus Solicitation the Center for Drug Evaluation and Research has identified several research and development opportunities that directly correspond to the work accomplished by the ADE Discoverer. Among the most relevant opportunities include: ""Develop methods for timely active surveillance of newly approved drug products in large populations to identify both expected and unexpected outcomes."", and ""Develop methods for actively collecting information on all cases of classically drug-associated events to augment the FDA's current passive surveillance system."" The ADE Discoverer actively monitors massive amounts of user generated content to identify adverse drug effects that would otherwise be missed by the FDA's current passive surveillance system.           In the 2010 Omnibus Solicitation the Center for Drug Evaluation and Research has identified several research and development opportunities that directly correspond to the work accomplished by the ADE Discoverer. Among the most relevant opportunities include: ""Develop methods for timely active surveillance of newly approved drug products in large populations to identify both expected and unexpected outcomes."", and ""Develop methods for actively collecting information on all cases of classically drug-associated events to augment the FDA's current passive surveillance system."" The ADE Discoverer actively monitors massive amounts of user generated content to identify adverse drug effects that would otherwise be missed by the FDA's current passive surveillance system.         ",Towards Automatically Discovering Adverse Drug Effects from User Generated Conten,8199321,R43FD004049,[''],FDA,"ACULUS, LLC",R43,2011,149640,UT-02,0.0300725463011112
"Predicting Smoking Abstinence via Mobile Monitoring of Stress and Social Context     DESCRIPTION (provided by applicant): Cigarette smoking is a leading preventable cause of death, responsible for one in five deaths annually in the United States alone. Many adult smokers want to or try to quit smoking, but, are unable to do so due to lack of personalized cessation treatments that ultimately leads to successful quitting. The primary hurdle has been the unavailability of technology that can be used to collect continuous measurements of stress contexts in field on predictors of abstinence and relapse. Without these measurements, it is difficult to understand the psychophysiological and biobehavioral stress mechanisms that may predict smoke lapse. This application proposes to use a new field deployable tool called AutoSense that was developed under NIH's GEI program to collect personal psychophysiological measures of stress and mediating social and environmental contexts in the natural environment of individuals to discover signatures of early relapse. AutoSense consists of several wireless sensors (e.g., ECG, respiration, triaxial accelerometer) attached to a chest band that transmit sensor measurements wirelessly to a smart phone. Fine-grained measurement of physiology enables computation of physiological measures that are predictive of stress such as minute ventilation and heart rate variability. The project uses sophisticated machine learning methods to estimate stress levels, smoking episodes and conversation episodes from physiological measurements. In addition, accelerometers are used to identify changes in posture and physical activity, and GPS measurements on the mobile phone are used to identify location and transportation modality. Seventy-two smokers who want to quit will be recruited. Two weeks prior to quit date, they will wear AutoSense for 24h in the field. Behavioral treatment for abstinence will begin in their visit to the lab prior to quitting. They wil wear AutoSense for 72h in the field, beginning on the quit date. In addition to collecting continuous measurements across all sensors, smoking and lapse events will be self-reported. Saliva samples will be collected for cortisol assessment, in addition to physiological measures of stress. Participants will report back to the lab one week after the quit date to determine smoking/lapse status. The aim of this project is to identify psychophysiological measures of stress and environmental cues that may predict early lapse. First, it will discover patterns in physiological and hormonal measures in response to withdrawal stress and acute stress that may predict lapse in the first week. Second, it will investigate the role of social and environmental context such as conversation behavior (e.g., duration and frequency of conversations), lifestyle factors (e.g., time spent in seated posture and in commuting), location (time spent at home vs. office), and indoor/outdoor status in mediating the relationship between stress and early lapse.        PUBLIC HEALTH RELEVANCE: By identifying psychophysiological and biobehavioral predictors of smoking lapse and by detecting smoking cues in the natural environment, this project will enable the development and evaluation of personalized cessation interventions that can be administered in real-time on smart phones, which could prove potent in preventing relapse. Given the adverse impact of smoking on smokers and non-smokers, such advancement will significantly improve the quality of life and reduce public health burden.              By identifying psychophysiological and biobehavioral predictors of smoking lapse and by detecting smoking cues in the natural environment, this project will enable the development and evaluation of personalized cessation interventions that can be administered in real-time on smart phones, which could prove potent in preventing relapse. Given the adverse impact of smoking on smokers and non-smokers, such advancement will significantly improve the quality of life and reduce public health burden.            ",Predicting Smoking Abstinence via Mobile Monitoring of Stress and Social Context,8402064,R01DA035502,"['Grain ', ' Cereals ', ' Dorsum ', ' Back ', ' Cause of Death ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Behavior ', ' driving ', ' Automobile Driving ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Electrocardiogram ', ' Future ', ' Health ', ' Genes ', ' Environment ', ' Commuting ', ' Cues ', ' Death ', ' Cessation of life ', ' Methods ', ' Therapeutic Hydrocortisone ', ' Proctocort ', ' Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' social role ', ' Role ', ' Technology ', ' Productivity ', ' Phone ', ' Telephone ', ' Saliva ', ' Stress ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' respiratory mechanism ', ' Respiration ', ' Public Health ', ' public health medicine (field) ', ' Smoke ', ' psycho-physiological ', ' physiopsychology ', ' Psychophysiological ', ' Physiological Psychology ', ' Physiologic Psychology ', ' Psychophysiology ', ' QOL ', ' Quality of life ', ' recruit ', ' Recruitment Activity ', ' Relapse ', ' Posture ', ' Physiology ', ' sedentary ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' Measures ', ' base ', ' health care ', ' Healthcare ', ' sensor ', ' Mediating ', ' Time ', ' Ventilation ', ' Environmental air flow ', ' Social Interaction ', ' Transportation ', ' Smoking ', ' United States ', ' Testing ', ' nonsmoker ', ' Non-smoker ', ' Home ', ' Home environment ', ' Visit ', ' Complex ', ' programs ', ' Event ', ' Pattern ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Salivary ', ' Frequency ', ' Frequencies (time pattern) ', ' Smoker ', ' tool ', ' Exposure to ', ' Evaluation ', ' Individual ', ' Measurement ', ' improved ', ' Withdrawal ', ' Physiologic ', ' Physiological ', ' Physical activity ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Cessation of Treatment ', ' Withholding Treatment ', ' social ', ' smoke cigarette ', ' cigarette smoking ', ' acute stress ', ' Modality ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Chest ', ' response ', ' Reporting ', ' Self-Report ', ' Patient Self-Report ', ' Sampling ', ' Participant ', ' Hormonal ', ' Location ', ' hazard ', ' biobehavioral ', ' biobehavior ', ' lifestyle factors ', ' cost ', ' developmental ', ' Development ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' Psychosocial Stress ', ' Data ', ' preventing ', ' prevent ', ' Moderate Activity ', ' Moderate Exercise ', ' Detection ', ' Mobile Phones ', ' Car Phone ', ' Abstinence ', ' heart rate variability ', ' coping ', ' smoking relapse ', ' ']",NIDA,UNIVERSITY OF MEMPHIS,R01,2012,441332,TN-09,0.03868408199990862
"Development of a Smartphone-Based Virtual Sensor for Detecting Smoking Behavior Cigarette smoking is the leading preventable cause of death and disability in the U.S.; worldwide it results in >5,000,000 premature deaths each year. The majority of smokers express a desire to quit, and each year more than half will. However, less than 7% of those who quit will achieve long-term abstinence. Much is known about the immediate and predictive antecedents of the first cigarette following a quit attempt (i.e. lapse), which include situations (e.g. presence of other smokers) and activities (e.g. alcohol consumption). While ideally this information could be used to develop a system that detects these predictive antecedents in real-time and provides just-in-time intervention; to date no such systems have been developed. The overarching goal of our research program is to develop and test such a system that uses smartphone technology. The system developed here can be incorporated into diverse application platforms that target the modification of smoking and multiple other health related behaviors including drug and alcohol use, food consumption and physical activity. Despite the fact that smoking is a known cause of death and disability, many smokers find it very difficult to quit and those who do quit often return to smoking (i.e. lapse). Although the situational factors leading up to a lapse are well documented, treatments designed to interrupt these situations before relapse occurs have not been forthcoming. Here, we propose to develop a smartphone-based system that can detect these situations in real-time. Once developed, the sensor system can be incorporated into mobile smoking cessation applications designed to help smokers avoid relapse.",Development of a Smartphone-Based Virtual Sensor for Detecting Smoking Behavior,8402249,R21DA034471,"['Acoustic ', ' Acoustics ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Algorithms ', ' Beds ', ' Behavior ', ' Cause of Death ', ' Systematics ', ' Classification ', ' Scotine ', ' 2-Pyrrolidinone, 1-methyl-5-(3-pyridinyl)-, (S)- ', ' Cotinine ', ' Death ', ' Cessation of life ', ' Goals ', ' Hand ', ' Health ', ' Hospitals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' inducement ', ' Incentives ', ' Libraries ', ' Literature ', ' Methods ', ' body movement ', ' Movement ', ' Paper ', ' Probability ', ' Real-Time Systems ', ' Relapse ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoke ', ' Smoking ', ' sound ', ' Technology ', ' Testing ', ' Time ', ' Work ', ' Targeted Modification ', ' Targeted DNA Modification ', ' Site-Specific Mutagenesis ', ' Site-Directed Mutagenesis ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' smoking cessation ', ' base ', ' sensor ', ' Left ', ' Clinical ', ' prematurity ', ' premature ', ' Series ', ' Evaluation ', ' Training ', ' Physical activity ', ' Mouth ', ' Cavitas Oris ', ' Buccal Cavity Head and Neck ', ' Buccal Cavity ', ' Oral cavity ', ' disability ', ' Individual ', ' drug use ', ' Drug usage ', ' Staging ', ' Smoker ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Event ', ' Scanning ', ' Salivary ', ' Distant ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' technology development ', ' Cigarette ', ' drinking ', ' Metric ', ' smoke cigarette ', ' cigarette smoking ', ' technology/technique ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' signal processing ', ' data processing ', ' computerized data processing ', ' Data ', ' Detection ', ' Smoking Behavior ', ' Monitor ', ' developmental ', ' Development ', ' food consumption ', ' cost ', ' virtual ', ' designing ', ' design ', ' Visual Motion ', ' visual area ', ' extrastriate cortex ', ' extrastriate area ', ' extrastriate visual cortex ', ' innovative ', ' innovate ', ' innovation ', ' data acquisition ', ' Abstinence ', ' clinical applicability ', ' clinical application ', ' addictive disorder ', ' addiction ', ' treatment design ', ' intervention design ', ' therapy design ', ' visual imagery ', ' ']",NIDA,DUKE UNIVERSITY,R21,2012,196250,NC-04,-0.024612274412418818
"A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia     DESCRIPTION (provided by applicant): Schizophrenia is a severe psychiatric disorder that is associated with staggeringly high individual and societal costs. Although the illness is typically chronic, it is not static, and the majority of people with schizophrenia vacillate between full or partial remission and episodes of symptomatic relapse. Relapses increase one's risk for major problems including homelessness, incarceration, victimization, and suicide. Moreover, patients with schizophrenia who relapse are three to four times more costly than those who do not. The goal of the proposed project is to develop and evaluate a novel paradigm for illness monitoring, detection of early warning signs, and relapse prevention in schizophrenia. Our interdisciplinary team of clinical researchers and computer scientists proposes to develop a mobile system that uses smartphone-embedded sensors (i.e. microphone, accelerometer, GPS, light sensor) coupled with computerized self-reports, to track a range of behaviors (i.e. paralinguistic aspect of speech, physical activity, location, sleep, mood, psychotic symptoms) that are relevant to relapse in schizophrenia. Using machine learning techniques, the system will leverage behavioral data and patient self-reported clinical updates to generate personalized early warning models. The models will evolve with use of the system over time, focusing on variability from one's typical behavioral patterns to calibrate a unique patient relapse signature. Treatment teams will be informed about patients' clinical status via secure website. When the mobile system ""flags"" trends that are consistent with one's relapse signature, it will trigger patient functions and provider functions (i.e. real-time notification, prompts to initiate contact, time-sensitive treatments) to help prevent progression to full psychotic relapse. In Phase 1 of the project, we will integrate multi-modal sensor, ecological momentary assessment, and machine learning technologies into a unified smartphone system that will be tested and refined in laboratory settings. In Phase 2, we will conduct field trials with individuals with schizophrenia i real-world conditions to identify and resolve technical and mechanical problems, adapt the software, and maximize system usability. In Phase 3, we will conduct a randomized 12- month trial of the monitoring and prevention system compared to treatment as usual in 150 outpatients with schizophrenia that are at high-risk for relapse. If successful, our proposed system can be rapidly made available to a population that is in dire need of more effective resources, and can serve as a template for mobile monitoring and treatment systems for a range of clinical conditions with an episodic nature.         PUBLIC HEALTH RELEVANCE: An effective multi-modal mobile monitoring, early detection, and intervention system for schizophrenia could alter illness trajectory, mitigating the acute and long term impact of psychotic relapses on patients, their caretakers, and communities. A broadly available system could radically change when, how, and to what effect treatments are delivered, allowing for a paradigmatic shift from reactive to preemptive care for schizophrenia.                ",A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia,8640521,R01MH103148,"['Accounting ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' clinical investigation ', ' Clinical Trials ', ' Communities ', ' Computers ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' Elements ', ' Goals ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' Hospitalization ', ' Laboratories ', ' Photoradiation ', ' Light ', ' Methods ', ' Moods ', ' National Institute of Mental Health ', ' NIMH ', ' National Institute of Mental Health (U.S.) ', ' Out-patients ', ' Outpatients ', ' Patients ', ' Relapse ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Science ', ' Sleep ', ' Social isolation ', ' computer program/software ', ' Software ', ' Computer software ', ' Speech ', ' Stress ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Suicide ', ' Technology ', ' Technology Assessment ', ' Testing ', ' Time ', ' self injury ', ' self harm ', ' intentional self injury ', ' intentional self harm ', ' deliberate self harm ', ' Deliberate Self-Harm ', ' Self-Injurious Behavior ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Self Management ', ' Caring ', ' base ', ' sensor ', ' Partial Remission ', ' Left ', ' Acute ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Ensure ', ' Physical activity ', ' medical complication ', ' disability ', ' unhoused ', ' homeless ', ' Homelessness ', ' Individual ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Collaborations ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Victimization ', ' mechanical ', ' Mechanics ', ' Scientist ', ' Notification ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' Remission ', ' Disease remission ', ' early detection ', ' Early Diagnosis ', ' experience ', ' novel ', ' Self-Report ', ' Patient Self-Report ', ' help seeking ', ' help-seeking behavior ', ' Prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' disorder later incidence prevention ', ' Modeling ', ' developing computer software ', ' develop software ', ' software development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Provider ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Infrastructure ', ' Research Infrastructure ', ' Update ', ' Monitor ', ' trend ', ' developmental ', ' Development ', ' Behavioral ', ' website ', ' web site ', ' cost ', ' computerized ', ' serious mental illness ', ' severe mental illness ', ' Outcome ', ' Population ', ' Coupled ', ' innovative ', ' innovate ', ' innovation ', ' treatment effect ', ' usability ', ' computer generated ', ' high risk ', ' high reward ', ' public health relevance ', ' usual care ', ' treatment as usual ', ' Secure ', ' ']",NIMH,DARTMOUTH COLLEGE,R01,2013,271188,NH-02,0.08588216750948427
"Moving beyond description: Statistical and casual inference for social media data     DESCRIPTION (provided by applicant): Human interactions via internet and mobile apps are increasing and ubiquitous among all walks of life. Young and older adults are prolific in these media, as well as public and private agencies seeking to promote health behaviors and communications. Over 500 million users are registered to Twitter.com, a microblogging and social network service that conveys text messages to a restricted set of followers. Given current new user registration rates, Twitter may reach over one billion users in the next year. Over 50% of nonprofits using social media sites employ Twitter, the second highest used social media application after Facebook. Every second, 2,200 new Tweets appear offering timely broadcasts about users' current states, interests and ideas. Bigdata sources such as Twitter afford new potential in combining ""real-time"" spatial and social networking information to study causal processes underlying who, where and how individuals are connected. These key features are lacking in the traditional research designs and intervention strategies for health and health-related behaviors. For example, social network analysis (SNA), a strand of systems science, offers a unique lens to understand how human interactions through social network may collectively optimize mental health outcomes in social and geographic ""locations."" The ability to model attributes of nodes and tie strength makes SNA a powerful descriptive and predictive method. Network analyses can capture integration and fragmentation, concepts integral to prevention system planning. Indeed, novel mixed methods of SNA with machine learning can enhance prediction of flu spread in a large real-world population and future criminal incidents in a real city. The goal of this project is to develop and apply a new class of statistical and causal inference models for human interactions and their impacts on health and health-related behavioral outcomes using network data from social media sources such as Twitter.com by focusing on three research studies that integrate online social media information to understand the roles of human interaction on (a) disease spread, (b) mental health in a hard-to-reach population, and (c) presence and extent of ""natural helping"" in promoting wellness and reducing norms supporting violence in low-income urban neighborhoods. RELEVANCE (See instructions): This project will impact behavioral and social health sciences, including systems science communities, broadly and specifically by: (a) filling a critical gap in the literature on causal inference models for social network interactions, (b) strengthening the evidence base for how social media is used and affecting health related outcomes and behaviors, and (c) improving community capacity-building in health.              ",Moving beyond description: Statistical and casual inference for social media data,8600055,R01GM108337,"['Affect ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Behavior ', ' Cities ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Future ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' Goals ', ' Health ', ' Health behavior ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Literature ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Neighborhoods ', ' study design ', ' Study Type ', ' Research Design ', ' social role ', ' Role ', ' Science ', ' Time ', ' violent behavior ', ' violent ', ' Violence ', ' Walking ', ' Social Network ', ' State Interests ', ' improved ', ' Site ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Source ', ' LOINC Axis 4 System ', ' System ', ' Services ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Prevention ', ' social ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Low income ', ' Data ', ' Health Communication ', ' Health Sciences ', ' Information and Media ', ' Process ', ' Text ', ' Behavioral ', ' Instruction ', ' Outcome ', ' Population ', ' flu ', ' lenses ', ' lens ', ' evidence base ', ' ']",NIGMS,UNIVERSITY OF ROCHESTER,R01,2013,201656,NY-25,0.037290616729408976
"Predicting Smoking Abstinence via Mobile Monitoring of Stress and Social Context     DESCRIPTION (provided by applicant): Cigarette smoking is a leading preventable cause of death, responsible for one in five deaths annually in the United States alone. Many adult smokers want to or try to quit smoking, but, are unable to do so due to lack of personalized cessation treatments that ultimately leads to successful quitting. The primary hurdle has been the unavailability of technology that can be used to collect continuous measurements of stress contexts in field on predictors of abstinence and relapse. Without these measurements, it is difficult to understand the psychophysiological and biobehavioral stress mechanisms that may predict smoke lapse. This application proposes to use a new field deployable tool called AutoSense that was developed under NIH's GEI program to collect personal psychophysiological measures of stress and mediating social and environmental contexts in the natural environment of individuals to discover signatures of early relapse. AutoSense consists of several wireless sensors (e.g., ECG, respiration, triaxial accelerometer) attached to a chest band that transmit sensor measurements wirelessly to a smart phone. Fine-grained measurement of physiology enables computation of physiological measures that are predictive of stress such as minute ventilation and heart rate variability. The project uses sophisticated machine learning methods to estimate stress levels, smoking episodes and conversation episodes from physiological measurements. In addition, accelerometers are used to identify changes in posture and physical activity, and GPS measurements on the mobile phone are used to identify location and transportation modality. Seventy-two smokers who want to quit will be recruited. Two weeks prior to quit date, they will wear AutoSense for 24h in the field. Behavioral treatment for abstinence will begin in their visit to the lab prior to quitting. They wil wear AutoSense for 72h in the field, beginning on the quit date. In addition to collecting continuous measurements across all sensors, smoking and lapse events will be self-reported. Saliva samples will be collected for cortisol assessment, in addition to physiological measures of stress. Participants will report back to the lab one week after the quit date to determine smoking/lapse status. The aim of this project is to identify psychophysiological measures of stress and environmental cues that may predict early lapse. First, it will discover patterns in physiological and hormonal measures in response to withdrawal stress and acute stress that may predict lapse in the first week. Second, it will investigate the role of social and environmental context such as conversation behavior (e.g., duration and frequency of conversations), lifestyle factors (e.g., time spent in seated posture and in commuting), location (time spent at home vs. office), and indoor/outdoor status in mediating the relationship between stress and early lapse.         PUBLIC HEALTH RELEVANCE: By identifying psychophysiological and biobehavioral predictors of smoking lapse and by detecting smoking cues in the natural environment, this project will enable the development and evaluation of personalized cessation interventions that can be administered in real-time on smart phones, which could prove potent in preventing relapse. Given the adverse impact of smoking on smokers and non-smokers, such advancement will significantly improve the quality of life and reduce public health burden.            ",Predicting Smoking Abstinence via Mobile Monitoring of Stress and Social Context,8542814,R01DA035502,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' driving ', ' Automobile Driving ', ' Dorsum ', ' Back ', ' Behavior ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Cause of Death ', ' Grain ', ' Cereals ', ' Commuting ', ' Cues ', ' Death ', ' Cessation of life ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Electrocardiogram ', ' Environment ', ' Future ', ' Genes ', ' Health ', ' Therapeutic Hydrocortisone ', ' Proctocort ', ' Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' Methods ', ' Physiology ', ' Posture ', ' Productivity ', ' psycho-physiological ', ' physiopsychology ', ' Psychophysiological ', ' Physiological Psychology ', ' Physiologic Psychology ', ' Psychophysiology ', ' Public Health ', ' public health medicine (field) ', ' QOL ', ' Quality of life ', ' recruit ', ' Recruitment Activity ', ' Relapse ', ' respiratory mechanism ', ' Respiration ', ' social role ', ' Role ', ' Saliva ', ' Smoke ', ' Smoking ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Social Interaction ', ' Stress ', ' Technology ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' Transportation ', ' United States ', ' Ventilation ', ' Environmental air flow ', ' Measures ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' smoking cessation ', ' health care ', ' Healthcare ', ' Mediating ', ' base ', ' sensor ', ' improved ', ' sedentary ', ' Physiologic ', ' Physiological ', ' Evaluation ', ' Physical activity ', ' Individual ', ' Withdrawal ', ' Measurement ', ' Exposure to ', ' tool ', ' Smoker ', ' nonsmoker ', ' Non-smoker ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Event ', ' Salivary ', ' Home ', ' Home environment ', ' Pattern ', ' Location ', ' Hormonal ', ' Visit ', ' hazard ', ' Participant ', ' Self-Report ', ' Patient Self-Report ', ' Modality ', ' smoke cigarette ', ' cigarette smoking ', ' Reporting ', ' social ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Chest ', ' acute stress ', ' Sampling ', ' response ', ' Cessation of Treatment ', ' Withholding Treatment ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Mobile Phones ', ' Car Phone ', ' preventing ', ' prevent ', ' Data ', ' Detection ', ' Moderate Activity ', ' Moderate Exercise ', ' lifestyle factors ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' developmental ', ' Development ', ' cost ', ' biobehavioral ', ' biobehavior ', ' coping ', ' Psychosocial Stress ', ' Abstinence ', ' public health relevance ', ' heart rate variability ', ' smoking relapse ', ' ']",NIDA,UNIVERSITY OF MEMPHIS,R01,2013,433185,TN-09,0.034530231548249794
"Development of a Smartphone-Based Virtual Sensor for Detecting Smoking Behavior Cigarette smoking is the leading preventable cause of death and disability in the U.S.; worldwide it results in >5,000,000 premature deaths each year. The majority of smokers express a desire to quit, and each year more than half will. However, less than 7% of those who quit will achieve long-term abstinence. Much is known about the immediate and predictive antecedents of the first cigarette following a quit attempt (i.e. lapse), which include situations (e.g. presence of other smokers) and activities (e.g. alcohol consumption). While ideally this information could be used to develop a system that detects these predictive antecedents in real-time and provides just-in-time intervention; to date no such systems have been developed. The overarching goal of our research program is to develop and test such a system that uses smartphone technology. The system developed here can be incorporated into diverse application platforms that target the modification of smoking and multiple other health related behaviors including drug and alcohol use, food consumption and physical activity. Despite the fact that smoking is a known cause of death and disability, many smokers find it very difficult to quit and those who do quit often return to smoking (i.e. lapse). Although the situational factors leading up to a lapse are well documented, treatments designed to interrupt these situations before relapse occurs have not been forthcoming. Here, we propose to develop a smartphone-based system that can detect these situations in real-time. Once developed, the sensor system can be incorporated into mobile smoking cessation applications designed to help smokers avoid relapse.",Development of a Smartphone-Based Virtual Sensor for Detecting Smoking Behavior,8494033,R21DA034471,"['Acoustic ', ' Acoustics ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Algorithms ', ' Beds ', ' Behavior ', ' Cause of Death ', ' Systematics ', ' Classification ', ' Scotine ', ' 2-Pyrrolidinone, 1-methyl-5-(3-pyridinyl)-, (S)- ', ' Cotinine ', ' Death ', ' Cessation of life ', ' Goals ', ' Hand ', ' Health ', ' Hospitals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' inducement ', ' Incentives ', ' Libraries ', ' Literature ', ' Methods ', ' body movement ', ' Movement ', ' Paper ', ' Probability ', ' Real-Time Systems ', ' Relapse ', ' Research ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoke ', ' Smoking ', ' sound ', ' Technology ', ' Testing ', ' Time ', ' Work ', ' Targeted Modification ', ' Targeted DNA Modification ', ' Site-Specific Mutagenesis ', ' Site-Directed Mutagenesis ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' smoking cessation ', ' base ', ' sensor ', ' Left ', ' Clinical ', ' prematurity ', ' premature ', ' Series ', ' Evaluation ', ' Training ', ' Physical activity ', ' Mouth ', ' Cavitas Oris ', ' Buccal Cavity Head and Neck ', ' Buccal Cavity ', ' Oral cavity ', ' disability ', ' Individual ', ' drug use ', ' Drug usage ', ' Staging ', ' Smoker ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Event ', ' Scanning ', ' Salivary ', ' Distant ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' technology development ', ' Cigarette ', ' drinking ', ' Metric ', ' smoke cigarette ', ' cigarette smoking ', ' technology/technique ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' signal processing ', ' data processing ', ' computerized data processing ', ' Data ', ' Detection ', ' Smoking Behavior ', ' Monitor ', ' developmental ', ' Development ', ' food consumption ', ' cost ', ' virtual ', ' designing ', ' design ', ' Visual Motion ', ' visual area ', ' extrastriate cortex ', ' extrastriate area ', ' extrastriate visual cortex ', ' innovative ', ' innovate ', ' innovation ', ' data acquisition ', ' Abstinence ', ' clinical applicability ', ' clinical application ', ' addictive disorder ', ' addiction ', ' treatment design ', ' intervention design ', ' therapy design ', ' visual imagery ', ' ']",NIDA,DUKE UNIVERSITY,R21,2013,188400,NC-04,-0.024612274412418818
"Influencing cervical cancer prevention and detection online through social media     DESCRIPTION (provided by applicant): Despite widespread availability and known effectiveness, Pap smear screening and human papilloma virus (HPV) vaccination rates remain below national targets. New modes of online communication through social media - which have transformed information sharing, especially for younger individuals - present opportunities to target health communication more effectively to improve cervical cancer prevention. Although the Internet has yet to realize its full potential for health-related communication, about 87% of US adults have used the Internet to look for health information, and a large majority of younger Americans report they would share personal health information on social media sites. Thus, pushing the current boundaries to capitalize on social media to inform decision-making about cancer screening and prevention offers great potential. The long-term goals of this research are to 1) generate validated methodologies to systematically study social media content, and 2) promote cervical cancer screening and prevention more effectively using social media. In pursuit of these goals, we will used a novel methodological approaches to characterize cervical cancer content present in social media and then to create and test messages within an experimental online social network. In Aim 1, we will identify and rank the key words related to cervical cancer screening and HPV vaccination in social media messages. We will identify statistically significant phrases that are co-occurring in messages drawn from six months of publically available content from Twitter and Facebook. This technique will allow us to synthesize the entire breadth of content on screening and vaccination on social media, and to extract the full-text of messages corresponding to the most common significant words/ phrases. In Aim 2, we will categorize and validate the range of cervical cancer screening and HPV vaccination discussion on social media websites. We will use qualitative content analysis informed by grounded theory to analyze a random sample of the findings from Aim 1, coding a minimum of 1500 messages. This will allow us to gain an in-depth understanding of the range of real-life discussions online. This will also serve as the validation of the machine learning result from Aim 1, as well as the basis for the development of new cervical cancer prevention messages that will be tested in Aim 3. Building upon both of these aims, in Aim 3, we will create tailored cervical cancer screening and HPV vaccination messages and track responses and spread in an online social network. Using the content knowledge from Aims 1 & 2, we will create tailored messages about cervical cancer screening and prevention and then pre-test them using virtual focus groups to gain insights from our target audience. We will establish a simulated online network to evaluate the spread of these messages, as each network member can directly share health opinions with others in the study. Within this setting, we will be able to determine the diffusion of specific, effective screening messages, as well as determine what types of network structures and message authors have the biggest impact.         PUBLIC HEALTH RELEVANCE:  We plan to study publicly available messages on online social media websites (for example, Twitter and Facebook) related to cervical cancer screening and prevention, such as comments about Pap smears. We will determine the major discussion topics on these websites, and then use this information to craft new messages about cervical cancer prevention. Finally, in an experiment, we will test how these messages are shared between individuals - in order to learn how public health agencies and researchers can improve their online health-related communication strategies to promote cervical cancer screening.                ",Influencing cervical cancer prevention and detection online through social media,8693710,R01CA178875,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Uterine Cervix Cancer ', ' Malignant Uterine Cervix Tumor ', ' Malignant Uterine Cervix Neoplasm ', ' Malignant Tumor of the Cervix Uteri ', ' Malignant Tumor of the Cervix ', ' Malignant Neoplasm of the Cervix ', ' Malignant Cervical Tumor ', ' Malignant Cervical Neoplasm ', ' Cervix Cancer ', ' Cervical Cancer ', ' Malignant neoplasm of cervix uteri ', ' Communication ', ' Data Collection ', ' Death ', ' Cessation of life ', ' Decision Making ', ' Diffusion ', ' Focus Groups ', ' Goals ', ' Grant ', ' Health ', ' Salutogenesis ', ' Health Promotion ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Human Papillomavirus ', ' Language ', ' Learning ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Perception ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Social Interaction ', ' Testing ', ' Time ', ' Vaccination ', ' Woman ', ' cervical/vaginal smear ', ' Vaginal Smears ', ' Papanicolaou Test ', ' Papanicolaou Smear ', ' Pap Test ', ' Cervical Smears ', ' Pap smear ', ' Latino ', ' Social Network ', ' Guidelines ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Site ', ' insight ', ' Individual ', ' Measurement ', ' uptake ', ' cervical cancer early detection ', ' Cervical Cancer Screening ', ' cervical cancer prevention ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' Simulate ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Techniques ', ' American ', ' experience ', ' success ', ' phrases ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Prevention ', ' Reporting ', ' social ', ' Coding System ', ' Code ', ' Modeling ', ' Sampling ', ' girls ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' theories ', ' health organization ', ' Effectiveness ', ' Data ', ' Health Communication ', ' Cancer Detection ', ' Validation ', ' Text ', ' developmental ', ' Development ', ' website ', ' web site ', ' virtual ', ' aged ', ' computer algorithm ', ' Computational algorithm ', ' public health relevance ', ' online social networking ', ' web-based social networking ', ' social networking web site ', ' social networking site ', ' social networking website ', ' screening ', ' Human Papillomavirus Vaccination ', ' HPV Vaccination ', ' Human Papilloma Virus Vaccination ', ' ']",NCI,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2014,504210,CA-12,0.004399366221095269
"Predicting Smoking Abstinence via Mobile Monitoring of Stress and Social Context     DESCRIPTION (provided by applicant): Cigarette smoking is a leading preventable cause of death, responsible for one in five deaths annually in the United States alone. Many adult smokers want to or try to quit smoking, but, are unable to do so due to lack of personalized cessation treatments that ultimately leads to successful quitting. The primary hurdle has been the unavailability of technology that can be used to collect continuous measurements of stress contexts in field on predictors of abstinence and relapse. Without these measurements, it is difficult to understand the psychophysiological and biobehavioral stress mechanisms that may predict smoke lapse. This application proposes to use a new field deployable tool called AutoSense that was developed under NIH's GEI program to collect personal psychophysiological measures of stress and mediating social and environmental contexts in the natural environment of individuals to discover signatures of early relapse. AutoSense consists of several wireless sensors (e.g., ECG, respiration, triaxial accelerometer) attached to a chest band that transmit sensor measurements wirelessly to a smart phone. Fine-grained measurement of physiology enables computation of physiological measures that are predictive of stress such as minute ventilation and heart rate variability. The project uses sophisticated machine learning methods to estimate stress levels, smoking episodes and conversation episodes from physiological measurements. In addition, accelerometers are used to identify changes in posture and physical activity, and GPS measurements on the mobile phone are used to identify location and transportation modality. Seventy-two smokers who want to quit will be recruited. Two weeks prior to quit date, they will wear AutoSense for 24h in the field. Behavioral treatment for abstinence will begin in their visit to the lab prior to quitting. They wil wear AutoSense for 72h in the field, beginning on the quit date. In addition to collecting continuous measurements across all sensors, smoking and lapse events will be self-reported. Saliva samples will be collected for cortisol assessment, in addition to physiological measures of stress. Participants will report back to the lab one week after the quit date to determine smoking/lapse status. The aim of this project is to identify psychophysiological measures of stress and environmental cues that may predict early lapse. First, it will discover patterns in physiological and hormonal measures in response to withdrawal stress and acute stress that may predict lapse in the first week. Second, it will investigate the role of social and environmental context such as conversation behavior (e.g., duration and frequency of conversations), lifestyle factors (e.g., time spent in seated posture and in commuting), location (time spent at home vs. office), and indoor/outdoor status in mediating the relationship between stress and early lapse.         PUBLIC HEALTH RELEVANCE: By identifying psychophysiological and biobehavioral predictors of smoking lapse and by detecting smoking cues in the natural environment, this project will enable the development and evaluation of personalized cessation interventions that can be administered in real-time on smart phones, which could prove potent in preventing relapse. Given the adverse impact of smoking on smokers and non-smokers, such advancement will significantly improve the quality of life and reduce public health burden.",Predicting Smoking Abstinence via Mobile Monitoring of Stress and Social Context,8720744,R01DA035502,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' driving ', ' Automobile Driving ', ' Dorsum ', ' Back ', ' Behavior ', ' lifestyle modification ', ' behavioral intervention ', ' behavior intervention ', ' Life Style Modification ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Behavior Therapy ', ' Cause of Death ', ' Grain ', ' Cereals ', ' Commuting ', ' Cues ', ' Death ', ' Cessation of life ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Electrocardiogram ', ' Environment ', ' Future ', ' Genes ', ' Health ', ' Therapeutic Hydrocortisone ', ' Proctocort ', ' Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- ', ' Nutracort ', ' Hytone ', ' Hydrocortone ', ' Eldecort ', ' Dermacort ', ' Cortril ', ' Cortispray ', ' Cortisol ', ' Cortenema ', ' Cortef ', ' Cort-Dome ', ' Cetacort ', ' Aeroseb-HC ', ' Hydrocortisone ', ' Methods ', ' Physiology ', ' Posture ', ' Productivity ', ' psycho-physiological ', ' physiopsychology ', ' Psychophysiological ', ' Physiological Psychology ', ' Physiologic Psychology ', ' Psychophysiology ', ' Public Health ', ' public health medicine (field) ', ' QOL ', ' Quality of life ', ' recruit ', ' Recruitment Activity ', ' Relapse ', ' respiratory mechanism ', ' Respiration ', ' social role ', ' Role ', ' Saliva ', ' Smoke ', ' Smoking ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Social Interaction ', ' Stress ', ' Technology ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' Transportation ', ' United States ', ' Ventilation ', ' Environmental air flow ', ' Measures ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' smoking cessation ', ' health care ', ' Healthcare ', ' Mediating ', ' base ', ' sensor ', ' improved ', ' sedentary ', ' Physiologic ', ' Physiological ', ' Evaluation ', ' Physical activity ', ' Individual ', ' Withdrawal ', ' Measurement ', ' Exposure to ', ' tool ', ' Smoker ', ' nonsmoker ', ' Non-smoker ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Event ', ' Salivary ', ' Home ', ' Home environment ', ' Pattern ', ' Location ', ' Hormonal ', ' Visit ', ' hazard ', ' Participant ', ' Self-Report ', ' Patient Self-Report ', ' Modality ', ' smoke cigarette ', ' cigarette smoking ', ' Reporting ', ' social ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Chest ', ' acute stress ', ' Sampling ', ' response ', ' Cessation of Treatment ', ' Withholding Treatment ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Mobile Phones ', ' Car Phone ', ' preventing ', ' prevent ', ' Data ', ' Detection ', ' Moderate Activity ', ' Moderate Exercise ', ' lifestyle factors ', ' wireless ', ' Wireless Technology ', ' Monitor ', ' developmental ', ' Development ', ' cost ', ' biobehavioral ', ' biobehavior ', ' coping ', ' Psychosocial Stress ', ' Abstinence ', ' public health relevance ', ' heart rate variability ', ' smoking relapse ', ' ']",NIDA,UNIVERSITY OF MEMPHIS,R01,2014,412836,TN-09,0.034530231548249794
"Trending:  Social media analysis to monitor cannabis and synthetic cannabinoid use     DESCRIPTION (provided by applicant): Cannabis remains one of the most commonly used psychoactive substances in the U.S., and current changes in legalization policy indicate broadening acceptability. At the same time, substance abusers have sought similar, or more enhanced highs, through use of synthetic cannabinoids, new designer drugs with constantly changing chemical formulations that have been linked to adverse health effects and present significant challenges to public health. Submitted in response to NIDA RFA-CA-14-008 (Research Area 1), this multi-PI study builds on multidisciplinary collaboration between the researchers in the Center for Interventions, Treatment, and Addictions Research, and the Ohio Center of Excellence in Knowledge-enabled Computing at Wright State University to develop an innovative software platform, eDrugTrends, that will facilitate analysis of trends in knowledge, attitudes, and behaviors related to the use of cannabis and synthetic cannabinoids as discussed on Web forums and Twitter. To date, no one has developed a computer platform capable of collecting and semi-automatically analyzing data from these two complementary social media sources. We will build on the existing infrastructure developed by our interdisciplinary research team: Twitris, a robust and highly scalable platform designed to analyze Twitter data, and PREDOSE, a platform developed for our collaborative NIH grant (R21 DA030571) to analyze Web forum data on illegal buprenorphine use. Key elements of Twitris and PREDOSE will be adapted and enhanced using Semantic Web, Natural Language Processing, and Machine Learning techniques to advance the analysis of social media data for drug abuse research and is thus maximally responsive to the RFA. The Specific Aims are to: 1) Develop a comprehensive software platform, eDrugTrends, for semi-automated processing and visualization of thematic, sentiment, spatio-temporal, and social network dimensions of social media data (Twitter and Web forums) on cannabis and synthetic cannabinoid use. 2) Deploy eDrugTrends to: a) Identify and compare trends in knowledge, attitudes, and behaviors related to cannabis and synthetic cannabinoid use across U.S. regions with different cannabis legalization policies using Twitter and Web forum data. b) Analyze social network characteristics and identify key influencers (opinions leaders) in cannabis and synthetic cannabinoid-related discussions on Twitter. The development of eDrugTrends will advance the field's technological and methodological capabilities, and our deployment of the platform will inform the field on new trends regarding the use of cannabis, synthetic cannabinoids and other drugs. eDrugTrends will have high public health impact by providing a tool that can be used to inform more timely interventions and policy responses to changes in cannabis and synthetic cannabinoid use and associated harms.         PUBLIC HEALTH RELEVANCE: Building on inter-disciplinary collaboration between substance abuse researchers and computer scientists, we will develop and deploy an innovative software platform, eDrugTrends, to facilitate analysis of Twitter and Web forum data on cannabis and synthetic cannabinoid use. The study will contribute to the advancement of social media surveillance methods to improve public health, and it will provide timely information on emerging trends in the context of changing cannabis laws in the U.S. that can ultimately be used to inform interventions and policy.            ",Trending:  Social media analysis to monitor cannabis and synthetic cannabinoid use,8827089,R01DA039454,"['epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Attitude ', ' Behavior ', ' 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- ', ' Buprenorphine ', ' Cannabinoids ', ' Computers ', ' Data Analysis ', ' Data Analyses ', ' Customized Drugs ', ' Designer Drugs ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Elements ', ' Engineering ', ' Epidemiological Monitoring ', ' Epidemiologic Monitoring ', ' Goals ', ' Grant ', ' Health ', ' Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Behaviors ', ' Health Knowledge, Attitudes, Practice ', ' Laws ', ' Maps ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' natural language understanding ', ' Natural Language Processing ', ' Ohio ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Seizures ', ' computer program/software ', ' Software ', ' Computer software ', ' Spices ', ' Time ', ' Toxicology ', ' United States ', ' Universities ', ' Social Network ', ' Visualization ', ' Imagery ', ' improved ', ' Area ', ' Link ', ' Chemicals ', ' insight ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Policies ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' mental status ', ' mental state ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' tool ', ' Drug user ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Dimensions ', ' Source ', ' Techniques ', ' Formulation ', ' Drug Formulations ', ' meetings ', ' empowered ', ' experience ', ' success ', ' substance abuse epidemiology ', ' computer science ', ' regional difference ', ' social ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Statistical Methods ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Hemp Plant ', ' Cannabis ', ' Legal ', ' Qualitative Methods ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Infrastructure ', ' Research Infrastructure ', ' Surveillance Methods ', ' Monitor ', ' trend ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' semantic web ', ' computer based Semantic Analysis ', ' designing ', ' design ', ' substance abuser ', ' innovative ', ' innovate ', ' innovation ', ' multidisciplinary ', ' addictive disorder ', ' addiction ', ' information processing ', ' public health relevance ', ' ']",NIDA,WRIGHT STATE UNIVERSITY,R01,2014,506725,OH-07,0.06539121096127298
"Moving beyond description: Statistical and casual inference for social media data     DESCRIPTION (provided by applicant): Human interactions via internet and mobile apps are increasing and ubiquitous among all walks of life. Young and older adults are prolific in these media, as well as public and private agencies seeking to promote health behaviors and communications. Over 500 million users are registered to Twitter.com, a microblogging and social network service that conveys text messages to a restricted set of followers. Given current new user registration rates, Twitter may reach over one billion users in the next year. Over 50% of nonprofits using social media sites employ Twitter, the second highest used social media application after Facebook. Every second, 2,200 new Tweets appear offering timely broadcasts about users' current states, interests and ideas. Bigdata sources such as Twitter afford new potential in combining ""real-time"" spatial and social networking information to study causal processes underlying who, where and how individuals are connected. These key features are lacking in the traditional research designs and intervention strategies for health and health-related behaviors. For example, social network analysis (SNA), a strand of systems science, offers a unique lens to understand how human interactions through social network may collectively optimize mental health outcomes in social and geographic ""locations."" The ability to model attributes of nodes and tie strength makes SNA a powerful descriptive and predictive method. Network analyses can capture integration and fragmentation, concepts integral to prevention system planning. Indeed, novel mixed methods of SNA with machine learning can enhance prediction of flu spread in a large real-world population and future criminal incidents in a real city. The goal of this project is to develop and apply a new class of statistical and causal inference models for human interactions and their impacts on health and health-related behavioral outcomes using network data from social media sources such as Twitter.com by focusing on three research studies that integrate online social media information to understand the roles of human interaction on (a) disease spread, (b) mental health in a hard-to-reach population, and (c) presence and extent of ""natural helping"" in promoting wellness and reducing norms supporting violence in low-income urban neighborhoods. RELEVANCE (See instructions): This project will impact behavioral and social health sciences, including systems science communities, broadly and specifically by: (a) filling a critical gap in the literature on causal inference models for social network interactions, (b) strengthening the evidence base for how social media is used and affecting health related outcomes and behaviors, and (c) improving community capacity-building in health.              ",Moving beyond description: Statistical and casual inference for social media data,8692958,R01GM108337,"['Affect ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Behavior ', ' Cities ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Future ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' Goals ', ' Health ', ' Health behavior ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Literature ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Neighborhoods ', ' study design ', ' Study Type ', ' Research Design ', ' social role ', ' Role ', ' Science ', ' Time ', ' violent behavior ', ' violent ', ' Violence ', ' Walking ', ' Social Network ', ' State Interests ', ' improved ', ' Site ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Source ', ' LOINC Axis 4 System ', ' System ', ' Services ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Prevention ', ' social ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Low income ', ' Data ', ' Health Communication ', ' Health Sciences ', ' Information and Media ', ' Process ', ' Text ', ' Behavioral ', ' Instruction ', ' Outcome ', ' Population ', ' flu ', ' lenses ', ' lens ', ' evidence base ', ' mobile app ', ' mobile application ', ' ']",NIGMS,UNIVERSITY OF ROCHESTER,R01,2014,208564,NY-25,0.037290616729408976
"A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia     DESCRIPTION (provided by applicant): Schizophrenia is a severe psychiatric disorder that is associated with staggeringly high individual and societal costs. Although the illness is typically chronic, it is not static, and the majority of people with schizophrenia vacillate between full or partial remission and episodes of symptomatic relapse. Relapses increase one's risk for major problems including homelessness, incarceration, victimization, and suicide. Moreover, patients with schizophrenia who relapse are three to four times more costly than those who do not. The goal of the proposed project is to develop and evaluate a novel paradigm for illness monitoring, detection of early warning signs, and relapse prevention in schizophrenia. Our interdisciplinary team of clinical researchers and computer scientists proposes to develop a mobile system that uses smartphone-embedded sensors (i.e. microphone, accelerometer, GPS, light sensor) coupled with computerized self-reports, to track a range of behaviors (i.e. paralinguistic aspect of speech, physical activity, location, sleep, mood, psychotic symptoms) that are relevant to relapse in schizophrenia. Using machine learning techniques, the system will leverage behavioral data and patient self-reported clinical updates to generate personalized early warning models. The models will evolve with use of the system over time, focusing on variability from one's typical behavioral patterns to calibrate a unique patient relapse signature. Treatment teams will be informed about patients' clinical status via secure website. When the mobile system ""flags"" trends that are consistent with one's relapse signature, it will trigger patient functions and provider functions (i.e. real-time notification, prompts to initiate contact, time-sensitive treatments) to help prevent progression to full psychotic relapse. In Phase 1 of the project, we will integrate multi-modal sensor, ecological momentary assessment, and machine learning technologies into a unified smartphone system that will be tested and refined in laboratory settings. In Phase 2, we will conduct field trials with individuals with schizophrenia i real-world conditions to identify and resolve technical and mechanical problems, adapt the software, and maximize system usability. In Phase 3, we will conduct a randomized 12- month trial of the monitoring and prevention system compared to treatment as usual in 150 outpatients with schizophrenia that are at high-risk for relapse. If successful, our proposed system can be rapidly made available to a population that is in dire need of more effective resources, and can serve as a template for mobile monitoring and treatment systems for a range of clinical conditions with an episodic nature.         PUBLIC HEALTH RELEVANCE: An effective multi-modal mobile monitoring, early detection, and intervention system for schizophrenia could alter illness trajectory, mitigating the acute and long term impact of psychotic relapses on patients, their caretakers, and communities. A broadly available system could radically change when, how, and to what effect treatments are delivered, allowing for a paradigmatic shift from reactive to preemptive care for schizophrenia.                ",A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia,8743296,R01MH103148,"['Accounting ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' clinical investigation ', ' Clinical Trials ', ' Communities ', ' Computers ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' Elements ', ' Goals ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' Hospitalization ', ' Laboratories ', ' Photoradiation ', ' Light ', ' Methods ', ' Moods ', ' National Institute of Mental Health ', ' NIMH ', ' National Institute of Mental Health (U.S.) ', ' Out-patients ', ' Outpatients ', ' Patients ', ' Relapse ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Science ', ' Sleep ', ' Social isolation ', ' computer program/software ', ' Software ', ' Computer software ', ' Speech ', ' Stress ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Suicide ', ' Technology ', ' Technology Assessment ', ' Testing ', ' Time ', ' self injury ', ' self harm ', ' intentional self injury ', ' intentional self harm ', ' deliberate self harm ', ' Deliberate Self-Harm ', ' Self-Injurious Behavior ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Self Management ', ' Caring ', ' base ', ' sensor ', ' Partial Remission ', ' Left ', ' Acute ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Ensure ', ' Physical activity ', ' medical complication ', ' disability ', ' unhoused ', ' homeless ', ' Homelessness ', ' Individual ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Collaborations ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Victimization ', ' mechanical ', ' Mechanics ', ' Scientist ', ' Notification ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' Remission ', ' Disease remission ', ' early detection ', ' Early Diagnosis ', ' experience ', ' novel ', ' Self-Report ', ' Patient Self-Report ', ' help seeking ', ' help-seeking behavior ', ' Prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' disorder later incidence prevention ', ' Modeling ', ' developing computer software ', ' develop software ', ' software development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Provider ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Infrastructure ', ' Research Infrastructure ', ' Update ', ' Monitor ', ' trend ', ' developmental ', ' Development ', ' Behavioral ', ' website ', ' web site ', ' cost ', ' computerized ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' Population ', ' Coupled ', ' innovative ', ' innovate ', ' innovation ', ' treatment effect ', ' usability ', ' computer generated ', ' high risk ', ' high reward ', ' public health relevance ', ' usual care ', ' treatment as usual ', ' Secure ', ' psychotic symptoms ', ' mobile health ', ' m-Health ', ' mHealth ', ' ']",NIMH,DARTMOUTH COLLEGE,R01,2014,324051,NH-02,0.08588216750948427
"A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia DESCRIPTION (provided by applicant): Schizophrenia is a severe psychiatric disorder that is associated with staggeringly high individual and societal costs. Although the illness is typically chronic, it is not static, and the majority of people with schizophrenia vacillate between full or partial remission and episodes of symptomatic relapse. Relapses increase one's risk for major problems including homelessness, incarceration, victimization, and suicide. Moreover, patients with schizophrenia who relapse are three to four times more costly than those who do not. The goal of the proposed project is to develop and evaluate a novel paradigm for illness monitoring, detection of early warning signs, and relapse prevention in schizophrenia. Our interdisciplinary team of clinical researchers and computer scientists proposes to develop a mobile system that uses smartphone-embedded sensors (i.e. microphone, accelerometer, GPS, light sensor) coupled with computerized self-reports, to track a range of behaviors (i.e. paralinguistic aspect of speech, physical activity, location, sleep, mood, psychotic symptoms) that are relevant to relapse in schizophrenia. Using machine learning techniques, the system will leverage behavioral data and patient self-reported clinical updates to generate personalized early warning models. The models will evolve with use of the system over time, focusing on variability from one's typical behavioral patterns to calibrate a unique patient relapse signature. Treatment teams will be informed about patients' clinical status via secure website. When the mobile system ""flags"" trends that are consistent with one's relapse signature, it will trigger patient functions and provider functions (i.e. real-time notification, prompts to initiate contact, time-sensitive treatments) to help prevent progression to full psychotic relapse. In Phase 1 of the project, we will integrate multi-modal sensor, ecological momentary assessment, and machine learning technologies into a unified smartphone system that will be tested and refined in laboratory settings. In Phase 2, we will conduct field trials with individuals with schizophrenia i real-world conditions to identify and resolve technical and mechanical problems, adapt the software, and maximize system usability. In Phase 3, we will conduct a randomized 12- month trial of the monitoring and prevention system compared to treatment as usual in 150 outpatients with schizophrenia that are at high-risk for relapse. If successful, our proposed system can be rapidly made available to a population that is in dire need of more effective resources, and can serve as a template for mobile monitoring and treatment systems for a range of clinical conditions with an episodic nature. PUBLIC HEALTH RELEVANCE: An effective multi-modal mobile monitoring, early detection, and intervention system for schizophrenia could alter illness trajectory, mitigating the acute and long term impact of psychotic relapses on patients, their caretakers, and communities. A broadly available system could radically change when, how, and to what effect treatments are delivered, allowing for a paradigmatic shift from reactive to preemptive care for schizophrenia.",A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia,8997225,R01MH103148,"['Accounting ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' clinical investigation ', ' Clinical Trials ', ' Communities ', ' Computers ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' Elements ', ' Goals ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' Hospitalization ', ' Laboratories ', ' Photoradiation ', ' Light ', ' Methods ', ' Moods ', ' National Institute of Mental Health ', ' NIMH ', ' National Institute of Mental Health (U.S.) ', ' Out-patients ', ' Outpatients ', ' Patients ', ' Relapse ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Science ', ' Sleep ', ' Social isolation ', ' computer program/software ', ' Software ', ' Computer software ', ' Speech ', ' Stress ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Suicide ', ' Technology ', ' Testing ', ' Time ', ' Self-Injurious Behavior ', ' self injury ', ' self harm ', ' intentional self injury ', ' intentional self harm ', ' deliberate self harm ', ' Deliberate Self-Harm ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Self Management ', ' Caring ', ' base ', ' sensor ', ' Partial Remission ', ' Left ', ' Acute ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Ensure ', ' Physical activity ', ' medical complication ', ' disability ', ' unhoused ', ' homeless ', ' Homelessness ', ' Individual ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Collaborations ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Victimization ', ' mechanical ', ' Mechanics ', ' Scientist ', ' Notification ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' Remission ', ' Disease remission ', ' early detection ', ' Early Diagnosis ', ' experience ', ' novel ', ' Self-Report ', ' Patient Self-Report ', ' help seeking ', ' help-seeking behavior ', ' Prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' disorder later incidence prevention ', ' Modeling ', ' developing computer software ', ' develop software ', ' software development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Cellular Telephone ', ' Cell Phone ', ' Cellular Phone ', ' Provider ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Infrastructure ', ' Research Infrastructure ', ' Update ', ' Monitor ', ' trend ', ' developmental ', ' Development ', ' Behavioral ', ' website ', ' web site ', ' cost ', ' computerized ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' Population ', ' Coupled ', ' innovative ', ' innovate ', ' innovation ', ' treatment effect ', ' usability ', ' computer generated ', ' high risk ', ' high reward ', ' usual care ', ' treatment as usual ', ' Secure ', ' psychotic symptoms ', ' mobile health ', ' m-Health ', ' mHealth ', ' ']",NIMH,DARTMOUTH COLLEGE,R01,2015,94089,NH-02,0.08588216750948427
"Moving beyond description: Statistical and casual inference for social media data DESCRIPTION (provided by applicant): Human interactions via internet and mobile apps are increasing and ubiquitous among all walks of life. Young and older adults are prolific in these media, as well as public and private agencies seeking to promote health behaviors and communications. Over 500 million users are registered to Twitter.com, a microblogging and social network service that conveys text messages to a restricted set of followers. Given current new user registration rates, Twitter may reach over one billion users in the next year. Over 50% of nonprofits using social media sites employ Twitter, the second highest used social media application after Facebook. Every second, 2,200 new Tweets appear offering timely broadcasts about users' current states, interests and ideas. Bigdata sources such as Twitter afford new potential in combining ""real-time"" spatial and social networking information to study causal processes underlying who, where and how individuals are connected. These key features are lacking in the traditional research designs and intervention strategies for health and health-related behaviors. For example, social network analysis (SNA), a strand of systems science, offers a unique lens to understand how human interactions through social network may collectively optimize mental health outcomes in social and geographic ""locations."" The ability to model attributes of nodes and tie strength makes SNA a powerful descriptive and predictive method. Network analyses can capture integration and fragmentation, concepts integral to prevention system planning. Indeed, novel mixed methods of SNA with machine learning can enhance prediction of flu spread in a large real-world population and future criminal incidents in a real city. The goal of this project is to develop and apply a new class of statistical and causal inference models for human interactions and their impacts on health and health-related behavioral outcomes using network data from social media sources such as Twitter.com by focusing on three research studies that integrate online social media information to understand the roles of human interaction on (a) disease spread, (b) mental health in a hard-to-reach population, and (c) presence and extent of ""natural helping"" in promoting wellness and reducing norms supporting violence in low-income urban neighborhoods. RELEVANCE (See instructions): This project will impact behavioral and social health sciences, including systems science communities, broadly and specifically by: (a) filling a critical gap in the literature on causal inference models for social network interactions, (b) strengthening the evidence base for how social media is used and affecting health related outcomes and behaviors, and (c) improving community capacity-building in health. ",Moving beyond description: Statistical and casual inference for social media data,8826778,R01GM108337,"['Affect ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Behavior ', ' Cities ', ' Communities ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Future ', ' Geographic Locations ', ' geographic site ', ' MeSH Descriptors Class 4 ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Goals ', ' Health ', ' Health behavior ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Literature ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Neighborhoods ', ' study design ', ' Study Type ', ' Research Design ', ' social role ', ' Role ', ' Science ', ' Time ', ' violent behavior ', ' violent ', ' Violence ', ' Walking ', ' Social Network ', ' State Interests ', ' improved ', ' Site ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Source ', ' LOINC Axis 4 System ', ' System ', ' Services ', ' novel ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Prevention ', ' social ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Low income ', ' Data ', ' Health Communication ', ' Health Sciences ', ' Information and Media ', ' Process ', ' Text ', ' Behavioral ', ' Instruction ', ' Outcome ', ' Population ', ' flu ', ' lenses ', ' lens ', ' evidence base ', ' mobile app ', ' mobile application ', ' ']",NIGMS,UNIVERSITY OF ROCHESTER,R01,2015,207182,NY-25,0.037290616729408976
"Influencing cervical cancer prevention and detection online through social media DESCRIPTION (provided by applicant): Despite widespread availability and known effectiveness, Pap smear screening and human papilloma virus (HPV) vaccination rates remain below national targets. New modes of online communication through social media - which have transformed information sharing, especially for younger individuals - present opportunities to target health communication more effectively to improve cervical cancer prevention. Although the Internet has yet to realize its full potential for health-related communication, about 87% of US adults have used the Internet to look for health information, and a large majority of younger Americans report they would share personal health information on social media sites. Thus, pushing the current boundaries to capitalize on social media to inform decision-making about cancer screening and prevention offers great potential. The long-term goals of this research are to 1) generate validated methodologies to systematically study social media content, and 2) promote cervical cancer screening and prevention more effectively using social media. In pursuit of these goals, we will used a novel methodological approaches to characterize cervical cancer content present in social media and then to create and test messages within an experimental online social network. In Aim 1, we will identify and rank the key words related to cervical cancer screening and HPV vaccination in social media messages. We will identify statistically significant phrases that are co-occurring in messages drawn from six months of publically available content from Twitter and Facebook. This technique will allow us to synthesize the entire breadth of content on screening and vaccination on social media, and to extract the full-text of messages corresponding to the most common significant words/ phrases. In Aim 2, we will categorize and validate the range of cervical cancer screening and HPV vaccination discussion on social media websites. We will use qualitative content analysis informed by grounded theory to analyze a random sample of the findings from Aim 1, coding a minimum of 1500 messages. This will allow us to gain an in-depth understanding of the range of real-life discussions online. This will also serve as the validation of the machine learning result from Aim 1, as well as the basis for the development of new cervical cancer prevention messages that will be tested in Aim 3. Building upon both of these aims, in Aim 3, we will create tailored cervical cancer screening and HPV vaccination messages and track responses and spread in an online social network. Using the content knowledge from Aims 1 & 2, we will create tailored messages about cervical cancer screening and prevention and then pre-test them using virtual focus groups to gain insights from our target audience. We will establish a simulated online network to evaluate the spread of these messages, as each network member can directly share health opinions with others in the study. Within this setting, we will be able to determine the diffusion of specific, effective screening messages, as well as determine what types of network structures and message authors have the biggest impact. PUBLIC HEALTH RELEVANCE:  We plan to study publicly available messages on online social media websites (for example, Twitter and Facebook) related to cervical cancer screening and prevention, such as comments about Pap smears. We will determine the major discussion topics on these websites, and then use this information to craft new messages about cervical cancer prevention. Finally, in an experiment, we will test how these messages are shared between individuals - in order to learn how public health agencies and researchers can improve their online health-related communication strategies to promote cervical cancer screening.",Influencing cervical cancer prevention and detection online through social media,8930929,R01CA178875,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Uterine Cervix Cancer ', ' Malignant Uterine Cervix Tumor ', ' Malignant Uterine Cervix Neoplasm ', ' Malignant Tumor of the Cervix Uteri ', ' Malignant Tumor of the Cervix ', ' Malignant Neoplasm of the Cervix ', ' Malignant Cervical Tumor ', ' Malignant Cervical Neoplasm ', ' Cervix Cancer ', ' Cervical Cancer ', ' Malignant neoplasm of cervix uteri ', ' Communication ', ' Data Collection ', ' Death ', ' Cessation of life ', ' Decision Making ', ' Diffusion ', ' Focus Groups ', ' Goals ', ' Grant ', ' Health ', ' Salutogenesis ', ' Health Promotion ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Human Papillomavirus ', ' Language ', ' Learning ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Ethnic and Racial Minorities ', ' Minority Groups ', ' Morbidity ', ' Morbidity - disease rate ', ' Mortality ', ' Mortality Vital Statistics ', ' Perception ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Social Interaction ', ' Testing ', ' Time ', ' Vaccination ', ' Woman ', ' cervical/vaginal smear ', ' Vaginal Smears ', ' Papanicolaou Test ', ' Papanicolaou Smear ', ' Pap Test ', ' Cervical Smears ', ' Pap smear ', ' Latino ', ' Social Network ', ' Guidelines ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Site ', ' insight ', ' Individual ', ' Measurement ', ' uptake ', ' cervical cancer early detection ', ' Cervical Cancer Screening ', ' cervical cancer prevention ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Techniques ', ' American ', ' experience ', ' success ', ' phrases ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Prevention ', ' Reporting ', ' social ', ' Coding System ', ' Code ', ' Modeling ', ' Sampling ', ' girls ', ' LOINC Axis 2 Property ', ' Property ', ' response ', ' theories ', ' health organization ', ' Effectiveness ', ' Data ', ' Health Communication ', ' Cancer Detection ', ' Validation ', ' Text ', ' developmental ', ' Development ', ' website ', ' web site ', ' virtual ', ' aged ', ' computer algorithm ', ' Computational algorithm ', ' online social networking ', ' web-based social networking ', ' social networking web site ', ' social networking site ', ' social networking website ', ' screening ', ' Human Papillomavirus Vaccination ', ' HPV Vaccination ', ' Human Papilloma Virus Vaccination ', ' ']",NCI,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2015,428238,CA-12,0.004399366221095269
"Trending:  Social media analysis to monitor cannabis and synthetic cannabinoid use DESCRIPTION (provided by applicant): Cannabis remains one of the most commonly used psychoactive substances in the U.S., and current changes in legalization policy indicate broadening acceptability. At the same time, substance abusers have sought similar, or more enhanced highs, through use of synthetic cannabinoids, new designer drugs with constantly changing chemical formulations that have been linked to adverse health effects and present significant challenges to public health. Submitted in response to NIDA RFA-CA-14-008 (Research Area 1), this multi-PI study builds on multidisciplinary collaboration between the researchers in the Center for Interventions, Treatment, and Addictions Research, and the Ohio Center of Excellence in Knowledge-enabled Computing at Wright State University to develop an innovative software platform, eDrugTrends, that will facilitate analysis of trends in knowledge, attitudes, and behaviors related to the use of cannabis and synthetic cannabinoids as discussed on Web forums and Twitter. To date, no one has developed a computer platform capable of collecting and semi-automatically analyzing data from these two complementary social media sources. We will build on the existing infrastructure developed by our interdisciplinary research team: Twitris, a robust and highly scalable platform designed to analyze Twitter data, and PREDOSE, a platform developed for our collaborative NIH grant (R21 DA030571) to analyze Web forum data on illegal buprenorphine use. Key elements of Twitris and PREDOSE will be adapted and enhanced using Semantic Web, Natural Language Processing, and Machine Learning techniques to advance the analysis of social media data for drug abuse research and is thus maximally responsive to the RFA. The Specific Aims are to: 1) Develop a comprehensive software platform, eDrugTrends, for semi-automated processing and visualization of thematic, sentiment, spatio-temporal, and social network dimensions of social media data (Twitter and Web forums) on cannabis and synthetic cannabinoid use. 2) Deploy eDrugTrends to: a) Identify and compare trends in knowledge, attitudes, and behaviors related to cannabis and synthetic cannabinoid use across U.S. regions with different cannabis legalization policies using Twitter and Web forum data. b) Analyze social network characteristics and identify key influencers (opinions leaders) in cannabis and synthetic cannabinoid-related discussions on Twitter. The development of eDrugTrends will advance the field's technological and methodological capabilities, and our deployment of the platform will inform the field on new trends regarding the use of cannabis, synthetic cannabinoids and other drugs. eDrugTrends will have high public health impact by providing a tool that can be used to inform more timely interventions and policy responses to changes in cannabis and synthetic cannabinoid use and associated harms. PUBLIC HEALTH RELEVANCE: Building on inter-disciplinary collaboration between substance abuse researchers and computer scientists, we will develop and deploy an innovative software platform, eDrugTrends, to facilitate analysis of Twitter and Web forum data on cannabis and synthetic cannabinoid use. The study will contribute to the advancement of social media surveillance methods to improve public health, and it will provide timely information on emerging trends in the context of changing cannabis laws in the U.S. that can ultimately be used to inform interventions and policy.",Trending:  Social media analysis to monitor cannabis and synthetic cannabinoid use,8913112,R01DA039454,"['epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Attitude ', ' Behavior ', ' 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))- ', ' Buprenorphine ', ' Computers ', ' Data Analysis ', ' Data Analyses ', ' Customized Drugs ', ' Designer Drugs ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Elements ', ' Engineering ', ' Epidemiological Monitoring ', ' Epidemiologic Monitoring ', ' Goals ', ' Grant ', ' Health ', ' Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Behaviors ', ' Health Knowledge, Attitudes, Practice ', ' Laws ', ' Maps ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' natural language understanding ', ' Natural Language Processing ', ' Ohio ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Public Health ', ' public health medicine (field) ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Seizures ', ' computer program/software ', ' Software ', ' Computer software ', ' Time ', ' Toxicology ', ' United States ', ' Universities ', ' Social Network ', ' Visualization ', ' Imagery ', ' improved ', ' Area ', ' Link ', ' Chemicals ', ' insight ', ' using substances ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Policies ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' mental status ', ' mental state ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' tool ', ' Drug user ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Dimensions ', ' Source ', ' Techniques ', ' Formulation ', ' Drug Formulations ', ' meetings ', ' empowered ', ' experience ', ' success ', ' substance abuse epidemiology ', ' computer science ', ' regional difference ', ' social ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Statistical Methods ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Hemp Plant ', ' Cannabis ', ' Legal ', ' Qualitative Methods ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Infrastructure ', ' Research Infrastructure ', ' Surveillance Methods ', ' Monitor ', ' trend ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' semantic web ', ' computer based Semantic Analysis ', ' designing ', ' design ', ' substance abuser ', ' innovative ', ' innovate ', ' innovation ', ' multidisciplinary ', ' addictive disorder ', ' addiction ', ' information processing ', ' ']",NIDA,WRIGHT STATE UNIVERSITY,R01,2015,461348,OH-07,0.06539121096127298
"A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia DESCRIPTION (provided by applicant): Schizophrenia is a severe psychiatric disorder that is associated with staggeringly high individual and societal costs. Although the illness is typically chronic, it is not static, and the majority of people with schizophrenia vacillate between full or partial remission and episodes of symptomatic relapse. Relapses increase one's risk for major problems including homelessness, incarceration, victimization, and suicide. Moreover, patients with schizophrenia who relapse are three to four times more costly than those who do not. The goal of the proposed project is to develop and evaluate a novel paradigm for illness monitoring, detection of early warning signs, and relapse prevention in schizophrenia. Our interdisciplinary team of clinical researchers and computer scientists proposes to develop a mobile system that uses smartphone-embedded sensors (i.e. microphone, accelerometer, GPS, light sensor) coupled with computerized self-reports, to track a range of behaviors (i.e. paralinguistic aspect of speech, physical activity, location, sleep, mood, psychotic symptoms) that are relevant to relapse in schizophrenia. Using machine learning techniques, the system will leverage behavioral data and patient self-reported clinical updates to generate personalized early warning models. The models will evolve with use of the system over time, focusing on variability from one's typical behavioral patterns to calibrate a unique patient relapse signature. Treatment teams will be informed about patients' clinical status via secure website. When the mobile system ""flags"" trends that are consistent with one's relapse signature, it will trigger patient functions and provider functions (i.e. real-time notification, prompts to initiate contact, time-sensitive treatments) to help prevent progression to full psychotic relapse. In Phase 1 of the project, we will integrate multi-modal sensor, ecological momentary assessment, and machine learning technologies into a unified smartphone system that will be tested and refined in laboratory settings. In Phase 2, we will conduct field trials with individuals with schizophrenia i real-world conditions to identify and resolve technical and mechanical problems, adapt the software, and maximize system usability. In Phase 3, we will conduct a randomized 12- month trial of the monitoring and prevention system compared to treatment as usual in 150 outpatients with schizophrenia that are at high-risk for relapse. If successful, our proposed system can be rapidly made available to a population that is in dire need of more effective resources, and can serve as a template for mobile monitoring and treatment systems for a range of clinical conditions with an episodic nature. PUBLIC HEALTH RELEVANCE: An effective multi-modal mobile monitoring, early detection, and intervention system for schizophrenia could alter illness trajectory, mitigating the acute and long term impact of psychotic relapses on patients, their caretakers, and communities. A broadly available system could radically change when, how, and to what effect treatments are delivered, allowing for a paradigmatic shift from reactive to preemptive care for schizophrenia.",A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia,8892263,R01MH103148,"['Accounting ', ' Behavior ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' clinical investigation ', ' Clinical Trials ', ' Communities ', ' Computers ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' Elements ', ' Goals ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' Hospitalization ', ' Laboratories ', ' Photoradiation ', ' Light ', ' Methods ', ' Moods ', ' National Institute of Mental Health ', ' NIMH ', ' National Institute of Mental Health (U.S.) ', ' Out-patients ', ' Outpatients ', ' Patients ', ' Relapse ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Science ', ' Sleep ', ' Social isolation ', ' computer program/software ', ' Software ', ' Computer software ', ' Speech ', ' Stress ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Suicide ', ' Technology ', ' Testing ', ' Time ', ' Self-Injurious Behavior ', ' self injury ', ' self harm ', ' intentional self injury ', ' intentional self harm ', ' deliberate self harm ', ' Deliberate Self-Harm ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' Self Management ', ' Caring ', ' base ', ' sensor ', ' Partial Remission ', ' Left ', ' Acute ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Ensure ', ' Physical activity ', ' medical complication ', ' disability ', ' unhoused ', ' homeless ', ' Homelessness ', ' Individual ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Collaborations ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Victimization ', ' mechanical ', ' Mechanics ', ' Scientist ', ' Notification ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' Remission ', ' Disease remission ', ' early detection ', ' Early Diagnosis ', ' experience ', ' novel ', ' Self-Report ', ' Patient Self-Report ', ' help seeking ', ' help-seeking behavior ', ' Prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' disorder later incidence prevention ', ' Modeling ', ' developing computer software ', ' develop software ', ' software development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Cellular Telephone ', ' Cell Phone ', ' Cellular Phone ', ' Provider ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Infrastructure ', ' Research Infrastructure ', ' Update ', ' Monitor ', ' trend ', ' developmental ', ' Development ', ' Behavioral ', ' website ', ' web site ', ' cost ', ' computerized ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' Population ', ' Coupled ', ' innovative ', ' innovate ', ' innovation ', ' treatment effect ', ' usability ', ' computer generated ', ' high risk ', ' high reward ', ' usual care ', ' treatment as usual ', ' Secure ', ' psychotic symptoms ', ' mobile health ', ' m-Health ', ' mHealth ', ' ']",NIMH,DARTMOUTH COLLEGE,R01,2015,413392,NH-02,0.08588216750948427
"Influencing cervical cancer prevention and detection online through social media DESCRIPTION (provided by applicant): Despite widespread availability and known effectiveness, Pap smear screening and human papilloma virus (HPV) vaccination rates remain below national targets. New modes of online communication through social media - which have transformed information sharing, especially for younger individuals - present opportunities to target health communication more effectively to improve cervical cancer prevention. Although the Internet has yet to realize its full potential for health-related communication, about 87% of US adults have used the Internet to look for health information, and a large majority of younger Americans report they would share personal health information on social media sites. Thus, pushing the current boundaries to capitalize on social media to inform decision-making about cancer screening and prevention offers great potential. The long-term goals of this research are to 1) generate validated methodologies to systematically study social media content, and 2) promote cervical cancer screening and prevention more effectively using social media. In pursuit of these goals, we will used a novel methodological approaches to characterize cervical cancer content present in social media and then to create and test messages within an experimental online social network. In Aim 1, we will identify and rank the key words related to cervical cancer screening and HPV vaccination in social media messages. We will identify statistically significant phrases that are co-occurring in messages drawn from six months of publically available content from Twitter and Facebook. This technique will allow us to synthesize the entire breadth of content on screening and vaccination on social media, and to extract the full-text of messages corresponding to the most common significant words/ phrases. In Aim 2, we will categorize and validate the range of cervical cancer screening and HPV vaccination discussion on social media websites. We will use qualitative content analysis informed by grounded theory to analyze a random sample of the findings from Aim 1, coding a minimum of 1500 messages. This will allow us to gain an in-depth understanding of the range of real-life discussions online. This will also serve as the validation of the machine learning result from Aim 1, as well as the basis for the development of new cervical cancer prevention messages that will be tested in Aim 3. Building upon both of these aims, in Aim 3, we will create tailored cervical cancer screening and HPV vaccination messages and track responses and spread in an online social network. Using the content knowledge from Aims 1 & 2, we will create tailored messages about cervical cancer screening and prevention and then pre-test them using virtual focus groups to gain insights from our target audience. We will establish a simulated online network to evaluate the spread of these messages, as each network member can directly share health opinions with others in the study. Within this setting, we will be able to determine the diffusion of specific, effective screening messages, as well as determine what types of network structures and message authors have the biggest impact. PUBLIC HEALTH RELEVANCE:  We plan to study publicly available messages on online social media websites (for example, Twitter and Facebook) related to cervical cancer screening and prevention, such as comments about Pap smears. We will determine the major discussion topics on these websites, and then use this information to craft new messages about cervical cancer prevention. Finally, in an experiment, we will test how these messages are shared between individuals - in order to learn how public health agencies and researchers can improve their online health-related communication strategies to promote cervical cancer screening.",Influencing cervical cancer prevention and detection online through social media,9122340,R01CA178875,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Uterine Cervix Cancer ', ' Malignant Uterine Cervix Tumor ', ' Malignant Uterine Cervix Neoplasm ', ' Malignant Tumor of the Cervix Uteri ', ' Malignant Tumor of the Cervix ', ' Malignant Neoplasm of the Cervix ', ' Malignant Cervical Tumor ', ' Malignant Cervical Neoplasm ', ' Cervix Cancer ', ' Cervical Cancer ', ' Malignant neoplasm of cervix uteri ', ' Communication ', ' Data Collection ', ' Death ', ' Cessation of life ', ' Decision Making ', ' Diffusion ', ' Focus Groups ', ' Goals ', ' Grant ', ' Health ', ' Salutogenesis ', ' Health Promotion ', ' wart virus ', ' Infectious Human Wart Virus ', ' Human Papilloma Virus ', ' HPV ', ' Human Papillomavirus ', ' Language ', ' Learning ', ' Methods ', ' Methodology ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Perception ', ' Public Health ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Social Interaction ', ' Testing ', ' Time ', ' Vaccination ', ' Woman ', ' Pap smear ', ' cervical/vaginal smear ', ' Vaginal Smears ', ' Papanicolaou Test ', ' Papanicolaou Smear ', ' Pap Test ', ' Cervical Smears ', ' Latino ', ' Social Network ', ' Guidelines ', ' base ', ' improved ', ' early cancer detection ', ' Cancer Screening for Patients ', ' Screening for cancer ', ' Site ', ' insight ', ' Individual ', ' Measurement ', ' uptake ', ' cervical cancer early detection ', ' Cervical Cancer Screening ', ' cervical cancer prevention ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Techniques ', ' American ', ' experience ', ' success ', ' phrases ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Prevention ', ' Reporting ', ' Coding System ', ' Code ', ' Modeling ', ' Sampling ', ' girls ', ' Property ', ' response ', ' theories ', ' health organization ', ' Effectiveness ', ' Data ', ' Health Communication ', ' Cancer Detection ', ' Validation ', ' Text ', ' developmental ', ' Development ', ' website ', ' web site ', ' virtual ', ' aged ', ' ethnic minority population ', ' ethnic minority ', ' Computational algorithm ', ' computer algorithm ', ' racial and ethnic ', ' social networking website ', ' web-based social networking ', ' social networking web site ', ' social networking site ', ' online social networking ', ' screening ', ' Human Papilloma Virus Vaccination ', ' Human Papillomavirus Vaccination ', ' HPV Vaccination ', ' social media ', ' ']",NCI,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2016,386725,CA-12,0.004399366221095269
"Trending:  Social media analysis to monitor cannabis and synthetic cannabinoid use DESCRIPTION (provided by applicant): Cannabis remains one of the most commonly used psychoactive substances in the U.S., and current changes in legalization policy indicate broadening acceptability. At the same time, substance abusers have sought similar, or more enhanced highs, through use of synthetic cannabinoids, new designer drugs with constantly changing chemical formulations that have been linked to adverse health effects and present significant challenges to public health. Submitted in response to NIDA RFA-CA-14-008 (Research Area 1), this multi-PI study builds on multidisciplinary collaboration between the researchers in the Center for Interventions, Treatment, and Addictions Research, and the Ohio Center of Excellence in Knowledge-enabled Computing at Wright State University to develop an innovative software platform, eDrugTrends, that will facilitate analysis of trends in knowledge, attitudes, and behaviors related to the use of cannabis and synthetic cannabinoids as discussed on Web forums and Twitter. To date, no one has developed a computer platform capable of collecting and semi-automatically analyzing data from these two complementary social media sources. We will build on the existing infrastructure developed by our interdisciplinary research team: Twitris, a robust and highly scalable platform designed to analyze Twitter data, and PREDOSE, a platform developed for our collaborative NIH grant (R21 DA030571) to analyze Web forum data on illegal buprenorphine use. Key elements of Twitris and PREDOSE will be adapted and enhanced using Semantic Web, Natural Language Processing, and Machine Learning techniques to advance the analysis of social media data for drug abuse research and is thus maximally responsive to the RFA. The Specific Aims are to: 1) Develop a comprehensive software platform, eDrugTrends, for semi-automated processing and visualization of thematic, sentiment, spatio-temporal, and social network dimensions of social media data (Twitter and Web forums) on cannabis and synthetic cannabinoid use. 2) Deploy eDrugTrends to: a) Identify and compare trends in knowledge, attitudes, and behaviors related to cannabis and synthetic cannabinoid use across U.S. regions with different cannabis legalization policies using Twitter and Web forum data. b) Analyze social network characteristics and identify key influencers (opinions leaders) in cannabis and synthetic cannabinoid-related discussions on Twitter. The development of eDrugTrends will advance the field's technological and methodological capabilities, and our deployment of the platform will inform the field on new trends regarding the use of cannabis, synthetic cannabinoids and other drugs. eDrugTrends will have high public health impact by providing a tool that can be used to inform more timely interventions and policy responses to changes in cannabis and synthetic cannabinoid use and associated harms. PUBLIC HEALTH RELEVANCE: Building on inter-disciplinary collaboration between substance abuse researchers and computer scientists, we will develop and deploy an innovative software platform, eDrugTrends, to facilitate analysis of Twitter and Web forum data on cannabis and synthetic cannabinoid use. The study will contribute to the advancement of social media surveillance methods to improve public health, and it will provide timely information on emerging trends in the context of changing cannabis laws in the U.S. that can ultimately be used to inform interventions and policy.",Trending:  Social media analysis to monitor cannabis and synthetic cannabinoid use,9112982,R01DA039454,"['epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Attitude ', ' Behavior ', ' Buprenorphine ', ' Computers ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Customized Drugs ', ' Designer Drugs ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Elements ', ' Engineering ', ' Epidemiological Monitoring ', ' Epidemiologic Monitoring ', ' Goals ', ' Grant ', ' Health ', ' Knowledge, Attitudes, Practice ', ' Knowledge, Attitudes, Behaviors ', ' Health Knowledge, Attitudes, Practice ', ' Laws ', ' Maps ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' natural language understanding ', ' Natural Language Processing ', ' Ohio ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Public Health ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Seizures ', ' Software ', ' Computer software ', ' Time ', ' Toxicology ', ' United States ', ' Universities ', ' Social Network ', ' Visualization ', ' Imagery ', ' improved ', ' Area ', ' Link ', ' Chemicals ', ' insight ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Policies ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' drug use ', ' Drug usage ', ' mental status ', ' mental state ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Collaborations ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' tool ', ' Drug user ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Dimensions ', ' Source ', ' Techniques ', ' meetings ', ' empowered ', ' experience ', ' success ', ' substance abuse epidemiology ', ' computer science ', ' regional difference ', ' social ', ' substance abuse ', ' abuse of substances ', ' Substance abuse problem ', ' Statistical Methods ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Cannabis ', ' Legal ', ' qualitative reasoning ', ' Qualitative Methods ', ' Data ', ' National Institute on Drug Abuse ', ' NIDA ', ' National Institute of Drug Abuse ', ' Infrastructure ', ' Research Infrastructure ', ' Surveillance Methods ', ' Monitor ', ' trend ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' semantic web ', ' computer based Semantic Analysis ', ' designing ', ' design ', ' substance abuser ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' addiction ', ' addictive disorder ', ' information processing ', ' synthetic cannabinoid ', ' K2/Spice ', ' marijuana legalization ', ' legalized marijuana ', ' legalized cannabis ', ' legal marijuana ', ' cannabis legalization ', ' marijuana use ', ' cannabis use ', ' social media ', ' trend analysis ', ' Formulation ', ' ']",NIDA,WRIGHT STATE UNIVERSITY,R01,2016,460736,OH-07,0.06539121096127298
"Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention     DESCRIPTION (provided by applicant): In recent years in the U.S., problems associated with opioid prescriptions, including non-medical use and overdose, increased to historically unprecedented levels and represent a public health crisis. Emergency departments (EDs) play an important role in opioid prescribing, particularly to individuals at high risk for adverse opioi-related outcomes. Half of all ED visits are for a painful condition, and one third of all ED visits result in an opioid being prescribed. Moreover, in our pilot work, a quarter of patients surveyed at the ED study site reported non-medical opioid use in the prior three months. Despite the importance of this problem, strategies to reduce non-medical opioid use after an ED visit have not been well-studied. Our recent trial of a motivational intervention delivered to patients in the ED by a therapist resulted in modest reductions in non- medical use after the ED visit compared to a control condition. However, the intervention was unable to address the implications of opioids prescribed as a result of the ED encounter on post-ED opioid use behavior. This project will adapt the intervention for delivery after the ED visit through mobile technology in order to directly address the use of ED-provided opioids. Patients (n=600) will be recruited during an ED visit for a randomized controlled trial of the adapted intervention based on having used opioids non-medically in the prior three months and being given an opioid by an ED prescriber. In the intervention condition, interactive voice response calls will repeatedly assess non-medical opioid use and pain level and deliver intervention content. The intervention will include several potential actions that vary in intensity: assessment only, a brief message, extended messaging, or connection to a therapist by phone. Because the most helpful intensity of intervention is unknown and likely to vary between patients, the project will use an artificial intelligence stratey called reinforcement learning (RL). The RL system will continuously ""learn"" from the success of prior actions in similar situations with similar patients in order to select the action most likelyto reduce non-medical opioid use for each participant during each call. The RCT will be complemented by qualitative interviews to inform later implementation. The specific aims are to: (1) Adapt and enhance an existing motivational intervention to decrease non-medical opioid use after an ED visit by optimizing intervention intensity and duration through RL; (2) Examine the impact of the intervention on non-medical opioid use level during the six months post-ED visit; (3) Examine the impact of the intervention on driving after opioid use, overdose risk behaviors, and subsequent opioid-related ED visits. Secondary Aims are: (1) to examine differences in intervention effects between participants with high and low baseline levels of non-medical opioid use; and (2) to understand barriers and facilitators of implementation. This project will use a highly innovative strategy, artificial intelligence, to address a highly significant problem, non-medical opioid use. Ultimately, this study can lead to reductions in opioid- related harms and move forward the field of mobile health.         PUBLIC HEALTH RELEVANCE: Non-medical use of opioid pain medications has increased substantially over the last decade, and ensuring the safe use of opioids prescribed as part of medical care has become a critical public health priority. Emergency Departments (EDs) are on the front lines of this emerging public health problem. This randomized controlled trial will test the impact of a mobile health intervention, which incorporates an innovative artificial intelligenc component to determine intervention duration and intensity, on non-medical opioid use and related harms for adult ED patients treated with opioids and who have a history of non-medical opioid use.            ",Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention,9026192,R01DA039159,"['Accounting ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' painkiller ', ' pain reliever ', ' pain medication ', ' pain killer ', ' Antinociceptive Drugs ', ' Antinociceptive Agents ', ' Anodynes ', ' Analgesic Preparation ', ' Analgesic Drugs ', ' Analgesic Agents ', ' Analgesics ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' driving ', ' Automobile Driving ', ' Behavior ', ' Complement Proteins ', ' Complement ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Future ', ' History ', ' Recording of previous events ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Methodology ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Out-patients ', ' Outpatients ', ' Overdose ', ' Painful ', ' Pain ', ' Patients ', ' Play ', ' Psychotherapy ', ' Public Health ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Reinforcement ', ' Psychological reinforcement ', ' Research ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' Safety ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Voice ', ' Work ', ' Research Methodology ', ' Research Methods ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Caring ', ' Guidelines ', ' Injury ', ' base ', ' improved ', ' Left ', ' Site ', ' Acute ', ' Clinical ', ' Medical ', ' Randomized Clinical Trials ', ' Ensure ', ' Individual ', ' Opioid ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Therapeutic ', ' Severities ', ' System ', ' Lack of Coordination ', ' Incoordination ', ' Dyscoordination ', ' Coordination Disorder ', ' Co-ordination disorder ', ' Abnormal coordination ', ' Emergency room ', ' Emergency Department ', ' Accident and Emergency department ', ' experience ', ' success ', ' skills ', ' Participant ', ' novel technologies ', ' new technology ', ' Reporting ', ' Health Care Technology ', ' Health Technology ', ' response ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Address ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Monitor ', ' Process ', ' Emergency medical care ', ' Emergency healthcare ', ' Emergency health care ', ' Emergency Room care ', ' Emergency Department care ', ' ER care ', ' ED care ', ' Emergency Care ', ' post intervention ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' motivational intervention ', ' high risk ', ' public health relevance ', ' treatment as usual ', ' usual care ', ' intervention effect ', ' brief motivational intervention ', ' clinical practice ', ' public health priorities ', ' prescription opioid ', ' adverse outcome ', ' adverse consequence ', ' screening ', ' mHealth ', ' mobile health ', ' m-Health ', ' Emergency Department patient ', ' Emergency Room patient ', ' ER patient ', ' ED patient ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' opioid use ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2016,578991,MI-12,0.11013675004649813
"A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia DESCRIPTION (provided by applicant): Schizophrenia is a severe psychiatric disorder that is associated with staggeringly high individual and societal costs. Although the illness is typically chronic, it is not static, and the majority of people with schizophrenia vacillate between full or partial remission and episodes of symptomatic relapse. Relapses increase one's risk for major problems including homelessness, incarceration, victimization, and suicide. Moreover, patients with schizophrenia who relapse are three to four times more costly than those who do not. The goal of the proposed project is to develop and evaluate a novel paradigm for illness monitoring, detection of early warning signs, and relapse prevention in schizophrenia. Our interdisciplinary team of clinical researchers and computer scientists proposes to develop a mobile system that uses smartphone-embedded sensors (i.e. microphone, accelerometer, GPS, light sensor) coupled with computerized self-reports, to track a range of behaviors (i.e. paralinguistic aspect of speech, physical activity, location, sleep, mood, psychotic symptoms) that are relevant to relapse in schizophrenia. Using machine learning techniques, the system will leverage behavioral data and patient self-reported clinical updates to generate personalized early warning models. The models will evolve with use of the system over time, focusing on variability from one's typical behavioral patterns to calibrate a unique patient relapse signature. Treatment teams will be informed about patients' clinical status via secure website. When the mobile system ""flags"" trends that are consistent with one's relapse signature, it will trigger patient functions and provider functions (i.e. real-time notification, prompts to initiate contact, time-sensitive treatments) to help prevent progression to full psychotic relapse. In Phase 1 of the project, we will integrate multi-modal sensor, ecological momentary assessment, and machine learning technologies into a unified smartphone system that will be tested and refined in laboratory settings. In Phase 2, we will conduct field trials with individuals with schizophrenia i real-world conditions to identify and resolve technical and mechanical problems, adapt the software, and maximize system usability. In Phase 3, we will conduct a randomized 12- month trial of the monitoring and prevention system compared to treatment as usual in 150 outpatients with schizophrenia that are at high-risk for relapse. If successful, our proposed system can be rapidly made available to a population that is in dire need of more effective resources, and can serve as a template for mobile monitoring and treatment systems for a range of clinical conditions with an episodic nature. PUBLIC HEALTH RELEVANCE: An effective multi-modal mobile monitoring, early detection, and intervention system for schizophrenia could alter illness trajectory, mitigating the acute and long term impact of psychotic relapses on patients, their caretakers, and communities. A broadly available system could radically change when, how, and to what effect treatments are delivered, allowing for a paradigmatic shift from reactive to preemptive care for schizophrenia.",A New Paradigm for Illness Monitoring  and Relapse Prevention in Schizophrenia,9119612,R01MH103148,"['Accounting ', ' Behavior ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Clinical Trials ', ' Communities ', ' Computers ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' Elements ', ' Goals ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' Hospitalization ', ' Laboratories ', ' Photoradiation ', ' Light ', ' Methods ', ' Moods ', ' NIMH ', ' National Institute of Mental Health ', ' Out-patients ', ' Outpatients ', ' Patients ', ' Relapse ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Science ', ' Sleep ', ' Social isolation ', ' Software ', ' Computer software ', ' Speech ', ' Stress ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Suicide ', ' Technology ', ' Testing ', ' Time ', ' Self-Injurious Behavior ', ' self injury ', ' self harm ', ' intentional self injury ', ' intentional self harm ', ' deliberate self harm ', ' Deliberate Self-Harm ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' Self Management ', ' Caring ', ' base ', ' sensor ', ' Partial Remission ', ' Left ', ' Acute ', ' Chronic ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Phase ', ' Ensure ', ' Physical activity ', ' medical complication ', ' disability ', ' unhoused ', ' homeless ', ' Homelessness ', ' Individual ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Collaborations ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Victimization ', ' mechanical ', ' Mechanics ', ' Scientist ', ' Notification ', ' Pattern ', ' Techniques ', ' System ', ' Location ', ' Remission ', ' Disease remission ', ' early detection ', ' Early Diagnosis ', ' experience ', ' novel ', ' Self-Report ', ' Patient Self-Report ', ' help seeking ', ' help-seeking behavior ', ' Prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' disorder later incidence prevention ', ' Modeling ', ' developing computer software ', ' develop software ', ' software development ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Cellular Phone ', ' Provider ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Randomized ', ' Infrastructure ', ' Research Infrastructure ', ' Update ', ' Monitor ', ' trend ', ' developmental ', ' Development ', ' Behavioral ', ' website ', ' web site ', ' cost ', ' computerized ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' Population ', ' Coupled ', ' innovation ', ' innovative ', ' innovate ', ' treatment effect ', ' usability ', ' computer generated ', ' high risk ', ' high reward ', ' treatment as usual ', ' usual care ', ' Secure ', ' psychotic symptoms ', ' mHealth ', ' mobile health ', ' m-Health ', ' severe psychiatric disorder ', ' Ecological momentary assessment ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' relapse patients ', ' mood symptom ', ' ']",NIMH,DARTMOUTH COLLEGE,R01,2016,388305,NH-02,0.08588216750948427
"Neural basis of smoking relapse     DESCRIPTION (provided by applicant): Smoking is the greatest preventable cause of mortality and a significant economic burden. Even with the best available treatments, most smokers relapse within days or weeks after a quit attempt. To improve quit rates significantly, we need a more refined mechanistic understanding of why so many smokers who attempt to quit will relapse quickly. The proposed functional magnetic resonance imaging (fMRI) study integrates concepts and tools from the fields of cognitive neuroscience and behavioral science to determine how brain states in early abstinence influence clinical outcomes among treatment-seeking smokers. The primary aims of this hypothesis-driven study are: (1) to identify brain mechanisms that increase vulnerability to smoking relapse, and (2) to test an integrated brain-behavior model of smoking relapse. Using our validated fMRI-based abstinence challenge paradigm, 200 treatment-seeking smokers will complete two 1-hour pre- treatment fMRI scans: after smoking satiety and after 24 hours of confirmed abstinence. We will examine neural and behavioral responses during performance of validated tasks probing working memory, cue reactivity, and stress response as well as resting state functional connectivity. Participants will then set a target quit date, receive smoking cessation counseling, and be monitored for 6-months to assess time (days) to relapse, using a validated smoking relapse protocol. The primary outcome is time to relapse. Secondary outcomes include abstinence symptoms and smoking status at 30 days. For human subjects reasons, relapsing smokers will be offered an opportunity to receive 8 weeks of nicotine patch treatment and counseling free of charge following study completion. Although neuroimaging is not likely to become a standard pre- cessation assessment the near future, this study will elucidate pathological neurobehavioral processes and specific neurocognitive domains that can be targeted in new treatments to aid smoking cessation.         PUBLIC HEALTH RELEVANCE: This project will clarify why the majority of smokers relapse quickly following a quit attempt.        ",Neural basis of smoking relapse,9079131,R01DA041402,"['Affect ', ' Behavioral Sciences ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Charge ', ' Systematics ', ' Classification ', ' Counseling ', ' Cues ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Exhibits ', ' Future ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Insula of Reil ', ' working memory ', ' Shortterm Memory ', ' Immediate Memory ', ' Short-Term Memory ', ' Methods ', ' mortality ', ' Nicotine Withdrawal ', ' Nucleus Accumbens ', ' Relapse ', ' Research Resources ', ' Resources ', ' Rest ', ' Risk ', ' social role ', ' Role ', ' satiety ', ' Satiation ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoke ', ' Smoking ', ' Stress ', ' Psychologic Stress ', ' Psychological Stress ', ' Task Performances ', ' Testing ', ' Time ', ' Measures ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' Mediating ', ' biological adaptation to stress ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' Prefrontal Cortex ', ' base ', ' human subject ', ' improved ', ' Left ', ' Anterior ', ' Medial ', ' Clinical ', ' psychological ', ' psychologic ', ' Evaluation ', ' memory dysfunction ', ' Memory Deficit ', ' Memory impairment ', ' tool ', ' Smoker ', ' Nicotine Skin Patch ', ' nicotine patch ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Investigation ', ' Hour ', ' Protocol ', ' Protocols documentation ', ' Pattern ', ' Neurocognitive ', ' behavior change ', ' Performance ', ' behavioral measurement ', ' behavioral measure ', ' behavior measurement ', ' cingulate cortex ', ' neural ', ' relating to nervous system ', ' neuro-imaging ', ' neuroimaging ', ' novel ', ' Participant ', ' Negotiation ', ' Negotiating ', ' Mediation ', ' Self-Report ', ' Patient Self-Report ', ' Ventral Striatum ', ' cue reactivity ', ' Modeling ', ' craving ', ' response ', ' Magnetic Resonance Imaging Scan ', ' MRI Scans ', ' Nicotine Replacement Therapy ', ' nicotine replacement ', ' Symptoms ', ' Economic Burden ', ' Cognitive ', ' Smoking Status ', ' Monitor ', ' Process ', ' Behavioral ', ' blood oxygenation level dependent ', ' blood oxygen level dependent ', ' pathway ', ' Pathway interactions ', ' neurobehavioral ', ' Outcome ', ' prospective ', ' neuromechanism ', ' neural mechanism ', ' cognitive neuroscience ', ' Abstinence ', ' brain behavior ', ' cognitive control ', ' public health relevance ', ' primary outcome ', ' secondary outcome ', ' smoking relapse ', ' stress reactivity ', ' behavioral response ', ' behavior response ', ' relapse risk ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2016,523814,PA-03,0.09122822795463399
"Neural basis of smoking relapse     DESCRIPTION (provided by applicant): Smoking is the greatest preventable cause of mortality and a significant economic burden. Even with the best available treatments, most smokers relapse within days or weeks after a quit attempt. To improve quit rates significantly, we need a more refined mechanistic understanding of why so many smokers who attempt to quit will relapse quickly. The proposed functional magnetic resonance imaging (fMRI) study integrates concepts and tools from the fields of cognitive neuroscience and behavioral science to determine how brain states in early abstinence influence clinical outcomes among treatment-seeking smokers. The primary aims of this hypothesis-driven study are: (1) to identify brain mechanisms that increase vulnerability to smoking relapse, and (2) to test an integrated brain-behavior model of smoking relapse. Using our validated fMRI-based abstinence challenge paradigm, 200 treatment-seeking smokers will complete two 1-hour pre- treatment fMRI scans: after smoking satiety and after 24 hours of confirmed abstinence. We will examine neural and behavioral responses during performance of validated tasks probing working memory, cue reactivity, and stress response as well as resting state functional connectivity. Participants will then set a target quit date, receive smoking cessation counseling, and be monitored for 6-months to assess time (days) to relapse, using a validated smoking relapse protocol. The primary outcome is time to relapse. Secondary outcomes include abstinence symptoms and smoking status at 30 days. For human subjects reasons, relapsing smokers will be offered an opportunity to receive 8 weeks of nicotine patch treatment and counseling free of charge following study completion. Although neuroimaging is not likely to become a standard pre- cessation assessment the near future, this study will elucidate pathological neurobehavioral processes and specific neurocognitive domains that can be targeted in new treatments to aid smoking cessation. PUBLIC HEALTH RELEVANCE: This project will clarify why the majority of smokers relapse quickly following a quit attempt.",Neural basis of smoking relapse,9233987,R01DA041402,"['Affect ', ' Behavioral Sciences ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Charge ', ' Systematics ', ' Classification ', ' Counseling ', ' Cues ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Exhibits ', ' Future ', ' Insula of Reil ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Short-Term Memory ', ' working memory ', ' Shortterm Memory ', ' Immediate Memory ', ' Methods ', ' mortality ', ' Nicotine Withdrawal ', ' Nucleus Accumbens ', ' Relapse ', ' Resources ', ' Research Resources ', ' Rest ', ' Risk ', ' Role ', ' social role ', ' Satiation ', ' satiety ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Smoke ', ' Smoking ', ' Stress ', ' Psychological Stress ', ' Psychologic Stress ', ' Task Performances ', ' Testing ', ' Time ', ' Measures ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' smoking cessation ', ' Mediating ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' biological adaptation to stress ', ' Prefrontal Cortex ', ' base ', ' human subject ', ' improved ', ' Left ', ' Anterior ', ' Medial ', ' Clinical ', ' psychological ', ' psychologic ', ' Evaluation ', ' memory dysfunction ', ' Memory Deficit ', ' Memory impairment ', ' tool ', ' Smoker ', ' nicotine patch ', ' Nicotine Skin Patch ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Investigation ', ' Hour ', ' Scanning ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' Neurocognitive ', ' behavior change ', ' Performance ', ' behavior measurement ', ' behavioral measurement ', ' behavioral measure ', ' cingulate cortex ', ' relating to nervous system ', ' neural ', ' neuroimaging ', ' neuro-imaging ', ' novel ', ' Participant ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Patient Self-Report ', ' Self-Report ', ' Ventral Striatum ', ' cue reactivity ', ' Modeling ', ' craving ', ' response ', ' nicotine replacement ', ' Nicotine Replacement Therapy ', ' Symptoms ', ' Economic Burden ', ' Cognitive ', ' Smoking Status ', ' Pathologic ', ' Monitor ', ' Process ', ' Behavioral ', ' blood oxygenation level dependent ', ' blood oxygen level dependent ', ' pathway ', ' Pathway interactions ', ' neurobehavioral ', ' Outcome ', ' prospective ', ' neuromechanism ', ' neural mechanism ', ' cognitive neuroscience ', ' Impairment ', ' Abstinence ', ' brain behavior ', ' cognitive control ', ' public health relevance ', ' multimodality ', ' primary outcome ', ' secondary outcome ', ' smoking relapse ', ' stress reactivity ', ' behavioral response ', ' behavior response ', ' relapse risk ', ' imaging study ', ' high dimensionality ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2017,604381,PA-03,0.09122822795463399
"Leveraging Social Media for Substance Use Behavioral Insight  Project Summary Substance misuse places a tremendous burden on individuals and society and remains high because so many youth initiate substance use at an early age and progress to dependence. In one of my NIDA sponsored R01s, I am funded to examine the effects of school and state-level penalties on youth substance use behaviors while accounting for anti-tobacco/drug media campaigns (R01 DA032843). My research signals a health issue of increasing importance that is youth exposure to the promotion of alcohol, tobacco, and other drug-related content via advertisements, online social networking, and other normalizing and pro-use messages. There is potential for leveraging social media as a tool to understand, inform, and potentially dissuade harmful substance use behaviors. However, a critical and necessary first step is to better understand displayed substance use references on key social media sites and how these displays are associated with use. In my second NIDA-sponsored R01, I am funded to investigate the implications of social media content and engagement for alcohol and marijuana use (R01 DA039456). I am a newly tenured investigator who has already made important contributions to the study of substance use policy and social media research. I will investigate social media posts for novel insight into drug use, especially newly emerging drugs that are increasing in popularity. I also aim to generate a strong scientific base about social media as a potential medium for delivering anti-/pro- substance use messages to young people. At this juncture, it is critical for me to receive support from this Independent Scientist Award so that I can devote all of my efforts towards continuing to build my research program and to enhance my scientific skills and advance me to the next level of achievement. I will collaborate with investigators at Washington University and nationally in order to gain further experience in sophisticated and efficient data mining analysis. I will additionally achieve an improved ability to synthesize results across multiple studies into strategic and actionable recommendations for tailored prevention messages to deliver on social media. This award will also enable me to devote a substantial amount of time to mentorship and the development of the next generation of researchers. In summary, this Independent Scientist Award will enable me to expand my knowledge base in targeted areas to significantly enhance my research trajectory in ways that would not be otherwise feasible. Project Narrative This study is significant to the public health field because it will harness social media posts for novel insight into drug use, especially newly emerging drugs that are increasing in popularity. This application requests 5 years of funding to support protected research time for Dr. Cavazos to learn and apply new skills in state-of-the-art big data analysis and to synthesize her results across studies into strategic and actionable recommendations for tailored prevention messages to deliver on social media.",Leveraging Social Media for Substance Use Behavioral Insight ,9285056,K02DA043657,"['Accounting ', ' Achievement Attainment ', ' Achievement ', ' ages ', ' Age ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Alcohol Chemical Class ', ' Alcohols ', ' Attitude ', ' Award ', ' Behavior ', ' Belief ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Sources ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Grant ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Influentials ', ' Leadership ', ' Learning ', ' Marijuana ', ' marihuana ', ' Mentors ', ' Mentorship ', ' Methods ', ' Minority Groups ', ' Mission ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Productivity ', ' Public Health ', ' Recommendation ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Wages ', ' Salaries ', ' Schools ', ' medical schools ', ' school of medicine ', ' medical college ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Societies ', ' Substance Addiction ', ' Substance Dependence ', ' Substance Use Disorder ', ' Survey Methodology ', ' Survey Method ', ' Educational process of instructing ', ' Teaching ', ' Technology ', ' Time ', ' Tobacco ', ' Universities ', ' Washington ', ' Work ', ' Cost Sharing ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' analytical method ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' insight ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policies ', ' Research Activity ', ' drug use ', ' Drug usage ', ' Funding ', ' Exposure to ', ' Shapes ', ' tool ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' programs ', ' Complex ', ' Dependence ', ' Pattern ', ' interest ', ' experience ', ' knowledge base ', ' knowledgebase ', ' skills ', ' expectation ', ' novel ', ' Media Campaign ', ' member ', ' hookah ', ' waterpipe ', ' water pipe ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' Positioning Attribute ', ' Position ', ' career development ', ' Advertisements ', ' Latina ', ' Latinas ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' data mining ', ' datamining ', ' Address ', ' Data ', ' Independent Scientist Award ', ' K02 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' underrepresentation of minorities ', ' under-represented minority ', ' under-representation of minorities ', ' Underrepresented Ethnic Minority ', ' Underrepresented Minority ', ' trend ', ' developmental ', ' Development ', ' Behavioral ', ' youth substance use ', ' substance use among adolescents ', ' adolescent substance use ', ' next generation ', ' addiction ', ' addictive disorder ', ' social networking website ', ' web-based social networking ', ' social networking web site ', ' social networking site ', ' online social networking ', ' social implication ', ' Secure ', ' Big Data ', ' BigData ', ' Electronic cigarette ', ' e-cigarette ', ' e-cig ', ' marijuana use ', ' cannabis use ', ' mid-career faculty ', ' associate professor ', ' associate faculty ', ' learning strategy ', ' learning method ', ' learning activity ', ' social media ', ' Data Analytics ', ' substance misuse ', ' ']",NIDA,WASHINGTON UNIVERSITY,K02,2017,118137,MO-01,0.042549820513271
"Leveraging Predictive Analytics Within Social Networks to Maximize Drug and Alcohol Treatment Efficacy and Relapse Prevention Sober Grid has built a smartphone-based, recovery-focused social network already in use by 50,297 recovering addicts and 13 addiction treatment facilities to help users achieve better health outcomes and reduce rates of relapse. The goal of this phase I SBIR study is to determine the feasibility of leveraging predictive analytics within the context of an addiction recovery focused social network to enable the system to identify users who are in need of support before they relapse. The specific aim is to assess the feasibility of using predictive modeling to identify those most vulnerable to relapse in order to advance phase II efforts.  Sober Grid will work with a team of addiction researchers including co-investigator Dr. Brenda Curtis, Assistant Professor at the Perlman School of Medicine at the University of Pennsylvania (U Penn), and consultant Dr. Warren Bickel, Director of Addiction Recovery Research Center and Professor of Psychiatry and Behavioral Medicine at the Virginia Tech Carilion School of Medicine (and Sober Grid advisor), to compile a database of known triggers (e.g., life stressors, environment/life changes, etc.), words and phrases, topics and lexica associated with relapse. The team will mine the data in order to identify the factors that correspond with relapse measures (e.g., change in sobriety status, content indicative of relapse, etc.) and employ supervised learning through support vector networks with labeled data as well as unsupervised learning through support vector clustering to identify patterns indicative of relapse within our unlabeled data. The team will build models on a training data set and assess them for prediction accuracy. Understanding the feasibility of mobile-based predictive capabilities and integrating the real-time adaptive interventions proposed shows significant potential for reducing relapse rates in populations regardless of whether they have attended treatment programs. These capabilities will not only increase treatment efficacy, they will also help to reduce overall costs within the healthcare system, including the Veterans Administration, and relieve pressure on already overburdened clinicians  a significant commercial opportunity for Sober Grid. Through the proposed project, Sober Grid will work to improve the efficacy and efficiency of its software and smartphone application for supporting peer groups and providers delivering drug and alcohol treatment to more than 22 million Americans who exhibit relapse rates as high as 90%. Applying predictive analytics within the context of Sober Grids addiction recovery focused social network will enable it to modify its system to predict relapse before it occurs, which will enable users and providers to realize greater treatment efficacy and health outcomes while significantly reducing costs to the system.",Leveraging Predictive Analytics Within Social Networks to Maximize Drug and Alcohol Treatment Efficacy and Relapse Prevention,9347303,R43DA044062,"['Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Behavior ', ' Behavioral Medicine ', ' life change ', ' Climacteric ', ' Continuum of Care ', ' Continuity of Care ', ' Continuity of Patient Care ', ' Cost Containment ', ' Cost Control ', ' Cues ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Environment ', ' Exhibits ', ' Feasibility Studies ', ' Foundations ', ' Patient Care Delivery ', ' Patient Care ', ' Goals ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' Language ', ' Learning ', ' Natural Language Processing ', ' natural language understanding ', ' Patients ', ' Peer Group ', ' Pennsylvania ', ' pressure ', ' Psychiatry ', ' Relapse ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' medical schools ', ' school of medicine ', ' medical college ', ' Computer software ', ' Software ', ' Supervision ', ' Time ', ' Veterans Administration ', ' United States Veterans Administration ', ' United States Department of Veterans Affairs ', ' Universities ', ' Virginia ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' Social Network ', ' base ', ' Label ', ' improved ', ' Phase ', ' Training ', ' Individual ', ' Recovery ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Area Under Curve ', ' Pattern ', ' System ', ' American ', ' stressor ', ' success ', ' professor ', ' phrases ', ' peer ', ' treatment program ', ' sobriety ', ' sober ', ' disorder later incidence prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' Modeling ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' alcohol abuse therapy ', ' alcohol treatment ', ' alcohol abuse treatment ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Provider ', ' prevent ', ' preventing ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Data ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' Modification ', ' Behavioral ', ' vector ', ' cost ', ' treatment center ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Outcome ', ' Population ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' innovation ', ' innovative ', ' innovate ', ' addiction ', ' addictive disorder ', ' mobile application ', ' mobile app ', ' peer support ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' Predictive Analytics ', ' relapse prediction ', ' predict relapse ', ' ']",NIDA,"SOBER GRID, INC.",R43,2017,147889,OH-11,0.06567512268205845
"Classifying addictions using machine learning analysis of multidimensional data ABSTRACT This Independent Scientist Award will significantly enhance my research capabilities, enabling me to become a leading quantitative investigator in the field of substance use disorders (SUDs). Specifically, it will allow me to increase my knowledge in the areas of SUD phenotypes, treatment and genetics. SUDs are clinically and etiologically heterogeneous and their classification has been difficult. This application reflects my ongoing commitment to developing an innovative and interdisciplinary research program on the classification of SUDs through quantitative analysis of multidimensional data. My extensive training in computational science and prior research on biomedical informatics have provided me with the skills to design, implement and evaluate advanced algorithms and sophisticated analyses to solve challenging problems in classifying SUDs. My ongoing NIDA-funded R01 employs a large (n=~12,000) sample aggregated from multiple genetic studies of cocaine, opioid, and alcohol dependence to develop and evaluate novel statistical models to generate clinical SUD subtypes that are optimized for gene finding. This K02 proposal extends that work to evaluate treatment outcome in refined subgroups of SUD populations using data from treatment studies for cocaine, opioid, alcohol and multiple substance dependence. This project will integrate data from diagnostic behavioral variables and genotypes, as well as biological/neurobiological features of the disorders and repeated measures of treatment outcome. The primary career development goals of this application are to: (1) understand the reliability, validity and functional mechanisms of various phenotyping methods; (2) to continue training in the genetics of addictions; and (3) to gain greater knowledge of different treatment approaches and their efficacy. A solid foundation in these areas will enhance my ability to realize the full potential of the data collected and aggregated from multiple dimensions, and to use the data to design the most clinically useful analysis and generate innovative solutions to diagnostic and predictive challenges in SUD research. Through formal coursework, directed readings, individual tutoring and intensive multidisciplinary collaboration with a diverse team of world-renowned researchers, I will receive training and collect pilot data for future R01 projects by examining (Aim I): whether clinically-defined highly heritable subtypes derived in my current R01 project predict differential treatment response; (Aim II) whether new statistical models that directly combine treatment data with behavioral, biological, and genomic data identify refined subtypes with confirmatory multilevel evidence; and (Aim III) whether there are genetic and social moderators of treatment outcome by subtype. The overall goal of this proposal is to further my independent and multidisciplinary research program in the development of statistical methods for refined classification of SUDs. The K02 award will provide me with the protected time necessary to fully engage in the training activities described that will enhance my knowledge and skills to enable me to make important, novel contributions to the genetics and treatment of SUD. PROJECT NARRATIVE This project will develop novel statistical and quantitative tools to identify homogeneous subtypes of substance use disorders (SUDs) and other complex diseases to enhance gene finding and treatment matching. The proposed project will perform secondary analyses of existing data from treatment studies of cocaine, opioid, alcohol, and mixed SUDs. The proposed novel approaches are expected to advance precision medicine approaches to SUDs by enabling treatment matching and a more refined SUD classification to gene finding.",Classifying addictions using machine learning analysis of multidimensional data,9224405,K02DA043063,"['post treatment ', ' After-Treatment ', ' After Care ', ' Aftercare ', ' ethanol use disorder ', ' alcohol use disorder ', ' Alcohol Chemical Class ', ' Alcohols ', ' Algorithms ', ' Systematics ', ' Classification ', ' Cluster Analyses ', ' Cluster Analysis ', ' Cocaine ', ' multimodality therapy ', ' combined treatment ', ' combined modality treatment ', ' combination therapy ', ' Multimodality Treatment ', ' Multimodal Treatment ', ' Multimodal Therapy ', ' Combined Modality Therapy ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' Disorder ', ' Disease ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Drug Use Disorder ', ' EEG ', ' Electroencephalography ', ' Foundations ', ' Future ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Joints ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Neurobiology ', ' neurobiological ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Reading ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk Factors ', ' Signs and Symptoms ', ' Diagnostic Findings ', ' Substance Addiction ', ' Substance Dependence ', ' Substance Use Disorder ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' training module ', ' Training Activity ', ' Work ', ' Measures ', ' Treatment outcome ', ' Dataset ', ' Data Set ', ' improved ', ' Area ', ' Solid ', ' Clinical ', ' Biological ', ' Training ', ' Diagnostic and Statistical Manual of Mental Disorders-IV ', ' Diagnostic and Statistical Manual of Mental Disorders, 4th edition ', ' DSM4 ', ' DSM-4 ', ' DSM-IV ', ' Individual ', ' Opioid ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Funding ', ' Collaborations ', ' Genetic ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Dimensions ', ' Complex ', ' Pattern ', ' Opiate Addiction ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' treatment planning ', ' Biosensor ', ' biological sensor ', ' Cocaine Dependences ', ' Cocaine Addiction ', ' skills ', ' novel ', ' disease classification ', ' nosology ', ' disorder classification ', ' contingency management ', ' social ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' career development ', ' disorder subtype ', ' disease subtype ', ' Genomics ', ' Diagnostic and Statistical Manual of Mental Disorders ', ' Diagnostic and Statistical Manual ', ' DSM-V ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' DSM5 ', ' DSM-5 ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' Symptoms ', ' Adherence ', ' Data ', ' Independent Scientist Award ', ' K02 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Subgroup ', ' Characteristics ', ' developmental ', ' Development ', ' Behavioral ', ' biomed informatics ', ' biomedical informatics ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Computational Science ', ' Population ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' endophenotype ', ' addiction ', ' addictive disorder ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' cocaine use ', ' precision medicine ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' Genetic study ', ' neural correlate ', ' tutoring ', ' tutorial support ', ' opioid use disorder ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' genomic data ', ' imaging genetics ', ' secondary analysis ', ' ']",NIDA,UNIVERSITY OF CONNECTICUT STORRS,K02,2017,163452,CT-02,0.004427923360704689
"Using Machine Learning to Predict Problematic Prescription Opioid Use and Opioid Overdose Problematic prescription opioid use, defined as nonmedical use, misuse, or abuse of opioid medications, is epidemic in the US. Prescription opioid overdose deaths more than quadrupled from 1999 to 2015. Efforts by health care systems and payers to combat the opioid epidemic are impeded by a lack of accurate and efficient methods to identify individuals most at risk for problematic opioid use and overdose, leading to broad interventions that are burdensome to patients and expensive for payers. Payers are currently defining high risk and targeting interventions (e.g. pharmacy lock-in programs) based on individual risk factors, such as high opioid dosage, identified in prior studies using traditional statistical approaches. However, these traditional approaches have significant limitations, especially when handling large datasets with numerous variables, multi-level interactions, and missing data. Moreover, the prior studies focused on identifying risk factors rather than predicting actual risk. Alternatively, machine learning is an advanced technique that handles complex interactions in large data, uncovers hidden patterns, and yields precise prediction algorithms that, in many cases, are superior to those developed using traditional methods. Machine learning is widely used in activities from fraud detection to cancer genomics, but has not yet been applied to address the opioid epidemic. Accordingly, the proposed study will apply machine learning to develop prediction algorithms that can more accurately identify patients at high risk of problematic opioid use and overdose using data sources that are readily available to payers and health care systems. The project will build on existing academic-state partnerships to apply novel machine learning approaches to administrative claims data for all Medicaid beneficiaries in Pennsylvania (PA) and Arizona (AZ). The project will also link Medicaid data in AZ to electronic health records to capture clinical information (e.g., lab results, pain severity) not available in administrative data, along with death certificate data on lethal overdose. These data, covering 2007-2016, will be used to achieve two specific aims: (1) to develop and validate two separate prediction algorithms to identify patients at risk of problematic opioid use and opioid overdose; (2) to compare the accuracy of a prediction algorithm that integrates clinical data with Medicaid claims versus a claims-based approach alone to identify patients at risk of problematic opioid use and opioid overdose. The machine learning approaches will include random forests and TreeNet with representative classification trees, and the predictive ability (e.g., misclassification rates) of these algorithms will be compared to traditional statistical models. Given the high prevalence of mental health/substance use disorders (~50%) and opioid utilization (>20%) among Medicaid enrollees and the lack of adequate prediction algorithms, Medicaid is an ideal setting for the proposed project. These analyses will provide the partnering Medicaid programs with valuable information and tools that they can apply to more precisely target interventions to prevent problematic opioid use and overdose. Prescription opioid overdose deaths quadrupled from 1999 to 2015, and drug overdose is now the leading cause of injury deaths among adults in the United States. This project will use innovative machine learning methods and readily available data for Medicaid beneficiaries in two states hard hit by the epidemic  Pennsylvania and Arizona  to develop algorithms to accurately predict who is at risk of problematic prescription opioid use and overdose. This information will empower health systems, payers, and policymakers to more effectively target interventions to prevent prescription opioid misuse and its consequences.",Using Machine Learning to Predict Problematic Prescription Opioid Use and Opioid Overdose,9421755,R01DA044985,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Algorithms ', ' Arizona ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Systematics ', ' Classification ', ' Data Sources ', ' Death ', ' Cessation of life ', ' Death Certificates ', ' Pre-clinical Drug Evaluation ', ' Drug Screening ', ' Preclinical Drug Evaluation ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Fraud ', ' Health Care Systems ', ' Healthcare Systems ', ' Hospitals ', ' Inpatients ', ' Medicaid ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Morphine ', ' Statex SR ', ' Roxanol ', ' Oramorph SR ', ' Oramorph ', ' Morphia ', ' MSir ', ' MS Contin ', ' Kadian ', ' Infumorph ', ' opioid abuse ', ' opiate abuse ', ' Overdose ', ' Pain ', ' Painful ', ' Patients ', ' Pennsylvania ', ' Pharmacy facility ', ' Pharmacies ', ' Research ', ' Risk ', ' Risk Factors ', ' Substance Use Disorder ', ' Time ', ' Trees ', ' United States ', ' United States Health Care Financing Administration ', ' Health Care Financing Administration ', ' Centers for Medicare and Medicaid Services ', ' United States Centers for Medicare and Medicaid Services ', ' Urine Urinary System ', ' Urine ', ' Work ', ' forest ', ' Managed Care ', ' Dataset ', ' Data Set ', ' Injury ', ' base ', ' dosage ', ' Clinical ', ' Logistic Regressions ', ' Link ', ' Ensure ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Opioid ', ' Fees for Service ', ' Fee-for-Service Plans ', ' Letters ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' milligram ', ' Severities ', ' Complex ', ' Pattern ', ' Techniques ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' American ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' prevent ', ' preventing ', ' Address ', ' Dose ', ' Health system ', ' Data ', ' Detection ', ' High Prevalence ', ' Subgroup ', ' Clinical Data ', ' Characteristics ', ' beneficiary ', ' Electronic Health Record ', ' oncogenomics ', ' cancer genomics ', ' designing ', ' design ', ' Outcome ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' service utilization ', ' high risk ', ' combat ', ' nonmedical use ', ' overdose death ', ' prescription opioid ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' clinical predictors ', ' prescription opioid misuse ', ' model building ', ' learning strategy ', ' learning method ', ' learning activity ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' opioid use ', ' ']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2017,601139,PA-18,0.15557263532670262
"Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention     DESCRIPTION (provided by applicant): In recent years in the U.S., problems associated with opioid prescriptions, including non-medical use and overdose, increased to historically unprecedented levels and represent a public health crisis. Emergency departments (EDs) play an important role in opioid prescribing, particularly to individuals at high risk for adverse opioi-related outcomes. Half of all ED visits are for a painful condition, and one third of all ED visits result in an opioid being prescribed. Moreover, in our pilot work, a quarter of patients surveyed at the ED study site reported non-medical opioid use in the prior three months. Despite the importance of this problem, strategies to reduce non-medical opioid use after an ED visit have not been well-studied. Our recent trial of a motivational intervention delivered to patients in the ED by a therapist resulted in modest reductions in non- medical use after the ED visit compared to a control condition. However, the intervention was unable to address the implications of opioids prescribed as a result of the ED encounter on post-ED opioid use behavior. This project will adapt the intervention for delivery after the ED visit through mobile technology in order to directly address the use of ED-provided opioids. Patients (n=600) will be recruited during an ED visit for a randomized controlled trial of the adapted intervention based on having used opioids non-medically in the prior three months and being given an opioid by an ED prescriber. In the intervention condition, interactive voice response calls will repeatedly assess non-medical opioid use and pain level and deliver intervention content. The intervention will include several potential actions that vary in intensity: assessment only, a brief message, extended messaging, or connection to a therapist by phone. Because the most helpful intensity of intervention is unknown and likely to vary between patients, the project will use an artificial intelligence stratey called reinforcement learning (RL). The RL system will continuously ""learn"" from the success of prior actions in similar situations with similar patients in order to select the action most likelyto reduce non-medical opioid use for each participant during each call. The RCT will be complemented by qualitative interviews to inform later implementation. The specific aims are to: (1) Adapt and enhance an existing motivational intervention to decrease non-medical opioid use after an ED visit by optimizing intervention intensity and duration through RL; (2) Examine the impact of the intervention on non-medical opioid use level during the six months post-ED visit; (3) Examine the impact of the intervention on driving after opioid use, overdose risk behaviors, and subsequent opioid-related ED visits. Secondary Aims are: (1) to examine differences in intervention effects between participants with high and low baseline levels of non-medical opioid use; and (2) to understand barriers and facilitators of implementation. This project will use a highly innovative strategy, artificial intelligence, to address a highly significant problem, non-medical opioid use. Ultimately, this study can lead to reductions in opioid- related harms and move forward the field of mobile health. PUBLIC HEALTH RELEVANCE: Non-medical use of opioid pain medications has increased substantially over the last decade, and ensuring the safe use of opioids prescribed as part of medical care has become a critical public health priority. Emergency Departments (EDs) are on the front lines of this emerging public health problem. This randomized controlled trial will test the impact of a mobile health intervention, which incorporates an innovative artificial intelligenc component to determine intervention duration and intensity, on non-medical opioid use and related harms for adult ED patients treated with opioids and who have a history of non-medical opioid use.",Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention,9266749,R01DA039159,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' opioid pain medication ', ' opioid analgesia ', ' opiate pain medication ', ' opiate analgesic ', ' opiate analgesia ', ' Opioid Analgesics ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' driving ', ' Automobile Driving ', ' Behavior ', ' Complement Proteins ', ' Complement ', ' Future ', ' History ', ' Recording of previous events ', ' Interview ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Methodology ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Outpatients ', ' Out-patients ', ' Overdose ', ' Pain ', ' Painful ', ' Patients ', ' Phonation ', ' Play ', ' Psychotherapy ', ' Public Health ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Psychological reinforcement ', ' Reinforcement ', ' Research ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Safety ', ' Surveys ', ' Survey Instrument ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Voice ', ' Work ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Caring ', ' Guidelines ', ' Injury ', ' base ', ' improved ', ' Site ', ' Acute ', ' Clinical ', ' Medical ', ' Randomized Clinical Trials ', ' Ensure ', ' Individual ', ' Opioid ', ' randomized controlled study ', ' Randomized Controlled Trials ', ' Therapeutic ', ' Severities ', ' System ', ' Abnormal coordination ', ' Lack of Coordination ', ' Incoordination ', ' Dyscoordination ', ' Coordination Disorder ', ' Co-ordination disorder ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' success ', ' skills ', ' Participant ', ' new technology ', ' novel technologies ', ' Reporting ', ' Health Technology ', ' Health Care Technology ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Address ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Monitor ', ' Process ', ' Emergency medical care ', ' Emergency healthcare ', ' Emergency health care ', ' Emergency Room care ', ' Emergency Department care ', ' ER care ', ' ED care ', ' Emergency Care ', ' post intervention ', ' drugged driving ', ' drug driving ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' motivational intervention ', ' high risk ', ' public health relevance ', ' treatment as usual ', ' usual care ', ' intervention effect ', ' brief motivational intervention ', ' clinical practice ', ' public health priorities ', ' prescription opioid ', ' adverse outcome ', ' adverse consequence ', ' screening ', ' mHealth ', ' mobile health ', ' m-Health ', ' Emergency Department patient ', ' Emergency Room patient ', ' ER patient ', ' ED patient ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' behavioral outcome ', ' behavior outcome ', ' learning progression ', ' continuous learning ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' opioid use ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2017,600547,MI-12,0.11013675004649813
"Predicting Stimulant Use Relapse using Neuroimaging Techniques Project Summary / Abstract  Neuroimaging methodologies, including electroencephalography (EEG), event-related potentials (ERPs), and both structural and functional magnetic resonance imaging (s/fMRI) have emerged as significant predictors of substance use relapse. These neuroimaging techniques have helped provide an objective, sensitive, and predictive measure of substance use relapse propensity. As the capabilities of biological science advance, a lingering impediment to progress is the study of individual brain regions implicated in predicting substance use relapse. Important to note, individual brain regions rarely work independently; rather, such regions often work in concert, as specific networks, continually sending and receiving information to other regions, to help facilitate learning, memory, and other cognitive processes. The investigation of ICA-derived functional network connectivity between brain regions may lend incremental utility for classifying, diagnosing, and predicting substance use relapse.  Here, using the worlds largest forensic database, which includes clinical and neuropsychological measures, electrophysiological measures, functional neuroimaging, and functional network connectivity measures, the primary goal of this project will be to delineate specific risk factors predictive of eventual stimulant use relapse propensity. This will be accomplished by integrating models incorporating logistic and Cox proportional-hazard regressions, and cross-validation machine learning pattern classifiers to predict stimulant use relapse one year after institutional release with an at-risk sample of adult incarcerated offenders.  First, we will examine the potential of various clinical and neuropsychological assessment measures in predicting stimulant use relapse. Second, we will investigate the predictive utility of error-monitoring neural measures using traditional ERPs and fMRI in predicting stimulant use relapse. Third, we will apply more agnostic, data-driven methods, including ICA-derived functional network connectivity analyses of fMRI data to measure functional connectivity between brain regions involved in error-processing to predict stimulant use relapse. Ultimately, this research will lend incremental utility in the successful prediction of stimulant use relapse, providing a more sensitive and predictive measure compared to previous investigations. The ultimate goal of the proposed training fellowship is to help provide a more biologically informed taxonomy of neurocognitive deficits associated with those prone to stimulant use relapse. Project Narrative  Prevalence estimates indicate that roughly half of incarcerated offenders meet criteria for previous history of substance use disorders (SUDs) (Center for Behavioral Health Statistics and Quality, 2015), with a majority (66.7%) relapsing within three years of institutional release (Langan & Levin, 2002). Identifying specific risk factors, including neurocognitive measures involved in predicting stimulant use relapse following release from custody could lead to important insights into this high-risk sample. The research proposed here will examine brain anatomy, function and connectivity, and psychological traits using the world's largest multi- modal database of its kind from an incarcerated sample to directly aid the development of more contemporary, scientifically-validated taxonomy of the pathophysiology related to neurocognitive deficits associated with stimulant use relapse propensity.",Predicting Stimulant Use Relapse using Neuroimaging Techniques,9394654,F31DA043328,"['adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anatomy ', ' Anxiety ', ' Attention ', ' Basal Nuclei ', ' Basal Ganglia ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' Biological Sciences ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Diagnosis ', ' Educational aspects ', ' Education ', ' EEG ', ' Electroencephalography ', ' electrophysiological ', ' Neurophysiology / Electrophysiology ', ' Electrophysiology ', ' Electrophysiology (science) ', ' Fellowship ', ' Forensics ', ' Forensic Medicine ', ' Goals ', ' hemodynamics ', ' History ', ' Recording of previous events ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Memory ', ' Methods ', ' Methodology ', ' Neuropsychology ', ' neuropsychologic ', ' Neuropsychologies ', ' New Mexico ', ' Regression Analysis ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Relapse ', ' Research ', ' Risk ', ' Risk Factors ', ' statistics ', ' Substance Use Disorder ', ' Work ', ' Measures ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' General Taxonomy ', ' Taxonomy ', ' Prefrontal Cortex ', ' court ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Anterior ', ' Dorsal ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Biological ', ' psychological ', ' psychologic ', ' Logistic Regressions ', ' Training ', ' insight ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Logistics ', ' Populations at Risk ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' event related potential ', ' Event-Related Potentials ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Knowledge ', ' Investigation ', ' Pattern ', ' Techniques ', ' Neurocognitive ', ' experience ', ' cingulate cortex ', ' hazard ', ' Biological Neural Networks ', ' neural network ', ' relating to nervous system ', ' neural ', ' trait ', ' neuroimaging ', ' neuro-imaging ', ' Participant ', ' Predictive Factor ', ' Modality ', ' offender ', ' criminal offender ', ' Reporting ', ' Impulsivity ', ' Modeling ', ' Sampling ', ' behavioral health ', ' response ', ' Brain region ', ' Age-Years ', ' Data ', ' Cognitive ', ' Validation ', ' Monitor ', ' developmental ', ' Development ', ' psychopathy ', ' psychopathic personality ', ' neurocognitive impairment ', ' neurocognitive decline ', ' IQ Deficit ', ' Neurocognitive Deficit ', ' Clinical assessments ', ' independent component analysis ', ' Prevalence ', ' high risk ', ' Institutional Review Boards ', ' IRBs ', ' IRB ', ' cognitive process ', ' symptomatology ', ' relapse prediction ', ' predict relapse ', ' imaging study ', ' ']",NIDA,UNIVERSITY OF NEW MEXICO,F31,2017,31856,NM-01,0.06317484697090106
"Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse Abstract The experience of drug craving is known to increase drug use1-6 and relapse after treatment7-16. Specifically, drug-related stimuli are known to elicit cue-induced craving, as well as physiological and neural responses, called cue reactivity, which have all been directly linked to drug use and relapse across addictions17-35, including gambling36-39. To date, hundreds of studies investigated neural cue-reactivity; however, there is little consensus in findings, due to significant variation in methods, drug types, cue types, and analysis procedures. Further, prior meta-analyses used suboptimal methods and inclusion criteria, and were underpowered40-44. In Aim 1, we propose to use state-of-the-art meta-analytic methods45-47 to summarize findings from ~120 published imaging studies, representing >3000 participants during neural cue reactivity/cue- induced craving (and 3x larger than any prior meta-analysis). Following our prior meta-analytic work in other domains48-61, we will use optimized inclusion criteria and correction methods, and account for multiple methodological differences in studies across substances (e.g., cigarettes, alcohol, cocaine, cannabis) and gambling, a behavioral addiction. Further, we will test for differences across drug types (e.g., cigarettes vs. alcohol) and different cue-types (e.g., pictures vs. video) to resolve several open questions in the field (e.g., role of insula in cigarette craving vs. drug craving in general62, 63; pre-scan abstinence64, 65). In Aim 2, we will go beyond meta-analysis to address an urgent need in addiction research66: development of predictive biomarkers67-69, which are stable indicators of biological processes. Biomarkers have been developed in other areas of medicine70, and we have recently done this in pain71, negative emotion72-74, and empathy74. To do this, we will combine the meta-analytic results obtained in Aim 1 with person-level fMRI data from our lab (of cue-induced craving75-79) using machine learning models, to establish a multivariate pattern of neural activity that can predict craving self-report from neural activity  a predictive neuromarker for craving. Given the associations between neural cue reactivity, craving, and drug use outcome, a multivariate neuromarker could provide a powerful neural predictor of outcomes66, 67. Thus, in Aim 3, we will validate this neuromarker on data from two ongoing clinical trials of N=128 cigarette smokers and N=150 cocaine users collected at Yale's Psychotherapy Development Center (P50 DA09241; Center PI: Carroll; Project PI: Kober). Here, the neuromarker will be used on pre-treatment fMRI cue-reactivity data to predict both self-reported craving and long-term clinical outcomes (e.g., cocaine abstinence). The validated neuromarker will provide well-defined brain targets that can then be used to test the efficacy of interventions to reduce craving and drug use, such as pharmacotherapies, brain stimulation, or cognitive training, and to monitor patient progress in both research and clinical settings. ! Project Narrative Among substance users, exposure to drug cues is associated with neural cue reactivity and cue-induced craving, both of which are directly linked to addiction severity and relapse after treatment. We will employ state-of-the-art statistical and computational methods to establish a consistent neural pattern associated with cue reactivity and cue-induced craving. Then we will validate it using recently-collected imaging data  moving towards a predictive biomarker of drug craving, which can be used to investigate brain processes related to treatment efficacy and drug use outcomes in research as well as clinical settings.",Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse,9286017,R01DA043690,"['post treatment ', ' After-Treatment ', ' After Care ', ' Aftercare ', ' Alcohol Chemical Class ', ' Alcohols ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Clinical Trials ', ' Cocaine ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Cues ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Gambling ', ' Insula of Reil ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Laboratories ', ' Methods ', ' Methodology ', ' Persons ', ' Paper ', ' Patient Monitoring ', ' Psychotherapy ', ' Publishing ', ' Relapse ', ' Research ', ' Role ', ' social role ', ' Smoking ', ' Specificity ', ' Testing ', ' Time ', ' Work ', ' Addictive Behavior ', ' Dataset ', ' Data Set ', ' Prefrontal Cortex ', ' base ', ' density ', ' improved ', ' Procedures ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Stimulus ', ' Individual ', ' Cocaine Users ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' drug use ', ' Drug usage ', ' Biological Function ', ' Biological Process ', ' Exposure to ', ' Cigarette Smoker ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Severities ', ' Event ', ' Scanning ', ' Techniques ', ' drug craving ', ' experience ', ' success ', ' Biological Neural Networks ', ' neural network ', ' relating to nervous system ', ' neural ', ' Cigarette ', ' neuroimaging ', ' neuro-imaging ', ' Participant ', ' movie ', ' Patient Self-Report ', ' Self-Report ', ' Ventral Striatum ', ' cue reactivity ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' craving ', ' response ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Cannabis ', ' DSM-V ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' DSM5 ', ' DSM-5 ', ' Brain region ', ' Address ', ' Length ', ' Base of the Brain ', ' Data ', ' Measurable ', ' Reproducibility ', ' Cognitive ', ' Pattern Recognition ', ' Update ', ' Process ', ' sex ', ' developmental ', ' Development ', ' Behavioral ', ' imaging ', ' Image ', ' cognitive training ', ' drug relapse ', ' designing ', ' design ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Outcome ', ' prospective ', ' neuromechanism ', ' neural mechanism ', ' Abstinence ', ' inclusion criteria ', ' addiction ', ' addictive disorder ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' neural patterning ', ' efficacy testing ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' neural correlate ', ' Data Analytics ', ' biomarker development ', ' predict clinical outcome ', ' predictor of clinical outcome ', ' clinical outcome prediction ', ' imaging study ', ' ']",NIDA,YALE UNIVERSITY,R01,2017,450712,CT-03,0.018693239052504047
"Using existing data to understand and ameliorate risk in opioid agonist therapy PROJECT SUMMARY/ABSTRACT The United States is in the midst of an opioid epidemic, leading to unprecedented levels of overdose deaths and other harms. Effective treatment for opioid use disorders is available, in the form of opioid agonist therapy (OAT) with methadone or buprenorphine. However, there are significant questions about the risk of adverse clinical outcomes, including mortality and hospitalization during and after treatment, and unplanned treatment cessation. What is the magnitude of these risks, and what patient, treatment setting, and provider factors may contribute to or protect against risk? Additionally, it is increasingly clear that more sophisticated approaches to patient assessment and treatment planning than are currently used are needed to minimise risk. We aim to: 1. Determine the magnitude of risk for specific adverse clinical outcomes (e.g. mortality, hospitalization and ED presentation, and unplanned treatment cessation) during and after OAT with methadone and buprenorphine; 2. Identify patient, treatment setting, and provider risk factors associated with adverse clinical outcomes during and after OAT with methadone and buprenorphine; and 3. Develop a risk prediction model to identify patients at greatest risk of adverse clinical outcomes during and after OAT. To achieve these aims, this project will use existing population-based Australian data on OAT, linked to several health and criminal justice datasets to provide a rich understanding of treatment exposures and outcomes. These data will be used to inform strategies to guide the delivery of high-quality treatment for opioid use disorder in the United States. Specifically, the project will provide data about the magnitude of risk of adverse clinical outcomes during specific treatment and post-treatment periods, and identify patient, treatment setting and provider factors that influence risk. Additionally, it will use innovative machine learning techniques to demonstrate the potential for routinely collected data to be used to assess patient risk at point-of-care, allowing for the development of tailored treatment plans that minimize risk and maximize treatment retention. PROJECT NARRATIVE Opioid agonist therapy is an effective treatment for opioid use disorder, including prescription opioid use disorder. However, important questions about safety and risks during treatment remain unanswered. This study will examine risk and protective factors for death, hospitalization, and unplanned treatment cessation during and after opioid agonist therapy.",Using existing data to understand and ameliorate risk in opioid agonist therapy,9365365,R01DA044170,"['post treatment ', ' After-Treatment ', ' After Care ', ' Aftercare ', ' Buprenorphine ', ' co-morbidity ', ' Comorbidity ', ' Death ', ' Cessation of life ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Goals ', ' Health ', ' History ', ' Recording of previous events ', ' Hospitalization ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methods ', ' mortality ', ' Persons ', ' New South Wales ', ' Overdose ', ' Patients ', ' Prisons ', ' Probability ', ' Research ', ' Risk ', ' Risk Factors ', ' Safety ', ' Time ', ' United States ', ' Criminal Justice ', ' forest ', ' Risk Assessment ', ' Specialist ', ' Dataset ', ' Data Set ', ' base ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' Link ', ' Training ', ' Opioid ', ' Logistics ', ' Agonist ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Event ', ' Clinic ', ' treatment duration ', ' treatment days ', ' Treatment Period ', ' Techniques ', ' experience ', ' treatment planning ', ' Neoadjuvant Therapy ', ' Neoadjuvant Treatment ', ' Neoadjuvant ', ' NEOADJ ', ' Induction Therapy ', ' novel ', ' Modeling ', ' response ', ' Withholding Treatment ', ' Cessation of Treatment ', ' Adverse event ', ' Adverse Experience ', ' Provider ', ' Data ', ' developmental ', ' Development ', ' point of care ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' Outcome ', ' scale up ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' population based ', ' effective therapy ', ' effective treatment ', ' overdose death ', ' risk minimization ', ' population health ', ' prescription opioid ', ' adverse outcome ', ' adverse consequence ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' Patient risk ', ' learning strategy ', ' learning method ', ' learning activity ', ' opioid use disorder ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' opioid use ', ' ']",NIDA,UNIVERSITY OF NEW SOUTH WALES,R01,2017,197214,,0.15256551575063096
"Opioid Use and Safety in US Nursing Homes PROJECT SUMMARY / ABSTRACT  Nationwide use of prescription opioids quadrupled to more than 240 million prescriptions per year between 1999 to 2010. This increase has been accompanied by an alarming rise in opioid misuse and abuse, addiction, and fatal and nonfatal overdoses. In response to this growing national epidemic, the Department of Health and Human Services has called for the creation of clear opioid prescribing guidelines and further developing the evidence base to guide opioid prescribing for the management of pain. To date, guidelines have largely focused on opioid use in younger adults despite the unique issues facing older adults (65 years old) including a large burden of pain, extensive analgesics use, and recent increase in drug overdose-related deaths in the elderly population. Prior guidelines have provided no direction regarding appropriate opioid use to treat pain in nursing home residents. This is problematic due to the high prevalence of chronic pain in nursing home residents as well as age-related vulnerability to adverse drug events due to changes in pharmacokinetics/pharmacodynamics and higher prevalence of multiple comorbidities and polypharmacy in this population as compared to noninstitutionalized older adults.  Using an in-house national repository of Minimum Data Set 3.0  a federally required clinical assessment of all residents in Medicare or Medicaid certified nursing homes  merged to Medicare Part A and D and facility-level characteristics in CASPER (Certification and Survey Provider and Enhanced Reporting) from 2011-2013, this proposal addresses the evidence gap in safe opioid use in US nursing home residents with three specific aims: 1) to identify sociodemographic, clinical, and facility-level correlates of opioid use in terms of duration of use (acute vs. chronic), duration of action (short- vs. long-acting), and dose in morphine equivalents; 2) to estimate the incidence of opioid-related drug overdoses and identify resident- and drug regimen-related risk factors for opioid overdose; and 3) to evaluate the comparative safety of specific commonly-initiated opioids in terms of serious adverse health outcomes (all-cause mortality, hospitalization for cardiovascular disease, fractures, and bowel obstruction). Methodological innovations include the use of multilevel modeling and targeted maximum likelihood estimation approaches. This proposal is directly relevant to the approximately 1.4 million older adults living in US nursing homes on any given day  many of whom will receive opioids while institutionalized. The knowledge generated will inform stakeholders on how opioids are used in this population, the risk of overdose when using opioids, and the comparative safety of short- and long- term use of commonly initiated opioids in the nursing home setting. PROJECT NARRATIVE Approximately 1.4 million US adults live in nursing homes on any given day; many experience acute and chronic pain often treated with opioid analgesics despite the potential risks associated with these medications. This study will describe the resident and facility risk factors associated with receiving opioids, risk factors for opioid overdose, and the comparative safety of commonly-initiated opioids. The results will inform stakeholders on the use and safety of opioids in nursing homes.",Opioid Use and Safety in US Nursing Homes,9328950,F31AG056078,"['Paracetamol ', ' Hydroxyacetanilide ', ' Acetominophen ', ' Acetamidophenol ', ' APAP ', ' Acetaminophen ', ' functional capacity ', ' functional ability ', ' daily living functionality ', ' Activities of everyday life ', ' Activities of Daily Living ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aggression ', ' Aggressive behavior ', ' pain treatment ', ' Pain Therapy ', ' Pain Control ', ' Pain management ', ' painkiller ', ' pain reliever ', ' pain medication ', ' pain killer ', ' Antinociceptive Drugs ', ' Antinociceptive Agents ', ' Anodynes ', ' Analgesic Preparation ', ' Analgesic Drugs ', ' Analgesic Agents ', ' Analgesics ', ' opioid pain medication ', ' opioid analgesia ', ' opiate pain medication ', ' opiate analgesic ', ' opiate analgesia ', ' Opioid Analgesics ', ' Antiinflammatory Agents ', ' Antiinflammatories ', ' Anti-Inflammatories ', ' Anti-Inflammatory Agents ', ' Anxiety ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Certification ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' Death ', ' Cessation of life ', ' depression ', ' Mental Depression ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' bone fracture ', ' Fracture ', ' Health ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' Hospitalization ', ' Incidence ', ' Intestinal Obstruction ', ' intestine obstruction ', ' Bowel Obstruction ', ' Medicaid ', ' Methodology ', ' Morphine ', ' Statex SR ', ' Roxanol ', ' Oramorph SR ', ' Oramorph ', ' Morphia ', ' MSir ', ' MS Contin ', ' Kadian ', ' Infumorph ', ' mortality ', ' Nursing Homes ', ' nursing home ', ' Nursing Research ', ' opioid abuse ', ' opiate abuse ', ' Overdose ', ' Pain ', ' Painful ', ' Drug Kinetics ', ' Pharmacokinetics ', ' Pharmacology ', ' Public Health ', ' Kidney Failure ', ' Renal Insufficiency ', ' Renal Failure ', ' Kidney Insufficiency ', ' Research ', ' Risk ', ' Risk Factors ', ' Safety ', ' Supervision ', ' Surveys ', ' Survey Instrument ', ' United States ', ' United States Department of Health and Human Services ', ' Department of Health and Human Services ', ' United States Dept. of Health and Human Services ', ' Medicare Hospital Insurance Program ', ' Medicare Part A ', ' Healthcare Costs ', ' Health Costs ', ' Health Care Costs ', ' chronic painful condition ', ' chronic pain ', ' Dataset ', ' Data Set ', ' medication therapy management ', ' Pharmacologic Management ', ' Analgesic Management ', ' Medication Management ', ' Guidelines ', ' base ', ' dosage ', ' improved ', ' Polypharmacy ', ' Acute Pain ', ' Left ', ' Acute ', ' Chronic ', ' Clinical ', ' Residual ', ' Residual state ', ' Medical ', ' Evaluation ', ' Distress ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' Opioid ', ' Therapeutic ', ' Sedation procedure ', ' sedation ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Dependence ', ' experience ', ' human old age (65+) ', ' 65+ years old ', ' Reporting ', ' Drug effect disorder ', ' drug action ', ' multilevel analysis ', ' multilevel modeling ', ' multilevel model ', ' methods to study multiple-level influences ', ' Statistical Methods ', ' Pharmacodynamics ', ' Modeling ', ' Property ', ' response ', ' repository ', ' Vulnerable Populations ', ' vulnerable group ', ' Provider ', ' Effectiveness ', ' Address ', ' Length ', ' Dose ', ' Data ', ' High Prevalence ', ' Anti-inflammatory ', ' nonmalignant ', ' Non-Malignant ', ' Risk Estimate ', ' Characteristics ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' beneficiary ', ' safety study ', ' age dependent ', ' age related ', ' neglect ', ' Clinical assessments ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' comparative ', ' addiction ', ' addictive disorder ', ' evidence base ', ' opioid misuse ', ' Regimen ', ' prescription opioid ', ' adverse outcome ', ' adverse consequence ', ' Big Data ', ' BigData ', ' Adverse drug event ', ' opioid use ', ' ']",NIA,UNIV OF MASSACHUSETTS MED SCH WORCESTER,F31,2017,23642,MA-02,-0.0018460276876110324
"Mining Social Media Messages for HIV Testing and Prevention Communication PROJECT SUMMARY With the advent of Big Data methods, social media is the proverbial low-hanging fruit to disseminate HIV prevention and testing messages on a large scale 1,2. These media already transmit messages on condom use, HIV testing, and Pre-Exposure Prophylaxis (PrEP), from government institutions, NGOs, private citizens, and community groups, but it does so in an informal way. This real-time repository of real-world health messages, along with our ability to mine and pinpoint counties that need to engage in a conversation about HIV prevention and testing, offers a unique opportunity to develop Big Data methods for geographically targeted message dissemination. Despite some interventions designed for online delivery 319, the overall potential of social media and their most promising contents (e.g., actionable messages with behavioral instructions) have surprisingly not been established to date. Our project will focus on the disease-burdened population of Men Who Have Sex With Men (MSM), and will develop a highly significant computing infrastructure (Aim 1) to automatically and continuously input social media postings from Twitter, Facebook, and Instagram, behavioral data from the American Men Internet Survey (AMIS), and HIV prevalence data from AIDSVu.org, and using that triangulation, to target counties that need social media messages about condom use, HIV testing, and/or PrEP for MSM. Using machine learning methods, the same platform will then select actionable and acceptable messages to fill county gaps. Once the platform has been refined with input from research participants who are employees of health departments, it will be used to send experimental messages (Aim 2), selected to match county needs, and to be actionable and acceptable to a group of health departments randomized to the experimental condition. The success of the experimental messages will be gauged by the hallmarks of social media, repostings, Likes, Dislike, and comment favorability, compared with the success of a random selection of HIV-relevant messages sent to a different group of health departments randomized to the control condition. The project is innovative in several ways. First, the social media messages will involve diverse inputs (text, images, videos) never before brought together in this area. Second, we are not aware of the prior use of the proposed triangulation involving epidemiological, behavioral, and social media data. Third, a method of mining naturally accruing messages will be new and transformative, allowing for the generation of live campaigns with messages selected that remain current, sustainable, and community-based by design. Further, the use of an implementation-science experiment at a large, geographically distributed, scale is highly novel. These research aims are facilitated by unique team expertise about communication and persuasion, Big Data methods, public health, and Bayesian spatio-temporal modeling, and leading institutions in the areas of psychology, public health, and computer science. PROJECT NARRATIVE  This project is concerned with identifying a method to disseminate public health information through social media in an optimal way. Findings from this project will inform prevention efforts in this area as well as in fighting other diseases in which social influences are important.",Mining Social Media Messages for HIV Testing and Prevention Communication,9569139,R01MH114847,"['Algorithms ', ' Anus ', ' Anal ', ' Awareness ', ' Communication ', ' Communities ', ' Consultations ', ' Disease ', ' Disorder ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Geography ', ' Government ', ' Health ', ' HIV ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' Human ', ' Modern Man ', ' Illinois ', ' Information Services ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' Mining ', ' Mission ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Persuasive Communication ', ' Persuasion ', ' Privatization ', ' Psychology ', ' Public Health ', ' Random Allocation ', ' Random Selection ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Public Health Schools ', ' Silicon Dioxide ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' World Health ', ' County ', ' Employee Health ', ' Generations ', ' Measures ', ' Administrator ', ' AIDS prevention ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS/HIV prevention ', ' base ', ' Prophylaxis ', ' Prophylactic treatment ', ' Area ', ' Link ', ' Ensure ', ' Fostering ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Funding ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Respondent ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' fighting ', ' Techniques ', ' interest ', ' Services ', ' Needs Assessment ', ' American ', ' success ', ' computer science ', ' condoms ', ' novel ', ' Participant ', ' member ', ' Prevention ', ' social ', ' HIV risk ', ' Modeling ', ' repository ', ' Institution ', ' prevent ', ' preventing ', ' Human immunodeficiency virus test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Data ', ' Harvest ', ' Health Sciences ', ' International ', ' National Institute of Allergy and Infectious Disease ', ' NIAID ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Research Infrastructure ', ' Infrastructure ', ' Training and Infrastructure ', ' sex ', ' Text ', ' Behavioral ', ' imaging ', ' Image ', ' Instruction ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' men who have sex with other men ', ' MSM ', ' men who have sex with men ', ' Population ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' participatory action research ', ' community based research ', ' community based design ', ' community based participatory research ', ' implementation science ', ' treatment design ', ' intervention design ', ' therapy design ', ' spatiotemporal ', ' evidence base ', ' infrastructure development ', ' BigData ', ' Big Data ', ' learning method ', ' learning activity ', ' learning strategy ', ' project dissemination ', ' program dissemination ', ' social media ', ' experimental research ', ' experiment ', ' experimental study ', ' PrEP ', ' pre-exposure prophylaxis ', ' ']",NIMH,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,R01,2018,648001,IL-13,-0.04408191919491884
"Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse Abstract The experience of drug craving is known to increase drug use1-6 and relapse after treatment7-16. Specifically, drug-related stimuli are known to elicit cue-induced craving, as well as physiological and neural responses, called cue reactivity, which have all been directly linked to drug use and relapse across addictions17-35, including gambling36-39. To date, hundreds of studies investigated neural cue-reactivity; however, there is little consensus in findings, due to significant variation in methods, drug types, cue types, and analysis procedures. Further, prior meta-analyses used suboptimal methods and inclusion criteria, and were underpowered40-44. In Aim 1, we propose to use state-of-the-art meta-analytic methods45-47 to summarize findings from ~120 published imaging studies, representing >3000 participants during neural cue reactivity/cue- induced craving (and 3x larger than any prior meta-analysis). Following our prior meta-analytic work in other domains48-61, we will use optimized inclusion criteria and correction methods, and account for multiple methodological differences in studies across substances (e.g., cigarettes, alcohol, cocaine, cannabis) and gambling, a behavioral addiction. Further, we will test for differences across drug types (e.g., cigarettes vs. alcohol) and different cue-types (e.g., pictures vs. video) to resolve several open questions in the field (e.g., role of insula in cigarette craving vs. drug craving in general62, 63; pre-scan abstinence64, 65). In Aim 2, we will go beyond meta-analysis to address an urgent need in addiction research66: development of predictive biomarkers67-69, which are stable indicators of biological processes. Biomarkers have been developed in other areas of medicine70, and we have recently done this in pain71, negative emotion72-74, and empathy74. To do this, we will combine the meta-analytic results obtained in Aim 1 with person-level fMRI data from our lab (of cue-induced craving75-79) using machine learning models, to establish a multivariate pattern of neural activity that can predict craving self-report from neural activity  a predictive neuromarker for craving. Given the associations between neural cue reactivity, craving, and drug use outcome, a multivariate neuromarker could provide a powerful neural predictor of outcomes66, 67. Thus, in Aim 3, we will validate this neuromarker on data from two ongoing clinical trials of N=128 cigarette smokers and N=150 cocaine users collected at Yale's Psychotherapy Development Center (P50 DA09241; Center PI: Carroll; Project PI: Kober). Here, the neuromarker will be used on pre-treatment fMRI cue-reactivity data to predict both self-reported craving and long-term clinical outcomes (e.g., cocaine abstinence). The validated neuromarker will provide well-defined brain targets that can then be used to test the efficacy of interventions to reduce craving and drug use, such as pharmacotherapies, brain stimulation, or cognitive training, and to monitor patient progress in both research and clinical settings. ! Project Narrative Among substance users, exposure to drug cues is associated with neural cue reactivity and cue-induced craving, both of which are directly linked to addiction severity and relapse after treatment. We will employ state-of-the-art statistical and computational methods to establish a consistent neural pattern associated with cue reactivity and cue-induced craving. Then we will validate it using recently-collected imaging data  moving towards a predictive biomarker of drug craving, which can be used to investigate brain processes related to treatment efficacy and drug use outcomes in research as well as clinical settings.",Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse,9489234,R01DA043690,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Alcohols ', ' Alcohol Chemical Class ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Clinical Trials ', ' Cocaine ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Cues ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Gambling ', ' Insula of Reil ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Laboratories ', ' Methods ', ' Methodology ', ' Persons ', ' Paper ', ' Patient Monitoring ', ' Psychotherapy ', ' Publishing ', ' Relapse ', ' Research ', ' Role ', ' social role ', ' Specificity ', ' Testing ', ' Time ', ' Work ', ' Addictive Behavior ', ' Data Set ', ' Dataset ', ' Prefrontal Cortex ', ' base ', ' density ', ' improved ', ' Procedures ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Physiologic ', ' Physiological ', ' Link ', ' Stimulus ', ' Individual ', ' Cocaine Users ', ' data base ', ' Data Bases ', ' Databases ', ' drug use ', ' Drug usage ', ' Biological Function ', ' Biological Process ', ' Exposure to ', ' Cigarette Smoker ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Severities ', ' Event ', ' Scanning ', ' Techniques ', ' drug craving ', ' experience ', ' success ', ' Biological Neural Networks ', ' neural network ', ' relating to nervous system ', ' neural ', ' Cigarette ', ' neuroimaging ', ' neuro-imaging ', ' Participant ', ' movie ', ' Patient Self-Report ', ' Self-Report ', ' Ventral Striatum ', ' cue reactivity ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' craving ', ' response ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Cannabis ', ' DSM-V ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' DSM5 ', ' DSM-5 ', ' Brain region ', ' Address ', ' Length ', ' Base of the Brain ', ' Data ', ' Measurable ', ' Reproducibility ', ' Cognitive ', ' Pattern Recognition ', ' Update ', ' Process ', ' sex ', ' developmental ', ' Development ', ' Behavioral ', ' imaging ', ' Image ', ' cognitive training ', ' drug relapse ', ' designing ', ' design ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Outcome ', ' prospective ', ' neural mechanism ', ' neuromechanism ', ' Abstinence ', ' inclusion criteria ', ' addictive disorder ', ' addiction ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' neural patterning ', ' efficacy testing ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' predictive marker ', ' neural correlate ', ' Data Analytics ', ' biomarker development ', ' predictor of clinical outcome ', ' clinical outcome prediction ', ' predict clinical outcome ', ' imaging study ', ' cue to smoke ', ' smoking cue ', ' ']",NIDA,YALE UNIVERSITY,R01,2018,430771,CT-03,0.018693239052504047
"Project FIGARO - Factors Important to Gather for Anticipating Relapses for Opioids PROJECT SUMMARY/ABSTRACT For individuals with opioid use disorder (OUD) the propensity for relapse is high when experiencing craving, independent of a desire to stay sober. Historically, tools to fight opioid addiction have been limited and retrospective. By the time a traditional intervention occurs, they are often already reusing. Addiction relapses too often lead to a costly downward spiral - committing crimes, getting rearrested, being hospitalized, overdosing, and/or dying. Recent advances in wearable sensors, smartphones and artificial intelligence have created an unprecedented opportunity to produce positive health outcomes by predicting and preventing OUD relapses and overdoses. With sensing and associated algorithms, it will be possible to detect relapse risk states and intervene in advance - before a relapse actually occurs. The first step in this new era of proactive opioid relapse prediction is to identify and measure digital biomarkers associated with reinitiating drug use and relapse and implement a predictive model with minimal false positive alerts to achieve just-in-time intervention. This will begin with the collection of quantitative and qualitative data on patients and healthcare professionals to identify desired features and functions. Behaivior LLC will develop a relapse prevention platform that will consider a combination of physiological sensor data from the patients wearable devices in combination with smartphone usage data, location data and  importantly  reports from people in his/her support network to identify and detect relapse triggers in real-time. SA-1: Demonstrate what makes a wrist wearable device acceptable and usable for people with OUD. SA-2.A: Identify positive correlations between physiological, location and smartphone data, and self-reported opioid cravings: Results will be used to create a predictive model that can operate in real-time. SA-2.B: Demonstrate feasibility of using support-network-reported data to predict opioid cravings. SA-3: Create a predictive model to anticipate opioid relapse as a step towards just-in-time intervention. SA-4: Demonstrate feasibility of predictive model by obtaining a sufficiently low false positive rate. A successful outcome of this project will be a wearables platform capable of predicting and preventing opioid addiction relapses, stemming the tide of the opioid epidemic. The platform will be ready for regulatory approvals and integration into existing electronic health records and monitoring systems. To achieve behavior modification, Behaivior will implement and commercialize a wearables platform and suite of effective interventions utilizing individualized, active machine learning, and continued iteration of next generation wearables and supporting mobile applications. A robust platform prototype capable of producing measurable change will be tested. Further development of the most promising MVP(s) will be pursued by a Phase II SBIR proposal. Project Narrative Knowing in realtime when someone with opioid use disorder is at a high risk of relapsing will revolutionize the ability to intervene at the right moment to help people stay clean and sober. Our research will contribute to fundamental knowledge about the specific information needed to be gathered in order to accurately detect when someone struggling with opioid use disorder is in a highrisk opioid craving/obsession state, and will enable the creation of a predictive model for justintime intervention. The number of deaths from opioid overdose is increasing every day, so reducing opioid addiction relapses will save lives and families and it will reduce rearrests, reincarcerations, and rehospitalizations.",Project FIGARO - Factors Important to Gather for Anticipating Relapses for Opioids,9545451,R43DA046149,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Algorithms ', ' Ambulatory Care ', ' outpatient treatment ', ' Outpatient Care ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Crime ', ' Data Reporting ', ' data representation ', ' Cessation of life ', ' Death ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Dropout ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Family ', ' Future ', ' Galvanic Skin Response ', ' skin conductance ', ' Skin Electric Conductance ', ' Psychogalvanic Reflex ', ' Electrodermal Response ', ' Hand ', ' Health ', ' Heart Rate ', ' Cardiac Chronotropism ', ' Hospitalization ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Moods ', ' Movement ', ' body movement ', ' Overdose ', ' Patients ', ' outcome forecast ', ' Prognosis ', ' Relapse ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk Factors ', ' Schools ', ' Sensitivity and Specificity ', ' Computer software ', ' Software ', ' Specificity ', ' Stress ', ' Substance Use Disorder ', ' Technology ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' United States ', ' Universities ', ' Wrist ', ' Computerized Medical Record ', ' Electronic Medical Record ', ' Measures ', ' Alcohol abuse ', ' problematic alcohol use ', ' problematic alcohol consumption ', ' problem drinking ', ' problem alcohol use ', ' hazardous alcohol use ', ' ethanol abuse ', ' alcohol problem ', ' alcohol co-abuse ', ' EtOH abuse ', ' Custom ', ' base ', ' sensor ', ' improved ', ' Phase ', ' Physiologic ', ' Physiological ', ' Training ', ' Obsession ', ' Individual ', ' Recovery ', ' Opiates ', ' Opioid ', ' drug use ', ' Drug usage ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' tool ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' fighting ', ' Source ', ' Pattern ', ' System ', ' Location ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' drug craving ', ' American ', ' experience ', ' computer science ', ' cohort ', ' Participant ', ' Agreement ', ' recidivism ', ' sobriety ', ' sober ', ' Patient Self-Report ', ' Self-Report ', ' General Population ', ' General Public ', ' drinking ', ' Devices ', ' Reporting ', ' disorder later incidence prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' Chest ', ' Thorax ', ' Thoracic ', ' Thorace ', ' craving ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' prevent ', ' preventing ', ' Data ', ' Measurable ', ' Collection ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' Monitor ', ' Text ', ' developmental ', ' Development ', ' Electronic Health Record ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' cost ', ' drug relapse ', ' reincarceration ', ' rearrest ', ' digital ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' next generation ', ' Outcome ', ' Population ', ' Vehicular crash ', ' Vehicular collision ', ' Motor vehicle crash ', ' Motor vehicle collision ', ' Car crash ', ' Car collision ', ' Automobile crash ', ' Automobile collision ', ' Vehicle crash ', ' usability ', ' stem ', ' addictive disorder ', ' addiction ', ' prototype ', ' high risk ', ' effective intervention ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' heart rate variability ', ' mobile app ', ' mobile application ', ' support network ', ' opiate use disorder ', ' opioid use disorder ', ' predictors of outcomes ', ' predictive outcomes ', ' outcome prediction ', ' predict relapse ', ' relapse prediction ', ' relapse risk ', ' opioid crisis ', ' opiate crisis ', ' opioid epidemic ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' opioid mortality ', ' wearable sensor ', ' wearable device ', ' Prescription overdose ', ' Prescription drug overdose ', ' ']",NIDA,"BEHAIVIOR, LLC",R43,2018,223791,PA-18,0.17529018563470494
"Leveraging Social Media for Substance Use Behavioral Insight  Project Summary Substance misuse places a tremendous burden on individuals and society and remains high because so many youth initiate substance use at an early age and progress to dependence. In one of my NIDA sponsored R01s, I am funded to examine the effects of school and state-level penalties on youth substance use behaviors while accounting for anti-tobacco/drug media campaigns (R01 DA032843). My research signals a health issue of increasing importance that is youth exposure to the promotion of alcohol, tobacco, and other drug-related content via advertisements, online social networking, and other normalizing and pro-use messages. There is potential for leveraging social media as a tool to understand, inform, and potentially dissuade harmful substance use behaviors. However, a critical and necessary first step is to better understand displayed substance use references on key social media sites and how these displays are associated with use. In my second NIDA-sponsored R01, I am funded to investigate the implications of social media content and engagement for alcohol and marijuana use (R01 DA039456). I am a newly tenured investigator who has already made important contributions to the study of substance use policy and social media research. I will investigate social media posts for novel insight into drug use, especially newly emerging drugs that are increasing in popularity. I also aim to generate a strong scientific base about social media as a potential medium for delivering anti-/pro- substance use messages to young people. At this juncture, it is critical for me to receive support from this Independent Scientist Award so that I can devote all of my efforts towards continuing to build my research program and to enhance my scientific skills and advance me to the next level of achievement. I will collaborate with investigators at Washington University and nationally in order to gain further experience in sophisticated and efficient data mining analysis. I will additionally achieve an improved ability to synthesize results across multiple studies into strategic and actionable recommendations for tailored prevention messages to deliver on social media. This award will also enable me to devote a substantial amount of time to mentorship and the development of the next generation of researchers. In summary, this Independent Scientist Award will enable me to expand my knowledge base in targeted areas to significantly enhance my research trajectory in ways that would not be otherwise feasible. Project Narrative This study is significant to the public health field because it will harness social media posts for novel insight into drug use, especially newly emerging drugs that are increasing in popularity. This application requests 5 years of funding to support protected research time for Dr. Cavazos to learn and apply new skills in state-of-the-art big data analysis and to synthesize her results across studies into strategic and actionable recommendations for tailored prevention messages to deliver on social media.",Leveraging Social Media for Substance Use Behavioral Insight ,9548190,K02DA043657,"['Accounting ', ' Achievement ', ' Achievement Attainment ', ' Age ', ' ages ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Attitude ', ' Award ', ' Behavior ', ' Belief ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Data Sources ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Grant ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Health ', ' Influentials ', ' Leadership ', ' Learning ', ' Marijuana ', ' marihuana ', ' Mentors ', ' Mentorship ', ' Methods ', ' Minority Groups ', ' Mission ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Productivity ', ' Public Health ', ' Recommendation ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Wages ', ' Salaries ', ' Schools ', ' medical schools ', ' school of medicine ', ' medical college ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Societies ', ' Substance Addiction ', ' Substance Dependence ', ' Substance Use Disorder ', ' Survey Methodology ', ' Survey Method ', ' Educational process of instructing ', ' Teaching ', ' Technology ', ' Time ', ' Tobacco ', ' Universities ', ' Washington ', ' Work ', ' Cost Sharing ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Youth ', ' Youth 10-21 ', ' analytical method ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' insight ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' Policies ', ' Research Activity ', ' drug use ', ' Drug usage ', ' Funding ', ' Exposure to ', ' Shapes ', ' tool ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' programs ', ' Complex ', ' Dependence ', ' Pattern ', ' interest ', ' experience ', ' knowledge base ', ' knowledgebase ', ' skills ', ' expectation ', ' novel ', ' Media Campaign ', ' member ', ' hookah ', ' waterpipe ', ' water pipe ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' Positioning Attribute ', ' Position ', ' career development ', ' Advertisements ', ' Latina ', ' Latinas ', ' health disparity ', ' disparity in health ', ' prevent ', ' preventing ', ' data mining ', ' datamining ', ' Address ', ' Data ', ' Independent Scientist Award ', ' K02 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' underrepresentation of minorities ', ' under-represented minority ', ' under-representation of minorities ', ' Underrepresented Ethnic Minority ', ' Underrepresented Minority ', ' trend ', ' developmental ', ' Development ', ' Behavioral ', ' youth substance use ', ' substance use among youth ', ' substance use among adolescents ', ' adolescent substance use ', ' next generation ', ' addictive disorder ', ' addiction ', ' web-based social networking ', ' social networking web site ', ' social networking site ', ' online social networking ', ' social networking website ', ' social implication ', ' Secure ', ' BigData ', ' Big Data ', ' ecigarette ', ' ecig ', ' e-cigarette ', ' e-cig ', ' Electronic cigarette ', ' cannabis use ', ' THC use ', ' THC co-use ', ' marijuana use ', ' associate professor ', ' associate faculty ', ' mid-career faculty ', ' learning method ', ' learning activity ', ' learning strategy ', ' social media ', ' Data Analytics ', ' substance misuse ', ' ']",NIDA,WASHINGTON UNIVERSITY,K02,2018,118137,MO-01,0.042549820513271
"Using Machine Learning to Predict Problematic Prescription Opioid Use and Opioid Overdose Problematic prescription opioid use, defined as nonmedical use, misuse, or abuse of opioid medications, is epidemic in the US. Prescription opioid overdose deaths more than quadrupled from 1999 to 2015. Efforts by health care systems and payers to combat the opioid epidemic are impeded by a lack of accurate and efficient methods to identify individuals most at risk for problematic opioid use and overdose, leading to broad interventions that are burdensome to patients and expensive for payers. Payers are currently defining high risk and targeting interventions (e.g. pharmacy lock-in programs) based on individual risk factors, such as high opioid dosage, identified in prior studies using traditional statistical approaches. However, these traditional approaches have significant limitations, especially when handling large datasets with numerous variables, multi-level interactions, and missing data. Moreover, the prior studies focused on identifying risk factors rather than predicting actual risk. Alternatively, machine learning is an advanced technique that handles complex interactions in large data, uncovers hidden patterns, and yields precise prediction algorithms that, in many cases, are superior to those developed using traditional methods. Machine learning is widely used in activities from fraud detection to cancer genomics, but has not yet been applied to address the opioid epidemic. Accordingly, the proposed study will apply machine learning to develop prediction algorithms that can more accurately identify patients at high risk of problematic opioid use and overdose using data sources that are readily available to payers and health care systems. The project will build on existing academic-state partnerships to apply novel machine learning approaches to administrative claims data for all Medicaid beneficiaries in Pennsylvania (PA) and Arizona (AZ). The project will also link Medicaid data in AZ to electronic health records to capture clinical information (e.g., lab results, pain severity) not available in administrative data, along with death certificate data on lethal overdose. These data, covering 2007-2016, will be used to achieve two specific aims: (1) to develop and validate two separate prediction algorithms to identify patients at risk of problematic opioid use and opioid overdose; (2) to compare the accuracy of a prediction algorithm that integrates clinical data with Medicaid claims versus a claims-based approach alone to identify patients at risk of problematic opioid use and opioid overdose. The machine learning approaches will include random forests and TreeNet with representative classification trees, and the predictive ability (e.g., misclassification rates) of these algorithms will be compared to traditional statistical models. Given the high prevalence of mental health/substance use disorders (~50%) and opioid utilization (>20%) among Medicaid enrollees and the lack of adequate prediction algorithms, Medicaid is an ideal setting for the proposed project. These analyses will provide the partnering Medicaid programs with valuable information and tools that they can apply to more precisely target interventions to prevent problematic opioid use and overdose. Prescription opioid overdose deaths quadrupled from 1999 to 2015, and drug overdose is now the leading cause of injury deaths among adults in the United States. This project will use innovative machine learning methods and readily available data for Medicaid beneficiaries in two states hard hit by the epidemic  Pennsylvania and Arizona  to develop algorithms to accurately predict who is at risk of problematic prescription opioid use and overdose. This information will empower health systems, payers, and policymakers to more effectively target interventions to prevent prescription opioid misuse and its consequences.",Using Machine Learning to Predict Problematic Prescription Opioid Use and Opioid Overdose,9547370,R01DA044985,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Algorithms ', ' Arizona ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Classification ', ' Systematics ', ' Data Sources ', ' Cessation of life ', ' Death ', ' Death Certificates ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Epidemic ', ' Fraud ', ' Healthcare Systems ', ' Health Care Systems ', ' Hospitals ', ' Inpatients ', ' Medicaid ', ' Mental Health ', ' Psychological Health ', ' Mental Hygiene ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Morphine ', ' Statex SR ', ' Roxanol ', ' Oramorph SR ', ' Oramorph ', ' Morphia ', ' MSir ', ' MS Contin ', ' Kadian ', ' Infumorph ', ' Overdose ', ' Pain ', ' Painful ', ' Patients ', ' Pennsylvania ', ' Pharmacy facility ', ' Pharmacies ', ' Research ', ' Risk ', ' Risk Factors ', ' Substance Use Disorder ', ' Time ', ' Trees ', ' United States ', ' United States Centers for Medicare and Medicaid Services ', ' United States Health Care Financing Administration ', ' Health Care Financing Administration ', ' Centers for Medicare and Medicaid Services ', ' Urine ', ' Urine Urinary System ', ' Work ', ' forest ', ' Managed Care ', ' Data Set ', ' Dataset ', ' Injury ', ' base ', ' dosage ', ' Clinical ', ' Logistic Regressions ', ' Link ', ' Ensure ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' Opiates ', ' Opioid ', ' Fees for Service ', ' Fee-for-Service Plans ', ' Letters ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' milligram ', ' Severities ', ' Complex ', ' Pattern ', ' Techniques ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' American ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' prevent ', ' preventing ', ' Address ', ' Dose ', ' Health system ', ' Data ', ' Detection ', ' High Prevalence ', ' Subgroup ', ' Clinical Data ', ' Characteristics ', ' beneficiary ', ' Electronic Health Record ', ' oncogenomics ', ' cancer genomics ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' Prevalence ', ' innovative ', ' innovate ', ' innovation ', ' service utilization ', ' high risk ', ' combat ', ' non-medical use ', ' nonmedical use ', ' prescription opiate abuse ', ' opioid prescription drug abuse ', ' opioid medication abuse ', ' prescription opioid abuse ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' prescription opioid ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' Emergency department visit ', ' clinical predictors ', ' model building ', ' learning method ', ' learning activity ', ' learning strategy ', ' predictor algorithm ', ' predictive algorithm ', ' prediction algorithm ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid use ', ' opioid crisis ', ' opiate crisis ', ' opioid epidemic ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid overdose ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' opioid mortality ', ' overdose risk ', ' Drug Screening ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' prescription opioid misuse ', ' Prescription opiate overdose ', ' Prescription opioid overdose ', ' ']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2018,585626,PA-18,0.15557263532670262
"Using existing data to understand and ameliorate risk in opioid agonist therapy PROJECT SUMMARY/ABSTRACT The United States is in the midst of an opioid epidemic, leading to unprecedented levels of overdose deaths and other harms. Effective treatment for opioid use disorders is available, in the form of opioid agonist therapy (OAT) with methadone or buprenorphine. However, there are significant questions about the risk of adverse clinical outcomes, including mortality and hospitalization during and after treatment, and unplanned treatment cessation. What is the magnitude of these risks, and what patient, treatment setting, and provider factors may contribute to or protect against risk? Additionally, it is increasingly clear that more sophisticated approaches to patient assessment and treatment planning than are currently used are needed to minimise risk. We aim to: 1. Determine the magnitude of risk for specific adverse clinical outcomes (e.g. mortality, hospitalization and ED presentation, and unplanned treatment cessation) during and after OAT with methadone and buprenorphine; 2. Identify patient, treatment setting, and provider risk factors associated with adverse clinical outcomes during and after OAT with methadone and buprenorphine; and 3. Develop a risk prediction model to identify patients at greatest risk of adverse clinical outcomes during and after OAT. To achieve these aims, this project will use existing population-based Australian data on OAT, linked to several health and criminal justice datasets to provide a rich understanding of treatment exposures and outcomes. These data will be used to inform strategies to guide the delivery of high-quality treatment for opioid use disorder in the United States. Specifically, the project will provide data about the magnitude of risk of adverse clinical outcomes during specific treatment and post-treatment periods, and identify patient, treatment setting and provider factors that influence risk. Additionally, it will use innovative machine learning techniques to demonstrate the potential for routinely collected data to be used to assess patient risk at point-of-care, allowing for the development of tailored treatment plans that minimize risk and maximize treatment retention. PROJECT NARRATIVE Opioid agonist therapy is an effective treatment for opioid use disorder, including prescription opioid use disorder. However, important questions about safety and risks during treatment remain unanswered. This study will examine risk and protective factors for death, hospitalization, and unplanned treatment cessation during and after opioid agonist therapy.",Using existing data to understand and ameliorate risk in opioid agonist therapy,9564860,R01DA044170,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Buprenorphine ', ' Comorbidity ', ' co-morbidity ', ' Cessation of life ', ' Death ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Epidemic ', ' Goals ', ' Health ', ' Recording of previous events ', ' History ', ' Hospitalization ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methods ', ' mortality ', ' Persons ', ' New South Wales ', ' Overdose ', ' Patients ', ' Prisons ', ' Probability ', ' Research ', ' Risk ', ' Risk Factors ', ' Safety ', ' Time ', ' United States ', ' Criminal Justice ', ' forest ', ' Risk Assessment ', ' Specialist ', ' Data Set ', ' Dataset ', ' base ', ' Clinical ', ' Specified ', ' Specific qualifier value ', ' Link ', ' Training ', ' Logistics ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Event ', ' Clinic ', ' treatment duration ', ' treatment days ', ' Treatment Period ', ' Techniques ', ' experience ', ' treatment planning ', ' Neoadjuvant Therapy ', ' Neoadjuvant Treatment ', ' Neoadjuvant ', ' NEOADJ ', ' Induction Therapy ', ' novel ', ' Modeling ', ' response ', ' Withholding Treatment ', ' treatment cessation ', ' cessation of treatment ', ' Adverse event ', ' Adverse Experience ', ' Provider ', ' Data ', ' developmental ', ' Development ', ' point of care ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' Outcome ', ' scale up ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' population based ', ' effective treatment ', ' effective therapy ', ' overdose death ', ' risk minimization ', ' population health ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' prescription opioid ', ' adverse consequence ', ' adverse outcome ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' Patient risk ', ' learning method ', ' learning activity ', ' learning strategy ', ' opiate use disorder ', ' opioid use disorder ', ' predictor algorithm ', ' predictive algorithm ', ' prediction algorithm ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid use ', ' opioid crisis ', ' opiate crisis ', ' opioid epidemic ', ' opioid agonist treatment ', ' opioid agonist therapy ', ' protective factors ', ' ']",NIDA,UNIVERSITY OF NEW SOUTH WALES,R01,2018,197617,,0.15256551575063096
"Neural basis of smoking relapse     DESCRIPTION (provided by applicant): Smoking is the greatest preventable cause of mortality and a significant economic burden. Even with the best available treatments, most smokers relapse within days or weeks after a quit attempt. To improve quit rates significantly, we need a more refined mechanistic understanding of why so many smokers who attempt to quit will relapse quickly. The proposed functional magnetic resonance imaging (fMRI) study integrates concepts and tools from the fields of cognitive neuroscience and behavioral science to determine how brain states in early abstinence influence clinical outcomes among treatment-seeking smokers. The primary aims of this hypothesis-driven study are: (1) to identify brain mechanisms that increase vulnerability to smoking relapse, and (2) to test an integrated brain-behavior model of smoking relapse. Using our validated fMRI-based abstinence challenge paradigm, 200 treatment-seeking smokers will complete two 1-hour pre- treatment fMRI scans: after smoking satiety and after 24 hours of confirmed abstinence. We will examine neural and behavioral responses during performance of validated tasks probing working memory, cue reactivity, and stress response as well as resting state functional connectivity. Participants will then set a target quit date, receive smoking cessation counseling, and be monitored for 6-months to assess time (days) to relapse, using a validated smoking relapse protocol. The primary outcome is time to relapse. Secondary outcomes include abstinence symptoms and smoking status at 30 days. For human subjects reasons, relapsing smokers will be offered an opportunity to receive 8 weeks of nicotine patch treatment and counseling free of charge following study completion. Although neuroimaging is not likely to become a standard pre- cessation assessment the near future, this study will elucidate pathological neurobehavioral processes and specific neurocognitive domains that can be targeted in new treatments to aid smoking cessation. PUBLIC HEALTH RELEVANCE: This project will clarify why the majority of smokers relapse quickly following a quit attempt.",Neural basis of smoking relapse,9412447,R01DA041402,"['Affect ', ' Behavioral Sciences ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Charge ', ' Classification ', ' Systematics ', ' Counseling ', ' Cues ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Exhibits ', ' Future ', ' Insula of Reil ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Short-Term Memory ', ' working memory ', ' Shortterm Memory ', ' Immediate Memory ', ' Methods ', ' mortality ', ' Nicotine Withdrawal ', ' Nucleus Accumbens ', ' Relapse ', ' Resources ', ' Research Resources ', ' Rest ', ' Risk ', ' Role ', ' social role ', ' Satiation ', ' satiety ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Smoke ', ' Smoking ', ' Stress ', ' Psychological Stress ', ' Psychologic Stress ', ' Task Performances ', ' Testing ', ' Time ', ' Measures ', ' smoking cessation ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' Mediating ', ' biological adaptation to stress ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' Prefrontal Cortex ', ' base ', ' human subject ', ' improved ', ' Left ', ' Anterior ', ' Medial ', ' Clinical ', ' psychological ', ' psychologic ', ' Evaluation ', ' memory dysfunction ', ' Memory Deficit ', ' Memory impairment ', ' tool ', ' Smoker ', ' nicotine patch ', ' Nicotine Skin Patch ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Investigation ', ' Hour ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' Neurocognitive ', ' behavior change ', ' Performance ', ' behavior measurement ', ' behavioral measurement ', ' behavioral measure ', ' cingulate cortex ', ' relating to nervous system ', ' neural ', ' neuroimaging ', ' neuro-imaging ', ' novel ', ' Participant ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Patient Self-Report ', ' Self-Report ', ' Ventral Striatum ', ' cue reactivity ', ' Modeling ', ' craving ', ' response ', ' MRI Scans ', ' Magnetic Resonance Imaging Scan ', ' nicotine replacement ', ' Nicotine Replacement Therapy ', ' Symptoms ', ' Economic Burden ', ' Cognitive ', ' Smoking Status ', ' Pathologic ', ' Monitor ', ' Process ', ' Behavioral ', ' blood oxygenation level dependent ', ' blood oxygen level dependent ', ' pathway ', ' Pathway interactions ', ' neurobehavioral ', ' Outcome ', ' prospective ', ' neural mechanism ', ' neuromechanism ', ' cognitive neuroscience ', ' Impairment ', ' Abstinence ', ' brain behavior ', ' cognitive control ', ' public health relevance ', ' multimodality ', ' primary outcome ', ' secondary outcome ', ' smoking relapse ', ' stress reactivity ', ' behavior response ', ' behavioral response ', ' relapse risk ', ' imaging study ', ' high dimensionality ', ' smoking abstinence ', ' cue to smoke ', ' smoking cue ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2018,613163,PA-03,0.09122822795463399
"Predicting Stimulant Use Relapse using Neuroimaging Techniques Project Summary / Abstract  Neuroimaging methodologies, including electroencephalography (EEG), event-related potentials (ERPs), and both structural and functional magnetic resonance imaging (s/fMRI) have emerged as significant predictors of substance use relapse. These neuroimaging techniques have helped provide an objective, sensitive, and predictive measure of substance use relapse propensity. As the capabilities of biological science advance, a lingering impediment to progress is the study of individual brain regions implicated in predicting substance use relapse. Important to note, individual brain regions rarely work independently; rather, such regions often work in concert, as specific networks, continually sending and receiving information to other regions, to help facilitate learning, memory, and other cognitive processes. The investigation of ICA-derived functional network connectivity between brain regions may lend incremental utility for classifying, diagnosing, and predicting substance use relapse.  Here, using the worlds largest forensic database, which includes clinical and neuropsychological measures, electrophysiological measures, functional neuroimaging, and functional network connectivity measures, the primary goal of this project will be to delineate specific risk factors predictive of eventual stimulant use relapse propensity. This will be accomplished by integrating models incorporating logistic and Cox proportional-hazard regressions, and cross-validation machine learning pattern classifiers to predict stimulant use relapse one year after institutional release with an at-risk sample of adult incarcerated offenders.  First, we will examine the potential of various clinical and neuropsychological assessment measures in predicting stimulant use relapse. Second, we will investigate the predictive utility of error-monitoring neural measures using traditional ERPs and fMRI in predicting stimulant use relapse. Third, we will apply more agnostic, data-driven methods, including ICA-derived functional network connectivity analyses of fMRI data to measure functional connectivity between brain regions involved in error-processing to predict stimulant use relapse. Ultimately, this research will lend incremental utility in the successful prediction of stimulant use relapse, providing a more sensitive and predictive measure compared to previous investigations. The ultimate goal of the proposed training fellowship is to help provide a more biologically informed taxonomy of neurocognitive deficits associated with those prone to stimulant use relapse. Project Narrative  Prevalence estimates indicate that roughly half of incarcerated offenders meet criteria for previous history of substance use disorders (SUDs) (Center for Behavioral Health Statistics and Quality, 2015), with a majority (66.7%) relapsing within three years of institutional release (Langan & Levin, 2002). Identifying specific risk factors, including neurocognitive measures involved in predicting stimulant use relapse following release from custody could lead to important insights into this high-risk sample. The research proposed here will examine brain anatomy, function and connectivity, and psychological traits using the world's largest multi- modal database of its kind from an incarcerated sample to directly aid the development of more contemporary, scientifically-validated taxonomy of the pathophysiology related to neurocognitive deficits associated with stimulant use relapse propensity.",Predicting Stimulant Use Relapse using Neuroimaging Techniques,9565939,F31DA043328,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Anatomy ', ' Anatomy Qualifier ', ' Anatomical Sciences ', ' Anatomic structures ', ' Anatomic Structures and Systems ', ' Anatomic Structure, System, or Substance ', ' Anatomic Sites ', ' Anatomic ', ' Anxiety ', ' Attention ', ' Basal Ganglia ', ' Basal Nuclei ', ' Biological Sciences ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Diagnosis ', ' Education ', ' Educational aspects ', ' Electroencephalography ', ' EEG ', ' Electrophysiology (science) ', ' electrophysiological ', ' Neurophysiology / Electrophysiology ', ' Electrophysiology ', ' Fellowship ', ' Forensic Medicine ', ' Forensics ', ' Goals ', ' hemodynamics ', ' Recording of previous events ', ' History ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Memory ', ' Methods ', ' Methodology ', ' Neuropsychology ', ' neuropsychologic ', ' Neuropsychologies ', ' New Mexico ', ' Regression Analysis ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Relapse ', ' Research ', ' Risk ', ' Risk Factors ', ' statistics ', ' Substance Use Disorder ', ' Work ', ' Measures ', ' depressive symptoms ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' Taxonomy ', ' General Taxonomy ', ' Prefrontal Cortex ', ' court ', ' image evaluation ', ' Image Analyses ', ' Image Analysis ', ' Anterior ', ' Dorsal ', ' Clinical ', ' incarceration ', ' incarcerated ', ' Imprisonment ', ' Biological ', ' psychological ', ' psychologic ', ' Logistic Regressions ', ' Training ', ' insight ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' data base ', ' Data Bases ', ' Databases ', ' Logistics ', ' Populations at Risk ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Functional disorder ', ' event related potential ', ' Event-Related Potentials ', ' instrument ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Knowledge ', ' Investigation ', ' Pattern ', ' Techniques ', ' Neurocognitive ', ' experience ', ' cingulate cortex ', ' hazard ', ' Biological Neural Networks ', ' neural network ', ' relating to nervous system ', ' neural ', ' trait ', ' neuroimaging ', ' neuro-imaging ', ' Participant ', ' Predictive Factor ', ' Modality ', ' offender ', ' criminal offender ', ' Reporting ', ' Impulsivity ', ' Modeling ', ' Sampling ', ' behavioral health ', ' response ', ' Brain region ', ' Age-Years ', ' Data ', ' Cognitive ', ' Validation ', ' Monitor ', ' developmental ', ' Development ', ' psychopathy ', ' psychopathic personality ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' neurocognitive impairment ', ' neurocognitive decline ', ' IQ Deficit ', ' Neurocognitive Deficit ', ' Clinical assessments ', ' independent component analysis ', ' Prevalence ', ' high risk ', ' IRBs ', ' IRB ', ' Institutional Review Boards ', ' cognitive process ', ' symptomatology ', ' predict relapse ', ' relapse prediction ', ' imaging study ', ' stimulant use ', ' ']",NIDA,UNIVERSITY OF NEW MEXICO,F31,2018,27846,NM-01,0.06317484697090106
"Biosignatures of opioid addiction treatment success The United States has experienced a four-fold increase in medical opioid use over the last two  decades. Medical opioid abuse and addiction have increased and afflict 5% and 2% of US adults  respectively; heroin addiction afflicts 0.5% of US adults. In 2016, >39,000 US individuals died of  a medical opioid, illicit opiate or synthetic opioid overdose, an increase of 18% from 2015. While  opioid addiction treatment admissions and treatment capacity have increased many-fold over the last  two decades, patient needs greatly exceed capacity. Medication assisted treatment (MAT) approaches for opioid use disorder include three approved  pharmacotherapies combined with psychosocial and supportive therapies. Active investigations are  evaluating established and novel therapies for opioid detoxification prior to MAT. MATs have  established but limited efficacy in treating opioid use disorders compared to placebo  pharmacotherapy. Patients treated with MATs have mortality rates during and after treatment that  exceed population mortality rates. Improving efficacy through personalized treatment is essential  to optimize MAT resources and reduce mortality. Biosignatures of opioid addiction treatment success offers a data science solution that aligns  with NIDA priorities and Institute of Medicine (IOM) guidance to expand use of MAT, and with HHS  priorities to support cutting edge research on pain and addiction. Our overall aim is to decode the  predictors of MAT success and enable health care providers to improve treatment efficacy using  accurate forecasting. In Aim 1, we will create a platform for applying learning algorithms to existing and future opioid  addiction treatment data. We will organize and merge clinical, treatment, and outcome variables  from clinical trials of opioid addiction treatment publicly available through the NIDA Data Share  resource. We will import these data into a database optimized for high dimensional data analysis.  Workflows will be developed to apply multiple Bayesian learning algorithms to the data. In Aim 2,  using the biosignature learning platform, we will identify sets of variables that together predict  opioid addiction treatment success. We will apply this platform to each trial independently, and  then to multiple trials in an integrative analysis. The learned biosignatures will be ranked by how  well they predict treatment success. The best models will be incorporated into a proof-of-concept calculator. The calculator will provide treatment success scores based on the  characteristics of new patients. We will present the prototype to multiple stakeholders for  assessment. At the end of Phase I, we will have created a biosignature learning platform and a proof-of-concept  opioid addiction treatment success calculator. We plan to fully develop these components with  additional datasets and variables in Phase II. Our commercial goal is to develop licensable and  easily deployable algorithms for healthcare networks treating opioid addiction. The algorithm will  help providers understand profiles of patients likely to be successful with MAT and to personalize  treatment strategies to maximize abstinence. In this project, we are using algorithms to learn the predictors of opioid addiction treatment  success from publicly available clinical trial data. Healthcare providers can use these models to  improve their opioid addiction treatment programs.",Biosignatures of opioid addiction treatment success,9559228,R43DA046325,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Algorithms ', ' Attitude ', ' Buprenorphine ', ' Clinical Trials ', ' Clonidine ', ' Klofenil ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Disease ', ' Disorder ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Fentanyl ', ' Phentanyl ', ' Fentyl ', ' Foundations ', ' Future ', ' Goals ', ' Health Personnel ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Heroin Dependence ', ' Heroin Addiction ', ' Institute of Medicine (U.S.) ', ' NAS/IOM ', ' Institute of Medicine ', ' Learning ', ' Methadone ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' mortality ', ' Naltrexone ', ' Vivitrol ', ' ReVia ', ' Nemexin ', ' Nalorex ', ' opioid abuse ', ' opioid drug abuse ', ' opiate drug abuse ', ' opiate abuse ', ' opioid withdrawal ', ' opioid detoxification ', ' opioid detox ', ' opiate withdrawal ', ' Pain ', ' Painful ', ' Patients ', ' Phenotype ', ' Placebos ', ' sham therapy ', ' Sham Treatment ', ' Relapse ', ' Research ', ' Resources ', ' Research Resources ', ' Tramadol ', ' United States ', ' Veterans ', ' lofexidine ', ' Treatment outcome ', ' Healthcare ', ' health care ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Phase ', ' Medical ', ' Individual ', ' data base ', ' Data Bases ', ' Databases ', ' Licensing ', ' Opiates ', ' Opioid ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' Published Comment ', ' Letters ', ' Supportive care ', ' Supportive Therapy ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' psychosocial ', ' experience ', ' success ', ' treatment program ', ' Admission activity ', ' Admission ', ' Modeling ', ' Provider ', ' prevent ', ' preventing ', ' Dose ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Resource Sharing ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' Characteristics ', ' developmental ', ' Development ', ' medication adherence ', ' drug compliance ', ' drug adherence ', ' medication compliance ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Treatment Efficacy ', ' Population ', ' Prevalence ', ' Abstinence ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' addictive disorder ', ' addiction ', ' prototype ', ' treatment strategy ', ' biosignature ', ' sharing data ', ' Software Algorithm ', ' Algorithmic Tools ', ' Algorithmic Software ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' Data Scientist ', ' Data Science ', ' opiate use disorder ', ' opioid use disorder ', ' Formulation ', ' medication-assisted treatment ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid use ', ' patient profile ', ' profiles in patients ', ' clinical translation ', ' high dimensionality ', ' Opioid receptor antagonist ', ' Opiate receptor antagonist ', ' Opiate Antagonist ', ' Opioid Antagonist ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid overdose ', ' illicit opiate ', ' illicit opioid ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' opioid mortality ', ' overdose risk ', ' Opioid receptor agonist ', ' Opiate receptor agonist ', ' Opiate agonist ', ' Opioid agonist ', ' heroin intake ', ' heroin use ', ' ']",NIDA,BIOREALM,R43,2018,224152,CA-37,0.12959226802479887
"Mining Social Media Big Data for Toxicovigilance: Automating the Monitoring of Prescription Medication Abuse via Natural Language Processing and Machine Learning Methods Project Summary The problem of prescription medication (PM) abuse has reached epidemic proportions in the United States. According to a 2014 report by the Director of the National Institute on Drug Abuse (NIDA), an estimated 52 million people, have been involved in the non-medical use of PMs a significant portion of which can be classified as abuse. PMs that are commonly abused include opioids, central nervous system depressants and stimulants, and the consequences of their abuse may be severe. Increases in PM misuse and abuse over the last 15 years have resulted in increased emergency department visits, rates of addiction and overdose deaths. Due to the rapidly escalating morbidity and mortality, it is now receiving national attention. The opioid crisis, which has its root in opioid-based PM abuse, has been declared a national emergency by the president of the United States. Despite the problems associated with PM abuse, surveillance programs such as prescription drug monitoring programs (PDMPs) are inadequate and suffer from numerous shortcomings, thus limiting their usefulness in real life. Studies evaluating the long-term effects of distinct classes of PMs on cohorts of abusers are scarce and expensive to conduct. To better characterize the problem and to monitor it in real-time, new sources of information need to be identified and novel monitoring techniques need to be developed. To address these problems, our project aims to utilize social media data for performing toxicovigilance. Social media encapsulates an abundance of knowledge about PM abuse and the abusers in the form of noisy natural language text. At the heart of the proposed approach is a machine learning system that can automatically distinguish between `abuse' and `non-abuse' indicating user posts collected from social media. Using this classification system, users will be categorized into multiple groups(i) abusers, (ii) medical users and (iii) non users. The developed system will collect longitudinal data for users exposed the selected PMs via periodic collection of their publicly available posts/discussions and automatically categorize them based on age, gender and additional demographic feature, when possible. This will enable the conducting of observational studies on targeted cohorts, involving hundreds of thousands of cohort members. The cohort studies will focus on analyzing the transition rates from medical use to abuse for distinct PMs and transition rates from abuse of PMs to illicit analogs. Implementation of this data-centric framework, which will be open source, will revolutionize the mechanism by which PM abuse monitoring is performed and enable the future development of intervention strategies targeted towards specific cohorts, at the most effective time periods. Narrative Prescription Medication (PM) abuse is a major epidemic in the United States, and monitoring and studying the characteristics of the PM abuse problem requires the development of novel approaches. Social media encapsulates an abundance of data about PM abuse from different demographics, but extracting that data and converting it to knowledge requires advanced natural language processing and data-centric artificial intelligence systems. Our proposed social media mining framework will automate the process of big data to knowledge conversion for PM abuse, providing crucial insights to toxicologists about targeted populations and enabling the future development of directed intervention strategies.",Mining Social Media Big Data for Toxicovigilance: Automating the Monitoring of Prescription Medication Abuse via Natural Language Processing and Machine Learning Methods,9577760,R01DA046619,"['Affect ', ' Age ', ' ages ', ' Algorithms ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Attention ', ' Automation ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Benzodiazepines ', ' Benzodiazepine Compounds ', ' Central Nervous System Depressants ', ' CNS Depressants ', ' Classification ', ' Systematics ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' Control Groups ', ' Data Collection ', ' Cessation of life ', ' Death ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Drug abuse ', ' abuses drugs ', ' abuse of drugs ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Emergency Situation ', ' Emergencies ', ' Epidemic ', ' Fentanyl ', ' Phentanyl ', ' Fentyl ', ' Forensic Medicine ', ' Forensics ', ' Future ', ' Geographic Locations ', ' geographic site ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Goals ', ' Health ', ' Heart ', ' Hospitalization ', ' Long-Term Effects ', ' Longterm Effects ', ' Manuals ', ' Methods ', ' Mining ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Names ', ' Natural Language Processing ', ' natural language understanding ', ' Occupations ', ' Professional Positions ', ' Jobs ', ' Overdose ', ' Oxycodone ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Dihydrohydroxycodeinone ', ' Periodicity ', ' Rhythmicity ', ' Cyclicity ', ' Pilot Projects ', ' pilot study ', ' Population Characteristics ', ' Public Health ', ' Research ', ' Schools ', ' Supervision ', ' Surveys ', ' Survey Instrument ', ' Target Populations ', ' Time ', ' United States ', ' Work ', ' Gender ', ' Percocet ', ' quetiapine ', ' TimeLine ', ' Data Set ', ' Dataset ', ' Social Impacts ', ' Guidelines ', ' Natural History ', ' base ', ' Clinical ', ' Encapsulated ', ' Variation ', ' Variant ', ' Medical ', ' Training ', ' Ingestion ', ' insight ', ' Individual ', ' Opiates ', ' Opioid ', ' root ', ' Plant Roots ', ' analog ', ' Adderall XR ', ' Adderall ', ' Exposure to ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Life ', ' Investigation ', ' Event ', ' Source ', ' Pattern ', ' Techniques ', ' System ', ' Vicodin ', ' Lorcet ', ' spelling ', ' interest ', ' misuse of prescription only drugs ', ' prescription misuse ', ' prescription drug misuse ', ' nonmedical prescription drug use ', ' non-medical prescription drug use ', ' Prescription medication misuse ', ' age group ', ' cohort ', ' intervention program ', ' novel ', ' member ', ' Patient Self-Report ', ' Self-Report ', ' Categories ', ' Reporting ', ' prescription drug abuse ', ' prescription medication abuse ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Address ', ' Data ', ' Detection ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Infrastructure ', ' Infrastructure ', ' Surveillance Program ', ' Collection ', ' Observational research ', ' Observation study ', ' Observation research ', ' Observational Study ', ' Monitor ', ' Characteristics ', ' Process ', ' Text ', ' developmental ', ' Development ', ' study characteristics ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' meta data ', ' Metadata ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Outcome ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' open source ', ' demographics ', ' addictive disorder ', ' addiction ', ' treatment development ', ' intervention development ', ' develop therapy ', ' therapy development ', ' natural language ', ' non-medical use ', ' nonmedical use ', ' overdose death ', ' adverse consequence ', ' adverse outcome ', ' BigData ', ' Big Data ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' Emergency department visit ', ' learning method ', ' learning activity ', ' learning strategy ', ' social media ', ' BD2K ', ' Big Data to Knowledge ', ' medication misuse ', ' drug misuse ', ' opioid crisis ', ' opiate crisis ', ' opioid epidemic ', ' Prescription Drug Monitoring Program ', ' prescription monitoring program ', ' experimental group ', ' deep neural network ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2018,402500,PA-03,0.038403048372342284
"Digital Phenotyping for Computational Models of Relapse Prediction in Early Course Psychosis Project Summary  The candidate requests support for a four-year program of training and research to better understand how smartphone based digital phenotyping and computational methods can predict relapse and create digital phenotypes of symptoms and clinical outcomes in early course psychosis.  In the proposed training plan, the candidate will build upon his previous experiences in engineering, clinical informatics, and clinical psychiatry to perform a multidisciplinary project at Beth Israel Deaconess Medical Center. His training plan includes training in: 1) statistical methods for multivariate longitudinal analysis and predictive inference 2) the neuropsychiatric assessment of schizophrenia 3) longitudinal clinical research methodology with a focus on mobile technologies, and 4) the responsible conduct of research.  Even with appropriate care, relapse is common in early course psychosis and each episode is associated higher costs of care, poorer lifetime outcomes, and chronicity of the disease. There is a need to learn more about the personal factors associated with relapse for individual patients in order to improve risk predictions, ensure appropriate early interventions, and support coordinated specialty care services for schizophrenia. This study proposes that smartphones sensors eg (GPS, accelerometer), wearable devices like smartwatches collecting physiology, and smartphone based surveys and cognitive tests, when combined with appropriate statistical methods, can capture digital biomarkers, refereed to here as digital phenotypes, of early course psychosis that can offer personalized relapse prediction and augment population level risk factors.  This candidate's research plan seeks to: 1) propose digital phenotypes and relapse models of early course psychosis captured in an affordable and scalable manner from subject's personal smartphones as well as a wearable sensor in order to automatically collect self-report of symptoms, behaviors, cognition, and physiology 2) and evaluate the accuracy of digital phenotypes and the relapse prediction models.  This study proposes to address this hypothesis by utilizing smartphone based digital phenotyping methods, primarily through running the Beiwe app on subjects' own smartphones, to capture longitudinal data on symptoms, behaviors, cognition, and physiology across subjects' natural environments. These studies will be performed across 3.5 years in subjects with early course psychosis and range between 6 to 12 months.  The broader aim of this research is to understand the systems and processes, both personal and environmental, which contribute to relapse in early course psychosis. An understanding of the computational basis of relapse will inform better nosology, allow development of biomarkers of illness that may offer better targets for biological research, inform development of personalized interventions for psychotic illnesses, and help support early interventions for schizophrenia. Schizophrenia is a chronic and disabling disorder that is characterized by episodes of relapse, and  is thought to impact ~1.5% of the population.  Our current treatments and ability to predict  relapse early are limited by our understanding of the longitudinal course, environmental factors,  and variability of clinical presentation. This study seeks to model this complexity using  computational methods and digital phenotyping so that we may design more effective early  interventions for this disease.",Digital Phenotyping for Computational Models of Relapse Prediction in Early Course Psychosis,9505230,K23MH116130,"['Anxiety ', ' Award ', ' Awareness ', ' Back ', ' Dorsum ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Chronic Disease ', ' chronic disorder ', ' Chronic Illness ', ' Clinical Informatics ', ' Clinical Research ', ' Clinical Study ', ' Cognition ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Engineering ', ' Environment ', ' Feedback ', ' Goals ', ' Health Services Accessibility ', ' treatment access ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Hospitalization ', ' Human ', ' Modern Man ', ' Interview ', ' Israel ', ' Learning ', ' Medicine ', ' Mentors ', ' Methods ', ' Moods ', ' Ownership ', ' Phenotype ', ' Physiology ', ' Pilot Projects ', ' pilot study ', ' Productivity ', ' Prospective Studies ', ' Psychiatry ', ' Psychotic Disorders ', ' psychotic illness ', ' Psychoses ', ' Quality of life ', ' QOL ', ' Relapse ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' Running ', ' Schizophrenia ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Science ', ' Sleep ', ' medical specialties ', ' Specialty ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Time ', ' Training Programs ', ' Work ', ' Measures ', ' Research Methodology ', ' Research Methods ', ' Treatment Cost ', ' Caring ', ' base ', ' sensor ', ' improved ', ' Chronic ', ' Clinical ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Logistic Regressions ', ' Ensure ', ' Training ', ' Physical activity ', ' Individual ', ' Measurement ', ' Early Intervention ', ' tool ', ' Impaired cognition ', ' cognitively impaired ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Event ', ' In Situ ', ' System ', ' Severity of illness ', ' disease severity ', ' Medical center ', ' experience ', ' Structure ', ' Participant ', ' economic cost ', ' Patient Self-Report ', ' Self-Report ', ' disease classification ', ' nosology ', ' disorder classification ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Devices ', ' social ', ' neural circuit ', ' synaptic circuitry ', ' synaptic circuit ', ' neural circuitry ', ' Statistical Methods ', ' Modeling ', ' Caregiver Burden ', ' caregiver stress ', ' care giver stress ', ' Care giver Burden ', ' neuropsychiatry ', ' neuropsychiatric ', ' functional disability ', ' Functional impairment ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Effectiveness ', ' prevent ', ' preventing ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' Health Sciences ', ' Predictive Value ', ' Reproducibility ', ' in vivo ', ' Cognitive ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' clinical phenotype ', ' care services ', ' care systems ', ' modeling of the data ', ' model the data ', ' model of data ', ' data modeling ', ' digital ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' functional outcomes ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' cost-effective ', ' cost effective ', ' Population ', ' clinical relevance ', ' clinically relevant ', ' biological research ', ' multidisciplinary ', ' neurotoxic ', ' open source ', ' evidence base ', ' primary outcome ', ' secondary outcome ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' longitudinal course ', ' longitudinal analysis ', ' responsible research conduct ', ' RDoC ', ' Research Domain Criteria ', ' mobile health ', ' m-Health ', ' mHealth ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' Emergency department visit ', ' cognitive assessment ', ' cognitive testing ', ' precision interventions ', ' personalized intervention ', ' learning method ', ' learning activity ', ' learning strategy ', ' mobile technology ', ' mobile platform ', ' mobile computing ', ' Data Scientist ', ' Data Science ', ' biomarker development ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' Accelerometer ', ' individual patient ', ' fitbit ', ' predict relapse ', ' relapse prediction ', ' relapse risk ', ' wearable sensor ', ' wearable device ', ' care costs ', ' clinical heterogeneity ', ' ']",NIMH,BETH ISRAEL DEACONESS MEDICAL CENTER,K23,2018,191000,MA-07,0.0674534676075783
"Classifying addictions using machine learning analysis of multidimensional data ABSTRACT This Independent Scientist Award will significantly enhance my research capabilities, enabling me to become a leading quantitative investigator in the field of substance use disorders (SUDs). Specifically, it will allow me to increase my knowledge in the areas of SUD phenotypes, treatment and genetics. SUDs are clinically and etiologically heterogeneous and their classification has been difficult. This application reflects my ongoing commitment to developing an innovative and interdisciplinary research program on the classification of SUDs through quantitative analysis of multidimensional data. My extensive training in computational science and prior research on biomedical informatics have provided me with the skills to design, implement and evaluate advanced algorithms and sophisticated analyses to solve challenging problems in classifying SUDs. My ongoing NIDA-funded R01 employs a large (n=~12,000) sample aggregated from multiple genetic studies of cocaine, opioid, and alcohol dependence to develop and evaluate novel statistical models to generate clinical SUD subtypes that are optimized for gene finding. This K02 proposal extends that work to evaluate treatment outcome in refined subgroups of SUD populations using data from treatment studies for cocaine, opioid, alcohol and multiple substance dependence. This project will integrate data from diagnostic behavioral variables and genotypes, as well as biological/neurobiological features of the disorders and repeated measures of treatment outcome. The primary career development goals of this application are to: (1) understand the reliability, validity and functional mechanisms of various phenotyping methods; (2) to continue training in the genetics of addictions; and (3) to gain greater knowledge of different treatment approaches and their efficacy. A solid foundation in these areas will enhance my ability to realize the full potential of the data collected and aggregated from multiple dimensions, and to use the data to design the most clinically useful analysis and generate innovative solutions to diagnostic and predictive challenges in SUD research. Through formal coursework, directed readings, individual tutoring and intensive multidisciplinary collaboration with a diverse team of world-renowned researchers, I will receive training and collect pilot data for future R01 projects by examining (Aim I): whether clinically-defined highly heritable subtypes derived in my current R01 project predict differential treatment response; (Aim II) whether new statistical models that directly combine treatment data with behavioral, biological, and genomic data identify refined subtypes with confirmatory multilevel evidence; and (Aim III) whether there are genetic and social moderators of treatment outcome by subtype. The overall goal of this proposal is to further my independent and multidisciplinary research program in the development of statistical methods for refined classification of SUDs. The K02 award will provide me with the protected time necessary to fully engage in the training activities described that will enhance my knowledge and skills to enable me to make important, novel contributions to the genetics and treatment of SUD. PROJECT NARRATIVE This project will develop novel statistical and quantitative tools to identify homogeneous subtypes of substance use disorders (SUDs) and other complex diseases to enhance gene finding and treatment matching. The proposed project will perform secondary analyses of existing data from treatment studies of cocaine, opioid, alcohol, and mixed SUDs. The proposed novel approaches are expected to advance precision medicine approaches to SUDs by enabling treatment matching and a more refined SUD classification to gene finding.",Classifying addictions using machine learning analysis of multidimensional data,9427988,K02DA043063,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' alcohol use disorder ', ' ethanol use disorder ', ' Alcohols ', ' Alcohol Chemical Class ', ' Algorithms ', ' Classification ', ' Systematics ', ' Cluster Analysis ', ' Cluster Analyses ', ' Cocaine ', ' Combined Modality Therapy ', ' multimodality therapy ', ' combined treatment ', ' combined modality treatment ', ' combination therapy ', ' Multimodality Treatment ', ' Multimodal Treatment ', ' Multimodal Therapy ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Drug Use Disorder ', ' Electroencephalography ', ' EEG ', ' Foundations ', ' Future ', ' Genes ', ' Genetic Markers ', ' genetic biomarker ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Joints ', ' Methods ', ' Statistical Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Neurobiology ', ' neurobiological ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Reading ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk Factors ', ' Signs and Symptoms ', ' Diagnostic Findings ', ' Substance Addiction ', ' Substance Dependence ', ' Substance Use Disorder ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Training Activity ', ' training module ', ' Work ', ' Measures ', ' Treatment outcome ', ' Data Set ', ' Dataset ', ' improved ', ' Area ', ' Solid ', ' Clinical ', ' Biological ', ' Training ', ' Diagnostic and Statistical Manual of Mental Disorders-IV ', ' Diagnostic and Statistical Manual of Mental Disorders, 4th edition ', ' DSM4 ', ' DSM-4 ', ' DSM-IV ', ' Individual ', ' Opiates ', ' Opioid ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Funding ', ' Collaborations ', ' Genetic ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Dimensions ', ' Complex ', ' Pattern ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' treatment planning ', ' Biosensor ', ' biological sensor ', ' Cocaine Dependence ', ' Cocaine Addiction ', ' skills ', ' novel ', ' disease classification ', ' nosology ', ' disorder classification ', ' contingency management ', ' social ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' career development ', ' disorder subtype ', ' disease subtype ', ' disease subgroups ', ' Genomics ', ' Diagnostic and Statistical Manual of Mental Disorders ', ' Diagnostic and Statistical Manual ', ' DSM-V ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' DSM5 ', ' DSM-5 ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' Symptoms ', ' Adherence ', ' Data ', ' Independent Scientist Award ', ' K02 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Subgroup ', ' Characteristics ', ' developmental ', ' Development ', ' Behavioral ', ' biomed informatics ', ' biomedical informatics ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Computational Science ', ' Population ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' Alcohol dependence ', ' innovative ', ' innovate ', ' innovation ', ' Heritability ', ' endophenotype ', ' addictive disorder ', ' addiction ', ' therapeutic response ', ' response to treatment ', ' treatment response ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' cocaine use ', ' precision-based medicine ', ' precision medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' Genetic study ', ' neural correlate ', ' tutorial support ', ' tutoring ', ' opiate use disorder ', ' opioid use disorder ', ' predictors of outcomes ', ' predictive outcomes ', ' outcome prediction ', ' genomic data ', ' imaging genetics ', ' secondary analysis ', ' recruit ', ' biomarker utility ', ' biomarker performance ', ' ']",NIDA,UNIVERSITY OF CONNECTICUT STORRS,K02,2018,162800,CT-02,0.004427923360704689
"Effects of oxycodone on functional connectivity Project Summary Prescription opioids, e.g., oxycodone (OXY), are commonly encountered in youth and pose a significant public health problem. In addition, there are significant individual differences in subjective responses to opioids which contribute to vulnerabilities for misuse. However, little is understood about OXY's effects on brain function, or on how individual differences in these effects might relate to variations in subjective responses. Assessment of OXY's effects on brain function is critical to understanding its abuse liability a n d will provide insight into how and why this drug leads to misuse and abuse/dependence in some, but not all, individuals. This proposal will assess the effects of low-dose OXY (10mg) on whole-brain functional connectivity (FC), and explore relationships with subjective responses in healthy young adults (ages 21 to 30 years, N=40) with limited prior opioid exposure. OXY's effects on FC during both reward- processing and resting-state will be assessed using a randomized, double-blind, placebo-controlled, cross-over design incorporating multiband fMRI scanning. Subjective measures of drug response (e.g., `drug liking') will be collected before, during and after neuroimaging using NIDA PhenX measures. Neuroimaging data will be analyzed using data-driven methods to facilitate assessment of OXY's effects on FC both within hypothesized networks (e.g., salience and reward networks) as well as on patterns of between- network connectivity. Specifically, FC changes following OXY versus placebo (Aim 1) and relationships between these changes and subjective drug responses (Aim 2) will be assessed using intrinsic connectivity distribution (ICD). ICD is a data-driven, voxel-to-voxel method of assessing whole-brain connectivity patterns that is not limited by specification of seed regions or connectivity thresholds. In addition, connectome-based machine-learning will be used to build a predictive model of subjective responses to OXY using data acquired during placebo scans (Aim 3). This project will for the first time assess the effects of a prescription opioid on whole-brain FC. Understanding OXY's effects on large-scale network dynamics is crucial for understanding its abuse liability, and will guide future studies of OXY in addicted and at-risk populations. Identification of networks that are predictive of subjective responses to OXY is an essential first step toward finding a reliable biomarker of opioid response that will help to identify individuals at highest risk for misuse. Project Narrative Prescription opioids are commonly encountered and, in a small proportion of individuals, may be a precursor to heroin initiation. This project will assess the effects of low-dose oxycodone (10mg) on brain function in healthy young adults (age 21 to 30 years). It will identify brain-based predictors of subjective opioid responses (`neural fingerprints') that can be used to inform prevention and intervention efforts.",Effects of oxycodone on functional connectivity,9507053,R21DA045969,"['Age ', ' ages ', ' Behavior ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cocaine ', ' Corpus striatum structure ', ' striatal ', ' Striatum ', ' Striate Body ', ' Corpus Striatum ', ' Heroin ', ' Diamorphine ', ' Diacetylmorphine ', ' Double-Blind Method ', ' Double-Masked Study ', ' Double-Masked Method ', ' Double-Blinded ', ' Double-Blind Study ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Fingerprint ', ' Future ', ' indexing ', ' Insula of Reil ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Magnetic Resonance Imaging ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Methods ', ' Morphine ', ' Statex SR ', ' Roxanol ', ' Oramorph SR ', ' Oramorph ', ' Morphia ', ' MSir ', ' MS Contin ', ' Kadian ', ' Infumorph ', ' neurochemistry ', ' neurochemical ', ' Oxycodone ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Dihydrohydroxycodeinone ', ' Perfusion ', ' Pharmacology ', ' Phenotype ', ' Placebos ', ' sham therapy ', ' Sham Treatment ', ' Public Health ', ' putamen ', ' Questionnaires ', ' Rest ', ' Rewards ', ' Risk ', ' Seeds ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Spin Labels ', ' Time ', ' Measures ', ' Youth ', ' Youth 10-21 ', ' base ', ' Anterior ', ' Medial ', ' Variation ', ' Variant ', ' Link ', ' insight ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' cerebral ', ' Cerebrum ', ' Opiates ', ' Opioid ', ' Populations at Risk ', ' Cross-Over Designs ', ' Crossover Design ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Complex ', ' Dependence ', ' Scanning ', ' Parietal ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' System ', ' Neurocognitive ', ' Inferior ', ' interest ', ' behavior prediction ', ' behavioral prediction ', ' Biological Neural Networks ', ' neural network ', ' relating to nervous system ', ' neural ', ' Heroin Users ', ' neuroimaging ', ' neuro-imaging ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' Reporting ', ' response ', ' Lobule ', ' LBUL ', ' executive function ', ' executive control ', ' Brain region ', ' Dose ', ' Base of the Brain ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Resolution ', ' Characteristics ', ' Behavioral ', ' imaging ', ' Image ', ' Behavioral Model ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' Individual Differences ', ' twenty-one years of age ', ' twenty-one year old ', ' age 21 years ', ' age 21 ', ' 21 years of age ', ' 21 year old ', ' Abstinence ', ' reward processing ', ' high risk ', ' treatment strategy ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' monetary incentive ', ' financial reward ', ' financial incentive ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' prescription opioid ', ' learning method ', ' learning activity ', ' learning strategy ', ' connectome ', ' fMRI scan ', ' functional MRI scan ', ' opioid exposed ', ' opiate exposure ', ' opiate exposed ', ' opioid exposure ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' prescription opioid misuse ', ' opiate misuse ', ' nonmedical opioid use ', ' non-medical opioid use ', ' opioid misuse ', ' ']",NIDA,YALE UNIVERSITY,R21,2018,209375,CT-03,0.0631193534922178
"A wearable device to detect opioid overdose and to prevent death Bioresp Technologies, Inc. proposes development of RespiLife, a new wearable device to to track physiologic data for early detection of opioid overdose and to relay data and the generated alerts to relevant caregivers for further intervention. The goal is to reduce the number opioids-related deaths by early detection of overdose. Opioid epidemic death toll has quadrupled since 1999. About half of those deaths are due to prescription opioids and for the most part are unintentional. RespiLife tracks oxygen saturation, respiratory rate, and pulse rate and based on a machine learning algorithm will determine changes from the baseline and correlation of those changes with changes in medications. Our specific aims are: (1) Production of five working prototypes with their algorithm to use in our validation study. (2) A validation study to compare our data with a gold-standard device and carry out statistical analysis for evaluation of agreement and accuracy. Public health relevance: Currently we in the midst of an opioid overdose epidemic that has resulted in a four fold increase in death rate since 1999.",A wearable device to detect opioid overdose and to prevent death,9465942,R43DA045407,"['Alcohols ', ' Alcohol Chemical Class ', ' Algorithms ', ' Benzodiazepines ', ' Benzodiazepine Compounds ', ' California ', ' Cause of Death ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Communities ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Statistical Data Interpretation ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Cessation of life ', ' Death ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Emergency Situation ', ' Emergencies ', ' Epidemic ', ' Forehead ', ' Patient Care ', ' Patient Care Delivery ', ' Goals ', ' Gold ', ' Human ', ' Modern Man ', ' Industry ', ' Methods ', ' Naloxone ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Overdose ', ' Oxygen ', ' O2 element ', ' O element ', ' Pain ', ' Painful ', ' Patients ', ' Production ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Safety ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Sleep ', ' Supervision ', ' Technology ', ' Testing ', ' Tidal Volume ', ' respiratory airway volume ', ' Caregivers ', ' Care Givers ', ' Family member ', ' Specialist ', ' sleep polysomnography ', ' sleep measurement ', ' polysomnographic ', ' Somnography ', ' Sleep Monitoring ', ' Polysomnography ', ' base ', ' dosage ', ' Physiologic ', ' Physiological ', ' Medical ', ' Death Rate ', ' Evaluation ', ' Pulse Rates ', ' data base ', ' Data Bases ', ' Databases ', ' Opiates ', ' Opioid ', ' Electrical Engineering ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' programs ', ' Physiologic pulse ', ' Pulse ', ' Event ', ' Home environment ', ' Home ', ' Clinic ', ' respiratory ', ' Early Diagnosis ', ' early detection ', ' experience ', ' monitoring device ', ' Agreement ', ' validation studies ', ' Devices ', ' Reporting ', ' Positioning Attribute ', ' Position ', ' Adverse effects ', ' treatment adverse effect ', ' therapy adverse effect ', ' side effect ', ' Treatment Side Effects ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Advertisements ', ' prevent ', ' preventing ', ' Dose ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Conduct Clinical Trials ', ' Monitor ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' first responder ', ' emergency service responder ', ' emergency service personnel ', ' Emergency responder ', ' emergency service/first responder ', ' website ', ' web site ', ' designing ', ' design ', ' innovative ', ' innovate ', ' innovation ', ' addictive disorder ', ' addiction ', ' prototype ', ' public health relevance ', ' FDA approved ', ' Regimen ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' prescription opioid ', ' signal processing ', ' 911 call ', ' Emergency response ', ' opioid crisis ', ' opiate crisis ', ' opioid epidemic ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid overdose ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' opioid mortality ', ' recruit ', ' wearable sensor ', ' wearable device ', ' primary care provider ', ' care providers ', ' patient with chronic pain ', ' chronic pain patient ', ' Opioid drug user ', ' Opiate user ', ' Opioid user ', ' ']",NIDA,"BIORESP TECHNOLOGIES, INC.",R43,2018,225000,CA-14,0.08348458942376236
"Digital Phenotyping for Computational Models of Relapse Prediction in Early Course Psychosis Project Summary  The candidate requests support for a four-year program of training and research to better understand how smartphone based digital phenotyping and computational methods can predict relapse and create digital phenotypes of symptoms and clinical outcomes in early course psychosis.  In the proposed training plan, the candidate will build upon his previous experiences in engineering, clinical informatics, and clinical psychiatry to perform a multidisciplinary project at Beth Israel Deaconess Medical Center. His training plan includes training in: 1) statistical methods for multivariate longitudinal analysis and predictive inference 2) the neuropsychiatric assessment of schizophrenia 3) longitudinal clinical research methodology with a focus on mobile technologies, and 4) the responsible conduct of research.  Even with appropriate care, relapse is common in early course psychosis and each episode is associated higher costs of care, poorer lifetime outcomes, and chronicity of the disease. There is a need to learn more about the personal factors associated with relapse for individual patients in order to improve risk predictions, ensure appropriate early interventions, and support coordinated specialty care services for schizophrenia. This study proposes that smartphones sensors eg (GPS, accelerometer), wearable devices like smartwatches collecting physiology, and smartphone based surveys and cognitive tests, when combined with appropriate statistical methods, can capture digital biomarkers, refereed to here as digital phenotypes, of early course psychosis that can offer personalized relapse prediction and augment population level risk factors.  This candidate's research plan seeks to: 1) propose digital phenotypes and relapse models of early course psychosis captured in an affordable and scalable manner from subject's personal smartphones as well as a wearable sensor in order to automatically collect self-report of symptoms, behaviors, cognition, and physiology 2) and evaluate the accuracy of digital phenotypes and the relapse prediction models.  This study proposes to address this hypothesis by utilizing smartphone based digital phenotyping methods, primarily through running the Beiwe app on subjects' own smartphones, to capture longitudinal data on symptoms, behaviors, cognition, and physiology across subjects' natural environments. These studies will be performed across 3.5 years in subjects with early course psychosis and range between 6 to 12 months.  The broader aim of this research is to understand the systems and processes, both personal and environmental, which contribute to relapse in early course psychosis. An understanding of the computational basis of relapse will inform better nosology, allow development of biomarkers of illness that may offer better targets for biological research, inform development of personalized interventions for psychotic illnesses, and help support early interventions for schizophrenia. Schizophrenia is a chronic and disabling disorder that is characterized by episodes of relapse, and  is thought to impact ~1.5% of the population.  Our current treatments and ability to predict  relapse early are limited by our understanding of the longitudinal course, environmental factors,  and variability of clinical presentation. This study seeks to model this complexity using  computational methods and digital phenotyping so that we may design more effective early  interventions for this disease.",Digital Phenotyping for Computational Models of Relapse Prediction in Early Course Psychosis,9676982,K23MH116130,"['Anxiety ', ' Award ', ' Awareness ', ' Back ', ' Dorsum ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Clinical Informatics ', ' Clinical Study ', ' Clinical Research ', ' Cognition ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Engineering ', ' Environment ', ' Feedback ', ' Goals ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Hospital Admission ', ' Hospitalization ', ' Modern Man ', ' Human ', ' Interview ', ' Israel ', ' Learning ', ' Medicine ', ' Mentors ', ' Methods ', ' Moods ', ' Ownership ', ' Phenotype ', ' Physiology ', ' pilot study ', ' Pilot Projects ', ' Productivity ', ' Prospective Studies ', ' Psychiatry ', ' psychotic illness ', ' Psychoses ', ' Psychotic Disorders ', ' QOL ', ' Quality of life ', ' Relapse ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Running ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Science ', ' Sleep ', ' Specialty ', ' medical specialties ', ' Survey Instrument ', ' Surveys ', ' Technology ', ' Time ', ' Training Programs ', ' Work ', ' Measures ', ' Research Methods ', ' Research Methodology ', ' Treatment Cost ', ' Caring ', ' base ', ' sensor ', ' improved ', ' Chronic ', ' Clinical ', ' Variant ', ' Variation ', ' Physiological ', ' Physiologic ', ' Logistic Regressions ', ' Ensure ', ' Training ', ' Physical activity ', ' Individual ', ' Measurement ', ' Early Intervention ', ' tool ', ' Impaired cognition ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Complex ', ' Event ', ' In Situ ', ' System ', ' Severity of illness ', ' disease severity ', ' Medical center ', ' experience ', ' Structure ', ' Participant ', ' economic cost ', ' Patient Self-Report ', ' Self-Report ', ' disease classification ', ' nosology ', ' disorder classification ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Devices ', ' social ', ' neural circuit ', ' synaptic circuitry ', ' synaptic circuit ', ' neural circuitry ', ' Statistical Methods ', ' Modeling ', ' Caregiver Burden ', ' caregiver stress ', ' care giver stress ', ' Care giver Burden ', ' neuropsychiatry ', ' neuropsychiatric ', ' functional disability ', ' Functional impairment ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Effectiveness ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Data ', ' Detection ', ' Health Sciences ', ' Predictive Value ', ' Reproducibility ', ' in vivo ', ' Cognitive ', ' Process ', ' Development ', ' developmental ', ' Behavioral ', ' clinical phenotype ', ' care systems ', ' care services ', ' data modeling ', ' modeling of the data ', ' model the data ', ' model of data ', ' digital ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' design ', ' designing ', ' functional outcomes ', ' severe mental illness ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' Outcome ', ' cost effective ', ' Population ', ' clinically relevant ', ' clinical relevance ', ' biological research ', ' multidisciplinary ', ' neurotoxic ', ' open source ', ' evidence base ', ' primary outcome ', ' secondary outcome ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' longitudinal course ', ' longitudinal analysis ', ' responsible research conduct ', ' Research Domain Criteria ', ' RDoC ', ' mHealth ', ' mobile health ', ' m-Health ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' cognitive testing ', ' cognitive assessment ', ' personalized intervention ', ' precision interventions ', ' learning strategy ', ' learning method ', ' learning activity ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' Data Science ', ' biomarker development ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' individual patient ', ' fitbit ', ' relapse prediction ', ' predict relapse ', ' relapse risk ', ' smart watch ', ' smartwatch ', ' wearable device ', ' wearable sensor ', ' body worn sensor ', ' body sensor ', ' care costs ', ' clinical heterogeneity ', ' computational basis ', ' ']",NIMH,BETH ISRAEL DEACONESS MEDICAL CENTER,K23,2019,190676,MA-07,0.0674534676075783
"Predicting Post-treatment Relapse in Pediatric Acute Myeloid Leukemia Using Single-cell Proteomics Project Summary  Pediatric Acute Myeloid Leukemia (AML) is the most lethal hematologic malignancy in childhood, with a probability of 5-year survival at only 60%. Most children diagnosed with AML initially respond well to standard chemotherapy; however, nearly 40% eventually develop relapsed disease, which responds poorly to treatment and is fatal in the majority of patients. Although age at diagnosis, response to induction chemotherapy, and cytogenetic status have been identified as coarse prognostic factors in pediatric AML, it is still unclear what molecular features lead certain patients to relapse over others. Thus, developing an enhanced understanding of the mechanistic drivers underlying relapse in pediatric AML represents a significant area of clinical need.  Many reports indicate that there are rare, hematopoietic stem cell-like subpopulations in AML patients that resist chemotherapy and drive relapse. However, the exact characteristics of these relapse-associated cellsoften called leukemic stem cells (LSCs)are a matter of contention, with reported phenotypes spanning much of the known hematopoietic developmental continuum and differing significantly between patients and throughout the course of disease. As such, the identity and importance of these relapse-associated cells as well as their relationship to normal hematopoietic developmental processes remain mysterious.  The proposed project will examine the relationship between single-cell AML phenotypes, clinical outcomes, and normal myeloid development in 60 clinically-annotated primary samples from pediatric AML patients in order to identify relapse-associated cellular subtypes. To achieve this, we will leverage the versatility of mass cytometry, a 40-parameter single-cell proteomics platform, and machine learning in simultaneously studying the complex surface and signaling phenotypes of millions of leukemic cells from patients diagnostic and relapse bone marrow samples relative to healthy controls. Central hypothesis: We hypothesize that high-dimensional molecular profiling of primary AML cells will reveal consistent, functional phenotypes associated with relapse-driving subpopulations that computationally align with particular stages of healthy hematopoietic development and represent points of future therapeutic intervention. Aim 1: Develop methods to computationally align high-dimensional, single-cell AML phenotypes with their  most analogous developmental state along the healthy myeloid continuum. Aim 2: Utilize predictive modeling to determine the surface, signaling, and functional phenotype of AML  subpopulations predicting relapse and functionally validate these characteristics in vitro and in vivo. Project Narrative: For reasons that remain poorly understood, nearly 40% of the roughly 500 children diagnosed with acute myeloid leukemia (AML) each year in the United States will experience relapse after initially responding to treatment. To better characterize why some AML patients relapse while others do not, the proposed project will use state-of-the-art molecular profiling approaches to characterize millions of primary AML cells and their computational alignment with healthy hematopoietic development. These data will be used to construct a method of predicting at diagnosis which patients have a high risk of relapse in order to identify prognostically important cell populations that represent future therapeutic targets in the management of pediatric AML.",Predicting Post-treatment Relapse in Pediatric Acute Myeloid Leukemia Using Single-cell Proteomics,9758774,F31CA239365,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Age ', ' ages ', ' Algorithms ', ' Automobile Driving ', ' driving ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Bone Marrow ', ' Bone Marrow Reticuloendothelial System ', ' Cell Body ', ' Cells ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Cox Models ', ' Cytogenetics ', ' Death ', ' Cessation of life ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Future ', ' hemopoietic stem cell ', ' hemopoietic progenitor ', ' hematopoietic stem progenitor cell ', ' hematopoietic progenitor ', ' blood stem cell ', ' Hematopoietic Progenitor Cells ', ' Blood Precursor Cell ', ' Hematopoietic stem cells ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' leukemia ', ' Precursor B Lymphoblastic Leukemia ', ' Pre-B-Cell Leukemia ', ' B-cell precursor acute lymphoblastic leukemia ', ' B-Cell Lymphoblastic Leukemia ', ' B-Cell  Acute Lymphocytic Leukemia ', ' B-ALL ', ' B cell progenitor acute lymphoblastic leukemia ', ' Acute B-Lymphocytic Leukemia ', ' B-Cell Acute Lymphoblastic Leukemia ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Acute Myelocytic Leukemia ', ' myelosis ', ' myeloid granulocytic leukemia ', ' Nonlymphocytic Leukemia ', ' Nonlymphoblastic Leukemia ', ' Non-Lymphocytic Leukemia ', ' Non-Lymphoblastic Leukemia ', ' Myelogenous Leukemia ', ' Myelocytic Leukemia ', ' Granulocytic Leukemia ', ' Myeloid Leukemia ', ' Photoradiation ', ' Light ', ' Maps ', ' Methods ', ' mortality ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Patients ', ' Phenotype ', ' Probability ', ' Prognosis ', ' outcome forecast ', ' Relapse ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Testing ', ' Time ', ' Treatment Schedule ', ' Treatment Regimen ', ' Treatment Protocols ', ' United States ', ' Work ', ' Fluorescence-Activated Cell Sortings ', ' Fluorescence Activated Cell Sorting Fractionation ', ' Fluorescence-Activated Cell Sorting ', ' Mediating ', ' base ', ' Area ', ' Surface ', ' Clinical ', ' Childhood Acute Myeloid Leukemia ', ' Pediatric Acute Myeloid Leukemia ', ' Pediatric Acute Myelogenous Leukemia ', ' Pediatric Acute Myelogeneous Leukemia ', ' Pediatric Acute Myelocytic Leukemia ', ' Pediatric Acute Myeloblastic Leukemia ', ' Pediatric AML ', ' Childhood Acute Myelogenous Leukemia ', ' Childhood Acute Myelogeneous Leukemia ', ' Childhood Acute Myelocytic Leukemia ', ' Childhood Acute Myeloblastic Leukemia ', ' Childhood Acute Granulocytic Leukemia ', ' Childhood AML ', ' prognostic ', ' Hematopoietic ', ' hemopoietic ', ' Childhood ', ' pediatric ', ' Individual ', ' Recurrent disease ', ' Relapsed Disease ', ' cancer cell ', ' Malignant Cell ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Hematologic Neoplasms ', ' Malignant Hematologic Neoplasm ', ' Hematopoietic Cancer ', ' Hematological Tumor ', ' Hematological Neoplasms ', ' Hematological Malignancies ', ' Hematologic Malignancies ', ' Hematologic Cancer ', ' programs ', ' Myelogenous ', ' Myeloid ', ' Complex ', ' Event ', ' cell type ', ' Disease remission ', ' Remission ', ' experience ', ' Graph ', ' Reporting ', ' Therapeutic Intervention ', ' intervention therapy ', ' Cytometry ', ' Modeling ', ' Sampling ', ' Property ', ' response ', ' Proteomics ', ' Cell Cycle Regulation ', ' Cell Cycle Control ', ' STAT3 gene ', ' STAT3 ', ' leukemic stem cell ', ' Address ', ' Data ', ' Developmental Process ', ' Molecular Profiling ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Prognostic Factor ', ' Prognostic/Survival Factor ', ' General Prognostic Factor ', ' in vivo ', ' Leukemic Cell ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Xenograft Model ', ' Characteristics ', ' Molecular ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' Metadata ', ' meta data ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' design ', ' designing ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Outcome ', ' Population ', ' Resistance ', ' resistant ', ' Cancerous ', ' chemotherapy ', ' self-renewal ', ' self-renew ', ' progenitor ', ' therapeutic target ', ' high risk ', ' pediatric patients ', ' child patients ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' individual patient ', ' relapse patients ', ' molecular targeted therapies ', ' molecular targeted treatment ', ' molecular targeted therapeutics ', ' molecular subtypes ', ' molecular subsets ', ' molecular sub-types ', ' expression subtypes ', ' relapse prediction ', ' predict relapse ', ' relapse risk ', ' high dimensionality ', ' stem-like cell ', ' acute myeloid leukemia cell ', ' acute nonlymphocytic leukemia cell ', ' acute myelogenous leukemia cell ', ' acute myelocytic leukemia cell ', ' acute myeloblastic leukemia cell ', ' acute granulocytic leukemia cell ', ' ']",NCI,STANFORD UNIVERSITY,F31,2019,38650,CA-18,0.038309014444542
"Using Machine Learning to Predict Problematic Prescription Opioid Use and Opioid Overdose Problematic prescription opioid use, defined as nonmedical use, misuse, or abuse of opioid medications, is epidemic in the US. Prescription opioid overdose deaths more than quadrupled from 1999 to 2015. Efforts by health care systems and payers to combat the opioid epidemic are impeded by a lack of accurate and efficient methods to identify individuals most at risk for problematic opioid use and overdose, leading to broad interventions that are burdensome to patients and expensive for payers. Payers are currently defining high risk and targeting interventions (e.g. pharmacy lock-in programs) based on individual risk factors, such as high opioid dosage, identified in prior studies using traditional statistical approaches. However, these traditional approaches have significant limitations, especially when handling large datasets with numerous variables, multi-level interactions, and missing data. Moreover, the prior studies focused on identifying risk factors rather than predicting actual risk. Alternatively, machine learning is an advanced technique that handles complex interactions in large data, uncovers hidden patterns, and yields precise prediction algorithms that, in many cases, are superior to those developed using traditional methods. Machine learning is widely used in activities from fraud detection to cancer genomics, but has not yet been applied to address the opioid epidemic. Accordingly, the proposed study will apply machine learning to develop prediction algorithms that can more accurately identify patients at high risk of problematic opioid use and overdose using data sources that are readily available to payers and health care systems. The project will build on existing academic-state partnerships to apply novel machine learning approaches to administrative claims data for all Medicaid beneficiaries in Pennsylvania (PA) and Arizona (AZ). The project will also link Medicaid data in AZ to electronic health records to capture clinical information (e.g., lab results, pain severity) not available in administrative data, along with death certificate data on lethal overdose. These data, covering 2007-2016, will be used to achieve two specific aims: (1) to develop and validate two separate prediction algorithms to identify patients at risk of problematic opioid use and opioid overdose; (2) to compare the accuracy of a prediction algorithm that integrates clinical data with Medicaid claims versus a claims-based approach alone to identify patients at risk of problematic opioid use and opioid overdose. The machine learning approaches will include random forests and TreeNet with representative classification trees, and the predictive ability (e.g., misclassification rates) of these algorithms will be compared to traditional statistical models. Given the high prevalence of mental health/substance use disorders (~50%) and opioid utilization (>20%) among Medicaid enrollees and the lack of adequate prediction algorithms, Medicaid is an ideal setting for the proposed project. These analyses will provide the partnering Medicaid programs with valuable information and tools that they can apply to more precisely target interventions to prevent problematic opioid use and overdose. Prescription opioid overdose deaths quadrupled from 1999 to 2015, and drug overdose is now the leading cause of injury deaths among adults in the United States. This project will use innovative machine learning methods and readily available data for Medicaid beneficiaries in two states hard hit by the epidemic  Pennsylvania and Arizona  to develop algorithms to accurately predict who is at risk of problematic prescription opioid use and overdose. This information will empower health systems, payers, and policymakers to more effectively target interventions to prevent prescription opioid misuse and its consequences.",Using Machine Learning to Predict Problematic Prescription Opioid Use and Opioid Overdose,9727956,R01DA044985,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Algorithms ', ' Arizona ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Data Sources ', ' Death ', ' Cessation of life ', ' Death Certificates ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Fraud ', ' Health Care Systems ', ' Healthcare Systems ', ' Hospitals ', ' Inpatients ', ' Medicaid ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Statex SR ', ' Roxanol ', ' Oramorph SR ', ' Oramorph ', ' Morphia ', ' MSir ', ' MS Contin ', ' Kadian ', ' Infumorph ', ' Morphine ', ' Overdose ', ' Painful ', ' Pain ', ' Patients ', ' Pennsylvania ', ' Pharmacies ', ' Pharmacy facility ', ' Research ', ' Risk ', ' Risk Factors ', ' Substance Use Disorder ', ' Time ', ' United States ', ' United States Health Care Financing Administration ', ' Health Care Financing Administration ', ' Centers for Medicare and Medicaid Services ', ' United States Centers for Medicare and Medicaid Services ', ' Urine Urinary System ', ' Urine ', ' Work ', ' Managed Care ', ' Dataset ', ' Data Set ', ' Injury ', ' base ', ' dosage ', ' Clinical ', ' Logistic Regressions ', ' Link ', ' Ensure ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Opioid ', ' Opiates ', ' Fee-for-Service Plans ', ' Fees for Service ', ' Letters ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' milligram ', ' Severities ', ' Complex ', ' Pattern ', ' Techniques ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' American ', ' novel ', ' Reporting ', ' Statistical Methods ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' preventing ', ' prevent ', ' Address ', ' Dose ', ' Health system ', ' Data ', ' Detection ', ' High Prevalence ', ' Subgroup ', ' Clinical Data ', ' Characteristics ', ' beneficiary ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' cancer genomics ', ' oncogenomics ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' design ', ' designing ', ' Outcome ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' service utilization ', ' high risk ', ' combat ', ' nonmedical use ', ' non-medical use ', ' prescription opioid abuse ', ' prescription opiate abuse ', ' opioid prescription drug abuse ', ' opioid medication abuse ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' clinical predictors ', ' model building ', ' learning strategy ', ' learning method ', ' learning activity ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid mortality ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' overdose risk ', ' Drug Screening ', ' prescription opioid misuse ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' Prescription opioid overdose ', ' Prescription opiate overdose ', ' random forest ', ' classification trees ', ' ']",NIDA,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R01,2019,588500,PA-18,0.15557263532670262
"Leveraging Social Media to Identify and Connect Teens with Eating Disorders to a Mobile Guided Self-Help Mobile Intervention Project Summary Clinical or subclinical eating disorders (EDs) impact 10% of individuals in their lifetime and are marked by significant functional impairment, early mortality, chronicity, and emotional distress. ED symptoms often emerge in adolescence, with peak onset age in the teenage years. Early recognition and treatment of these devastating illnesses are needed to prevent long-term consequences and a chronic course. Most (80%) individuals with EDs, including teens with EDs (TwEDs), do not receive treatment. Due to major barriers to access and to the delivery of treatment for TwEDs, there is a need for a new model of service delivery that can identify and help TwEDs. We have studied ED-related networking on social media and have demonstrated our ability to harness social media, which is used ubiquitously among teens, to identify and efficiently recruit large numbers of TwEDs. At the same time, our team has successfully developed a guided self-help cognitive- behavioral therapy (CBT)-based mobile app, StudentBodies-Eating Disorders (SB-ED), which includes personalized coaching and interactive sessions to address key ED treatment targets and has demonstrated efficacy among college women with EDs. This tool has great potential to be adapted to address the specific needs of TwEDs. In Aim #1 of the proposed study, we will update and adapt SB-ED to create #ByeED for TwEDs by 1) simplifying language and making content relevant to adolescent issues, 2) including a rewards feature to motivate continued app use, 3) including a within-app social networking feature to facilitate group exchanges and coach-led weekly group sessions, and 4) harnessing machine learning to digest users social networking data within #ByeED to respond to potential recovery setbacks in real-time and tailor coaching interactions. Following a small focus group of TwEDs to assess initial impressions of the app, #ByeED will be piloted among 20 TwEDs recruited from Instagram, garnering feedback via a mixed methods approach on the efficiency, technical effectiveness, and satisfaction with #ByeED. The app will be further refined for a small pilot randomized controlled trial (RCT) in Aim #2, where we will again leverage Instagram for recruitment of TwEDs who are not engaged in treatment. This RCT will approximate the preliminary effectiveness of #ByeED (n=50) versus a control group (encouraging in-person treatment in their communities, n=50) in reducing ED symptoms, improving quality of life, increasing uptake of care, and impacting targets that are associated with outcomes. We will explore within-app predictors of outcomes, potential moderators of treatment effects (e.g., psychiatric comorbidity), and participant perspectives on potential additional parental involvement in #ByeED. Effect size and attrition estimates will aid in the planning of a larger RCT (R01 mechanism) where we will further expand #ByeED (e.g., automated coaching, parental involvement) and test the app on a larger scale to improve its potential to reduce the extraordinary burden of EDs among teens. Relevance to Public Health Eating disorders often emerge in adolescence and most of these teens do not receive treatment. We will use social media to reach teens networking about eating disorder behaviors and test a mobile app specifically developed for teens, including a social networking component, to help reduce eating disorder symptoms and improve their quality of life. We will also obtain teen perspectives on acceptable approaches to include parents in this intervention to inform a future version of the app.",Leveraging Social Media to Identify and Connect Teens with Eating Disorders to a Mobile Guided Self-Help Mobile Intervention,9719997,R34MH119170,"['Adolescence ', ' adolescence (12-20) ', ' 12-20 years old ', ' Anxiety ', ' Body Image ', ' body perception ', ' Body Weight ', ' cognitive behavioral treatment ', ' cognitive behavioral therapy ', ' cognitive behavioral modification ', ' cognitive behavioral intervention ', ' cognitive behavior therapy ', ' cognitive behavior modification ', ' cognitive behavior intervention ', ' Cognitive Psychotherapy ', ' Cognition Therapy ', ' Cognitive Therapy ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' Control Groups ', ' depression ', ' Mental Depression ', ' dietary ', ' Diet ', ' Food Intake ', ' Eating ', ' Eating Disorders ', ' Feedback ', ' Focus Groups ', ' Future ', ' Goals ', ' Health ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Language ', ' Mental Hygiene Services ', ' Mental Health Services ', ' Methods ', ' mortality ', ' Persons ', ' NIMH ', ' National Institute of Mental Health ', ' Parents ', ' Public Health ', ' QOL ', ' Quality of life ', ' Research ', ' Research Resources ', ' Resources ', ' Rewards ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' suicidal attempt ', ' nonfatal attempt ', ' non fatal attempt ', ' Suicide attempt ', ' Testing ', ' Time ', ' Translating ', ' Weight ', ' Woman ', ' Caring ', ' Social Network ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Age of Onset ', ' Individual ', ' Recovery ', ' satisfaction ', ' uptake ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Shapes ', ' tool ', ' restraint ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' interest ', ' college ', ' collegiate ', ' preference ', ' impression ', ' self help ', ' Participant ', ' behavior test ', ' behavioral test ', ' disorder risk ', ' disease risk ', ' outreach ', ' Prevention ', ' emotional distress ', ' feeling upset ', ' feeling distress ', ' Health Technology ', ' Healthcare Technology ', ' Health Care Technology ', ' response ', ' social stigma ', ' stigma ', ' functional disability ', ' Functional impairment ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Vulnerable Populations ', ' vulnerable group ', ' DSM-V ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' DSM5 ', ' DSM-5 ', ' Effectiveness ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Consent ', ' Data ', ' Detection ', ' Update ', ' Teenagers ', ' teenage ', ' teen years ', ' Teen ', ' Development ', ' developmental ', ' cost ', ' digital ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' parental involvement ', ' treatment effect ', ' high risk ', ' primary outcome ', ' secondary outcome ', ' treatment as usual ', ' usual care ', ' mHealth ', ' mobile health ', ' m-Health ', ' mobile application ', ' mobile app ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' social media ', ' reduced food intake ', ' reduced eating ', ' eat less ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' recruit ', ' Service delivery model ', ' healthcare delivery model ', ' health care delivery model ', ' care delivery model ', ' Service model ', ' barrier to care ', ' obstacle to healthcare ', ' obstacle to care ', ' barrier to treatment ', ' barrier to healthcare ', ' barrier to health care ', ' service delivery ', ' machine learning algorithm ', ' ']",NIMH,WASHINGTON UNIVERSITY,R34,2019,244552,MO-01,0.04525151746003194
"Telemedicine for Treatment of Opioid Use Disorder PROJECT SUMMARY: A key challenge in combating the opioid epidemic has been connecting individuals with opioid use disorder to evidence-based treatments. The President's Commission on Combating Drug Addiction and the Opioid Crisis and others have suggested that telemedicine for substance use disorder (tele- SUD) may be part of the solution. In preliminary analyses, we have found that tele-SUD use is growing rapidly, and there is widespread policy interest in Congress and state legislatures in how to accelerate this growth. The SUPPORT for Patients and Communities Act, signed into law in October 2018, includes several provisions intended to reduce barriers to tele-SUD use and will likely increase the availability of and reimbursement for tele-SUD. However, despite the widespread interest and growing use, there has never been a rigorous assessment of tele-SUD. For example, what are the different tele-SUD models being used to treat opioid use disorder, what barriers exist to greater use of tele-SUD, and is tele-SUD use associated with improved (or potentially worse) quality of care for people with opioid use disorder? To fill this knowledge gap, we propose a comprehensive national evaluation of telemedicine for opioid use disorder using data through 2021 from Medicaid, Medicare, and commercial insurance as well as a series of qualitative interviews. Our Aims are to: (1) describe the different models of how tele-SUD is being incorporated into opioid use disorder care and how this is changing over time, (2) identify regional factors associated with greater tele-SUD use for opioid use disorder, (3) examine the association between tele-SUD use and quality of opioid use disorder care received and whether this varies by model, and (4) describe existing tele-SUD programs, and identify barriers and facilitators to tele-SUD adoption and sustainability. The proposed mixed-methods study will help providers interested in using tele-SUD and inform ongoing debates about regulations and reimbursement for tele-SUD in Congress and state legislatures. Our goal is to highlight policies and practices that drive greater use of tele-SUD and explore its potential role in improving access to, and quality of, care for individuals with opioid use disorder. Our research will help inform how tele- SUD may be leveraged to combat the opioid epidemic as well as other substance use disorders, such as alcohol and methamphetamine use disorders. PROJECT NARRATIVE: Many patients with opioid use disorder have great difficulty accessing substance use disorder (SUD) treatment. Telemedicine for SUD (tele-SUD) is one potential solution, and many states and the Congress are considering laws and regulations to encourage greater tele-SUD use. In this project, our goal is to understand how tele-SUD is being used for patients, what drives the variation in use, whether tele-SUD is associated with better care, and how some providers have successfully used tele-SUD.",Telemedicine for Treatment of Opioid Use Disorder,9835697,R01DA048533,"['Adoption ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Buprenorphine ', ' Communities ', ' meeting reports ', ' Congresses ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' health insurance for disabled ', ' Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Medicare ', ' Insurance ', ' Interview ', ' Laws ', ' Medicaid ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Methods ', ' Vivitrol ', ' ReVia ', ' Nemexin ', ' Nalorex ', ' Naltrexone ', ' Persons ', ' Patients ', ' Play ', ' Recommendation ', ' Research ', ' social role ', ' Role ', ' Substance Use Disorder ', ' Time ', ' Transportation ', ' USFDA ', ' Food and Drug Administration ', ' United States Food and Drug Administration ', ' Work ', ' Measures ', ' Privacy ', ' physical handicap ', ' physical disability ', ' Physically Disabled ', ' Physically Handicapped ', ' Caring ', ' Telemedicine ', ' base ', ' rural area ', ' rural region ', ' improved ', ' Clinical ', ' Variant ', ' Variation ', ' Series ', ' Evaluation ', ' Individual ', ' Policies ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' treatment duration ', ' treatment days ', ' Treatment Period ', ' interest ', ' Visit ', ' American ', ' Speed ', ' Structure ', ' Disease model ', ' disorder model ', ' Regulation ', ' Modeling ', ' Quality of Care ', ' QOC ', ' Provider ', ' Address ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Data ', ' Improve Access ', ' Enrollment ', ' enroll ', ' Characteristics ', ' Evidence based treatment ', ' design ', ' designing ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' combat ', ' randomized trial ', ' Randomization trial ', ' screening ', ' methamphetamine use ', ' methamphetamine using ', ' METH using ', ' METH use ', ' learning strategy ', ' learning method ', ' learning activity ', ' opioid use disorder ', ' opiate use disorder ', ' improved outcome ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid mortality ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' ']",NIDA,HARVARD MEDICAL SCHOOL,R01,2019,735192,MA-07,0.13030638033529468
"Mining Social Media Messages for HIV Testing and Prevention Communication PROJECT SUMMARY With the advent of Big Data methods, social media is the proverbial low-hanging fruit to disseminate HIV prevention and testing messages on a large scale 1,2. These media already transmit messages on condom use, HIV testing, and Pre-Exposure Prophylaxis (PrEP), from government institutions, NGOs, private citizens, and community groups, but it does so in an informal way. This real-time repository of real-world health messages, along with our ability to mine and pinpoint counties that need to engage in a conversation about HIV prevention and testing, offers a unique opportunity to develop Big Data methods for geographically targeted message dissemination. Despite some interventions designed for online delivery 319, the overall potential of social media and their most promising contents (e.g., actionable messages with behavioral instructions) have surprisingly not been established to date. Our project will focus on the disease-burdened population of Men Who Have Sex With Men (MSM), and will develop a highly significant computing infrastructure (Aim 1) to automatically and continuously input social media postings from Twitter, Facebook, and Instagram, behavioral data from the American Men Internet Survey (AMIS), and HIV prevalence data from AIDSVu.org, and using that triangulation, to target counties that need social media messages about condom use, HIV testing, and/or PrEP for MSM. Using machine learning methods, the same platform will then select actionable and acceptable messages to fill county gaps. Once the platform has been refined with input from research participants who are employees of health departments, it will be used to send experimental messages (Aim 2), selected to match county needs, and to be actionable and acceptable to a group of health departments randomized to the experimental condition. The success of the experimental messages will be gauged by the hallmarks of social media, repostings, Likes, Dislike, and comment favorability, compared with the success of a random selection of HIV-relevant messages sent to a different group of health departments randomized to the control condition. The project is innovative in several ways. First, the social media messages will involve diverse inputs (text, images, videos) never before brought together in this area. Second, we are not aware of the prior use of the proposed triangulation involving epidemiological, behavioral, and social media data. Third, a method of mining naturally accruing messages will be new and transformative, allowing for the generation of live campaigns with messages selected that remain current, sustainable, and community-based by design. Further, the use of an implementation-science experiment at a large, geographically distributed, scale is highly novel. These research aims are facilitated by unique team expertise about communication and persuasion, Big Data methods, public health, and Bayesian spatio-temporal modeling, and leading institutions in the areas of psychology, public health, and computer science. PROJECT NARRATIVE  This project is concerned with identifying a method to disseminate public health information through social media in an optimal way. Findings from this project will inform prevention efforts in this area as well as in fighting other diseases in which social influences are important.",Mining Social Media Messages for HIV Testing and Prevention Communication,9785634,R01MH114847,"['Algorithms ', ' Anus ', ' Anal ', ' Awareness ', ' Communication ', ' Communities ', ' Consultations ', ' Disorder ', ' Disease ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Geography ', ' Government ', ' Health ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' Modern Man ', ' Human ', ' Illinois ', ' Information Services ', "" men's "", ' men ', ' Methods ', ' Methodology ', ' Mining ', ' Mission ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Persuasion ', ' Persuasive Communication ', ' Privatization ', ' Psychology ', ' Public Health ', ' Random Selection ', ' Random Allocation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Public Health Schools ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Silicon Dioxide ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' World Health ', ' County ', ' Employee Health ', ' Generations ', ' Measures ', ' Administrator ', ' HIV/AIDS prevention ', ' HIV Prevention ', ' AIDS prevention ', ' base ', ' Prophylactic treatment ', ' Prophylaxis ', ' Area ', ' Link ', ' Ensure ', ' Fostering ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Funding ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Respondent ', ' Published Comment ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' fighting ', ' Techniques ', ' interest ', ' Services ', ' Needs Assessment ', ' American ', ' success ', ' computer science ', ' condoms ', ' novel ', ' Participant ', ' member ', ' Prevention ', ' social ', ' HIV risk ', ' Modeling ', ' repository ', ' Institution ', ' preventing ', ' prevent ', ' HIV-2 test ', ' HIV-1 test ', ' HIV test ', ' AIDS/HIV test ', ' AIDS test ', ' Human immunodeficiency virus test ', ' Data ', ' Harvest ', ' Health Sciences ', ' International ', ' National Institute of Allergy and Infectious Disease ', ' NIAID ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Training and Infrastructure ', ' sex ', ' Text ', ' Behavioral ', ' Image ', ' imaging ', ' Instruction ', ' burden of illness ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' men who have sex with men ', ' men who have sex with other men ', ' MSM ', ' Population ', ' Prevalence ', ' innovation ', ' innovative ', ' innovate ', ' community based participatory research ', ' participatory action research ', ' community based research ', ' community based design ', ' implementation science ', ' therapy design ', ' treatment design ', ' intervention design ', ' spatiotemporal ', ' evidence base ', ' infrastructure development ', ' Big Data ', ' BigData ', ' learning strategy ', ' learning method ', ' learning activity ', ' program dissemination ', ' project dissemination ', ' social media ', ' experimental study ', ' experimental research ', ' experiment ', ' pre-exposure prophylaxis ', ' PrEP ', ' Facebook ', ' Twitter ', ' Infrastructure ', ' Big Data Methods ', ' Big Data Tools ', ' Big Data Analytics ', ' ']",NIMH,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,R01,2019,565763,IL-13,-0.04408191919491884
"Great Lakes Node of the Drug Abuse Clinical Trials Network Project Summary/Abstract In alignment with RFA-DA-19-008, this application seeks to establish the Great Lakes Node (GLN) of the NIDA-supported Drug Abuse Clinical Trials Network (CTN). This node will draw on an experienced set of investigators who have active collaborations and represent all of the major academic medical centers in the Greater Chicago and Wisconsin areas. The node will serve as a vital Midwestern hub for the CTN and will expand on the success of the CTN approach. In addition, the GLN will bring substantial experience in adolescent/young adult research, seniors/aging research, digital & mobile technologies, opioid misuse, collaborative care/population health, telehealth, and electronic health record and systems-driven interventions and research methodologies. The GLN will support engagement with CTN protocols and also add the following: Aim 1: GLN will identify and recommend substance misuse research and intervention protocols focused on systems-based practice using hospital-based screening, collaborative care, and population approaches. Aim 2: We will establish a digital and computation health core that will leverage our expertise in these domains and serve as a conduit for studies in mHealth, eHealth, artificial intelligence, natural language processing, and telehealth interventions. Aim 3: Our node will bring substantial expertise with youth/adolescent health and seniors/aging that will enable us to recommend studies to the CTN that examine the genesis of substance misuse and the potential for prevention strategies to mitigate these life-course pathways. Aim 4: In alignment with our teams expertise, we plan to support work on substance and opioid misuse that focuses on health disparities including socioeconomic, geographic, sexual orientation, and gender identity. Aim 5: Leveraging our experience in professional education and practice-based learning, our node will rigorously test the impact of professional education on opioid and substance treatment. We have built on the ECHO model to develop methods to conduct high-quality distance education and supported training that are currently being trialed in Illinois with plans to expand these programs nationally. Aim 6: GLN will expand the pipeline of early investigators interested in substance misuse research. We will align this part of our program with our very successful CTSA-supported programs and build specific subprogramming that supports addiction and substance misuse research, training, and mentorship. Project Narrative This application will establish the Great Lakes Node of the Drug Abuse Clinical Trials Network. The creation of this node will help facilitate research on substance and opioid misuse which are key components of NIH and federal government strategy to reduce the mortality and morbidity associated with the current opioid and substance epidemics. This node will support clinical trials relevant to the epidemics and also advance research in novel models of care, data analytics, mobile interventions and training.",Great Lakes Node of the Drug Abuse Clinical Trials Network,9839124,UG1DA049467,"['Academic Medical Centers ', ' University Medical Centers ', ' Aging ', ' Opioid Analgesics ', ' opioid painkiller ', ' opioid pain reliever ', ' opioid pain medication ', ' opioid anesthetic ', ' opioid analgesia ', ' opiate pain reliever ', ' opiate pain medication ', ' opiate analgesic ', ' opiate analgesia ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Buprenorphine ', ' Chicago ', ' Cities ', ' Clinical Trials ', ' Communities ', ' Death ', ' Cessation of life ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' Professional Education ', ' Epidemic ', ' National Government ', ' Federal Government ', ' Gender Identity ', ' Geography ', ' Health ', ' Hospitals ', ' Illinois ', ' Indiana ', ' Learning ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Los Angeles ', ' Mentorship ', ' Methods ', ' Midwest US ', ' Midwest U.S. ', ' Midwest ', ' Midwestern United States ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' natural language understanding ', ' Natural Language Processing ', ' New York ', ' healthcare professional practice ', ' health care professional practice ', ' Professional Practice ', ' Public Health ', ' Refugees ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Rest ', ' school of medicine ', ' medical college ', ' medical schools ', ' Testing ', ' Training Support ', ' Universities ', ' Veterans ', ' Wisconsin ', ' Work ', ' oriental ', ' Asians ', ' County ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Latino ', ' Research Methods ', ' Research Methodology ', ' Caring ', ' base ', ' rural area ', ' rural region ', ' suburb ', ' suburbia ', ' suburban ', ' urban area ', ' Area ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Sex Orientation ', ' Sexual Orientation ', ' Training ', ' Homelessness ', ' unhoused ', ' homeless ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Rural ', ' Pacific Island Americans ', ' Pacific Islander American ', ' Pacific Islander ', ' Opioid ', ' Opiates ', ' Collaborations ', ' Native Americans ', ' cooking ', ' programs ', ' Side ', ' Home environment ', ' Home ', ' Protocols documentation ', ' Protocol ', ' System ', ' interest ', ' experience ', ' success ', ' metropolitan ', ' Distance Education ', ' novel ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Vulnerable Populations ', ' vulnerable group ', ' disparity in health ', ' health disparity ', ' telehealth ', ' Health system ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Research Training ', ' socioeconomics ', ' socioeconomically ', ' socio-economically ', ' socio-economic ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' Pathway interactions ', ' pathway ', ' digital ', ' Clinical Trials Network ', ' Minority ', ' Population ', ' racial and ethnic ', ' collaborative care ', ' addiction ', ' addictive disorder ', ' overdose death ', ' population health ', ' waiver ', ' screening ', ' mHealth ', ' mobile health ', ' m-Health ', ' eHealth ', ' e-Health ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' Data Analytics ', ' adolescent health ', ' ethnic diversity ', ' ethnically diverse ', ' racial diversity ', ' racially diverse ', ' substance misuse ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid treatment program ', ' opioid misuse ', ' opiate misuse ', ' nonmedical opioid use ', ' non-medical opioid use ', ' sexual identity ', ' ']",NIDA,RUSH UNIVERSITY MEDICAL CENTER,UG1,2019,444441,IL-07,0.06706860357750141
"Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention     DESCRIPTION (provided by applicant): In recent years in the U.S., problems associated with opioid prescriptions, including non-medical use and overdose, increased to historically unprecedented levels and represent a public health crisis. Emergency departments (EDs) play an important role in opioid prescribing, particularly to individuals at high risk for adverse opioi-related outcomes. Half of all ED visits are for a painful condition, and one third of all ED visits result in an opioid being prescribed. Moreover, in our pilot work, a quarter of patients surveyed at the ED study site reported non-medical opioid use in the prior three months. Despite the importance of this problem, strategies to reduce non-medical opioid use after an ED visit have not been well-studied. Our recent trial of a motivational intervention delivered to patients in the ED by a therapist resulted in modest reductions in non- medical use after the ED visit compared to a control condition. However, the intervention was unable to address the implications of opioids prescribed as a result of the ED encounter on post-ED opioid use behavior. This project will adapt the intervention for delivery after the ED visit through mobile technology in order to directly address the use of ED-provided opioids. Patients (n=600) will be recruited during an ED visit for a randomized controlled trial of the adapted intervention based on having used opioids non-medically in the prior three months and being given an opioid by an ED prescriber. In the intervention condition, interactive voice response calls will repeatedly assess non-medical opioid use and pain level and deliver intervention content. The intervention will include several potential actions that vary in intensity: assessment only, a brief message, extended messaging, or connection to a therapist by phone. Because the most helpful intensity of intervention is unknown and likely to vary between patients, the project will use an artificial intelligence stratey called reinforcement learning (RL). The RL system will continuously ""learn"" from the success of prior actions in similar situations with similar patients in order to select the action most likelyto reduce non-medical opioid use for each participant during each call. The RCT will be complemented by qualitative interviews to inform later implementation. The specific aims are to: (1) Adapt and enhance an existing motivational intervention to decrease non-medical opioid use after an ED visit by optimizing intervention intensity and duration through RL; (2) Examine the impact of the intervention on non-medical opioid use level during the six months post-ED visit; (3) Examine the impact of the intervention on driving after opioid use, overdose risk behaviors, and subsequent opioid-related ED visits. Secondary Aims are: (1) to examine differences in intervention effects between participants with high and low baseline levels of non-medical opioid use; and (2) to understand barriers and facilitators of implementation. This project will use a highly innovative strategy, artificial intelligence, to address a highly significant problem, non-medical opioid use. Ultimately, this study can lead to reductions in opioid- related harms and move forward the field of mobile health. PUBLIC HEALTH RELEVANCE: Non-medical use of opioid pain medications has increased substantially over the last decade, and ensuring the safe use of opioids prescribed as part of medical care has become a critical public health priority. Emergency Departments (EDs) are on the front lines of this emerging public health problem. This randomized controlled trial will test the impact of a mobile health intervention, which incorporates an innovative artificial intelligenc component to determine intervention duration and intensity, on non-medical opioid use and related harms for adult ED patients treated with opioids and who have a history of non-medical opioid use.",Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention,9416993,R01DA039159,"['Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Opioid Analgesics ', ' opioid painkiller ', ' opioid pain reliever ', ' opioid pain medication ', ' opioid anesthetic ', ' opioid analgesia ', ' opiate pain reliever ', ' opiate pain medication ', ' opiate analgesic ', ' opiate analgesia ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Automobile Driving ', ' driving ', ' Behavior ', ' Complement Proteins ', ' Complement ', ' Future ', ' History ', ' Recording of previous events ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Methodology ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Out-patients ', ' Outpatients ', ' Overdose ', ' Painful ', ' Pain ', ' Patients ', ' Play ', ' Psychotherapy ', ' Public Health ', ' Reinforcement ', ' Psychological reinforcement ', ' Research ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' Safety ', ' Survey Instrument ', ' Surveys ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' Voice ', ' Work ', ' Research Methods ', ' Research Methodology ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Caring ', ' Guidelines ', ' Injury ', ' base ', ' improved ', ' Site ', ' Acute ', ' Clinical ', ' Medical ', ' Randomized Clinical Trials ', ' Ensure ', ' Individual ', ' Opioid ', ' Opiates ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' Therapeutic ', ' Severities ', ' System ', ' Abnormal coordination ', ' Lack of Coordination ', ' Incoordination ', ' Dyscoordination ', ' Coordination Disorder ', ' Co-ordination disorder ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' experience ', ' success ', ' skills ', ' Participant ', ' new technology ', ' novel technologies ', ' Reporting ', ' Health Technology ', ' Healthcare Technology ', ' Health Care Technology ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Address ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Monitor ', ' Process ', ' Emergency Care ', ' Emergency medical care ', ' Emergency healthcare ', ' Emergency health care ', ' Emergency Room care ', ' Emergency Department care ', ' ER care ', ' ED care ', ' post intervention ', ' drugged driving ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' multidisciplinary ', ' motivational intervention ', ' high risk ', ' public health relevance ', ' treatment as usual ', ' usual care ', ' intervention effect ', ' brief motivational intervention ', ' clinical practice ', ' nonmedical use ', ' non-medical use ', ' public health priorities ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' adverse outcome ', ' adverse consequence ', ' screening ', ' mHealth ', ' mobile health ', ' m-Health ', ' Emergency Department patient ', ' Emergency Room patient ', ' ER patient ', ' ED patient ', ' Emergency department visit ', ' Emergency room visit ', ' Emergency care visit ', ' ER visit ', ' ED visit ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' behavioral outcome ', ' behavior outcome ', ' learning progression ', ' continuous learning ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid therapy ', ' opiate therapy ', ' recruit ', ' overdose risk ', ' opioid misuse ', ' opiate misuse ', ' nonmedical opioid use ', ' non-medical opioid use ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2019,537201,MI-12,0.11013675004649813
"Using existing data to understand and ameliorate risk in opioid agonist therapy PROJECT SUMMARY/ABSTRACT The United States is in the midst of an opioid epidemic, leading to unprecedented levels of overdose deaths and other harms. Effective treatment for opioid use disorders is available, in the form of opioid agonist therapy (OAT) with methadone or buprenorphine. However, there are significant questions about the risk of adverse clinical outcomes, including mortality and hospitalization during and after treatment, and unplanned treatment cessation. What is the magnitude of these risks, and what patient, treatment setting, and provider factors may contribute to or protect against risk? Additionally, it is increasingly clear that more sophisticated approaches to patient assessment and treatment planning than are currently used are needed to minimise risk. We aim to: 1. Determine the magnitude of risk for specific adverse clinical outcomes (e.g. mortality, hospitalization and ED presentation, and unplanned treatment cessation) during and after OAT with methadone and buprenorphine; 2. Identify patient, treatment setting, and provider risk factors associated with adverse clinical outcomes during and after OAT with methadone and buprenorphine; and 3. Develop a risk prediction model to identify patients at greatest risk of adverse clinical outcomes during and after OAT. To achieve these aims, this project will use existing population-based Australian data on OAT, linked to several health and criminal justice datasets to provide a rich understanding of treatment exposures and outcomes. These data will be used to inform strategies to guide the delivery of high-quality treatment for opioid use disorder in the United States. Specifically, the project will provide data about the magnitude of risk of adverse clinical outcomes during specific treatment and post-treatment periods, and identify patient, treatment setting and provider factors that influence risk. Additionally, it will use innovative machine learning techniques to demonstrate the potential for routinely collected data to be used to assess patient risk at point-of-care, allowing for the development of tailored treatment plans that minimize risk and maximize treatment retention. PROJECT NARRATIVE Opioid agonist therapy is an effective treatment for opioid use disorder, including prescription opioid use disorder. However, important questions about safety and risks during treatment remain unanswered. This study will examine risk and protective factors for death, hospitalization, and unplanned treatment cessation during and after opioid agonist therapy.",Using existing data to understand and ameliorate risk in opioid agonist therapy,9749122,R01DA044170,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Buprenorphine ', ' co-morbidity ', ' Comorbidity ', ' Death ', ' Cessation of life ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Goals ', ' Health ', ' History ', ' Recording of previous events ', ' Hospital Admission ', ' Hospitalization ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Methods ', ' mortality ', ' Persons ', ' New South Wales ', ' Overdose ', ' Patients ', ' Prisons ', ' Probability ', ' Research ', ' Risk ', ' Risk Factors ', ' Safety ', ' Time ', ' United States ', ' Criminal Justice ', ' Risk Assessment ', ' Specialist ', ' Dataset ', ' Data Set ', ' base ', ' Clinical ', ' Specific qualifier value ', ' Specified ', ' Link ', ' Training ', ' Logistics ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Event ', ' Clinic ', ' treatment duration ', ' treatment days ', ' Treatment Period ', ' Techniques ', ' experience ', ' treatment planning ', ' Neoadjuvant Therapy ', ' Neoadjuvant Treatment ', ' Neoadjuvant ', ' NEOADJ ', ' Induction Therapy ', ' novel ', ' Modeling ', ' response ', ' Withholding Treatment ', ' treatment cessation ', ' cessation of treatment ', ' Adverse event ', ' Adverse Experience ', ' Provider ', ' Data ', ' Development ', ' developmental ', ' point of care ', ' Outcome ', ' scale up ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' population based ', ' effective therapy ', ' effective treatment ', ' overdose death ', ' risk minimization ', ' population health ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' adverse outcome ', ' adverse consequence ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' Patient risk ', ' learning strategy ', ' learning method ', ' learning activity ', ' opioid use disorder ', ' opiate use disorder ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid agonist therapy ', ' opioid agonist treatment ', ' protective factors ', ' random forest ', ' risk prediction model ', ' mortality risk ', ' death risk ', ' adverse event risk ', ' ']",NIDA,UNIVERSITY OF NEW SOUTH WALES,R01,2019,197617,,0.15256551575063096
"Technology Improving Success of Medication-Assisted Treatment in Primary Care Project Abstract The opioid epidemic is the U.S.'s most widespread behavioral public health problem, with a higher number of deaths due to drug overdose in 2016 compared to deaths due to HIV at the peak of the AIDS epidemic. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious. However, only a fraction of persons with OUD access MAT, and treatment non-adherence and drop out is common. There is a dire need to improve systems to address these issues and to expand the use of MAT for many patients who are out of care. This R44 STTR application responds to RFA-DA-19-020, HEAL Initiative: America's Startups and Small Businesses Build Technologies to Stop the Opioid Crisis. It joins an outstanding scientific team at UCLA and a small business that has developed, Opioid Addiction Recovery Support (OARS) -- a software platform that by integrating with the Electronic Health Record (EHR) improves clinical management of patients by primary care providers (PCPs) treating patients with OUD using MAT. OARS platform uses a dashboard to show real-time measurement of patient achievements in recovery. It provides opportunities for patients to interact with their PCPs, allowing for better connection to and support from their PCPs. OARS platform features artificial intelligence to analyze information from the EHR and from patients to provide relapse risk assessment for patients receiving MAT for OUD, an innovation that sets OARS apart from other software solutions. The specific aim of Phase 1 of this STTR Fast Track proposal, is to modify the OARS platform for use in primary care settings by conducting interviews with PCPs (N=20) and their patients with OUD (N=40) in primary care settings to collect data on feasibility and acceptability of engaging with OARS to inform user- centered design of OARS. The specific aims of Phase 2 of this STTR Fast Track proposal are to: (1) employ a stepped wedge design to assess the effectiveness of OARS in improving opioid agonist treatment outcomes across 6 treatment programs (N=200 treated patients) and (2) evaluate sustainability and return on investment of OARS implementation across 6 treatment programs. A commercialization plan documents progress to date for OARS platform and presents a market plan to improve both scale-up and quality of MAT services delivered by PCPs in primary care, which is a major contribution to addressing the ongoing opioid epidemic. ! Project Narrative With over 72,000 overdose deaths in 2017, of which 47,600 are attributable to opioid overdose, the opioid epidemic has become North Americas most widespread behavioral public health problem. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious. The Opioid Addiction Recovery Support (OARS), comprises of a healthcare team portal connected to a patient mobile application, to provide opioid related education, promote connectedness with clinicians, and track MAT treatment progress. This STTR Fast Track proposal will conduct interviews with patients that will inform optimal design of OARS and utilize a stepped wedge effectiveness design to assess the effectiveness of OARS in improving opioid agonist treatment outcomes in primary care settings and evaluate sustainability and return on investment.",Technology Improving Success of Medication-Assisted Treatment in Primary Care,9912034,R42DA050398,"['Achievement ', ' Achievement Attainment ', ' Acquired Immunodeficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immune Deficiency ', ' AIDS ', ' Americas ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Belief ', ' Continuum of Care ', ' Continuity of Care ', ' Continuity of Patient Care ', ' Death ', ' Cessation of life ', ' Dropout ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Educational aspects ', ' Education ', ' Epidemic ', ' Virus-HIV ', ' Lymphadenopathy-Associated Virus ', ' LAV-HTLV-III ', ' Human Immunodeficiency Viruses ', ' Acquired Immunodeficiency Syndrome Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' AIDS Virus ', ' HIV ', ' indexing ', ' Interview ', ' Investments ', ' Medicine ', ' Methods ', ' Persons ', ' North America ', ' Out-patients ', ' Outpatients ', ' Overdose ', ' Patients ', ' Primary Healthcare ', ' Primary Care ', ' Primary Health Care ', ' Public Health ', ' Relapse ', ' Risk ', ' Software ', ' Computer software ', ' Specialty ', ' medical specialties ', ' Technology ', ' Testing ', ' United States ', ' Work ', ' Treatment outcome ', ' Cost Savings ', ' Businesses ', ' Healthcare Team ', ' Health Care Team ', ' Medical Care Team ', ' Risk Assessment ', ' Specialist ', ' Caring ', ' Custom ', ' improved ', ' Area ', ' Clinical ', ' Phase ', ' Link ', ' insight ', ' Recovery ', ' Opioid ', ' Opiates ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Scientist ', ' Clinic ', ' System ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Visit ', ' Services ', ' empowered ', ' experience ', ' success ', ' treatment program ', ' social stigma ', ' stigma ', ' Drops ', ' Provider ', ' Effectiveness ', ' Address ', ' Length ', ' Adherence ', ' Data ', ' Clinical Management ', ' Small Business Technology Transfer Research ', ' STTR ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Development ', ' developmental ', ' Electronic Health Record ', ' electronic healthcare record ', ' electronic health care record ', ' Behavioral ', ' cost ', ' design ', ' designing ', ' Outcome ', ' scale up ', ' innovation ', ' innovative ', ' innovate ', ' Abstinence ', ' user centered design ', ' iterative design ', ' implementation science ', ' addiction ', ' addictive disorder ', ' commercialization ', ' patient population ', ' primary care setting ', ' overdose death ', ' waiver ', ' mobile application ', ' mobile app ', ' temporal measurement ', ' time measurement ', ' temporal resolution ', ' opioid use disorder ', ' opiate use disorder ', ' medication-assisted treatment ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' relapse risk ', ' dashboard ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid agonist therapy ', ' opioid agonist treatment ', ' recruit ', ' care providers ', ' primary care provider ', ' treatment services ', ' Suboxone ', ' buprenorphine/naloxone ', ' buprenorphine-naloxone ', ' buprenorphine with naloxone ', ' buprenorphine and naloxone ', ' buprenorphine + naloxone ', ' Zubsolv ', ' Bunavail ', ' phase 2 testing ', ' phase II testing ', ' phase II evaluation ', ' phase 2 evaluation ', ' ']",NIDA,"Q2I, LLC",R42,2019,225000,NH-02,0.15705829807094687
"Integration of Virtual Reality Mindfulness Application Within a Mobile-Based Recovery Platform to Support Rehab and Post-Rehab Engagement ABSTRACT Post-treatment substance use disorder (SUD) relapse rates are high (40-60% at one year), with relapse occurring early (median time to relapse 1-3 months), indicating that the transition period from inpatient care to the home environment is particularly challenging for patients seeking sobriety. Telehealth and VR technologies have the ability to greatly increase the accessibility of highly engaging recovery support. Combining these two approaches provides a unique opportunity to create a highly engaging, cost-effective take home recovery support solution targeting the critical transition from inpatient care. Sober Grid proposes to leverage its existing highly accessible social and peer coaching mobile recovery app, to develop a convenient and cost-effective integrated take-home combined VR and professional peer coaching recovery support intervention (RecoVRi) that begins in the inpatient clinic. RecoVRi is designed to increase engagement with recovery therapy during the critical transition from inpatient to home, thereby reducing the risk of relapse and associated health and monetary costs. Sober Grid is collaborating with TRIPP, Inc. to utilize TRIPPs immersive wellness platform. The design of the TRIPP experience leverages a large body of existing research on the use of VR technology in the mental wellness arena and utilizes proven mindfulness structures, targeted sound frequencies, visuals and interactions that have a multiplicative effect when administered through immersion. The Sober Grid Network will create a support wrapper to the VR experience that facilitates access to crisis management experts and community for the person in early recovery. The unique combination of a personalized and targeted self-regulation toolkit and community and professional support is a key differentiator for this service. In phase I of the project, we will develop and pilot test a proof-of-concept RecoVRi VR-mindfulness protocol and intervention to ascertain feasibility and acceptability (Aim 1). In phase II of the project, a production-quality intervention will be developed with new VR content created by the TRIPP development team specifically targeting themes supporting recovery from alcohol, stimulant and opioid SUD separately (Aim 2). We will then test post-treatment recovery support engagement in the RecoVRi intervention in comparison to treatment as usual in a randomized comparison trial involving 80 patients receiving inpatient treatment and transitioning to the home setting (Aim 3). Over the span of both phases, we will seek regulatory guidance from the FDA in order to attain clearance for use of the RecoVRi intervention as a therapeutic medical device (Aim 4). NARRATIVE Substance use treatment research findings indicate that the transition period from inpatient care to the home environment is particularly challenging for patients seeking sobriety. Sober Grid proposes to leverage its highly accessible social and peer coaching mobile recovery app to develop and test a convenient and cost-effective, integrated, take-home combined, virtual reality and professional peer coaching recovery support intervention (RecoVRi) designed to increase engagement with recovery therapy during the critical transition from the inpatient clinic to home.",Integration of Virtual Reality Mindfulness Application Within a Mobile-Based Recovery Platform to Support Rehab and Post-Rehab Engagement,9898123,R44DA050222,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Alcohols ', ' Alcohol Chemical Class ', ' Communities ', ' Feedback ', ' Focus Groups ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Immersion ', ' Immersion Investigative Technique ', ' Inpatients ', ' Medical Device ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Mission ', ' Persons ', ' Patients ', ' wellbeing ', ' well-being ', ' Personal Satisfaction ', ' Production ', ' Relapse ', ' Research ', ' Research Resources ', ' Resources ', ' Self Regulation ', ' Informal Social Control ', ' Substance Use Disorder ', ' Technology ', ' Testing ', ' Time ', ' Training Support ', ' Universities ', ' Caring ', ' base ', ' improved ', ' Clinical ', ' Phase ', ' Training ', ' Psyche structure ', ' mental ', ' Visual ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Recovery ', ' Opioid ', ' Opiates ', ' Therapeutic ', ' Scientist ', ' Well in self ', ' sense of wellbeing ', ' self wellness ', ' psychological wellness ', ' psychological wellbeing ', ' mental wellbeing ', ' mental well-being ', ' emotional wellbeing ', ' Sense of well-being ', ' Psychological Well Being ', ' Normal psyche ', ' Normal mental state ', ' Normal mental condition ', ' Feels well ', ' Emotional well being ', ' Home environment ', ' Home ', ' Clinic ', ' Protocols documentation ', ' Protocol ', ' Services ', ' experience ', ' sound frequency ', ' success ', ' Structure ', ' Participant ', ' peer ', ' treatment program ', ' member ', ' sobriety ', ' sober ', ' new technology ', ' novel technologies ', ' social ', ' virtual reality ', ' virtual world ', ' virtual environment ', ' VR simulation ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Enhancement Technology ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' telehealth ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Preparation ', ' Therapeutic Effect ', ' Development ', ' developmental ', ' cost ', ' inpatient service ', ' inpatient care ', ' design ', ' designing ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Outcome ', ' cost effective ', ' Population ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' Coupled ', ' innovation ', ' innovative ', ' innovate ', ' addiction ', ' addictive disorder ', ' therapy design ', ' treatment design ', ' intervention design ', ' prototype ', ' evidence base ', ' treatment as usual ', ' usual care ', ' mindfulness ', ' mobile application ', ' mobile app ', ' peer coaching ', ' peer teaching ', ' peer mentoring ', ' peer led team learning ', ' peer instruction ', ' peer support ', ' mindfulness intervention ', ' mindfulness-based intervention ', ' Android ', ' relapse prediction ', ' predict relapse ', ' relapse risk ', ' machine learning algorithm ', ' ']",NIDA,"SOBER GRID, INC.",R44,2019,225000,OH-11,-0.007785144018142934
"Using existing data to understand and ameliorate risk in opioid agonist therapy PROJECT SUMMARY/ABSTRACT The United States is in the midst of an opioid epidemic, leading to unprecedented levels of overdose deaths and other harms. Effective treatment for opioid use disorders is available, in the form of opioid agonist therapy (OAT) with methadone or buprenorphine. However, there are significant questions about the risk of adverse clinical outcomes, including mortality and hospitalization during and after treatment, and unplanned treatment cessation. What is the magnitude of these risks, and what patient, treatment setting, and provider factors may contribute to or protect against risk? Additionally, it is increasingly clear that more sophisticated approaches to patient assessment and treatment planning than are currently used are needed to minimise risk. We aim to: 1. Determine the magnitude of risk for specific adverse clinical outcomes (e.g. mortality, hospitalization and ED presentation, and unplanned treatment cessation) during and after OAT with methadone and buprenorphine; 2. Identify patient, treatment setting, and provider risk factors associated with adverse clinical outcomes during and after OAT with methadone and buprenorphine; and 3. Develop a risk prediction model to identify patients at greatest risk of adverse clinical outcomes during and after OAT. To achieve these aims, this project will use existing population-based Australian data on OAT, linked to several health and criminal justice datasets to provide a rich understanding of treatment exposures and outcomes. These data will be used to inform strategies to guide the delivery of high-quality treatment for opioid use disorder in the United States. Specifically, the project will provide data about the magnitude of risk of adverse clinical outcomes during specific treatment and post-treatment periods, and identify patient, treatment setting and provider factors that influence risk. Additionally, it will use innovative machine learning techniques to demonstrate the potential for routinely collected data to be used to assess patient risk at point-of-care, allowing for the development of tailored treatment plans that minimize risk and maximize treatment retention. PROJECT NARRATIVE Opioid agonist therapy is an effective treatment for opioid use disorder, including prescription opioid use disorder. However, important questions about safety and risks during treatment remain unanswered. This study will examine risk and protective factors for death, hospitalization, and unplanned treatment cessation during and after opioid agonist therapy.",Using existing data to understand and ameliorate risk in opioid agonist therapy,9904242,R01DA044170,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Buprenorphine ', ' co-morbidity ', ' Comorbidity ', ' Death ', ' Cessation of life ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Epidemic ', ' Goals ', ' Health ', ' History ', ' Recording of previous events ', ' Hospital Admission ', ' Hospitalization ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Methods ', ' mortality ', ' Persons ', ' New South Wales ', ' Overdose ', ' Patients ', ' Prisons ', ' Probability ', ' Research ', ' Risk ', ' Risk Factors ', ' Safety ', ' Time ', ' United States ', ' Criminal Justice ', ' Risk Assessment ', ' Specialist ', ' Dataset ', ' Data Set ', ' base ', ' Clinical ', ' Specific qualifier value ', ' Specified ', ' Link ', ' Training ', ' Logistics ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Event ', ' Clinic ', ' treatment duration ', ' treatment days ', ' Treatment Period ', ' Techniques ', ' experience ', ' treatment planning ', ' Neoadjuvant Therapy ', ' Neoadjuvant Treatment ', ' Neoadjuvant ', ' NEOADJ ', ' Induction Therapy ', ' novel ', ' Modeling ', ' response ', ' Withholding Treatment ', ' treatment cessation ', ' cessation of treatment ', ' Adverse event ', ' Adverse Experience ', ' Provider ', ' Data ', ' Development ', ' developmental ', ' point of care ', ' Outcome ', ' scale up ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' population based ', ' effective therapy ', ' effective treatment ', ' overdose death ', ' risk minimization ', ' population health ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' adverse outcome ', ' adverse consequence ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' Patient risk ', ' learning strategy ', ' learning method ', ' learning activity ', ' opioid use disorder ', ' opiate use disorder ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid agonist therapy ', ' opioid agonist treatment ', ' protective factors ', ' random forest ', ' risk prediction model ', ' mortality risk ', ' death risk ', ' adverse event risk ', ' ']",NIDA,UNIVERSITY OF NEW SOUTH WALES,R01,2019,48600,,0.15256551575063096
"Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse Abstract The experience of drug craving is known to increase drug use1-6 and relapse after treatment7-16. Specifically, drug-related stimuli are known to elicit cue-induced craving, as well as physiological and neural responses, called cue reactivity, which have all been directly linked to drug use and relapse across addictions17-35, including gambling36-39. To date, hundreds of studies investigated neural cue-reactivity; however, there is little consensus in findings, due to significant variation in methods, drug types, cue types, and analysis procedures. Further, prior meta-analyses used suboptimal methods and inclusion criteria, and were underpowered40-44. In Aim 1, we propose to use state-of-the-art meta-analytic methods45-47 to summarize findings from ~120 published imaging studies, representing >3000 participants during neural cue reactivity/cue- induced craving (and 3x larger than any prior meta-analysis). Following our prior meta-analytic work in other domains48-61, we will use optimized inclusion criteria and correction methods, and account for multiple methodological differences in studies across substances (e.g., cigarettes, alcohol, cocaine, cannabis) and gambling, a behavioral addiction. Further, we will test for differences across drug types (e.g., cigarettes vs. alcohol) and different cue-types (e.g., pictures vs. video) to resolve several open questions in the field (e.g., role of insula in cigarette craving vs. drug craving in general62, 63; pre-scan abstinence64, 65). In Aim 2, we will go beyond meta-analysis to address an urgent need in addiction research66: development of predictive biomarkers67-69, which are stable indicators of biological processes. Biomarkers have been developed in other areas of medicine70, and we have recently done this in pain71, negative emotion72-74, and empathy74. To do this, we will combine the meta-analytic results obtained in Aim 1 with person-level fMRI data from our lab (of cue-induced craving75-79) using machine learning models, to establish a multivariate pattern of neural activity that can predict craving self-report from neural activity  a predictive neuromarker for craving. Given the associations between neural cue reactivity, craving, and drug use outcome, a multivariate neuromarker could provide a powerful neural predictor of outcomes66, 67. Thus, in Aim 3, we will validate this neuromarker on data from two ongoing clinical trials of N=128 cigarette smokers and N=150 cocaine users collected at Yale's Psychotherapy Development Center (P50 DA09241; Center PI: Carroll; Project PI: Kober). Here, the neuromarker will be used on pre-treatment fMRI cue-reactivity data to predict both self-reported craving and long-term clinical outcomes (e.g., cocaine abstinence). The validated neuromarker will provide well-defined brain targets that can then be used to test the efficacy of interventions to reduce craving and drug use, such as pharmacotherapies, brain stimulation, or cognitive training, and to monitor patient progress in both research and clinical settings. ! Project Narrative Among substance users, exposure to drug cues is associated with neural cue reactivity and cue-induced craving, both of which are directly linked to addiction severity and relapse after treatment. We will employ state-of-the-art statistical and computational methods to establish a consistent neural pattern associated with cue reactivity and cue-induced craving. Then we will validate it using recently-collected imaging data  moving towards a predictive biomarker of drug craving, which can be used to investigate brain processes related to treatment efficacy and drug use outcomes in research as well as clinical settings.",Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse,9688971,R01DA043690,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Alcohols ', ' Alcohol Chemical Class ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Clinical Trials ', ' Cocaine ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Cues ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Gambling ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Insula of Reil ', ' Laboratories ', ' Methods ', ' Methodology ', ' Persons ', ' Paper ', ' Patient Monitoring ', ' Psychotherapy ', ' Publishing ', ' Relapse ', ' Research ', ' social role ', ' Role ', ' Specificity ', ' Testing ', ' Time ', ' Work ', ' Addictive Behavior ', ' Dataset ', ' Data Set ', ' Prefrontal Cortex ', ' base ', ' density ', ' improved ', ' Procedures ', ' Area ', ' Clinical ', ' Variant ', ' Variation ', ' Biological ', ' Physiological ', ' Physiologic ', ' Link ', ' Stimulus ', ' Individual ', ' Cocaine Users ', ' Databases ', ' data base ', ' Data Bases ', ' Drug usage ', ' drug use ', ' Biological Process ', ' Biological Function ', ' Exposure to ', ' Cigarette Smoker ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Severities ', ' Event ', ' Scanning ', ' Techniques ', ' drug craving ', ' experience ', ' success ', ' relating to nervous system ', ' neural ', ' Cigarette ', ' neuroimaging ', ' neuro-imaging ', ' Participant ', ' movie ', ' Patient Self-Report ', ' Self-Report ', ' Ventral Striatum ', ' cue reactivity ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' craving ', ' response ', ' Meta-Analysis ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Cannabis ', ' DSM-V ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' DSM5 ', ' DSM-5 ', ' Brain region ', ' Address ', ' Length ', ' Base of the Brain ', ' Data ', ' Measurable ', ' Reproducibility ', ' Cognitive ', ' Pattern Recognition ', ' Update ', ' Process ', ' sex ', ' Development ', ' developmental ', ' Behavioral ', ' Image ', ' imaging ', ' cognitive training ', ' drug relapse ', ' design ', ' designing ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Outcome ', ' prospective ', ' neuromechanism ', ' neural mechanism ', ' Abstinence ', ' inclusion criteria ', ' addiction ', ' addictive disorder ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' neural patterning ', ' efficacy testing ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' neural correlate ', ' Data Analytics ', ' biomarker development ', ' predict clinical outcome ', ' predictor of clinical outcome ', ' clinical outcome prediction ', ' imaging study ', ' smoking cue ', ' cue to smoke ', ' neural network ', ' ']",NIDA,YALE UNIVERSITY,R01,2019,446497,CT-03,0.018693239052504047
"RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders PROJECT SUMMARY The research project outlined in this SBIR submission will develop the Realize, Analyze, Engage (RAE) platform into a tool to promote sustained recovery in individuals receiving treatment for substance use disorder. In this proposal, the investigators intend to deploy the RAE system- consisting of a wearable sensor, a smartphone app, and a clinical portal- to provide individuals in recovery and their treatment providers with an opportunity to identify moments of high risk for relapse and to access real time intervention opportunities. Wearable biosensors are small, noninvasive devices that continuously record physiology. These sensors have the ability to detect digital biomarkers of drug use and stress, the latter of which herald an increased risk of relapse. RAE aims to utilize this capability to create a real-time solution for individuals in recovery. The components of RAE are: 1) The Empatica Embrace, a wrist mounted sensor similar in form factor to a smart watch, that continuously monitors skin temperature, electrodermal activity (EDA) and locomotion. Detection algorithms for stress and drug use will be embedded on the Embrace firmware. 2) The RAE smartphone application (app), for the individual in recovery. The app will be triggered either by detection of an event on the Embrace or manually by the user when needed and will provide multiple options for annotations, stress reduction techniques and immediate contact with individuals in the pre-defined support system via call or SMS text. The app will also log sleep, physical activity, and geographic location of events. 3) The RAE Portal, for the treatment provider, will deliver immediate alerts when an event is detected on the users device for the opportunity to intervene in real time and will also provide metrics on the users recorded activities. The research plan has two Specific Aims: Aim 1) To deploy and optimize the RAE system in a population of individuals in treatment for substance use disorder and Aim 2) To demonstrate the impact of the RAE system on outcomes in substance use treatment. To achieve these aims the investigators will first deploy the technology in a population of individuals in recovery and collect data on accuracy, usability and functionality (Aim 1). The data from Aim 1 will be used to optimize the system and achieve millstones prior to transition to Aim 2 which will include sensitivity, specify, accuracy and user compliance targets. The investigators will then undertake a multi-site, randomized controlled trial (Aim 2) to evaluate the efficacy of RAE on key outcomes including rates of relapse, retention in treatment programs, and psychosocial wellbeing. The investigators have assembled a leadership team and advisory team with the necessary expertise in business, medicine, wearable technology and engineering to develop RAE into a tool that dramatically improves the success of treatment for substance use disorder, promotes sustained sobriety, and reduces morbidity and mortality from relapse to substance use. PROJECT NARRATIVE Morbidity and mortality related to substance use disorder has reached staggering proportions, and treatment options suffer from high rates of relapse. RAE (Realize, Analyze, Engage) is a mobile based solution that combines a wearable sensor, a smartphone app and a cloud based clinical portal to detect stress and drug use in individuals in treatment for substance use disorder. The goal of the RAE system is to provide real-time intervention tools for patients, to allow clinicians to personalize the treatment approach for each patient, and ultimately to reduce morbidity and mortality from substance use disorder by improving the success of treatment programs.","RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders",9545385,R44DA046151,"['Algorithms ', ' Anxiety ', ' Award ', ' Behavior ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Disorder ', ' Disease ', ' Engineering ', ' Environment ', ' Explosion ', ' Foundations ', ' geographic site ', ' Geographical Location ', ' Geographic Region ', ' Geographic Area ', ' Geographic Locations ', ' Goals ', ' Health ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' Industry ', ' Italy ', ' Leadership ', ' Locomotion ', ' Manuals ', ' Medicine ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Persons ', ' Patients ', ' wellbeing ', ' well-being ', ' Personal Satisfaction ', ' Physiology ', ' Precipitating Factors ', ' psychosocial variables ', ' Psychosocial Factor ', ' Publishing ', ' Relapse ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' Seizures ', ' Sensitivity and Specificity ', ' Skin Temperature ', ' Sleep ', ' Stress ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' Post-Traumatic Stress Disorders ', ' Substance Use Disorder ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Suicide ', ' Technology ', ' Time ', ' User Compliance ', ' Wrist ', ' Measures ', ' Businesses ', ' health care ', ' Healthcare ', ' Caring ', ' stress buffering ', ' stress management ', ' Journals ', ' Magazine ', ' Advisory Committees ', ' advisory team ', ' Task Forces ', ' base ', ' sensor ', ' improved ', ' Site ', ' Clinical ', ' Specific qualifier value ', ' Specified ', ' Physiological ', ' Physiologic ', ' Link ', ' Predisposition ', ' Susceptibility ', ' Physical activity ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Recovery ', ' Opioid ', ' Opiates ', ' Drug usage ', ' drug use ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Randomized Controlled Trials ', ' randomized controlled study ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Event ', ' Stream ', ' Techniques ', ' System ', ' Location ', ' psychosocial ', ' experience ', ' success ', ' Biosensor ', ' biological sensor ', ' Health Insurance Portability and Accountability Act ', ' United States Health Insurance Portability and Accountability Act ', ' Public Law 104-191 ', ' PL104-191 ', ' PL 104-191 ', ' Kennedy Kassebaum Act ', ' HIPAA ', ' Participant ', ' treatment program ', ' sobriety ', ' sober ', ' Devices ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Support System ', ' Social Support System ', ' Modeling ', ' craving ', ' software development ', ' developing computer software ', ' develop software ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Car Phone ', ' Mobile Phones ', ' Provider ', ' preventing ', ' prevent ', ' Data ', ' Detection ', ' Research Project Summaries ', ' Small Business Innovation Research Grant ', ' Small Business Innovation Research ', ' SBIR ', ' Wireless Technology ', ' wireless ', ' Monitor ', ' Text ', ' active method ', ' active treatment ', ' active technique ', ' substance abuse treatment ', ' substance abuse therapy ', ' cost ', ' digital ', ' design ', ' designing ', ' Outcome ', ' cost effective ', ' Population ', ' handheld mobile device ', ' mobile device ', ' usability ', ' addiction ', ' addictive disorder ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' mobile application ', ' mobile app ', ' signal processing ', ' cloud based ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' wearable technology ', ' relapse risk ', ' smartphone Application ', ' iPhone Application ', ' iPhone App ', ' iOS application ', ' iOS app ', ' Smartphone App ', ' Smart Phone Application ', ' Smart Phone App ', ' Cellular Phone Application ', ' Cellular Phone App ', ' Cell phone App ', ' Cell Phone Application ', ' Android Application ', ' Android App ', ' smart watch ', ' smartwatch ', ' wearable device ', ' wearable sensor ', ' body worn sensor ', ' body sensor ', ' service providers ', ' stress reduction ', ' ']",NIDA,"CONTINUEYOU, LLC",R44,2019,224991,ME-01,0.015511837532733358
"Real-time fMRI neurofeedback of large-scale network dynamics in opioid use disorder PROJECT SUMMARY The misuse of opioids, opioid addiction and overdose are a serious national public health crisisthe opioid epidemicthat despite increased scientific, clinical and government attention, continues to grow. Methadone is a generally effective treatment for opioid use disorder, however relapse rates remain high, and risk of overdose is greatest during relapse. There is a need for improved mechanistic understanding of the factors that contribute to opioid relapse to improve our understanding of opioid use disorder and its treatment. Using connectome-based methods (i.e., functional connectivity) in functional magnetic resonance imaging (fMRI), we recently identified a large-scale brain network that predicted opioid relapse from both resting and task states. Connectome-based methods enable data-driven characterization of whole brain networks related to behavior that might be better suited to describe complex clinical phenomena (e.g., opioid relapse). Building on prior work indicating the utility of real-time fMRI neurofeedback to test brain activation patterns related to specific functions and individual abilities to regulate these functions, the proposed project will use connectome-based neurofeedback to target patterns of functional connectivity within our recently identified opioid abstinence network. This information is critical to improve understanding of mechanisms of opioid relapse. Individuals on methadone will be randomized to receive either active (n=12) or sham (n=12) connectome-based neurofeedback at 3 weekly scanning sessions including feedback and transfer runs. Additional baseline and follow-up scans will include resting state and reward and cognitive task runs. Craving, negative affect and opioid use will be measured weekly and at 1-mo follow-up. Based on our pilot data, connectome-based feedback will be targeted at the opioid abstinence network and we hypothesize that increased connectivity in this network will be associated with improved clinical outcomes. Aim 1 will test the hypothesis that active feedback is associated with reduced opioid use from baseline to follow-up scans (Aim 1a) and at 1-mo follow- up (Aim 1b). Aim 2 will test the hypothesis that active feedback is associated with increased opioid abstinence network connectivity in resting state (Aim 2a) and task (reward, cognitive) state (Aim 2b) versus sham feedback, as in our pilot work. Aim 3 will test the hypothesis that active feedback is associated with greater improvements in clinical features of opioid use disorder (craving, negative affect) than sham feedback (Aim 3a) and that increased opioid abstinence network connectivity will correlate with these improvements (Aim 3b). Overall, this project tests a potentially transformative hypothesis relating large-scale brain network dynamics to outcomes in opioid use disorder, and tests a highly innovative method for real-time fMRI neurofeedback from the opioid abstinence network to improve clinical features of opioid use disorder. This project will provide unprecedented insight into the functional neurobiology of opioid relapse and more generally has the potential to transform existing real-time fMRI paradigms in addictions. PROJECT NARRATIVE This project leverages advances in real-time fMRI neurofeedback and machine learning to test whether methadone-treated individuals with opioid use disorder can increase functional connectivity within an empirically-derived opioid abstinence network that has previously been identified to predict opioid relapse. This project will provide critical data and information to improve our understanding of opioid relapse and may transform existing real-time fMRI paradigms in addictions more generally. Findings should contribute to the scientific and clinical response to the growing opioid epidemic and be used to inform treatment development.",Real-time fMRI neurofeedback of large-scale network dynamics in opioid use disorder,9841187,R21DA049583,"['Attention ', ' Behavior ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Feedback ', ' Government ', ' Learning ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Methods ', ' neurobiological ', ' Neurobiology ', ' Public Health ', ' Relapse ', ' Research ', ' Rest ', ' Rewards ', ' Running ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Testing ', ' Time ', ' Work ', ' Measures ', ' base ', ' improved ', ' Clinical ', ' Refractory ', ' Link ', ' Training ', ' insight ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Opioid ', ' Opiates ', ' Therapeutic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Complex ', ' Scanning ', ' Pattern ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' relating to nervous system ', ' neural ', ' novel ', ' Reporting ', ' Modeling ', ' craving ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Brain region ', ' Dose ', ' Symptoms ', ' Data ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Cognitive ', ' Characteristics ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Behavioral ', ' Pathway interactions ', ' pathway ', ' design ', ' designing ', ' Outcome ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' Abstinence ', ' brain behavior ', ' addiction ', ' addictive disorder ', ' therapy development ', ' treatment development ', ' intervention development ', ' develop therapy ', ' high risk ', ' effective therapy ', ' effective treatment ', ' neural patterning ', ' neurofeedback ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' cognitive task ', ' cognitive process ', ' Data Analytics ', ' opioid use disorder ', ' opiate use disorder ', ' improved outcome ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' connectome ', ' negative affect ', ' negative affectivity ', ' imaging study ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' overdose risk ', ' methadone treatment ', ' methadone maintenance treatment ', ' methadone maintenance therapy ', ' methadone maintenance program ', ' methadone maintenance ', ' opioid misuse ', ' opiate misuse ', ' nonmedical opioid use ', ' non-medical opioid use ', ' neural network ', ' ']",NIDA,YALE UNIVERSITY,R21,2019,251250,CT-03,0.18870195215849425
"Online Evidence of Withdrawal Self-Medication PROJECT SUMMARY/ABSTRACT Withdrawal symptoms from opioid use can be severe and are major contributing factors to relapse and continuing misuse. Many opioid users are actively experimenting with remedies that can alleviate withdrawal, and they are discussing their effectiveness in blogs and forums. In this pilot study we will use Natural Language Processing (NLP) and human expertise to examine over 50,000 recent posts in two Reddit forums OpiatesRecovery and Opiates to assess systematically which remedies are being used, how they are being used, and what are the reported consequences of such self-help experimentation. We will create a curated database of user-reported remedies. Information will be semiautomatically extracted from the online, self-reported use of alternative treatments (i.e., other prescription drugs, over the counter medications, food supplements, activities such as meditation and yoga). A team of a pharmacologist, physician, and ethnographer will evaluate database entries to uncover (1) potential harm associated with uncontrolled and unsupervised experimentation, (2) potentially effective available treatments (e.g., traditional medicine), (3) potentially promising compound leads, and (4) patients' needs and issues that are most important to them. Aim 1. To assemble an extensive database of opioid withdrawal and remedy-associated terminology from posts on OpiatesRecovery and Opiates Reddit communities. NLP will be used to build a language model that understands how words are used in context (word2vec). Aim 2. To develop a dataset of instances of self-reported remedy use from Reddit and conduct a bipartite network analysis of remedies and users. Using NLP tools and the word embedding model we will develop an exclusive dataset containing extracted information associated with remedies targeting withdrawal and craving. This aim will use elements of artificial intelligence and close human supervision to extract remedies, including variations of spelling, from the texts. The result of this aim will be a remedy database that includes spelling variations and slang references and a network analysis linking remedies and users. Aim 3. To organize, aggregate, and systematically assess information from mentions of remedy use. Potential compounds and other remedies will be classified to provide an initial assessment of their potential relevance to the opioid treatment process. This process will require the most human oversight and assessment. Network analysis tools will be used to assess and identify the relationships between the types of remedies and potential therapeutic effect and will create the benchmarks for similar future studies. PROJECT NARRATIVE Withdrawal symptoms from opioid use can be severe and are major contributing factors to relapse and continuing misuse. Many opioid users are actively experimenting with remedies that can alleviate withdrawal, and they are discussing their effectiveness in blogs and forums. In this pilot study we will use Natural Language Processing and human expertise to examine over 50,000 recent posts in two Reddit forums OpiatesRecovery and Opiatesto assess systematically which remedies are being used, how they are being used, and what are the reported consequences of such self-help experimentation.",Online Evidence of Withdrawal Self-Medication,9786868,R21DA048739,"['Acupuncture Therapy ', ' acupuncture ', ' Acupuncture procedure ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Automation ', ' Belief ', ' Cluster Analyses ', ' Cluster Analysis ', ' Communities ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Patent Medicines ', ' Over-the-Counter Drugs ', ' OTC Drugs ', ' Nonprescription Drugs ', ' Non-Prescription Drugs ', ' Elements ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Food or Food Product ', ' Food ', ' Food Additives ', ' Future ', ' Habits ', ' Herb ', ' Modern Man ', ' Human ', ' Language ', ' marihuana ', ' Marijuana ', ' Herbal Medicine ', ' Traditional Medicine ', ' Methods ', ' Methodology ', ' natural language understanding ', ' Natural Language Processing ', ' Terminology ', ' opioid detoxification ', ' opioid detox ', ' opiate withdrawal ', ' opioid withdrawal ', ' Patients ', ' Physicians ', ' pilot study ', ' Pilot Projects ', ' Drug Prescribing ', ' Drug Prescriptions ', ' Relapse ', ' Research ', ' Research Resources ', ' Resources ', ' Self Medication ', ' Supervision ', ' USFDA ', ' Food and Drug Administration ', ' United States Food and Drug Administration ', ' Vitamins ', ' Yoga ', ' Withdrawal Symptom ', ' Dataset ', ' Data Set ', ' Meditation ', ' Variant ', ' Variation ', ' Medical ', ' Link ', ' Withdrawal ', ' dietary supplements ', ' nutritional supplement ', ' diet supplement ', ' Databases ', ' data base ', ' Data Bases ', ' Opioid ', ' Opiates ', ' non-opioid analgesic ', ' nonopioid ', ' nonopiate analgesic ', ' non-opioid ', ' non-opiate analgesic ', ' non-narcotic analgesic ', ' Nonopioid Analgesics ', ' Nonnarcotic Analgesics ', ' Collaborations ', ' Published Comment ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' tool ', ' Knowledge ', ' Life ', ' Food Supplements ', ' Benchmarking ', ' Best Practice Analysis ', ' spelling ', ' interest ', ' experience ', ' self help ', ' novel ', ' Harm Reduction ', ' Harm Minimization ', ' Patient Self-Report ', ' Self-Report ', ' Categories ', ' epidemiology study ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Studies ', ' Epidemiologic Research ', ' Reporting ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' craving ', ' Effectiveness ', ' Data ', ' Epidemiologist ', ' trend ', ' Process ', ' Text ', ' Therapeutic Effect ', ' cost ', ' alternative treatment ', ' patient population ', ' online community ', ' virtual community ', ' on-line community ', ' social media ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' experimental study ', ' experimental research ', ' experiment ', ' Opioid user ', ' Opioid drug user ', ' Opiate user ', ' opioid misuse ', ' opiate misuse ', ' nonmedical opioid use ', ' non-medical opioid use ', ' Twitter ', ' off-label drug ', ' off-label medication ', ' off-label use ', ' off-label prescribing ', ' off-label application ', ' ']",NIDA,RESEARCH TRIANGLE INSTITUTE,R21,2019,228384,NC-04,0.05194197963426062
"Remote vital sign and opioid overdose detection via a non-invasive wearable sensing patch PROJECT SUMMARY/ ABSTRACT Approximately 2 million Americans are living with an opioid use disorder, and in 2017, 17,029 people overdosed on prescription opioids. Opioids cause respiratory depression; however, fatal overdose usually occurs over a period of 13 hours, leaving a window of opportunity to intervene with the inexpensive drug naloxone, an opioid antagonist, that can reverse the effects of opioids, quickly restoring normal respiration rates. VivaLNK proposes to enhance the currently marketed Vital Scout wellness wearable sensing patch for use in people at risk for opioid overdose, by detecting physiologic indicators of an opioid overdose (slow respiration rate, low heart rate and low blood pressure), and the ability to send a potentially life-saving overdose alert, which could be received by an emergency contact/caregiver and hasten treatment with an opioid antagonist such as naloxone. Health monitoring emergency notification systems that can remotely monitor patient vital signs for indications of deterioration and send a potentially life-saving alert to emergency contacts/caregivers, have the potential to greatly reduce the number of fatal opioid overdoses in the US. The Vital Scout patch is already strategically positioned to monitor overdose parameters utilizing the built in ECG sensor to continuously register waveforms from which respiration rate, heart rate, heart rate variability, and activity are calculated. While several devices are currently being developed for overdose alerts, the Vital Scout is the only alert which has the potential to capture the three critical vital signs indicative of an overdose, and simultaneously monitor physical activity, providing additional context to the vital signs data. The vital signs collected by the Vital Scout patch are based on a machine-learning algorithm which we propose to further develop by the following specific aims: 1) Refinement and optimization of the Vital Scout to incorporate an overdose algorithm with an alert function by improving the sensitivity in order to detect lower respiration and heart rate indicative of a potential overdose. 2) Expand the sensing capabilities of the Vital Scout system to include blood pressure monitoring. The algorithm will be optimized using three volunteer cohorts (~20/ cohort) (i) healthy volunteers, (ii) elderly patients over the age of 65 (more likely to have low BP due to medically-induced hypotension) and (iii) low BP patients (represented by elite student-athletes). Data from these cohorts will provide the initial broad range of data for the machine-learning linear regression algorithm. We will assess whether these are appropriate designations for providing accurate blood pressure measurements, similar to what is seen within the opioid population. Meeting all of these goals will result in an enhanced Vital Scout that will be the most sensitive device for opioid overdose detection to remotely monitor the vital signs of people addicted to opioids and those at-risk for opioid overdose, including but not limited to, people with pulmonary disease or those taking antidepressants. PROJECT NARRATIVE The US is experiencing an opioid epidemic, with approximately 2 million Americans living with an opioid use disorder, and in 2017, 17,029 people overdosed on prescription opioids. Health monitoring emergency notification systems that can remotely monitor patient vital signs for indications of deterioration at out-patient aftercare facilities, or at-home, and send a potentially life-saving alert to emergency contacts/caregivers, have the potential to greatly reduce the number of fatal opioid overdoses in the US.",Remote vital sign and opioid overdose detection via a non-invasive wearable sensing patch,9907564,R43DA050344,"['Symptoms ', ' Data ', ' Detection ', ' Reproducibility ', ' Clinical Data ', ' Wireless Technology ', ' wireless ', ' Monitor ', ' Development ', ' Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Algorithms ', ' Antidepressive Agents ', ' anti-depressive agents ', ' anti-depressants ', ' anti-depressant drugs ', ' anti-depressant agent ', ' Antidepressants ', ' Antidepressant Drugs ', ' Antidepressant Agent ', ' Blood Pressure ', ' Blood Pressure Monitors ', ' Continuous Sphygmomanometers ', ' Dangerousness ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Electrocardiography ', ' EKG ', ' ECG ', ' Electrocardiogram ', ' Emergencies ', ' Emergency Situation ', ' Equipment ', ' febris ', ' febrile ', ' Pyrexia ', ' Fever ', ' Goals ', ' Health ', ' Cardiac Chronotropism ', ' Heart Rate ', ' Vascular Hypotensive Disorder ', ' Low Blood Pressure ', ' Hypotension ', ' Postural Hypotension ', ' Orthostatic Hypotension ', ' Linear Regressions ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Naloxone ', ' Noise ', ' Out-patients ', ' Outpatients ', ' Overdose ', ' Patient Monitoring ', ' Patients ', ' respiratory mechanism ', ' Respiration ', ' Risk ', ' Savings ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' sound ', ' Temperature ', ' Measures ', ' Care Givers ', ' Caregivers ', ' base ', ' sensor ', ' improved ', ' Phase ', ' Physiological ', ' Physiologic ', ' Medical ', ' Physical activity ', ' Ventilatory Depression ', ' depression of breathing ', ' depressed breathing ', ' Respiratory Depression ', ' Opioid ', ' Opiates ', ' Measurement ', ' Ambulatory Blood Pressure Monitoring ', ' Depressed mood ', ' sadness ', ' depressed ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Capnography ', ' Capnographies ', ' Life ', ' Notification ', ' Hour ', ' Home environment ', ' Home ', ' Upper arm ', ' System ', ' meetings ', ' American ', ' experience ', ' human old age (65+) ', ' aged 65 ', ' aged 65 and greater ', ' age 65 and older ', ' age 65 and greater ', ' Aged 65 and Over ', ' 65+ years old ', ' success ', ' cohort ', ' Devices ', ' Positioning Attribute ', ' Position ', ' Deterioration ', ' Modeling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Drops ', ' Intravenous Fluid ', ' IV Fluid ', ' Address ', ' developmental ', ' Output ', ' improved functioning ', ' older patient ', ' elderly patient ', ' Population ', ' user-friendly ', ' volunteer ', ' healthy volunteer ', ' FDA approved ', ' heart rate variability ', ' flexibility ', ' flexible ', ' prescription opioid abuse ', ' prescription opiate abuse ', ' opioid prescription drug abuse ', ' opioid medication abuse ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' student athlete ', ' opioid use disorder ', ' opiate use disorder ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' Opioid Antagonist ', ' Opioid receptor antagonist ', ' Opiate receptor antagonist ', ' Opiate Antagonist ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid mortality ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' machine learning algorithm ', ' feature detection ', ' feature recognition ', ' regression algorithm ', ' ']",NIDA,"VIVALNK, INC.",R43,2019,299814,CA-18,0.11969587899098798
"iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Nave Individuals PROJECT SUMMARY The integrated research and training plans outlined in this K23 submission will prepare me for a career as a clinician-scientist conducting translational substance abuse research. My career goal is to perform hypothesis- driven original research investigations directed toward reducing morbidity and mortality from opioid overdose. In this proposal, I intend to deploy wearable biosensors (small devices that continuously record physiology) to study the effects of therapeutic administration of opioid analgesics. I have already studied wearable biosensors in individuals receiving opioids; my preliminary data demonstrates that opioid-tolerant individuals have different biometric signals than non-tolerant individuals. This observation suggests that biosensors can be used to identify the onset of tolerance, an important event that correlates with higher doses of opioid analgesics, and higher risk of death from opioid overdose. Biosensor data management and analysis requires signal processing, data analytic, and machine learning techniques; these approaches are beyond the areas of traditional medical training. My short-term goal is to utilize this K23 award to fill my knowledge gaps in wearable biosensing and advanced data analysis so that I can generate ever more innovative responses to the problem of opioid prescribing, tolerance, misuse, addiction, and overdose. To optimize this important line of investigation, I have developed a training plan that includes: 1) completing a PhD through the Millennium PhD program; 2) expanding my skills in wearable biosensing and behavioral health-based research; 3) developing an understanding of signal processing and machine learning; 4) developing data analytic and data science skills; and 5) expanding my research presentation and dissemination skills. I will achieve these goals through directed coursework, focused seminars, and practical experience. My mentorship team of expert investigators who will ensure my productivity and success includes E. Boyer (primary mentor), D. Smelson, J. Fang, and P. Indic (secondary mentors), and D. Ganesan (advisor) My research plan has three specific aims: 1) to deploy a wearable biosensor technology to detect digital biomarkers associated with the initiation of opioid analgesic therapy in an opioid nave population; 2) to use signal-processing analytics to identify transitions in digital biomarkers with progressive opioid use and to identify individual characteristics associated with this transition; and, 3) to apply and explore supervised learning algorithms that can predict transitions in digital biomarkers that herald the onset of opioid tolerance. To identify dynamic patterns in response to opioids, I will study the digital biomarkers of opioid-nave patients with acute fractures who are prescribed opioid analgesics. Results will be used to develop big data approaches to apply predictive algorithms to identify the onset of opioid tolerance. This work has the potential to prevent development of problematic opioid use and will provide the basis for subsequent R01 submissions to implement sensor-based interventions triggered by the onset of tolerance in individuals receiving opioid analgesics. PROJECT NARRATIVE Morbidity and mortality related to opioids (both prescription and illicit) has reached staggering proportions: more than half of individuals who currently abuse heroin report that opioid abuse began with a prescription opioid. Dr. Carreiro has demonstrated that wearable biosensors can discriminate between individuals who are nave to the effects of opioids from those who are opioid tolerant, a characteristic that increases risk for opioid-related death. This career development award will provide her with the training to use of wearable biosensors to identify the onset of opioid tolerance and the expertise to reach her ultimate goal of developing tools to prevent opioid-related death and increase the safety of opioid prescribing.",iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Nave Individuals,9666315,K23DA045242,"['Age ', ' ages ', ' Algorithms ', ' Analgesics ', ' painkiller ', ' pain reliever ', ' pain medication ', ' pain killer ', ' Antinociceptive Drugs ', ' Antinociceptive Agents ', ' Anodynes ', ' Analgesic Preparation ', ' Analgesic Drugs ', ' Analgesic Agents ', ' Opioid Analgesics ', ' opioid painkiller ', ' opioid pain reliever ', ' opioid pain medication ', ' opioid anesthetic ', ' opioid analgesia ', ' opiate pain reliever ', ' opiate pain medication ', ' opiate analgesic ', ' opiate analgesia ', ' Behavior Therapy ', ' behavioral intervention ', ' behavior intervention ', ' Conditioning Therapy ', ' Behavioral Treatment ', ' Behavioral Therapy ', ' Behavioral Modification ', ' Behavioral Conditioning Therapy ', ' Behavior Treatment ', ' Behavior Modification ', ' Behavior Conditioning Therapy ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Biosensing Techniques ', ' biosensing ', ' Biosensing Technics ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Collection ', ' abuses drugs ', ' abuse of drugs ', ' Drug abuse ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Evolution ', ' bone fracture ', ' Fracture ', ' skin conductance ', ' Skin Electric Conductance ', ' Psychogalvanic Reflex ', ' Electrodermal Response ', ' Galvanic Skin Response ', ' Goals ', ' Immersion ', ' Immersion Investigative Technique ', ' Italy ', ' Mentors ', ' Mentorship ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Motion ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' opioid drug abuse ', ' opiate drug abuse ', ' opiate abuse ', ' opioid abuse ', ' Overdose ', ' Painful ', ' Pain ', ' Patients ', ' Physiology ', ' pilot study ', ' Pilot Projects ', ' Productivity ', ' Public Health ', ' Records ', ' Relapse ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Safety ', ' Science ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Skin Temperature ', ' Substance Use Disorder ', ' Technology ', ' Testing ', ' Time ', ' Work ', ' Wrist ', ' Gender ', ' Measures ', ' Dataset ', ' Data Set ', ' analytical method ', ' base ', ' career ', ' sensor ', ' Area ', ' Acute ', ' Physiological ', ' Physiologic ', ' Medical ', ' Ensure ', ' Evaluation ', ' Training ', ' Ingestion ', ' insight ', ' Individual ', ' Opioid ', ' Opiates ', ' Measurement ', ' Funding ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Therapeutic ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Event ', ' Protocols documentation ', ' Protocol ', ' Source ', ' Pattern ', ' Techniques ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Accident and Emergency department ', ' Emergency room ', ' Emergency Department ', ' data management ', ' experience ', ' success ', ' Heroin Abuse ', ' Biosensor ', ' biological sensor ', ' skills ', ' novel ', ' Participant ', ' Devices ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' behavioral health ', ' response ', ' data integrity ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Therapeutic Uses ', ' preventing ', ' prevent ', ' Dose ', ' Consent ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Mentored Patient-Oriented Research Career Development Award ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' K23 Program ', ' K23 Mechanism ', ' K23 Award ', ' K-Series Research Career Programs ', ' Research Career Program ', ' K-Awards ', ' Career Development Programs K-Series ', ' Career Development Awards and Programs ', ' Career Development Awards ', ' Research Training ', ' Pattern Recognition ', ' Monitor ', ' Characteristics ', ' Therapeutic Effect ', ' Development ', ' developmental ', ' Behavioral ', ' digital ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' comparative ', ' addiction ', ' addictive disorder ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' opiate tolerance ', ' tolerance to opiates ', ' opioid tolerance ', ' opioid habituation ', ' Teacher Professional Development ', ' teacher development ', ' instructor training ', ' faculty professional development ', ' faculty development ', ' Teacher Training ', ' Teacher Preparation ', ' Teacher Educator ', ' Teacher Education ', ' Faculty Training ', ' Faculty Education ', ' mHealth ', ' mobile health ', ' m-Health ', ' signal processing ', ' Big Data ', ' BigData ', ' learning strategy ', ' learning method ', ' learning activity ', ' Predictive Analytics ', ' Data Science ', ' Data Analytics ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' opioid therapy ', ' opiate therapy ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid mortality ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' recruit ', ' machine learning algorithm ', ' supervised learning ', ' supervised machine learning ', ' learning algorithm ', ' ']",NIDA,UNIV OF MASSACHUSETTS MED SCH WORCESTER,K23,2019,188575,MA-02,0.15362055064930596
"Contextualized daily prediction of lapse risk in opioid use disorder by digital phenotyping PROJECT SUMMARY Opioid use disorder is increasingly widespread, leading to devastating consequences and costs for patients and their families, friends, and communities. Available treatments for opioid and other substance use disorders (SUD) are not successful at sustaining sobriety. The vast majority of people with SUD relapse within a year. Critically, they often fail to detect dynamic, day-by-day changes in their risk for relapse and do not adequately employ skills they developed or take advantage of support available through continuing care. The broad goals of this project are to develop and deliver a highly contextualized, lapse risk prediction models for forecasting day-by-day probability of opioid and other drug use lapse among people pursuing drug abstinence. This lapse risk prediction model will be delivered within the Addiction-Comprehensive Health Enhancement Support System (A-CHESS) mobile app, which has been established by RCT as a state-of-the-art mHealth system for providing continuing care services for alcohol and substance use disorders. To accomplish these broad goals, a diverse sample of 480 participants with opioid use disorder who are pursing abstinence will be recruited. These participants will be followed for 12 months of their recovery, with observations occurring as early as one week post-abstinence and as late as 18 months post-abstinence across participants in the sample. Well-established distal, static relapse risk signals (e.g., addiction severity, comorbid psychopathology) will be measured on intake. A range of more proximal, time-varying opioid (and other drug use) lapse risk signals will also be collected via participants smartphones. These signals include self-report surveys every two months, daily ecological momentary assessments, daily video recovery check-ins, voice phone call and text message logs, text message content, moment-by-moment location (via smartphone GPS and location services), physical activity (via smartphone sensors), and usage of the mobile A-CHESS Recovery Support app. The predictive power of these risk signals will be further increased by anchoring them within an inter-personal context of known people, locations, dates, and times that support or detract from participants abstinence efforts. Machine learning methods will be used to train, validate, and test opioid (and other drug) lapse risk prediction models based on these contextualized static and dynamic risk signals. These lapse risk prediction models will provide participant specific, day-by-day probabilistic forecast of a lapse to opioid (or other drug) use among opioid abstinent individuals. These lapse risk prediction models will be formally added to the A-CHESS continuing care mobile app at the completion of the project for use in clinical care. These project goals position A-CHESS to make relapse prevention and recovery support, information, and risk monitoring available to patients continuously. Compared to conventional continuing care, A-CHESS will provide personalized care and be available and implemented during moments of greatest need. Integrated real-time risk prediction holds substantial promise to encourage sustained recovery through adaptive use of these continuing care services. PROJECT NARRATIVE The projects goals are to develop and deliver a real-time model for forecasting day-by-day opioid use lapse among abstinent patients with opioid use disorder. This lapse prediction model will be integrated into an existing, validated mHealth app to encourage sustained recovery through adaptive use of continuing care services.",Contextualized daily prediction of lapse risk in opioid use disorder by digital phenotyping,9818617,R01DA047315,"['Acoustics ', ' Acoustic ', ' Advertising ', ' Affect ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Communication ', ' Communities ', ' co-morbidity ', ' Comorbidity ', ' Data Sources ', ' Diagnosis ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' balance function ', ' balance ', ' Equilibrium ', ' facial ', ' faces ', ' Face ', ' Family ', ' Foundations ', ' Goals ', ' Health ', ' Methods ', ' Theoretic Models ', ' Theoretical model ', ' Narcotics ', ' natural language understanding ', ' Natural Language Processing ', ' Paper ', ' Patients ', ' Phenotype ', ' Probability ', ' abnormal psychology ', ' Psychopathology ', ' Publishing ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Relapse ', ' Risk ', ' Risk Factors ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Substance Use Disorder ', ' Survey Instrument ', ' Surveys ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' Voice ', ' Friends ', ' Gender ', ' Measures ', ' chronic pain ', ' Caring ', ' Social Network ', ' base ', ' suburb ', ' suburbia ', ' suburban ', ' sensor ', ' Distal ', ' Clinical ', ' Medical ', ' Training ', ' Physical activity ', ' Visual ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' drug abstinence ', ' Recovery ', ' Opioid ', ' Opiates ', ' Drug usage ', ' drug use ', ' Patient Recruitments ', ' participant recruitment ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Frequencies ', ' Severities ', ' Home environment ', ' Home ', ' Pattern ', ' System ', ' Location ', ' meetings ', ' Services ', ' information gathering ', ' experience ', ' stressor ', ' skills ', ' Participant ', ' peer ', ' sobriety ', ' sober ', ' Patient Self-Report ', ' Self-Report ', ' Positioning Attribute ', ' Position ', ' Support System ', ' Social Support System ', ' disorder later incidence prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' Modeling ', ' Sampling ', ' craving ', ' real time model ', ' realtime model ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' preventing ', ' prevent ', ' Intake ', ' Enrollment ', ' enroll ', ' Monitor ', ' Characteristics ', ' cost ', ' care systems ', ' care services ', ' digital ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' innovation ', ' innovative ', ' innovate ', ' Abstinence ', ' alcohol testing ', ' ethanol testing ', ' addiction ', ' addictive disorder ', ' clinical care ', ' overdose death ', ' mHealth ', ' mobile health ', ' m-Health ', ' mobile application ', ' mobile app ', ' signal processing ', ' personalized care ', ' personalized patient care ', ' individualized patient care ', ' individualized care ', ' Precision care ', ' Ecological momentary assessment ', ' learning strategy ', ' learning method ', ' learning activity ', ' social media ', ' Predictive Analytics ', ' opioid use disorder ', ' opiate use disorder ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' relapse risk ', ' rural setting ', ' rural place ', ' rural locality ', ' recruit ', ' Mobile Health Application ', ' mHealth application ', ' mHealth app ', ' m-Health application ', ' m-Health app ', ' Mobile Health App ', ' Text Messaging ', ' texting ', ' short message service ', ' care providers ', ' primary care provider ', ' sleep quality ', ' quality of sleep ', ' Facebook ', ' microphone ', ' risk prediction model ', ' ']",NIDA,UNIVERSITY OF WISCONSIN-MADISON,R01,2019,683430,WI-02,0.13571561264563656
"Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial PROJECT SUMMARY Overdose deaths have skyrocketed in the United States since 1999. The epidemic has prompted widespread federal and state actions, yet the number of people who die of an overdose continues to increase. In light of the accelerating and rapidly evolving overdose epidemic, new strategies are needed to identify communities most at risk, and to utilize resources more effectively to curb overdose deaths. To address these public health priorities, we will develop a forecasting tool to predict overdose deaths before they occur, and then conduct a randomized, statewide, community-level intervention to evaluate resource targeting based on these predictions. The study will take place in Rhode Island, a state with the 10th highest rate of overdose fatality in 2016. The study has two phases. First, we will develop a predictive analytics model that forecasts future overdose mortality at the neighborhood-level, using publicly available information and data from a multicomponent overdose surveillance system. This tool, called PROVIDENT (Preventing Overdose using Information and Data from the Environment) will be used to predict the likelihood of magnitude of future overdose deaths in every neighborhood across Rhode Island. Next, we will conduct a randomized policy experiment to evaluate whether targeting overdose prevention interventions to neighborhoods at highest risk reduces overdose morbidity and mortality. The state's department of health will receive PROVIDENT model predictions for half of the 39 cities/towns in Rhode Island. Within these cities/town, the health department will work with stakeholders to target overdose prevention interventions to neighborhoods with the highest probability of future overdose deaths. Interventions include efforts to: (1) prevent high-risk prescribing (through academic detailing and other educational efforts); (2) expand access to opioid agonist therapy, including buprenorphine and methadone; (3) increase naloxone distribution (through community and pharmacy-based efforts); and (4) expand street-based peer recovery coaching and referrals. Control cities/town will continue to receive these interventions, but without targeting to specific neighborhoods. Fatal and non-fatal opioid overdose rates in the control cities/towns will be compared to those that received the PROVIDENT model predictions. To achieve these aims, we will leverage a unique partnership between an academic institution and a state's health department, which allows for unprecedented access to and sharing of population-based overdose surveillance data. Our results will improve public health decision-making and inform resource allocation to communities that should be prioritized for evidence-based prevention, treatment, recovery, and overdose rescue services. If found to be effective, the PROVIDENT forecasting model will be disseminated to other states, which could adapt the tool to guide resource allocation and maximize public health impact. In sum, this project is highly responsive to a top research priority of the National Institute on Drug Abuse, and directly addresses one of the nation's most challenging public health crises. PROJECT NARRATIVE The objectives of this project are to leverage surveillance data to predict future overdose outbreaks, and to evaluate the impact of a randomized, statewide, community-level intervention trial to target overdose prevention programs to neighborhoods at highest risk of future overdose deaths. This study develops and tests an opioid overdose forecasting tool, which will allow other states to identify and deploy interventions to communities at highest risk of opioid-related death. This results study will significantly improve the allocation of resources to curb the opioid overdose epidemic in the United States.","Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial",9817054,R01DA046620,"['Buprenorphine ', ' Censuses ', ' Cities ', ' Systematics ', ' Classification ', ' Communities ', ' Community Pharmacy ', ' Decision Making ', ' Outbreaks ', ' Disease Outbreaks ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' emergency service ', ' Emergency medical service ', ' Environment ', ' Epidemic ', ' Future ', ' Goals ', ' Health ', ' Health Priorities ', ' History ', ' Recording of previous events ', ' Hospitals ', ' indexing ', ' Photoradiation ', ' Light ', ' Methadose ', ' Dolophine ', ' Althose ', ' Adanon ', ' Methadone ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' Naloxone ', ' Neighborhoods ', ' Overdose ', ' Probability ', ' Public Health ', ' Publishing ', ' Records ', ' Research Resources ', ' Resources ', ' Rhode Island ', ' Risk ', ' Testing ', ' United States ', ' Work ', ' Resource Allocation ', ' base ', ' improved ', ' Area ', ' Phase ', ' Recovery ', ' Policies ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' programs ', ' Source ', ' System ', ' Visit ', ' Services ', ' American ', ' experience ', ' resource guides ', ' novel ', ' Prevention program ', ' peer ', ' Prevention ', ' Admission activity ', ' Admission ', ' Intervention Trial ', ' Interventional trial ', ' Modeling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Institution ', ' preventing ', ' prevent ', ' Address ', ' Dose ', ' Academic Detailing ', ' Data ', ' Intervention Community Trial ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Strategic Planning ', ' Sum ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Population ', ' addiction ', ' addictive disorder ', ' spatiotemporal ', ' high risk ', ' evidence base ', ' population based ', ' primary outcome ', ' overdose prevention ', ' overdose death ', ' public health priorities ', ' surveillance data ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' learning strategy ', ' learning method ', ' learning activity ', ' Predictive Analytics ', ' opioid use disorder ', ' opiate use disorder ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' experimental study ', ' experimental research ', ' experiment ', ' opioid policy ', ' opioid legislation ', ' opioid law ', ' opioid guideline ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' opioid mortality ', ' opioid related death ', ' opioid overdose death ', ' opioid deaths ', ' opiate mortality ', ' opiate deaths ', ' opioid agonist therapy ', ' opioid agonist treatment ', ' referral services ', ' overdose risk ', ' treatment arm ', ' intervention arm ', ' opioid misuse ', ' opiate misuse ', ' nonmedical opioid use ', ' non-medical opioid use ', ' ']",NIDA,BROWN UNIVERSITY,R01,2019,718669,RI-01,0.07758941720403953
"Neural basis of smoking relapse     DESCRIPTION (provided by applicant): Smoking is the greatest preventable cause of mortality and a significant economic burden. Even with the best available treatments, most smokers relapse within days or weeks after a quit attempt. To improve quit rates significantly, we need a more refined mechanistic understanding of why so many smokers who attempt to quit will relapse quickly. The proposed functional magnetic resonance imaging (fMRI) study integrates concepts and tools from the fields of cognitive neuroscience and behavioral science to determine how brain states in early abstinence influence clinical outcomes among treatment-seeking smokers. The primary aims of this hypothesis-driven study are: (1) to identify brain mechanisms that increase vulnerability to smoking relapse, and (2) to test an integrated brain-behavior model of smoking relapse. Using our validated fMRI-based abstinence challenge paradigm, 200 treatment-seeking smokers will complete two 1-hour pre- treatment fMRI scans: after smoking satiety and after 24 hours of confirmed abstinence. We will examine neural and behavioral responses during performance of validated tasks probing working memory, cue reactivity, and stress response as well as resting state functional connectivity. Participants will then set a target quit date, receive smoking cessation counseling, and be monitored for 6-months to assess time (days) to relapse, using a validated smoking relapse protocol. The primary outcome is time to relapse. Secondary outcomes include abstinence symptoms and smoking status at 30 days. For human subjects reasons, relapsing smokers will be offered an opportunity to receive 8 weeks of nicotine patch treatment and counseling free of charge following study completion. Although neuroimaging is not likely to become a standard pre- cessation assessment the near future, this study will elucidate pathological neurobehavioral processes and specific neurocognitive domains that can be targeted in new treatments to aid smoking cessation. PUBLIC HEALTH RELEVANCE: This project will clarify why the majority of smokers relapse quickly following a quit attempt.",Neural basis of smoking relapse,9625742,R01DA041402,"['Affect ', ' Behavioral Sciences ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Charge ', ' Systematics ', ' Classification ', ' Counseling ', ' Cues ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Exhibits ', ' Future ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Insula of Reil ', ' working memory ', ' Shortterm Memory ', ' Immediate Memory ', ' Short-Term Memory ', ' Methods ', ' mortality ', ' Nicotine Withdrawal ', ' Nucleus Accumbens ', ' Relapse ', ' Research Resources ', ' Resources ', ' Rest ', ' Risk ', ' social role ', ' Role ', ' satiety ', ' Satiation ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoke ', ' Smoking ', ' Stress ', ' Psychologic Stress ', ' Psychological Stress ', ' Task Performances ', ' Testing ', ' Time ', ' Measures ', ' stop smoking ', ' quit smoking ', ' cease smoking ', ' smoking cessation ', ' Mediating ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' biological adaptation to stress ', ' Prefrontal Cortex ', ' base ', ' human subject ', ' improved ', ' Left ', ' Anterior ', ' Medial ', ' Clinical ', ' psychologic ', ' psychological ', ' Evaluation ', ' Memory impairment ', ' memory dysfunction ', ' Memory Deficit ', ' tool ', ' Smoker ', ' nicotine patch ', ' Nicotine Skin Patch ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Investigation ', ' Hour ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' Neurocognitive ', ' behavior change ', ' Performance ', ' behavior measurement ', ' behavioral measurement ', ' behavioral measure ', ' cingulate cortex ', ' relating to nervous system ', ' neural ', ' neuroimaging ', ' neuro-imaging ', ' novel ', ' Participant ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Patient Self-Report ', ' Self-Report ', ' Ventral Striatum ', ' cue reactivity ', ' Modeling ', ' craving ', ' response ', ' MRI Scans ', ' Magnetic Resonance Imaging Scan ', ' Nicotine Replacement Therapy ', ' nicotine replacement ', ' Symptoms ', ' Economic Burden ', ' Cognitive ', ' Smoking Status ', ' Pathologic ', ' Monitor ', ' Process ', ' Behavioral ', ' blood oxygen level dependent ', ' blood oxygenation level dependent ', ' Pathway interactions ', ' pathway ', ' neurobehavioral ', ' Outcome ', ' prospective ', ' neuromechanism ', ' neural mechanism ', ' cognitive neuroscience ', ' Impairment ', ' Abstinence ', ' brain behavior ', ' cognitive control ', ' public health relevance ', ' multimodality ', ' multi-modality ', ' primary outcome ', ' secondary outcome ', ' smoking relapse ', ' stress reactivity ', ' behavioral response ', ' behavior response ', ' relapse risk ', ' imaging study ', ' high dimensionality ', ' smoking abstinence ', ' smoking cue ', ' cue to smoke ', ' ']",NIDA,UNIVERSITY OF PENNSYLVANIA,R01,2019,613163,PA-03,0.09122822795463399
"Leveraging Social Media Data and Machine Learning to Optimize Treatment Paradigms for Youth with Schizophrenia Abstract Schizophrenia constitutes a chronic and disabling illness. While patients show high rates of response to treatment after a rst-episode of schizophrenia, the long-term course of the illness is typically characterized by frequent re- lapses, persistence of symptoms, and enduring cognitive and functional decits. Despite the prioritization of relapse prevention as a treatment goal, about four out of ve patients experience a relapse within the rst ve years of treatment. Relapses are known to have serious psychosocial, educational, or vocational implications in young adultsa population at high risk of psychosis. However, current psychiatric ability to recognize indicators of relapse in order to prevent escalation of psychotic symptoms is markedly limited. Challenges stem from a lack of availability of comprehensive information about early warning signs, and reliance on xed time point sampling of cross-sectional data as well as patient or family reported observations, that is subject to recall bias, or on clin- ician sought information, that needs frequent and timely contact. The present proposal seeks to address these gaps in early psychosis treatment, by leveraging patient-generated and patient-volunteered social media data, and developing and validating machine learning approaches for digital phenotyping and relapse prediction. Our proposed work is founded on the observation that social media sites have emerged as prominent platforms of emotional and linguistic expressionyoung adults are among the heaviest users of social media. The work signif- icantly advances the research agenda and extensive pilot investigations of the team, who a) have demonstrated that social media data of individuals can serve as a powerful lens toward understanding and inferring mental health state, illness course, and likelihood of relapse, including among young adults with early psychosis; and b) have been involved in examining the role of emergent technologies, like social media, in improving access to and delivery of psychiatric care. Aim 1 will provide theoretically-grounded and clinically meaningful methods for extracting and modeling digital phenotypes and symptoms from social media data of young adult early psychosis patients. Then in Aim 2, we will develop and evaluate machine learning methods that will utilize the extracted social media digital phenotypes to infer patient-specic personalized risk of relapse, and identify its antecedents. Finally, Aim 3 will develop a two-faceted validation framework, to assess the statistical and clinical efcacy and utility of the social media derived inferences of psychosis and relapse in inuencing clinical outcomes and in facilitating evidence-based treatment. To accomplish these aims, the project brings together a strong multidisci- plinary team, combining expertise in social media analytics, psychiatry, psychology, natural language analysis, machine learning, information privacy, and research ethics. Our novel approach offers unprecedented opportuni- ties to initiate the adoption of personalized, responsive, and preemptive evidence-based strategies in treatment of psychosis. The knowledge will set the stage for future research on launching large-scale trials aimed to develop interventions that diminish the severity of relapses, or prevent their occurrence altogether. Project Narrative Timely monitoring of symptoms and preventing relapse after an initial psychotic episode are essential component of early intervention programs and have a critical impact on long term outcome in individuals with psychotic dis- orders. Employing patient-contributed social media data as a viable source of collateral information, this proposal provides a suite of robust, scalable, and eld evaluated machine learning methods to facilitate early and precise identication of digital phenotypes, symptomatic exacerbation, and risk of psychotic relapse in early psychosis patients. The knowledge would provide the necessary opportunity to initiate personalized, adaptive, and proac- tive illness management strategies, inform better nosology, and assist the adoption of improved evidence-based care approaches to diminish the severity of relapses, or prevent their occurrence altogether.",Leveraging Social Media Data and Machine Learning to Optimize Treatment Paradigms for Youth with Schizophrenia,9739933,R01MH117172,"['Adoption ', ' Affect ', ' Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Behavior ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' daily biorhythm ', ' circadian process ', ' Twenty-Four Hour Rhythm ', ' Nyctohemeral Rhythm ', ' Circadian Rhythms ', ' Clinical Study ', ' Clinical Research ', ' Clinical Trials ', ' Cognition ', ' Computers ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Collection ', ' depression ', ' Mental Depression ', ' Family ', ' Feedback ', ' Foundations ', ' Goals ', ' Health ', ' Hospital Admission ', ' Hospitalization ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Linguistic ', ' Linguistics ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Theoretic Models ', ' Theoretical model ', ' Moods ', ' NIMH ', ' National Institute of Mental Health ', ' Patients ', ' Phenotype ', ' Psychiatry ', ' Psychology ', ' Clinical Psychology ', ' Social Psychology ', ' psychotic illness ', ' Psychoses ', ' Psychotic Disorders ', ' Relapse ', ' Research ', ' Risk ', ' social role ', ' Role ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Stigmatization ', ' suicidality ', ' intent to die ', ' fatal suicide ', ' fatal attempt ', ' Suicide ', ' Testing ', ' Texas ', ' Time ', ' Universities ', ' violent behavior ', ' violent ', ' Violence ', ' Work ', ' Privacy ', ' Research Methods ', ' Research Methodology ', ' Youth 10-21 ', ' Youth ', ' Caring ', ' base ', ' improved ', ' Psychiatric therapeutic procedure ', ' psychiatric treatment ', ' psychiatric therapy ', ' psychiatric care ', ' Site ', ' Surface ', ' Chronic ', ' Clinical ', ' Phase ', ' Evaluation ', ' medical complication ', ' disability ', ' Disorientation ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Early Intervention ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Scientist ', ' Adopted ', ' Investigation ', ' Severities ', ' Source ', ' Techniques ', ' psychosocial ', ' innovative technologies ', ' Early Diagnosis ', ' early detection ', ' experience ', ' cohort ', ' intervention program ', ' novel ', ' peer ', ' disease classification ', ' nosology ', ' disorder classification ', ' Reporting ', ' social ', ' disorder later incidence prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' Research Ethics ', ' Emotional ', ' Deterioration ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Data ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Improve Access ', ' Strategic Planning ', ' Clinical Data ', ' Cognitive ', ' Computational Technique ', ' Emerging Technologies ', ' Emergent Technologies ', ' Patient-Focused Outcomes ', ' Patient-Centered Outcomes ', ' Patient outcome ', ' Validation ', ' Monitor ', ' Development ', ' developmental ', ' Behavioral ', ' Evidence based treatment ', ' digital ', ' Social Functioning ', ' clinical efficacy ', ' willingness ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' first episode schizophrenia ', ' Outcome ', ' Population ', ' prospective ', ' biological research ', ' multidisciplinary ', ' volunteer ', ' stem ', ' digital models ', ' lens ', ' lenses ', ' high risk ', ' evidence base ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' treatment strategy ', ' natural language ', ' psychotic symptoms ', ' Adolescent and Young Adult ', ' Big Data ', ' BigData ', ' personalized intervention ', ' precision interventions ', ' learning strategy ', ' learning method ', ' learning activity ', ' social media ', ' support tools ', ' digital media ', ' biomarker development ', ' relapse patients ', ' relapse prediction ', ' predict relapse ', ' relapse risk ', ' recruit ', ' clinical decision support ', ' clinical heterogeneity ', ' treatment optimization ', ' therapy optimization ', ' deep learning ', ' computational basis ', ' ']",NIMH,GEORGIA INSTITUTE OF TECHNOLOGY,R01,2019,682250,GA-05,0.10502751397856458
"Classifying addictions using machine learning analysis of multidimensional data ABSTRACT This Independent Scientist Award will significantly enhance my research capabilities, enabling me to become a leading quantitative investigator in the field of substance use disorders (SUDs). Specifically, it will allow me to increase my knowledge in the areas of SUD phenotypes, treatment and genetics. SUDs are clinically and etiologically heterogeneous and their classification has been difficult. This application reflects my ongoing commitment to developing an innovative and interdisciplinary research program on the classification of SUDs through quantitative analysis of multidimensional data. My extensive training in computational science and prior research on biomedical informatics have provided me with the skills to design, implement and evaluate advanced algorithms and sophisticated analyses to solve challenging problems in classifying SUDs. My ongoing NIDA-funded R01 employs a large (n=~12,000) sample aggregated from multiple genetic studies of cocaine, opioid, and alcohol dependence to develop and evaluate novel statistical models to generate clinical SUD subtypes that are optimized for gene finding. This K02 proposal extends that work to evaluate treatment outcome in refined subgroups of SUD populations using data from treatment studies for cocaine, opioid, alcohol and multiple substance dependence. This project will integrate data from diagnostic behavioral variables and genotypes, as well as biological/neurobiological features of the disorders and repeated measures of treatment outcome. The primary career development goals of this application are to: (1) understand the reliability, validity and functional mechanisms of various phenotyping methods; (2) to continue training in the genetics of addictions; and (3) to gain greater knowledge of different treatment approaches and their efficacy. A solid foundation in these areas will enhance my ability to realize the full potential of the data collected and aggregated from multiple dimensions, and to use the data to design the most clinically useful analysis and generate innovative solutions to diagnostic and predictive challenges in SUD research. Through formal coursework, directed readings, individual tutoring and intensive multidisciplinary collaboration with a diverse team of world-renowned researchers, I will receive training and collect pilot data for future R01 projects by examining (Aim I): whether clinically-defined highly heritable subtypes derived in my current R01 project predict differential treatment response; (Aim II) whether new statistical models that directly combine treatment data with behavioral, biological, and genomic data identify refined subtypes with confirmatory multilevel evidence; and (Aim III) whether there are genetic and social moderators of treatment outcome by subtype. The overall goal of this proposal is to further my independent and multidisciplinary research program in the development of statistical methods for refined classification of SUDs. The K02 award will provide me with the protected time necessary to fully engage in the training activities described that will enhance my knowledge and skills to enable me to make important, novel contributions to the genetics and treatment of SUD. PROJECT NARRATIVE This project will develop novel statistical and quantitative tools to identify homogeneous subtypes of substance use disorders (SUDs) and other complex diseases to enhance gene finding and treatment matching. The proposed project will perform secondary analyses of existing data from treatment studies of cocaine, opioid, alcohol, and mixed SUDs. The proposed novel approaches are expected to advance precision medicine approaches to SUDs by enabling treatment matching and a more refined SUD classification to gene finding.",Classifying addictions using machine learning analysis of multidimensional data,9625118,K02DA043063,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' alcohol use disorder ', ' ethanol use disorder ', ' Alcohols ', ' Alcohol Chemical Class ', ' Algorithms ', ' Systematics ', ' Classification ', ' Cluster Analyses ', ' Cluster Analysis ', ' Cocaine ', ' multi-modal treatment ', ' multi-modal therapy ', ' combined treatment ', ' combined modality treatment ', ' combination therapy ', ' Multimodal Treatment ', ' Multimodal Therapy ', ' Combined Modality Therapy ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Diagnosis ', ' Disorder ', ' Disease ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Drug Use Disorder ', ' EEG ', ' Electroencephalography ', ' Foundations ', ' Future ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Joints ', ' Methods ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' neurobiological ', ' Neurobiology ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk Factors ', ' Diagnostic Findings ', ' Signs and Symptoms ', ' Substance Dependence ', ' Substance Addiction ', ' Substance Use Disorder ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' training module ', ' Training Activity ', ' Work ', ' Measures ', ' Treatment outcome ', ' Dataset ', ' Data Set ', ' improved ', ' Area ', ' Solid ', ' Clinical ', ' Biological ', ' Training ', ' DSM-IV ', ' Diagnostic and Statistical Manual of Mental Disorders-IV ', ' Diagnostic and Statistical Manual of Mental Disorders, 4th edition ', ' DSM4 ', ' DSM-4 ', ' Individual ', ' Opioid ', ' Opiates ', ' Interdisciplinary Study ', ' Multidisciplinary Research ', ' Multidisciplinary Collaboration ', ' Interdisciplinary Research ', ' Measurement ', ' Funding ', ' Collaborations ', ' Genetic ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Dimensions ', ' Complex ', ' Pattern ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' treatment planning ', ' Biosensor ', ' biological sensor ', ' Cocaine Dependence ', ' Cocaine Addiction ', ' skills ', ' novel ', ' disease classification ', ' nosology ', ' disorder classification ', ' contingency management ', ' social ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' career development ', ' disorder subtype ', ' disease subtype ', ' disease subgroups ', ' Genomics ', ' Diagnostic and Statistical Manual of Mental Disorders ', ' Diagnostic and Statistical Manual ', ' DSM-V ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' DSM5 ', ' DSM-5 ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' Symptoms ', ' Adherence ', ' Data ', ' Independent Scientist Award ', ' K02 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Subgroup ', ' Characteristics ', ' Development ', ' developmental ', ' Behavioral ', ' biomedical informatics ', ' biomed informatics ', ' design ', ' designing ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Computational Science ', ' Population ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' endophenotype ', ' addiction ', ' addictive disorder ', ' treatment response ', ' therapeutic response ', ' response to treatment ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' cocaine use ', ' precision medicine ', ' precision-based medicine ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' Genetic study ', ' neural correlate ', ' tutoring ', ' tutorial support ', ' opioid use disorder ', ' opiate use disorder ', ' outcome prediction ', ' predictors of outcomes ', ' predictive outcomes ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' imaging genetics ', ' secondary analysis ', ' recruit ', ' biomarker performance ', ' biomarker utility ', ' multidimensional data ', ' high dimensional data ', ' ']",NIDA,UNIVERSITY OF CONNECTICUT STORRS,K02,2019,162123,CT-02,0.004427923360704689
"LEVERAGING PREDICTIVE ANALYTICS WITHIN SOCIAL NETWORKS TO MAXIMIZE DRUG ANDALCOHOL TREATMENT EFFICACY AND RELAPSE PREVENTION PROJECT SUMMARY/ABSTRACT Sober Grid has developed a smartphone-based mobile application currently in use by over 120,000 individuals worldwide who are in, or seeking, recovery from drug and alcohol addiction. The Grid, as it is known, is a mobile-based, social recovery community providing rapid context- specific peer support, efficient help seeking, motivational enhancement exercises, and member ratings of support content  all aimed to prevent relapse. The overarching goal of this phase II project is to extend the current capabilities of the Sober Grid app to achieve a comprehensive social recovery support app featuring intelligent, context appropriate resource matching and 24/7 rapid response peer-coaching that is effective in reducing disordered substance use and is cost effective. We hypothesize that providing this functionality to high-risk members will be acceptable, feasible, increase access to and engagement with resources, and have a positive effect in increasing time to relapse and days of consecutive abstinence. The companys priority commercial goal is to leverage the insights gained from its large database of information and behaviors recorded in its existing addiction recovery-focused social network, combined with its recently completed SBIR phase I work, to identify users at risk for relapse and deliver tailored lay and professional peer support, telehealth, and provider interventions prompted by near real-time automated risk indicators built into an Enhanced Sober Grid (ESG) solution. The specific goals of this proposed phase II project include: (1) implementing the relapse risk scoring algorithm successfully developed in phase I in a production environment, (2) developing a ML resource relevancy matching algorithm, and (3) using this system to pilot test the feasibility and acceptability as well as to estimate the effect on abstinence of providing peer-coaching and resource information to a national sample of Sober Grid members in recovery from non- alcohol/nicotine substances who are predicted to be at high risk for relapse. We will accomplish our objectives by: (Aim 1) Implementing an accurate, near real-time production risk prediction system; (Aim 2) Developing an enhanced, in-app substance-addiction recovery resource locator; and, (Aim 3) Determining the feasibility, acceptability and estimating the effect size of the proposed ESG among high relapse-risk participants in recovery from opioid, stimulant, or cannabis use. The expected impact of this project is to substantially enhance Sober Grid's ability to deliver effective and timely interventions to the right individuals, at the right time  including those high-need and underserved populations that would otherwise lack access to care and draw considerable resources from the healthcare system. This capability holds the promise to reduce drug and alcohol relapse and the associated negative health impacts at both an individual and societal level while reducing the total cost of providing treatment services. PROJECT NARRATIVE Sober Grid is combining near real-time risk prediction with automated phone-app messaging, peer-coaching, and resource visibility and transparency in order to dramatically improve support for recovery from substance abuse. The strategy is to provide continuously available responsive connection and support with simple and familiar ways to search, filter, sort, identify, and review/rate resource options in order to lower overall relapse rates within the population, enabling Sober Grid users to achieve improved health outcomes and institutional payers to reduce the total cost of achieving those outcomes. Over time, the innovations resulting from this project will significantly reduce costs for individuals, public and private payers, the healthcare system, and society at large.",LEVERAGING PREDICTIVE ANALYTICS WITHIN SOCIAL NETWORKS TO MAXIMIZE DRUG ANDALCOHOL TREATMENT EFFICACY AND RELAPSE PREVENTION,9681118,R44DA044062,"['Aftercare ', ' post treatment ', ' After-Treatment ', ' After Care ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Algorithms ', ' Back ', ' Dorsum ', ' Behavior ', ' Client ', ' Communities ', ' Cost Containment ', ' Cost Control ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Environment ', ' Exercise ', ' Foundations ', ' Goals ', ' Group Meetings ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' Insurance ', ' Intelligence ', ' Motivation ', ' natural language understanding ', ' Natural Language Processing ', ' Nicotine ', ' Patients ', ' Privatization ', ' Production ', ' Relapse ', ' Research Resources ', ' Resources ', ' Risk ', ' self help organization ', ' Self-Help Groups ', ' Support Groups ', ' social support network ', ' Social support ', ' Societies ', ' Substance Dependence ', ' Substance Addiction ', ' Substance Use Disorder ', ' Survey Instrument ', ' Surveys ', ' Technology ', ' Phone ', ' Telephone ', ' Testing ', ' Time ', ' Work ', ' Writing ', ' Caring ', ' Social Network ', ' base ', ' improved ', ' Clinical ', ' Phase ', ' insight ', ' Personality Traits ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Recovery ', ' Databases ', ' data base ', ' Data Bases ', ' Opioid ', ' Opiates ', ' satisfaction ', ' Drug usage ', ' drug use ', ' Published Comment ', ' Viewpoint ', ' Editorial Comment ', ' Commentary ', ' Comment ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Stream ', ' System ', ' Location ', ' Opiate Addiction ', ' opioid dependent ', ' opioid dependence ', ' opioid addiction ', ' Opiate Dependence ', ' Services ', ' preference ', ' success ', ' Participant ', ' peer ', ' treatment program ', ' member ', ' sobriety ', ' sober ', ' help-seeking behavior ', ' help seeking ', ' new technology ', ' novel technologies ', ' Reporting ', ' social ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' disorder later incidence prevention ', ' relapse prevention ', ' recurrence prevention ', ' disorder recurrence prevention ', ' disease recurrence prevention ', ' Modeling ', ' Sampling ', ' response ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Cannabis ', ' Enhancement Technology ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' Provider ', ' preventing ', ' prevent ', ' telehealth ', ' Drug Addiction ', ' Drug Dependency ', ' Drug Dependence ', ' Chemical Dependence ', ' Data ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Small Business Innovation Research Grant ', ' Small Business Innovation Research ', ' SBIR ', ' Monitor ', ' Characteristics ', ' Process ', ' Behavioral ', ' cost ', ' drug relapse ', ' alcohol relapse ', ' ethanol relapse ', ' treatment center ', ' Underserved Population ', ' underserved people ', ' under served population ', ' design ', ' designing ', ' Treatment Efficacy ', ' therapy efficacy ', ' therapeutically effective ', ' therapeutic efficacy ', ' intervention efficacy ', ' Outcome ', ' cost effective ', ' Population ', ' Alcohol dependence ', ' alcohol-dependent ', ' alcohol dependency ', ' alcohol addiction ', ' innovation ', ' innovative ', ' innovate ', ' Abstinence ', ' provider intervention ', ' addiction ', ' addictive disorder ', ' high risk ', ' effective therapy ', ' effective treatment ', ' phase 2 study ', ' phase II study ', ' mobile application ', ' mobile app ', ' cloud based ', ' marijuana use ', ' cannabis use ', ' THC use ', ' THC co-use ', ' peer coaching ', ' peer teaching ', ' peer mentoring ', ' peer led team learning ', ' peer instruction ', ' peer support ', ' social media ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' Predictive Analytics ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' medication-assisted treatment ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' Android ', ' relapse risk ', ' high risk population ', ' high risk group ', ' treatment services ', ' stimulant use ', ' machine learning algorithm ', ' ']",NIDA,"SOBER GRID, INC.",R44,2019,499907,OH-11,0.06809592125678733
"Development of a tracheal sound sensor for early detection of hypoventilation due to opioid overdose. Abstract More than 64,000 Americans died from drug overdose in 2016 and drug overdose is now the most common cause of death for people under 50 years old in the United States. Furthermore, the number of overdose deaths is increasing with the rise of abuse of powerful synthetic opioids, such as fentanyl. In May of 2017 National Institutes of Health (NIH) and National Institute on Drug Abuse (NIDA) directors Drs. Collins and Volkow outlined how research may help reduce the death toll associated with the current opioid epidemic; one of the current critical needs is the development of new overdose-reversal interventions, including wearable technologies that can detect an (impending) overdose from physiological signals to signal for help, or trigger a coupled automated injection of naloxone. Automated detection of overdose is essential because most opioid overdoses occur when individuals are alone and unobserved by family members or first responders. Opioids cause respiration to slow and become irregular due to mu-opioid receptor mediated suppression of respiratory related regions of the brainstem and spinal cord. Importantly, there are characteristic early changes in breathing pattern that indicate a progression towards significant hypoventilation, but there is currently no easy-to use method or device to measure these patterns non-invasively. Recently, there has been a renewed interest in respiratory monitoring using tracheal sounds. Tracheal sounds originate from the vibrations of the tracheal wall and surrounding soft tissues caused by gas pressure fluctuations in the trachea. These sounds can be collected from a microphone placed over the trachea and analyzed to determine the real-time respiratory rate and an estimate of respiratory flow and tidal volume. We hypothesize that individual trends in tracheal sounds detected by a machine- learning algorithm will provide an early warning sign of the onset of hypoventilation as a result of opioid overdose in humans. The aims of this proposal are to develop a machine learning algorithm that detects impending hypoventilation due to an opioid overdose and to develop an initial design for a miniature wireless tracheal sound sensor. Project Narrative RTM Vital Signs, LLC is developing a non-invasive Tracheal Sound Sensor for early detection of impending hypoventilation due to an opioid overdose. The sensor will continuously monitor an individuals respiratory pattern to detect a significant change from baseline, in which case it will contact a caregiver and/or emergency personnel detailing the location and status of the person experiencing an opioid overdose or initiate a coupled naloxone injection. This technology has the potential to prevent a significant number of deaths as a result of opioid overdose by allowing for the timely detection of hypoventilation and administration of naloxone.",Development of a tracheal sound sensor for early detection of hypoventilation due to opioid overdose.,9680488,R41DA047779,"['Abdomen ', ' Abdominal ', ' Adult ', ' adulthood ', ' Adult Human ', ' 21+ years old ', ' airway obstruction ', ' obstructed airway ', ' obstructed airflow ', ' airflow obstruction ', ' Algorithms ', ' Breathing ', ' inspiration ', ' Respiratory Inspiration ', ' Respiratory Aspiration ', ' Brain Stem ', ' Brainstem ', ' Cause of Death ', ' Death ', ' Cessation of life ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' emergency medical personnel ', ' Emergency Paramedics ', ' Emergency Medicine Technicians ', ' Emergency Medical Technicians ', ' Engineering ', ' Phentanyl ', ' Fentyl ', ' Fentanest ', ' Duragesic ', ' Actiq ', ' Fentanyl ', ' Future ', ' Gases ', ' Goals ', ' Head ', ' Modern Man ', ' Human ', ' indexing ', ' Methods ', ' body movement ', ' Movement ', ' Naloxone ', ' Persons ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Noise ', ' opioid drug abuse ', ' opiate drug abuse ', ' opiate abuse ', ' opioid abuse ', ' Out-patients ', ' Outpatients ', ' Overdose ', ' Patients ', ' pressure ', ' Research ', ' respiratory mechanism ', ' Respiration ', ' Risk ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Snoring ', ' sound ', ' Medulla Spinalis ', ' Spinal Cord ', ' Technology ', ' Telemetries ', ' Telemetry ', ' respiratory airway volume ', ' Tidal Volume ', ' Time ', ' teeth ', ' Tooth ', ' Tooth structure ', ' windpipe ', ' Trachea Proper ', ' Trachea ', ' United States ', ' Universities ', ' Vendor ', ' Ventilation ', ' Environmental air flow ', ' Work ', ' OR ', ' -OR ', '  opioid receptors ', ' mu opioid receptors ', ' Measures ', ' notch receptors ', ' notch ', ' notch protein ', ' Care Givers ', ' Caregivers ', ' Family member ', ' Mediating ', ' base ', ' sensor ', ' Clinical ', ' Phase ', ' Physiological ', ' Physiologic ', ' soft tissue ', ' Individual ', ' Opioid ', ' Opiates ', ' Subcutaneous Tissue ', ' Tela Subcutanea ', ' Superficial Fascia ', ' Subcutis ', ' Hypodermis ', ' Sorbus ', ' Rowan ', ' Mountain Ash ', ' Sedation procedure ', ' sedation ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Body Patterning ', ' Body Pattern Specification ', ' Body Pattern Formation ', ' programs ', ' Hypercapnic respiratory failure ', ' Hypoventilation ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' System ', ' Location ', ' vibration ', ' respiratory ', ' interest ', ' Infusion procedures ', ' Infusion ', ' American ', ' Early Diagnosis ', ' early detection ', ' experience ', ' Performance ', ' Study Subject ', ' Devices ', ' Hypoxemia ', ' hypoxemic ', ' Substance abuse problem ', ' substance abuse ', ' abuse of substances ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Skin ', ' Cellular Phone ', ' smartphone ', ' smart phone ', ' iPhone ', ' Cellular Telephone ', ' Cell Phone ', ' body position ', ' Thickness ', ' Thick ', ' preventing ', ' prevent ', ' Diameter ', ' Caliber ', ' alertness ', ' Data ', ' Detection ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Small Business Innovation Research Grant ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Technology Transfer Research ', ' STTR ', ' Validation ', ' Wireless Technology ', ' wireless ', ' Monitor ', ' trend ', ' Characteristics ', ' Development ', ' developmental ', ' emergency service responder ', ' emergency service personnel ', ' emergency responder ', ' emergency personnel ', ' time use ', ' design ', ' designing ', ' Coupled ', ' clinically significant ', ' clinical significance ', ' volunteer ', ' engineering design ', ' high risk ', ' overdose death ', ' phase 2 study ', ' phase II study ', ' signal processing ', ' clinical predictors ', ' learning strategy ', ' learning method ', ' learning activity ', ' wearable technology ', ' Accelerometer ', ' activity tracker ', ' activity monitor ', ' accelerometry ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' experimental study ', ' experimental research ', ' experiment ', ' opioid epidemic ', ' opioid crisis ', ' opiate crisis ', ' opioid overdose ', ' opioid toxicity ', ' opioid related overdose ', ' opioid poisoning ', ' opioid medication overdose ', ' opioid intoxication ', ' opioid induced overdose ', ' opioid drug overdose ', ' opiate related overdose ', ' opiate overdose ', ' smartphone Application ', ' iPhone Application ', ' iPhone App ', ' iOS application ', ' iOS app ', ' Smartphone App ', ' Smart Phone Application ', ' Smart Phone App ', ' Cellular Phone Application ', ' Cellular Phone App ', ' Cell phone App ', ' Cell Phone Application ', ' Android Application ', ' Android App ', ' Injections ', ' microphone ', ' machine learning algorithm ', ' synthetic opioid ', ' synthetic opiate ', ' first responder ', ' ']",NIDA,"RTM VITAL SIGNS, LLC",R41,2019,236381,PA-03,0.08259891738404387
"Mobile Peer Support for Opioid Use Disorders: Refinement of an Innovative Machine Learning Tool PROJECT SUMMARY This proposal develops a novel, artificial-intelligence (AI) enabled, mobile treatment delivery method that fulfills the need for a robust, secure, technology-based peer support platform to support patients with opioid use disorders (OUDs). The majority of individuals with OUDs in the United States do not receive any formal substance use treatment, and growing evidence suggests that many OUD patients turn to online social platforms to access peer support and obtain health-related information about addiction and recovery. While engagement with peers before and during recovery is a key component of many evidence-based addiction recovery programs, commonly-used online social platforms (e.g. Reddit) lack effective content moderation, with inappropriate messages ranging from misinformed advice to maliciousness. This lack of oversight precludes a deeper integration of peer support and clinical care. Our mobile platform allows patients to access a tailored support group 24/7, and is augmented with AI tools capable of understanding the emotional sentiment in messages, automatically `flagging' critical or clinically relevant content, creating a scalable system to keep groups safe and constructive. This phase I proposal demonstrates the robustness of these AI tools by adapting them to catch OUD-specific `flags' in peer messages while also examining the adoptability of the platform itself within OUD patients. A subsequent phase II proposal will test tailored, real-time interventions to `flags', allowing the commercialization of a system to harness the engagement and self-disclosure of peer groups in a clinical setting. PROJECT NARRATIVE The widespread and chronic nature of opioid use disorder (OUD) necessitates investment in highly scalable technology solutions. Our work has the potential to dramatically broaden access to care for patients, particularly those in highly stigmatized and rural communities, while taking an entirely novel approach to patient triaging and tracking through artificial intelligence technology. Such technology has the potential to enable new modalities of treatment and lays the foundation for a more cost-effective, yet personalized, approach to chronic OUD care.",Mobile Peer Support for Opioid Use Disorders: Refinement of an Innovative Machine Learning Tool,9679778,R41DA047837,"['Algorithms ', ' Ambulatory Care ', ' outpatient treatment ', ' Outpatient Care ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Communities ', ' ethical ', ' Ethics ', ' Feedback ', ' Foundations ', ' Patient Care Delivery ', ' Patient Care ', ' Goals ', ' Health ', ' Health Care Systems ', ' Healthcare Systems ', ' treatment access ', ' service availability ', ' health services availability ', ' health service access ', ' care access ', ' availability of services ', ' accessibility to health services ', ' access to treatment ', ' access to services ', ' access to health services ', ' Access to Care ', ' Health Services Accessibility ', ' History ', ' Recording of previous events ', ' Hospitals ', ' Interview ', ' Investments ', ' Language ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' mortality ', ' natural language understanding ', ' Natural Language Processing ', ' Painful ', ' Pain ', ' Patients ', ' Peer Group ', ' Recurrent ', ' Recurrence ', ' Relapse ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Rhode Island ', ' Risk ', ' Self Disclosure ', ' self help organization ', ' Self-Help Groups ', ' Support Groups ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Speech ', ' Stigmatization ', ' Technology ', ' Testing ', ' Time ', ' United States ', ' Work ', ' self injury ', ' self harm ', ' intentional self injury ', ' intentional self harm ', ' deliberate self harm ', ' Deliberate Self-Harm ', ' Self-Injurious Behavior ', ' Rural Community ', ' Caring ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Phase ', ' Training ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' Recovery ', ' Databases ', ' data base ', ' Data Bases ', ' Opioid ', ' Opiates ', ' satisfaction ', ' Patient Recruitments ', ' participant recruitment ', ' tool ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Adopted ', ' Protocols documentation ', ' Protocol ', ' Source ', ' System ', ' Services ', ' American ', ' experience ', ' Self Efficacy ', ' novel ', ' Participant ', ' peer ', ' Modality ', ' social ', ' Emotional ', ' Modeling ', ' Sampling ', ' craving ', ' social stigma ', ' stigma ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Provider ', ' Consent ', ' Data ', ' Research Infrastructure ', ' Security ', ' Small Business Technology Transfer Research ', ' STTR ', ' Monitor ', ' Text ', ' Development ', ' developmental ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' cost effective ', ' innovation ', ' innovative ', ' innovate ', ' clinically relevant ', ' clinical relevance ', ' usability ', ' addiction ', ' addictive disorder ', ' commercialization ', ' clinical care ', ' evidence base ', ' primary outcome ', ' standard care ', ' standard treatment ', ' clinical infrastructure ', ' efficacy testing ', ' Secure ', ' mHealth ', ' mobile health ', ' m-Health ', ' mobile application ', ' mobile app ', ' Patient Triage ', ' behavioral health intervention ', ' peer support ', ' Industry Standard ', ' mobile computing ', ' mobile technology ', ' mobile platform ', ' personalized approach ', ' tailored approach ', ' precision approach ', ' individualized approach ', ' Personalized medical approach ', ' opioid use disorder ', ' opiate use disorder ', ' opioid use ', ' opioid intake ', ' opioid drug use ', ' opioid consumption ', ' opiate use ', ' opiate intake ', ' opiate drug use ', ' opiate consumption ', ' Text Messaging ', ' texting ', ' short message service ', ' barrier to care ', ' obstacle to healthcare ', ' obstacle to care ', ' barrier to treatment ', ' barrier to healthcare ', ' barrier to health care ', ' ']",NIDA,"BEACON TECH, INC.",R41,2019,225000,MA-08,0.07823445510274527
"Leveraging Social Media for Substance Use Behavioral Insight  Project Summary Substance misuse places a tremendous burden on individuals and society and remains high because so many youth initiate substance use at an early age and progress to dependence. In one of my NIDA sponsored R01s, I am funded to examine the effects of school and state-level penalties on youth substance use behaviors while accounting for anti-tobacco/drug media campaigns (R01 DA032843). My research signals a health issue of increasing importance that is youth exposure to the promotion of alcohol, tobacco, and other drug-related content via advertisements, online social networking, and other normalizing and pro-use messages. There is potential for leveraging social media as a tool to understand, inform, and potentially dissuade harmful substance use behaviors. However, a critical and necessary first step is to better understand displayed substance use references on key social media sites and how these displays are associated with use. In my second NIDA-sponsored R01, I am funded to investigate the implications of social media content and engagement for alcohol and marijuana use (R01 DA039456). I am a newly tenured investigator who has already made important contributions to the study of substance use policy and social media research. I will investigate social media posts for novel insight into drug use, especially newly emerging drugs that are increasing in popularity. I also aim to generate a strong scientific base about social media as a potential medium for delivering anti-/pro- substance use messages to young people. At this juncture, it is critical for me to receive support from this Independent Scientist Award so that I can devote all of my efforts towards continuing to build my research program and to enhance my scientific skills and advance me to the next level of achievement. I will collaborate with investigators at Washington University and nationally in order to gain further experience in sophisticated and efficient data mining analysis. I will additionally achieve an improved ability to synthesize results across multiple studies into strategic and actionable recommendations for tailored prevention messages to deliver on social media. This award will also enable me to devote a substantial amount of time to mentorship and the development of the next generation of researchers. In summary, this Independent Scientist Award will enable me to expand my knowledge base in targeted areas to significantly enhance my research trajectory in ways that would not be otherwise feasible. Project Narrative This study is significant to the public health field because it will harness social media posts for novel insight into drug use, especially newly emerging drugs that are increasing in popularity. This application requests 5 years of funding to support protected research time for Dr. Cavazos to learn and apply new skills in state-of-the-art big data analysis and to synthesize her results across studies into strategic and actionable recommendations for tailored prevention messages to deliver on social media.",Leveraging Social Media for Substance Use Behavioral Insight ,9769518,K02DA043657,"['Accounting ', ' Achievement ', ' Achievement Attainment ', ' Age ', ' ages ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Attitude ', ' Award ', ' Behavior ', ' Belief ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Data Sources ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Grant ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Health ', ' Influentials ', ' Leadership ', ' Learning ', ' marihuana ', ' Marijuana ', ' Mentors ', ' Mentorship ', ' Methods ', ' Minority Groups ', ' Mission ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Productivity ', ' Public Health ', ' Recommendation ', ' Research ', ' R&D ', ' R & D ', ' Development and Research ', ' research and development ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Salaries ', ' Wages ', ' Schools ', ' school of medicine ', ' medical college ', ' medical schools ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Societies ', ' Substance Dependence ', ' Substance Addiction ', ' Substance Use Disorder ', ' Survey Method ', ' Survey Methodology ', ' Teaching ', ' Educational process of instructing ', ' Technology ', ' Time ', ' Tobacco ', ' Universities ', ' Washington ', ' Work ', ' Cost Sharing ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' analytical method ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' insight ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Policies ', ' Research Activity ', ' Drug usage ', ' drug use ', ' Funding ', ' Exposure to ', ' Shapes ', ' tool ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Research Priority ', ' programs ', ' Complex ', ' Dependence ', ' Source ', ' Pattern ', ' interest ', ' experience ', ' knowledge base ', ' knowledgebase ', ' skills ', ' expectation ', ' novel ', ' Media Campaign ', ' member ', ' hookah ', ' waterpipe ', ' water pipe ', ' shisha ', ' narghile ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' social ', ' Positioning Attribute ', ' Position ', ' career development ', ' Advertisements ', ' Latina ', ' Latinas ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' datamining ', ' data mining ', ' Address ', ' Data ', ' Independent Scientist Award ', ' K02 Award ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Request for Applications ', ' NIH RFA ', ' Underrepresented Minority ', ' underrepresentation of minorities ', ' under-representation of minorities ', ' Underrepresented Ethnic Minority ', ' trend ', ' Development ', ' developmental ', ' Behavioral ', ' adolescent substance use ', ' youth substance use ', ' substance use among youth ', ' substance use among adolescents ', ' next generation ', ' addiction ', ' addictive disorder ', ' social networking website ', ' web-based social networking ', ' social networking web site ', ' social networking site ', ' online social networking ', ' on-line social networking ', ' social implication ', ' Secure ', ' Big Data ', ' BigData ', ' Electronic cigarette ', ' ecigarette ', ' ecig ', ' e-cigarette ', ' e-cig ', ' marijuana use ', ' cannabis use ', ' THC use ', ' THC co-use ', ' mid-career faculty ', ' midcareer faculty ', ' associate professor ', ' associate faculty ', ' learning strategy ', ' learning method ', ' learning activity ', ' social media ', ' Data Analytics ', ' substance misuse ', ' Twitter ', ' Big Data Methods ', ' Big Data Tools ', ' Big Data Analytics ', ' ']",NIDA,WASHINGTON UNIVERSITY,K02,2019,118137,MO-01,0.042549820513271
"Effects of oxycodone on functional connectivity Project Summary Prescription opioids, e.g., oxycodone (OXY), are commonly encountered in youth and pose a significant public health problem. In addition, there are significant individual differences in subjective responses to opioids which contribute to vulnerabilities for misuse. However, little is understood about OXY's effects on brain function, or on how individual differences in these effects might relate to variations in subjective responses. Assessment of OXY's effects on brain function is critical to understanding its abuse liability a n d will provide insight into how and why this drug leads to misuse and abuse/dependence in some, but not all, individuals. This proposal will assess the effects of low-dose OXY (10mg) on whole-brain functional connectivity (FC), and explore relationships with subjective responses in healthy young adults (ages 21 to 30 years, N=40) with limited prior opioid exposure. OXY's effects on FC during both reward- processing and resting-state will be assessed using a randomized, double-blind, placebo-controlled, cross-over design incorporating multiband fMRI scanning. Subjective measures of drug response (e.g., `drug liking') will be collected before, during and after neuroimaging using NIDA PhenX measures. Neuroimaging data will be analyzed using data-driven methods to facilitate assessment of OXY's effects on FC both within hypothesized networks (e.g., salience and reward networks) as well as on patterns of between- network connectivity. Specifically, FC changes following OXY versus placebo (Aim 1) and relationships between these changes and subjective drug responses (Aim 2) will be assessed using intrinsic connectivity distribution (ICD). ICD is a data-driven, voxel-to-voxel method of assessing whole-brain connectivity patterns that is not limited by specification of seed regions or connectivity thresholds. In addition, connectome-based machine-learning will be used to build a predictive model of subjective responses to OXY using data acquired during placebo scans (Aim 3). This project will for the first time assess the effects of a prescription opioid on whole-brain FC. Understanding OXY's effects on large-scale network dynamics is crucial for understanding its abuse liability, and will guide future studies of OXY in addicted and at-risk populations. Identification of networks that are predictive of subjective responses to OXY is an essential first step toward finding a reliable biomarker of opioid response that will help to identify individuals at highest risk for misuse. Project Narrative Prescription opioids are commonly encountered and, in a small proportion of individuals, may be a precursor to heroin initiation. This project will assess the effects of low-dose oxycodone (10mg) on brain function in healthy young adults (age 21 to 30 years). It will identify brain-based predictors of subjective opioid responses (`neural fingerprints') that can be used to inform prevention and intervention efforts.",Effects of oxycodone on functional connectivity,9688964,R21DA045969,"['Age ', ' ages ', ' Behavior ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Cocaine ', ' striatal ', ' Striatum ', ' Striate Body ', ' Corpus Striatum ', ' Corpus striatum structure ', ' Diamorphine ', ' Diacetylmorphine ', ' Heroin ', ' Double-Masked Study ', ' Double-Masked Method ', ' Double-Blinded ', ' Double-Blind Study ', ' Double-Blind Method ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Fingerprint ', ' Future ', ' indexing ', ' Island of Reil ', ' Insula ', ' Central Lobe ', ' Insula of Reil ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Methods ', ' Statex SR ', ' Roxanol ', ' Oramorph SR ', ' Oramorph ', ' Morphia ', ' MSir ', ' MS Contin ', ' Kadian ', ' Infumorph ', ' Morphine ', ' neurochemical ', ' neurochemistry ', ' Roxicodone ', ' Oxycontin ', ' Oxycodone SR ', ' Oxycodeinon ', ' Dihydrohydroxycodeinone ', ' Oxycodone ', ' Perfusion ', ' Pharmacology ', ' Phenotype ', ' sham therapy ', ' Sham Treatment ', ' Placebos ', ' Public Health ', ' putamen ', ' Questionnaires ', ' Rest ', ' Rewards ', ' Risk ', ' seed ', ' Plant Zygotes ', ' Plant Embryos ', ' Seeds ', ' Spin Labels ', ' Time ', ' Measures ', ' Youth 10-21 ', ' Youth ', ' base ', ' Anterior ', ' Medial ', ' Variant ', ' Variation ', ' Link ', ' insight ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Cerebrum ', ' cerebral ', ' Opioid ', ' Opiates ', ' Populations at Risk ', ' Crossover Design ', ' Cross-Over Designs ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Functional Magnetic Resonance Imaging ', ' fMRI ', ' Functional MRI ', ' Complex ', ' Dependence ', ' Scanning ', ' Parietal ', ' Protocols documentation ', ' Protocol ', ' Pattern ', ' System ', ' Neurocognitive ', ' Inferior ', ' interest ', ' behavior prediction ', ' behavioral prediction ', ' relating to nervous system ', ' neural ', ' Heroin Users ', ' Structure ', ' neuroimaging ', ' neuro-imaging ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' Reporting ', ' response ', ' Lobule ', ' LBUL ', ' executive function ', ' executive control ', ' Brain region ', ' Dose ', ' Base of the Brain ', ' Data ', ' National Institute of Drug Abuse ', ' National Institute on Drug Abuse ', ' NIDA ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Resolution ', ' Characteristics ', ' Behavioral ', ' Image ', ' imaging ', ' Behavioral Model ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' Individual Differences ', ' 21 year old ', ' twenty-one years of age ', ' twenty-one year old ', ' age 21 years ', ' age 21 ', ' 21 years of age ', ' Abstinence ', ' reward processing ', ' high risk ', ' treatment strategy ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' financial incentive ', ' monetary incentive ', ' financial reward ', ' prescription opioid ', ' prescription opiate ', ' prescribed opioid ', ' prescribed opiate ', ' opioid medication ', ' opiate medication ', ' licit opioid ', ' learning strategy ', ' learning method ', ' learning activity ', ' connectome ', ' functional MRI scan ', ' fMRI scan ', ' opioid exposure ', ' opioid exposed ', ' opiate exposure ', ' opiate exposed ', ' prescription opioid misuse ', ' prescription opiate misuse ', ' opioid prescription medication misuse ', ' opioid medication misuse ', ' opioid analgesic misuse ', ' nonmedical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' non-medical use of prescription opioids ', ' non-medical use of prescription opiates ', ' opioid misuse ', ' opiate misuse ', ' nonmedical opioid use ', ' non-medical opioid use ', ' neural network ', ' connectome based predictive modeling ', ' ']",NIDA,YALE UNIVERSITY,R21,2019,251250,CT-03,0.0631193534922178
"Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial PROJECT SUMMARY Overdose deaths have skyrocketed in the United States since 1999. The epidemic has prompted widespread federal and state actions, yet the number of people who die of an overdose continues to increase. In light of the accelerating and rapidly evolving overdose epidemic, new strategies are needed to identify communities most at risk, and to utilize resources more effectively to curb overdose deaths. To address these public health priorities, we will develop a forecasting tool to predict overdose deaths before they occur, and then conduct a randomized, statewide, community-level intervention to evaluate resource targeting based on these predictions. The study will take place in Rhode Island, a state with the 10th highest rate of overdose fatality in 2016. The study has two phases. First, we will develop a predictive analytics model that forecasts future overdose mortality at the neighborhood-level, using publicly available information and data from a multicomponent overdose surveillance system. This tool, called PROVIDENT (Preventing Overdose using Information and Data from the Environment) will be used to predict the likelihood of magnitude of future overdose deaths in every neighborhood across Rhode Island. Next, we will conduct a randomized policy experiment to evaluate whether targeting overdose prevention interventions to neighborhoods at highest risk reduces overdose morbidity and mortality. The state's department of health will receive PROVIDENT model predictions for half of the 39 cities/towns in Rhode Island. Within these cities/town, the health department will work with stakeholders to target overdose prevention interventions to neighborhoods with the highest probability of future overdose deaths. Interventions include efforts to: (1) prevent high-risk prescribing (through academic detailing and other educational efforts); (2) expand access to opioid agonist therapy, including buprenorphine and methadone; (3) increase naloxone distribution (through community and pharmacy-based efforts); and (4) expand street-based peer recovery coaching and referrals. Control cities/town will continue to receive these interventions, but without targeting to specific neighborhoods. Fatal and non-fatal opioid overdose rates in the control cities/towns will be compared to those that received the PROVIDENT model predictions. To achieve these aims, we will leverage a unique partnership between an academic institution and a state's health department, which allows for unprecedented access to and sharing of population-based overdose surveillance data. Our results will improve public health decision-making and inform resource allocation to communities that should be prioritized for evidence-based prevention, treatment, recovery, and overdose rescue services. If found to be effective, the PROVIDENT forecasting model will be disseminated to other states, which could adapt the tool to guide resource allocation and maximize public health impact. In sum, this project is highly responsive to a top research priority of the National Institute on Drug Abuse, and directly addresses one of the nation's most challenging public health crises. PROJECT NARRATIVE The objectives of this project are to leverage surveillance data to predict future overdose outbreaks, and to evaluate the impact of a randomized, statewide, community-level intervention trial to target overdose prevention programs to neighborhoods at highest risk of future overdose deaths. This study develops and tests an opioid overdose forecasting tool, which will allow other states to identify and deploy interventions to communities at highest risk of opioid-related death. This results study will significantly improve the allocation of resources to curb the opioid overdose epidemic in the United States.","Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial",10026087,R01DA046620,"['Buprenorphine ', ' Censuses ', ' Cities ', ' Classification ', ' Systematics ', ' Communities ', ' Community Pharmacy ', ' Decision Making ', ' Disease Outbreaks ', ' Outbreaks ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Emergency medical service ', ' emergency service ', ' Environment ', ' Epidemic ', ' Future ', ' Goals ', ' Health ', ' Health Priorities ', ' Recording of previous events ', ' History ', ' Hospitals ', ' indexing ', ' Light ', ' Photoradiation ', ' Methadone ', ' Adanon ', ' Althose ', ' Dolophine ', ' Methadose ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Naloxone ', ' Neighborhoods ', ' Overdose ', ' Probability ', ' Public Health ', ' Publishing ', ' Records ', ' Resources ', ' Research Resources ', ' Rhode Island ', ' Risk ', ' Testing ', ' United States ', ' Work ', ' Resource Allocation ', ' base ', ' improved ', ' Area ', ' Phase ', ' Recovery ', ' Policies ', ' tool ', ' machine learned ', ' Machine Learning ', ' Research Priority ', ' programs ', ' Source ', ' System ', ' Visit ', ' Services ', ' American ', ' experience ', ' resource guides ', ' novel ', ' Prevention program ', ' peer ', ' Prevention ', ' Admission ', ' Admission activity ', ' Interventional trial ', ' Intervention Trial ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Institution ', ' preventing ', ' prevent ', ' Address ', ' Dose ', ' Academic Detailing ', ' Data ', ' Intervention Community Trial ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Strategic Planning ', ' Sum ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Population ', ' addictive disorder ', ' addiction ', ' spatiotemporal ', ' high risk ', ' evidence base ', ' population based ', ' primary outcome ', ' overdose prevention ', ' overdose death ', ' public health priorities ', ' surveillance data ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' Predictive Analytics ', ' opiate use disorder ', ' opioid use disorder ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' experiment ', ' experimental research ', ' experimental study ', ' opioid guideline ', ' opioid law ', ' opioid legislation ', ' opioid policy ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' opiate deaths ', ' opiate mortality ', ' opioid deaths ', ' opioid overdose death ', ' opioid related death ', ' opioid mortality ', ' opioid agonist treatment ', ' opioid agonist therapy ', ' referral services ', ' overdose risk ', ' intervention arm ', ' treatment arm ', ' non-medical opioid use ', ' nonmedical opioid use ', ' opiate misuse ', ' opioid misuse ', ' machine learning method ', ' ']",NIDA,BROWN UNIVERSITY,R01,2020,654124,RI-01,0.07758941720403953
"The Ohio Valley Node of the Clinical Trials Network Project Summary (Abstract): Since its establishment in 2000, the Ohio Valley Node (OVN) has been one of the most productive of NIDA's Clinical Trials Network (CTN) nodes, both in leading and participating in multi-site trials. The OVN includes successful partnerships with four healthcare systems, two pharmacy networks, and six addiction specialty/ infectious disease programs. These collaborating sites span a seven-state region including some of the states most heavily impacted by opioid (Ohio, Kentucky, and West Virginia) and methamphetamine (Missouri, Kentucky, and North Dakota) use. The OVN includes Midwestern, Appalachian, Upper South, and Native American representation, which significantly enhances the geographical and cultural diversity of the CTN. The OVN Research Core is the driving force of the OVN and is led by Dr. Winhusen, one of the foremost experts in conducting multi-site addiction clinical trials in clinical practice settings. The OVN investigators have extensive expertise in substance use disorders (Winhusen, Brown, Burlew, Lyons, Montgomery, Lofwall, Walsh) and bioinformatics (Kaelber, Xu). The six members of the OVN research-implementation team bring > 60 years of combined experience conducting CTN clinical trials. If funded, our overall goal would be to utilize the wealth of experience and expertise gained over the past 19 years to conduct the research needed to address public health care crises, including the opioid use epidemic and the alarming increase in stimulant use. To this end, we would work with our healthcare partners to engage a diverse set of patients and service systems in areas highly impacted by substance use in CTN research. We would also contribute our expertise in conducting efficacy, effectiveness, and implementation trials testing the full range of interventions, from medications to behavioral interventions and health service innovations, for both opioid and stimulant use disorders. Moreover, we would contribute our expertise in the use of electronic health records for prospective and retrospective research studies, including the application of artificial intelligence to large healthcare datasets. In sum, we seek to continue providing scientific leadership, particularly on studies that could meaningfully impact clinical practice, and to effectively collaborate with a variety of professionals including treatment providers, investigators from diverse institutions, and staff of the Center for CTN (CCTN), clinical coordinating center (CCC) and data and statistics center (DSC) in support of the CTN mission. Project Narrative: Since its establishment in 2000, the Ohio Valley Node (OVN) has been one of the most productive of NIDA's Clinical Trials Network (CTN) nodes, both in leading and participating in multi-site trials. The OVN includes successful partnerships with four healthcare systems, two pharmacy networks, and six addiction specialty/ infectious disease programs spanning a seven-state region including some of the states most heavily impacted by opioid (Ohio, Kentucky, and West Virginia) and methamphetamine (Missouri, Kentucky, and North Dakota) use. Our overall goal is to utilize the wealth of experience and expertise gained over the past 19 years to conduct the research needed to address public health care crises, including the opioid use epidemic and the alarming increase in stimulant use.",The Ohio Valley Node of the Clinical Trials Network,10056685,UG1DA013732,"['Appalachian Region ', ' Appalachia ', ' Appalachian ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Buprenorphine ', ' Clinical Trials ', ' Communicable Diseases ', ' Infectious Disease Pathway ', ' Infectious Diseases ', ' Infectious Disorder ', ' Communities ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Investigational Drugs ', ' Investigational New Drugs ', ' Epidemic ', ' Geography ', ' Goals ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Health Services ', ' Recording of previous events ', ' History ', ' Hospitals ', ' Kentucky ', ' Leadership ', ' Methamphetamine ', ' Crystal Meth ', ' Deoxyephedrine ', ' Desoxyephedrine ', ' Methylamphetamine ', ' N-Methylamphetamine ', ' Mission ', ' Missouri ', ' North Dakota ', ' Ohio ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Pharmacists ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Productivity ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Serine ', ' L-Serine ', ' medical specialties ', ' Specialty ', ' statistics ', ' Substance Use Disorder ', ' Technology ', ' Testing ', ' West Virginia ', ' Work ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' health care ', ' Healthcare ', ' Dataset ', ' Data Set ', ' base ', ' Peripartum ', ' Perinatal ', ' Site ', ' Area ', ' Clinical ', ' Ensure ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Data Bases ', ' data base ', ' Databases ', ' Opiates ', ' Opioid ', ' Funding ', ' Native Americans ', ' Multiculturalism ', ' Cultural Diversity ', ' programs ', ' South American ', ' Clinic ', ' System ', ' meetings ', ' Services ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' experience ', ' health care organization ', ' healthcare organization ', ' healthcare service organization ', ' health care service organization ', ' Performance ', ' Participant ', ' treatment program ', ' member ', ' research study ', ' validation studies ', ' behavioral health ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Bio-Informatics ', ' Bioinformatics ', ' Institution ', ' Address ', ' Data ', ' Multi-center clinical trial ', ' Multi-site clinical trial ', ' Multicenter clinical trial ', ' Multisite clinical trial ', ' Multi-Institutional Clinical Trial ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Sum ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' enroll ', ' Enrollment ', ' trend ', ' point of care ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' implementation research ', ' Clinical Trials Network ', ' designing ', ' design ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' driving force ', ' addictive disorder ', ' addiction ', ' FDA approved ', ' multisite trial ', ' multi-site trial ', ' clinical practice ', ' cocaine use ', ' retention strategy ', ' student retention ', ' retention rate ', ' support tools ', ' opiate use disorder ', ' opioid use disorder ', ' Formulation ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' racially diverse ', ' racial diversity ', ' substance misuse ', ' recruit ', ' practice setting ', ' Prescription Drug Monitoring Program ', ' prescription monitoring program ', ' stimulant use ', ' stimulant use disorder ', ' Infrastructure ', ' adverse event risk ', ' effectiveness implementation trial ', ' clinical trial participant ', ' clinical center ', ' ']",NIDA,UNIVERSITY OF CINCINNATI,UG1,2020,982781,OH-01,0.09259162013583427
"Leveraging Social Media to Identify and Connect Teens with Eating Disorders to a Mobile Guided Self-Help Mobile Intervention Project Summary Clinical or subclinical eating disorders (EDs) impact 10% of individuals in their lifetime and are marked by significant functional impairment, early mortality, chronicity, and emotional distress. ED symptoms often emerge in adolescence, with peak onset age in the teenage years. Early recognition and treatment of these devastating illnesses are needed to prevent long-term consequences and a chronic course. Most (80%) individuals with EDs, including teens with EDs (TwEDs), do not receive treatment. Due to major barriers to access and to the delivery of treatment for TwEDs, there is a need for a new model of service delivery that can identify and help TwEDs. We have studied ED-related networking on social media and have demonstrated our ability to harness social media, which is used ubiquitously among teens, to identify and efficiently recruit large numbers of TwEDs. At the same time, our team has successfully developed a guided self-help cognitive- behavioral therapy (CBT)-based mobile app, StudentBodies-Eating Disorders (SB-ED), which includes personalized coaching and interactive sessions to address key ED treatment targets and has demonstrated efficacy among college women with EDs. This tool has great potential to be adapted to address the specific needs of TwEDs. In Aim #1 of the proposed study, we will update and adapt SB-ED to create #ByeED for TwEDs by 1) simplifying language and making content relevant to adolescent issues, 2) including a rewards feature to motivate continued app use, 3) including a within-app social networking feature to facilitate group exchanges and coach-led weekly group sessions, and 4) harnessing machine learning to digest users social networking data within #ByeED to respond to potential recovery setbacks in real-time and tailor coaching interactions. Following a small focus group of TwEDs to assess initial impressions of the app, #ByeED will be piloted among 20 TwEDs recruited from Instagram, garnering feedback via a mixed methods approach on the efficiency, technical effectiveness, and satisfaction with #ByeED. The app will be further refined for a small pilot randomized controlled trial (RCT) in Aim #2, where we will again leverage Instagram for recruitment of TwEDs who are not engaged in treatment. This RCT will approximate the preliminary effectiveness of #ByeED (n=50) versus a control group (encouraging in-person treatment in their communities, n=50) in reducing ED symptoms, improving quality of life, increasing uptake of care, and impacting targets that are associated with outcomes. We will explore within-app predictors of outcomes, potential moderators of treatment effects (e.g., psychiatric comorbidity), and participant perspectives on potential additional parental involvement in #ByeED. Effect size and attrition estimates will aid in the planning of a larger RCT (R01 mechanism) where we will further expand #ByeED (e.g., automated coaching, parental involvement) and test the app on a larger scale to improve its potential to reduce the extraordinary burden of EDs among teens. Relevance to Public Health Eating disorders often emerge in adolescence and most of these teens do not receive treatment. We will use social media to reach teens networking about eating disorder behaviors and test a mobile app specifically developed for teens, including a social networking component, to help reduce eating disorder symptoms and improve their quality of life. We will also obtain teen perspectives on acceptable approaches to include parents in this intervention to inform a future version of the app.",Leveraging Social Media to Identify and Connect Teens with Eating Disorders to a Mobile Guided Self-Help Mobile Intervention,9908180,R34MH119170,"['Adolescence ', ' 12-20 years old ', ' adolescence (12-20) ', ' Anxiety ', ' Body Image ', ' body perception ', ' Body Weight ', ' Cognitive Therapy ', ' Cognition Therapy ', ' Cognitive Psychotherapy ', ' cognitive behavior intervention ', ' cognitive behavior modification ', ' cognitive behavior therapy ', ' cognitive behavioral intervention ', ' cognitive behavioral modification ', ' cognitive behavioral therapy ', ' cognitive behavioral treatment ', ' Communities ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Control Groups ', ' Mental Depression ', ' depression ', ' Diet ', ' dietary ', ' Eating ', ' Food Intake ', ' Eating Disorders ', ' Feedback ', ' Focus Groups ', ' Future ', ' Goals ', ' Health ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' Language ', ' Mental Health Services ', ' Mental Hygiene Services ', ' Methods ', ' mortality ', ' Persons ', ' National Institute of Mental Health ', ' NIMH ', ' Parents ', ' Public Health ', ' Quality of life ', ' QOL ', ' Research ', ' Resources ', ' Research Resources ', ' Rewards ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Suicide attempt ', ' non fatal attempt ', ' nonfatal attempt ', ' suicidal attempt ', ' Testing ', ' Time ', ' Translating ', ' Weight ', ' Woman ', ' Caring ', ' Social Network ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Age of Onset ', ' Individual ', ' Recovery ', ' satisfaction ', ' uptake ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' Randomized Controlled Trials ', ' Shapes ', ' tool ', ' restraint ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' interest ', ' collegiate ', ' college ', ' preference ', ' impression ', ' self help ', ' Participant ', ' behavioral test ', ' behavior test ', ' disease risk ', ' disorder risk ', ' outreach ', ' Prevention ', ' feeling distress ', ' feeling upset ', ' emotional distress ', ' Health Care Technology ', ' Healthcare Technology ', ' Health Technology ', ' response ', ' stigma ', ' social stigma ', ' Functional impairment ', ' functional disability ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' DSM-5 ', ' DSM5 ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' DSM-V ', ' Effectiveness ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Consent ', ' Data ', ' Detection ', ' Update ', ' Teen ', ' teen years ', ' teenage ', ' Teenagers ', ' developmental ', ' Development ', ' cost ', ' digital ', ' Outcome ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' parental involvement ', ' treatment effect ', ' high risk ', ' primary outcome ', ' secondary outcome ', ' usual care ', ' treatment as usual ', ' m-Health ', ' mobile health ', ' mHealth ', ' mobile app ', ' mobile application ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' social media ', ' eat less ', ' reduced eating ', ' reduced food intake ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' recruit ', ' Service model ', ' care delivery model ', ' health care delivery model ', ' healthcare delivery model ', ' Service delivery model ', ' barrier to health care ', ' barrier to healthcare ', ' barrier to treatment ', ' obstacle to care ', ' obstacle to healthcare ', ' barrier to care ', ' service delivery ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NIMH,WASHINGTON UNIVERSITY,R34,2020,232191,MO-01,0.04525151746003194
"Contextualized daily prediction of lapse risk in opioid use disorder by digital phenotyping PROJECT SUMMARY Opioid use disorder is increasingly widespread, leading to devastating consequences and costs for patients and their families, friends, and communities. Available treatments for opioid and other substance use disorders (SUD) are not successful at sustaining sobriety. The vast majority of people with SUD relapse within a year. Critically, they often fail to detect dynamic, day-by-day changes in their risk for relapse and do not adequately employ skills they developed or take advantage of support available through continuing care. The broad goals of this project are to develop and deliver a highly contextualized, lapse risk prediction models for forecasting day-by-day probability of opioid and other drug use lapse among people pursuing drug abstinence. This lapse risk prediction model will be delivered within the Addiction-Comprehensive Health Enhancement Support System (A-CHESS) mobile app, which has been established by RCT as a state-of-the-art mHealth system for providing continuing care services for alcohol and substance use disorders. To accomplish these broad goals, a diverse sample of 480 participants with opioid use disorder who are pursing abstinence will be recruited. These participants will be followed for 12 months of their recovery, with observations occurring as early as one week post-abstinence and as late as 18 months post-abstinence across participants in the sample. Well-established distal, static relapse risk signals (e.g., addiction severity, comorbid psychopathology) will be measured on intake. A range of more proximal, time-varying opioid (and other drug use) lapse risk signals will also be collected via participants smartphones. These signals include self-report surveys every two months, daily ecological momentary assessments, daily video recovery check-ins, voice phone call and text message logs, text message content, moment-by-moment location (via smartphone GPS and location services), physical activity (via smartphone sensors), and usage of the mobile A-CHESS Recovery Support app. The predictive power of these risk signals will be further increased by anchoring them within an inter-personal context of known people, locations, dates, and times that support or detract from participants abstinence efforts. Machine learning methods will be used to train, validate, and test opioid (and other drug) lapse risk prediction models based on these contextualized static and dynamic risk signals. These lapse risk prediction models will provide participant specific, day-by-day probabilistic forecast of a lapse to opioid (or other drug) use among opioid abstinent individuals. These lapse risk prediction models will be formally added to the A-CHESS continuing care mobile app at the completion of the project for use in clinical care. These project goals position A-CHESS to make relapse prevention and recovery support, information, and risk monitoring available to patients continuously. Compared to conventional continuing care, A-CHESS will provide personalized care and be available and implemented during moments of greatest need. Integrated real-time risk prediction holds substantial promise to encourage sustained recovery through adaptive use of these continuing care services. PROJECT NARRATIVE The projects goals are to develop and deliver a real-time model for forecasting day-by-day opioid use lapse among abstinent patients with opioid use disorder. This lapse prediction model will be integrated into an existing, validated mHealth app to encourage sustained recovery through adaptive use of continuing care services.",Contextualized daily prediction of lapse risk in opioid use disorder by digital phenotyping,9980350,R01DA047315,"['Acoustics ', ' Acoustic ', ' Advertising ', ' Affect ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Alcohols ', ' Alcohol Chemical Class ', ' Behavior ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Communication ', ' Communities ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Data Sources ', ' Diagnosis ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Equilibrium ', ' balance ', ' balance function ', ' Face ', ' faces ', ' facial ', ' Family ', ' Foundations ', ' Goals ', ' Health ', ' Methods ', ' Theoretical model ', ' Theoretic Models ', ' Narcotics ', ' Natural Language Processing ', ' natural language understanding ', ' Paper ', ' Patients ', ' Phenotype ', ' Probability ', ' Psychopathology ', ' abnormal psychology ', ' Publishing ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Relapse ', ' Risk ', ' Risk Factors ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Social Environment ', ' social climate ', ' social context ', ' socioenvironment ', ' socioenvironmental ', ' Substance Use Disorder ', ' Surveys ', ' Survey Instrument ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Voice ', ' Friends ', ' Gender ', ' Measures ', ' chronic pain ', ' Caring ', ' Social Network ', ' base ', ' suburban ', ' suburbia ', ' suburb ', ' sensor ', ' Distal ', ' Clinical ', ' Medical ', ' Training ', ' Physical activity ', ' Visual ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' drug abstinence ', ' Recovery ', ' Opiates ', ' Opioid ', ' drug use ', ' Drug usage ', ' participant recruitment ', ' Patient Recruitments ', ' Frequencies ', ' Severities ', ' Home ', ' Home environment ', ' Pattern ', ' System ', ' Location ', ' meetings ', ' Services ', ' information gathering ', ' experience ', ' stressor ', ' skills ', ' Participant ', ' peer ', ' sober ', ' sobriety ', ' Self-Report ', ' Patient Self-Report ', ' Position ', ' Positioning Attribute ', ' Social Support System ', ' Support System ', ' disease recurrence prevention ', ' disorder recurrence prevention ', ' recurrence prevention ', ' relapse prevention ', ' disorder later incidence prevention ', ' Modeling ', ' Sampling ', ' craving ', ' realtime model ', ' real time model ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' preventing ', ' prevent ', ' Intake ', ' enroll ', ' Enrollment ', ' Monitor ', ' Characteristics ', ' cost ', ' care services ', ' care systems ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' innovate ', ' innovative ', ' innovation ', ' Abstinence ', ' ethanol testing ', ' alcohol testing ', ' addictive disorder ', ' addiction ', ' clinical care ', ' overdose death ', ' m-Health ', ' mobile health ', ' mHealth ', ' mobile app ', ' mobile application ', ' signal processing ', ' Precision care ', ' individualized care ', ' individualized patient care ', ' personalized patient care ', ' personalized care ', ' Ecological momentary assessment ', ' social media ', ' Predictive Analytics ', ' opiate use disorder ', ' opioid use disorder ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' relapse risk ', ' rural locality ', ' rural place ', ' rural setting ', ' recruit ', ' Mobile Health App ', ' m-Health app ', ' m-Health application ', ' mHealth app ', ' mHealth application ', ' Mobile Health Application ', ' short message service ', ' texting ', ' Text Messaging ', ' primary care provider ', ' care providers ', ' quality of sleep ', ' sleep quality ', ' Facebook ', ' microphone ', ' risk prediction model ', ' machine learning method ', ' ']",NIDA,UNIVERSITY OF WISCONSIN-MADISON,R01,2020,681159,WI-02,0.13571561264563656
"Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders Treatment of Opioid Use Disorders (OUDs) includes medications with effects on opioid receptors such as buprenorphine, but access is limited for many patients and others are opposed to treating addictions with medications that have opioid agonist properties. Naltrexone is an opioid antagonist that is more acceptable for many patients, and recent studies show it to be equivalent in efficacy. Initiation of treatment with long-acting naltrexone, however, requires a period of abstinence of about seven days during which time patients suffer from intense symptoms of withdrawal with a risk of relapse that can lead to overdose-related death. Opioids have an inhibitory effect on norepinephrine and the sympathetic nervous system, and many symptoms of withdrawal are driven by rebound activation of these systems. Dopaminergic systems in brain areas including ventral striatum (nucleus accumbens) and medial prefrontal cortex (anterior cingulate) play an important role in opioid addiction, craving and relapse, as do increases in inflammation. This project will assess a form of neuromodulation involving non-invasive electrical stimulation of the vagus nerve that may play a useful role during the period of opioid withdrawal before the initiation of long-term naltrexone treatment in blocking norepinephrine, sympathetic, and inflammatory responses and enhancing peripheral parasympathetic and central brain function in areas modulating drug craving (ventral striatum, anterior cingulate). Our preliminary data on the effects of non-invasive Vagal Nerve Stimulation (nVNS) on stress response in traumatized human subjects and patients with posttraumatic stress disorder (PTSD) show that nVNS reliably blocks peripheral sympathetic and enhances parasympathetic function, reduces inflammatory responses (interleukin-6, or IL-6), and enhances central brain responses (anterior cingulate) to stress. We now propose to apply this technology to the treatment of patients with OUDs. Following verification using modelling and determination of optimal dosing parameters, we will use these parameters to assess effects of nVNS versus sham stimulation on opioid craving, peripheral autonomic, cardiovascular, inflammatory, and brain functional responses measured with High-Resolution Positron Emission Tomography (HR-PET) and radiolabeled water to videos of drug cues in recently treated patients with OUDs. Based on the outcome of this research, we will proceed to the UH3 phase, which will involve a randomized, sham-controlled trial of nVNS in patients with OUDs during the one to two week period of opioid withdrawal followed by assessment of craving, HR-PET imaging of both brain function and brain dopaminergic function, and assessment of peripheral autonomic, cardiovascular and inflammatory responses in conjunction with administration of nVNS or sham. We hypothesize that nVNS will reduce opioid craving and inflammatory, peripheral autonomic and cardiovascular responses and enhance brain responses (anterior cingulate function and dopamine function in ventral striatum), and promote successful conversion to long-acting naltrexone, in patients with OUDs. Opioid use disorders (OUDs) have been associated with a 4-fold increase in drug overdose deaths in the past decade, and current treatments including medications that block the opioid receptor require a withdrawal period during which time many patients relapse and tragically may overdose and die. This project will assess a new device, non-invasive Vagal Nerve Stimulation (nVNS), that does not require surgery or implantation, and that electrically stimulates the vagus nerve as it passes through the neck, dampening the sympathetic nervous system and modulating brain regions in a way that may help patients during the opioid withdrawal period and reduce relapse. Studying the effects of nVNS on opioid craving and brain and physiological responses in patients with OUDs has the potential to reduce relapse and save lives, as well as increase our knowledge of changes to the brain and physiology that underlie OUDs and successful response to treatment.",Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders,9983431,UG3DA048502,"['Brain ', ' Brain Nervous System ', ' Encephalon ', ' Buprenorphine ', ' Cardiovascular system ', ' Cardiovascular ', ' Cardiovascular Body System ', ' Cardiovascular Organ System ', ' Heart Vascular ', ' circulatory system ', ' Cardiovascular Physiology ', ' cardiovascular function ', ' Cues ', ' Cessation of life ', ' Death ', ' Dopamine ', ' Hydroxytyramine ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Electric Stimulation ', ' Electrical Stimulation ', ' electrostimulation ', ' Family ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' Inflammation ', ' Interleukin-6 ', ' B cell differentiation factor ', ' B cell stimulating factor 2 ', ' B-Cell Differentiation Factor ', ' B-Cell Differentiation Factor-2 ', ' B-Cell Stimulatory Factor-2 ', ' BCDF ', ' BSF-2 ', ' BSF2 ', ' HPGF ', ' Hepatocyte-Stimulating Factor ', ' Hybridoma Growth Factor ', ' IFN-beta 2 ', ' IFNB2 ', ' IL-6 ', ' IL6 Protein ', ' MGI-2 ', ' Myeloid Differentiation-Inducing Protein ', ' Plasmacytoma Growth Factor ', ' interferon beta 2 ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Methods ', ' Movement ', ' body movement ', ' Naltrexone ', ' Nalorex ', ' Nemexin ', ' ReVia ', ' Vivitrol ', ' Neck ', ' Nerve ', ' Norepinephrine ', ' Levarterenol ', ' Levonorepinephrine ', ' Noradrenaline ', ' Nucleus Accumbens ', ' opioid withdrawal ', ' opiate withdrawal ', ' opioid detox ', ' opioid detoxification ', ' Overdose ', ' Patients ', ' Physiology ', ' Pilot Projects ', ' pilot study ', ' Play ', ' Positron-Emission Tomography ', ' PET ', ' PET Scan ', ' PET imaging ', ' PETSCAN ', ' PETT ', ' Positron Emission Tomography Medical Imaging ', ' Positron Emission Tomography Scan ', ' Rad.-PET ', ' positron emission tomographic (PET) imaging ', ' positron emission tomographic imaging ', ' positron emitting tomography ', ' Positron ', ' Opioid Receptor ', ' Opiate Receptors ', ' Relapse ', ' Respiration ', ' respiratory mechanism ', ' Rewards ', ' Role ', ' social role ', ' Stress ', ' Post-Traumatic Stress Disorders ', ' PTSD ', ' Post-Traumatic Neuroses ', ' Posttraumatic Neuroses ', ' Posttraumatic Stress Disorders ', ' post-trauma stress disorder ', ' posttrauma stress disorder ', ' traumatic neurosis ', ' Sympathetic Nervous System ', ' Technology ', ' Time ', ' tomography ', ' United States ', ' Vagus nerve structure ', ' Cranial Nerve X ', ' Pneumogastric Nerve ', ' Tenth Cranial Nerve ', ' Vagus Nerve ', ' vasoconstriction ', ' vascular constriction ', ' Water ', ' Hydrogen Oxide ', ' Measures ', ' Injectable ', ' Outcomes Research ', ' Withdrawal Symptom ', ' reaction', ' crisis ', ' stress response ', ' stress', ' reaction ', ' biological adaptation to stress ', ' Light Reflection Rheography ', ' Photoreflexometries ', ' Photoreflexometry ', ' Photoplethysmography ', ' Prefrontal Cortex ', ' Imagery ', ' base ', ' human subject ', ' Anterior ', ' Medial ', ' Peripheral ', ' Area ', ' Phase ', ' Physiologic ', ' Physiological ', ' Visual ', ' Withdrawal ', ' Opiates ', ' Opioid ', ' drug use ', ' Drug usage ', ' analog ', ' Inflammatory ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' System ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' Operative Procedures ', ' Surgical ', ' Surgical Interventions ', ' Surgical Procedure ', ' surgery ', ' Operative Surgical Procedures ', ' drug craving ', ' Adverse reactions ', ' neural control ', ' neural regulation ', ' neuromodulation ', ' neuromodulatory ', ' neuroregulation ', ' Devices ', ' Ventral Striatum ', ' Thorace ', ' Thoracic ', ' Thorax ', ' Chest ', ' Modeling ', ' Sampling ', ' craving ', ' Property ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Inflammatory Response ', ' Brain region ', ' Dose ', ' Symptoms ', ' Data ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Resolution ', ' Validation ', ' Vasomotor ', ' Transmission ', ' transmission process ', ' Cardiac ', ' Radiolabeled ', ' vagus nerve stimulation ', ' Outcome ', ' resistant ', ' Resistance ', ' Abstinence ', ' implantation ', ' addictive disorder ', ' addiction ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' overdose death ', ' opiate use disorder ', ' opioid use disorder ', ' relapse patients ', ' response markers ', ' response biomarker ', ' relapse risk ', ' Opiate Antagonist ', ' Opiate receptor antagonist ', ' Opioid receptor antagonist ', ' Opioid Antagonist ', ' Opiate agonist ', ' Opiate receptor agonist ', ' Opioid receptor agonist ', ' Opioid agonist ', ' ']",NIDA,EMORY UNIVERSITY,UG3,2020,739505,GA-05,0.14888536995551604
"Telemedicine for Treatment of Opioid Use Disorder PROJECT SUMMARY: A key challenge in combating the opioid epidemic has been connecting individuals with opioid use disorder to evidence-based treatments. The President's Commission on Combating Drug Addiction and the Opioid Crisis and others have suggested that telemedicine for substance use disorder (tele- SUD) may be part of the solution. In preliminary analyses, we have found that tele-SUD use is growing rapidly, and there is widespread policy interest in Congress and state legislatures in how to accelerate this growth. The SUPPORT for Patients and Communities Act, signed into law in October 2018, includes several provisions intended to reduce barriers to tele-SUD use and will likely increase the availability of and reimbursement for tele-SUD. However, despite the widespread interest and growing use, there has never been a rigorous assessment of tele-SUD. For example, what are the different tele-SUD models being used to treat opioid use disorder, what barriers exist to greater use of tele-SUD, and is tele-SUD use associated with improved (or potentially worse) quality of care for people with opioid use disorder? To fill this knowledge gap, we propose a comprehensive national evaluation of telemedicine for opioid use disorder using data through 2021 from Medicaid, Medicare, and commercial insurance as well as a series of qualitative interviews. Our Aims are to: (1) describe the different models of how tele-SUD is being incorporated into opioid use disorder care and how this is changing over time, (2) identify regional factors associated with greater tele-SUD use for opioid use disorder, (3) examine the association between tele-SUD use and quality of opioid use disorder care received and whether this varies by model, and (4) describe existing tele-SUD programs, and identify barriers and facilitators to tele-SUD adoption and sustainability. The proposed mixed-methods study will help providers interested in using tele-SUD and inform ongoing debates about regulations and reimbursement for tele-SUD in Congress and state legislatures. Our goal is to highlight policies and practices that drive greater use of tele-SUD and explore its potential role in improving access to, and quality of, care for individuals with opioid use disorder. Our research will help inform how tele- SUD may be leveraged to combat the opioid epidemic as well as other substance use disorders, such as alcohol and methamphetamine use disorders. PROJECT NARRATIVE: Many patients with opioid use disorder have great difficulty accessing substance use disorder (SUD) treatment. Telemedicine for SUD (tele-SUD) is one potential solution, and many states and the Congress are considering laws and regulations to encourage greater tele-SUD use. In this project, our goal is to understand how tele-SUD is being used for patients, what drives the variation in use, whether tele-SUD is associated with better care, and how some providers have successfully used tele-SUD.",Telemedicine for Treatment of Opioid Use Disorder,9952335,R01DA048533,"['Adoption ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Buprenorphine ', ' Communities ', ' Congresses ', ' meeting reports ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemic ', ' Goals ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Health ', ' Medicare ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Title 18 ', ' health insurance for disabled ', ' Insurance ', ' Interview ', ' Laws ', ' Medicaid ', ' Methadone ', ' Adanon ', ' Althose ', ' Dolophine ', ' Methadose ', ' Methods ', ' Naltrexone ', ' Nalorex ', ' Nemexin ', ' ReVia ', ' Vivitrol ', ' Persons ', ' Patients ', ' Play ', ' Recommendation ', ' Research ', ' Role ', ' social role ', ' Substance Use Disorder ', ' Time ', ' Transportation ', ' United States Food and Drug Administration ', ' Food and Drug Administration ', ' USFDA ', ' Work ', ' Measures ', ' Privacy ', ' physical disability ', ' physically disabled ', ' physically handicapped ', ' Caring ', ' Telemedicine ', ' base ', ' rural region ', ' rural area ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Series ', ' Evaluation ', ' Individual ', ' Policies ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Treatment Period ', ' treatment days ', ' treatment duration ', ' interest ', ' Visit ', ' American ', ' Speed ', ' Structure ', ' disorder model ', ' Disease model ', ' Regulation ', ' Modeling ', ' QOC ', ' Quality of Care ', ' Provider ', ' Address ', ' Chemical Dependence ', ' Drug Dependence ', ' Drug Dependency ', ' Drug Addiction ', ' Data ', ' Improve Access ', ' enroll ', ' Enrollment ', ' Characteristics ', ' Evidence based treatment ', ' designing ', ' design ', ' intervention efficacy ', ' therapeutic efficacy ', ' therapeutically effective ', ' therapy efficacy ', ' Treatment Efficacy ', ' combat ', ' Randomization trial ', ' randomized trial ', ' screening ', ' METH use ', ' METH using ', ' methamphetamine using ', ' methamphetamine use ', ' opiate use disorder ', ' opioid use disorder ', ' improved outcome ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' opiate deaths ', ' opiate mortality ', ' opioid deaths ', ' opioid overdose death ', ' opioid related death ', ' opioid mortality ', ' machine learning method ', ' ']",NIDA,HARVARD MEDICAL SCHOOL,R01,2020,756872,MA-07,0.13030638033529468
"Using Machine Learning to Detect and Characterize Synthetic Psychoactive Drug Digital Marketing and Distribution The study will address a critical challenge regarding the public health threat of synthetic psychoactive drugs (SPDs): identifying and characterizing how social media is used to market, distribute and sell these products to the public. We will carry out these aims by examining large volumes of data from popular social media platforms Twitter and Instagram using an innovative methodology involving machine learning and multidisciplinary data analysis. This research project addresses a key NIDA research objective: research on factors which influence initiation, continuation and desistance of use of specific SPDs in different populations. Examples include:market and distribution factors; policies; and the role of peer influences, social media and the internet. We will first collect large volumes of data filtered for SPD drug diversion, marketing, and drug dealing via social media posts, comments, and other messages. We will then code the data using an advanced machine learning protocol. Finally, we will analyze the data using statistical, geospatial and network analysis to assess associations between SPD marketing and specific risk factors for user groups. We will accomplish these objectives using a multidisciplinary approach that involves disciplines and methods from public health-epidemiology, substance abuse research, computation science, legal and policy analysis, and geospatial analysis. The project has the following specific aims:  Aim 1: Conduct digital surveillance of popular social media platforms Twitter and Instagram in order to  describe the nature and magnitude of online marketing, sale and distribution of SPDs;  Aim 2: Characterize the types of marketing strategies used by SPD vendors and drug dealers on these  platforms, including marketing messages used to influence knowledge, attitudes and perceptions  pertaining to SPDs and identification of the users and networks they target;  Aim 3: Using statistical, network and geospatial methods, describe, test, and visualize associations  between SPD marketing and distribution and specific risk factors and user groups. This is a critical opportunity to better understand how social media contributes to a growing digital risk environment that can influence user initiation and enable illegal access to SPDs. Though research examining the linkages between social media and substance abuse has been growing, no study has specifically examined online marketing and access characteristics on more than one platform while at the same time assessing how geographic and user network factors can impact this unique and largely unregulated risk environment. Results from this study can generate further study hypotheses on the association between SPD behavioral risk factors and SPD product trends, while also informing future interventions utilizing e-health tools including targeted regulation, health education, and counter-marketing. The emergence of the public health threat of synthetic cannabinoids and other new synthetic psychoactive substances (SPDs) is coinciding with an increase in the use of the Internet and social media to promote substance abuse behavior and illicit access. In response, the proposed project will leverage advanced methods in big data analysis to identify and characterize marketing and distribution of SPDs by conducting surveillance of SPD content and messages on Twitter and Instagram. This will be accomplished using an innovative methodology involving advanced machine learning, statistical, geospatial and network analysis.",Using Machine Learning to Detect and Characterize Synthetic Psychoactive Drug Digital Marketing and Distribution,9951970,R21DA050689,"['Age ', ' ages ', ' Attitude ', ' Behavior ', ' Communications Media ', ' Forms of Communication ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Environment ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Fentanyl ', ' Actiq ', ' Duragesic ', ' Fentanest ', ' Fentyl ', ' Phentanyl ', ' Future ', ' Geography ', ' Goals ', ' Health ', ' Health education ', ' Health Instruction ', ' Health Tutoring ', ' Health Promotion ', ' Salutogenesis ', ' promoting health ', ' Intelligence ', ' Laws ', ' Statutes and Laws ', ' Legislation ', ' Marketing ', ' Methods ', ' Methodology ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Perception ', ' Psychotropic Drugs ', ' Psychoactive Agents ', ' Psychoactive Compound ', ' Psychoactive Drugs ', ' Psychopharmaceuticals ', ' Public Health ', ' Publishing ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Sales ', ' Computer software ', ' Software ', ' Technology ', ' Testing ', ' Time ', ' Vendor ', ' Policy Analyses ', ' Policy Analysis ', ' Youth 10-21 ', ' Youth ', ' Social Network ', ' Law Enforcement ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Link ', ' Discipline ', ' Opiates ', ' Opioid ', ' Policies ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' Comment ', ' Commentary ', ' Editorial Comment ', ' Viewpoint ', ' Published Comment ', ' tool ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Protocol ', ' Protocols documentation ', ' Source ', ' experience ', ' Prevention ', ' abuse of substances ', ' substance abuse ', ' Substance abuse problem ', ' prescription medication abuse ', ' prescription drug abuse ', ' Coding System ', ' Code ', ' Regulation ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Legal ', ' datamining ', ' data mining ', ' Address ', ' Data ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' trend ', ' Characteristics ', ' developmental ', ' Development ', ' Behavioral ', ' patient advocacy group ', ' digital ', ' Computational Science ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' peer influence ', ' multidisciplinary ', ' multidisciplinary approach ', ' interdisciplinary approach ', ' e-Health ', ' eHealth ', ' BigData ', ' Big Data ', ' synthetic cannabinoid ', ' social media ', ' study population ', ' service providers ', ' deep learning ', ' Twitter ', ' ']",NIDA,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R21,2020,236250,CA-52,0.06990871140928316
"Northeast Node of the National Drug Abuse Clinical Trials Network Project Summary/Abstract  This proposal is a competing renewal application of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN), which joined the CTN in 2015. The Northeast Node brought hundreds of community and healthcare partners across the states of New Hampshire, Vermont, and Maine to the CTN community for the first time. These states have among the very highest rates of substance use in the U.S., including opioid use, and they include some of the most rural communities in the U.S. The Node has brought significant expertise to the CTN in conducting practical, rigorous, innovative, and highly impactful trials focused on improving the treatment of substance use disorders (SUDs) in community systems in the Northeast and in partnership with other CTN Nodes across the nation. Node Investigators have extensive experience in leading national and multi-national clinical trials, digital technology; medication and behavioral treatments for opioid use disorder; co-occurring SUDs and mental health disorders; SUD and chronic pain; SUD in pregnant women; opioid, cannabis, tobacco, alcohol, stimulant, and polydrug treatment; SUD prevention and treatment among youth; and implementation science. The Northeast Node is embedded within the Center for Technology and Behavioral Health (CTBH), a NIDA-funded P30 Center of Excellence. The Node thus brings significant expertise in developing, evaluating, and implementing digital treatments for SUDs, with a focus on overcoming the striking disparities in treatment access and treatment quality evident in healthcare across the globe.  In the renewal period, the Node proposes to enhance its activities and contributions to the national CTN to embrace advances in scientific discovery and research innovations that offer great promise for increasing the reach and effectiveness of treatments for SUDs. The Node will engage a broader group of investigators that bring additional expertise in data science (bioinformatics, predictive modeling, artificial intelligence, social media, data privacy/security) and experimental design (micro-randomized trials, adaptive designs, and implementation/systems science). With this expanded group of partners, it will support and grow a productive research agenda in the CTN with a focus on (a) digital health and data analytics, including research focused on providing personalized, science-based resources to individuals with SUD via digital technology and (b) expanding low threshold access to science-based SUD care, particularly in rural contexts (e.g., general medical settings; pharmacies; and community organizations). And the Node will lead an expansion of CTN research on the (c) rapidly evolving landscape of cannabis use as well as (d) co-morbid SUD and mental health disorders. The Node will establish Community and Policy Advisory Boards to complement the existing communication infrastructure between Node investigators and their partners, with a focus on identifying the most significant and timely SUD needs in our communities and scaling-up and sustaining best practices. Project Narrative The proposed activities of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) embrace advances in scientific discovery and research innovations that offer great promise for increasing the reach and effectiveness of treatments for substance use disorders (SUD). These activities reflect a vision for the next iteration of the CTN in the next 5 years. This work will advance translational science in SUD research and markedly reduce the gap between SUD research and clinical practice -- with a focus on scaling-up and sustaining best practices.",Northeast Node of the National Drug Abuse Clinical Trials Network,10161464,UG1DA040309,"['Achievement ', ' Achievement Attainment ', ' Alcohols ', ' Alcohol Chemical Class ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Behavior ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Clinical Trials ', ' Communication ', ' Communities ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Complement ', ' Complement Proteins ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Experimental Designs ', ' Fire - disasters ', ' Fires ', ' fire ', ' Health ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' Justice ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Leadership ', ' Maine ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Persons ', ' New Hampshire ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Phenotype ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Science ', ' medical specialties ', ' Specialty ', ' Substance Use Disorder ', ' Technology ', ' Time ', ' Tobacco ', ' United States Food and Drug Administration ', ' Food and Drug Administration ', ' USFDA ', ' Vermont ', ' Vision ', ' Sight ', ' visual function ', ' Work ', ' ranpirnase ', ' P-30 Protein ', ' P30 ', ' P30 Protein ', ' Community Health Care ', ' Community Healthcare ', ' health care ', ' Healthcare ', ' Research Methods ', ' Research Methodology ', ' Rural Community ', ' Treatment Effectiveness ', ' Youth 10-21 ', ' Youth ', ' chronic pain ', ' Caring ', ' base ', ' improved ', ' Clinical ', ' Medical ', ' Series ', ' Link ', ' Training ', ' insight ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Rural ', ' Opiates ', ' Opioid ', ' Policies ', ' Funding ', ' Community Networks ', ' Therapeutic ', ' System ', ' meetings ', ' collegiate ', ' college ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' experience ', ' high school ', ' special interest group ', ' novel ', ' disease prevention ', ' disorder prevention ', ' member ', ' research study ', ' behavioral health ', ' Cannabis ', ' Provider ', ' Bio-Informatics ', ' Bioinformatics ', ' AIDS test ', ' AIDS/HIV test ', ' HIV test ', ' HIV-1 test ', ' HIV-2 test ', ' Human immunodeficiency virus test ', ' telehealth ', ' Data ', ' International ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Research Infrastructure ', ' Strategic Planning ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Security ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Authorization ', ' Permission ', ' Authorization documentation ', ' Federally Qualified Health Center ', ' drug adherence ', ' drug compliance ', ' medication adherence ', ' medication compliance ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Clinical Trials Network ', ' designing ', ' design ', ' scale up ', ' innovate ', ' innovative ', ' innovation ', ' community organizations ', ' mobile device ', ' handheld mobile device ', ' implementation science ', ' addictive disorder ', ' addiction ', ' clinical practice ', ' flexible ', ' flexibility ', ' cocaine use ', ' Randomization trial ', ' randomized trial ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' screening ', ' NCI National Clinical Trials Network ', ' National Clinical Trials Network ', ' health data ', ' THC co-use ', ' THC use ', ' Tetrahydrocannabinol co-use ', ' Tetrahydrocannabinol use ', ' cannabis use ', ' marijuana use ', ' social media ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' Data Science ', ' Data Analytics ', ' opiate use disorder ', ' opioid use disorder ', ' personalized healthcare ', ' precision health care ', ' precision healthcare ', ' personalized health care ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' disparities in treatment ', ' treatment disparity ', ' high risk group ', ' high risk population ', ' rural locality ', ' rural place ', ' rural setting ', ' recruit ', ' smartwatch ', ' smart watch ', ' body sensor ', ' body worn sensor ', ' wearable sensor ', ' wearable system ', ' wireless sensor technology ', ' wearable sensor technology ', ' healthcare settings ', ' health care settings ', ' Infrastructure ', ' data privacy ', ' ']",NIDA,DARTMOUTH COLLEGE,UG1,2020,622500,NH-02,0.04188694002548188
"Technology Improving Success of Medication-Assisted Treatment in Primary Care Project Abstract The opioid epidemic is the U.S.'s most widespread behavioral public health problem, with a higher number of deaths due to drug overdose in 2016 compared to deaths due to HIV at the peak of the AIDS epidemic. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious. However, only a fraction of persons with OUD access MAT, and treatment non-adherence and drop out is common. There is a dire need to improve systems to address these issues and to expand the use of MAT for many patients who are out of care. This R44 STTR application responds to RFA-DA-19-020, HEAL Initiative: America's Startups and Small Businesses Build Technologies to Stop the Opioid Crisis. It joins an outstanding scientific team at UCLA and a small business that has developed, Opioid Addiction Recovery Support (OARS) -- a software platform that by integrating with the Electronic Health Record (EHR) improves clinical management of patients by primary care providers (PCPs) treating patients with OUD using MAT. OARS platform uses a dashboard to show real-time measurement of patient achievements in recovery. It provides opportunities for patients to interact with their PCPs, allowing for better connection to and support from their PCPs. OARS platform features artificial intelligence to analyze information from the EHR and from patients to provide relapse risk assessment for patients receiving MAT for OUD, an innovation that sets OARS apart from other software solutions. The specific aim of Phase 1 of this STTR Fast Track proposal, is to modify the OARS platform for use in primary care settings by conducting interviews with PCPs (N=20) and their patients with OUD (N=40) in primary care settings to collect data on feasibility and acceptability of engaging with OARS to inform user- centered design of OARS. The specific aims of Phase 2 of this STTR Fast Track proposal are to: (1) employ a stepped wedge design to assess the effectiveness of OARS in improving opioid agonist treatment outcomes across 6 treatment programs (N=200 treated patients) and (2) evaluate sustainability and return on investment of OARS implementation across 6 treatment programs. A commercialization plan documents progress to date for OARS platform and presents a market plan to improve both scale-up and quality of MAT services delivered by PCPs in primary care, which is a major contribution to addressing the ongoing opioid epidemic. Project Narrative With over 72,000 overdose deaths in 2017, of which 47,600 are attributable to opioid overdose, the opioid epidemic has become North Americas most widespread behavioral public health problem. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious. The Opioid Addiction Recovery Support (OARS), comprises of a healthcare team portal connected to a patient mobile application, to provide opioid related education, promote connectedness with clinicians, and track MAT treatment progress. This STTR Fast Track proposal will conduct interviews with patients that will inform optimal design of OARS and utilize a stepped wedge effectiveness design to assess the effectiveness of OARS in improving opioid agonist treatment outcomes in primary care settings and evaluate sustainability and return on investment.",Technology Improving Success of Medication-Assisted Treatment in Primary Care,10212519,R42DA050398,"['Effectiveness ', ' Address ', ' Length ', ' Adherence ', ' Data ', ' Clinical Management ', ' STTR ', ' Small Business Technology Transfer Research ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' Behavioral ', ' cost ', ' designing ', ' design ', ' Outcome ', ' scale up ', ' innovate ', ' innovative ', ' innovation ', ' Abstinence ', ' user centered design ', ' iterative design ', ' implementation science ', ' addictive disorder ', ' addiction ', ' commercialization ', ' patient population ', ' primary care setting ', ' overdose death ', ' waiver ', ' mobile app ', ' mobile application ', ' temporal resolution ', ' time measurement ', ' temporal measurement ', ' opiate use disorder ', ' opioid use disorder ', ' medication-assisted treatment ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' relapse risk ', ' dashboard ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' opioid agonist treatment ', ' opioid agonist therapy ', ' recruit ', ' primary care provider ', ' care providers ', ' treatment services ', ' Bunavail ', ' Zubsolv ', ' buprenorphine + naloxone ', ' buprenorphine and naloxone ', ' buprenorphine with naloxone ', ' buprenorphine-naloxone ', ' buprenorphine/naloxone ', ' Suboxone ', ' phase 2 evaluation ', ' phase II evaluation ', ' phase II testing ', ' phase 2 testing ', ' compare treatment ', ' treatment comparison ', ' Achievement ', ' Achievement Attainment ', ' Acquired Immunodeficiency Syndrome ', ' AIDS ', ' Acquired Immune Deficiency ', ' Acquired Immune Deficiency Syndrome ', ' Acquired Immuno-Deficiency Syndrome ', ' Acquired Immunologic Deficiency Syndrome ', ' Americas ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Belief ', ' Continuity of Patient Care ', ' Continuity of Care ', ' Continuum of Care ', ' Cessation of life ', ' Death ', ' Dropout ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Education ', ' Educational aspects ', ' Epidemic ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' indexing ', ' Interview ', ' Investments ', ' Medicine ', ' Methods ', ' Persons ', ' North America ', ' Outpatients ', ' Out-patients ', ' Overdose ', ' Patients ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Public Health ', ' Relapse ', ' Risk ', ' Computer software ', ' Software ', ' medical specialties ', ' Specialty ', ' Technology ', ' Testing ', ' United States ', ' Work ', ' Treatment outcome ', ' Cost Savings ', ' Businesses ', ' Health Care Team ', ' Healthcare Team ', ' Medical Care Team ', ' Risk Assessment ', ' Specialist ', ' Caring ', ' Custom ', ' improved ', ' Area ', ' Clinical ', ' Phase ', ' Link ', ' insight ', ' Recovery ', ' Opiates ', ' Opioid ', ' tool ', ' machine learned ', ' Machine Learning ', ' programs ', ' Scientist ', ' Clinic ', ' System ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' Visit ', ' Services ', ' empowered ', ' experience ', ' success ', ' treatment program ', ' stigma ', ' social stigma ', ' Drops ', ' Provider ', ' ']",NIDA,"Q2I, LLC",R42,2020,837803,NH-02,0.15705829807094687
"A Wearable, Biomarker-Tracking Device Platform Using Machine Learning and Predictive Technology for Positive Behavior Change. Project Summary/Abstract Behaivior is developing a patent-pending platform to predict and prevent addiction relapses and overdoses by treating those in recovery with timely interventions using wearables (like an advanced FitBit) and artificial intelligence. Knowing in real time when someone with opioid use disorder is at a high risk of relapsing revolutionizes the ability to intervene at the right moment to help people stay sober. Our research will contribute to fundamental knowledge about the specific information needed to be gathered in order to accurately detect when someone struggling with opioid use disorder is in a high risk opioid craving/obsession state and enabled the creation of a predictive model for just in time intervention. The number of deaths from opioid overdose is increasing every day, so reducing opioid addiction relapses will save lives and families and it will reduce rearrests, reincarcerations, and rehospitalizations. Over 23 million Americans are addicted to drugs and alcohol, and these addictions cost the U.S. $442 billion per year, according to the US Surgeon Generals office. The majority of treatment tools used to keep those in recovery sober have low or mixed success rates. Many people in recovery end up relapsing multiple times, with the heroin relapse rate around 90%. With the technology that we are developing, Behaivior will detect if someone in recovery is in a red alert craving or obsession state and then, using artificial intelligence, we will provide support in real time by connecting someone to a support network member and/or provide a customized digital intervention. The broader impact/commercial potential of this I-Corps project revolves around the human brains proclivity towards substances detrimental to human health and wellbeing, such as dangerous amounts of sugar, salt, and drugs, which is causing global health and safety risks. Inability to avoid these temptations shortens lifespans, increases healthcare costs, and strains resources. This team uses machine learning and pattern recognition AI to identify and react to factors that result in destructive human behaviors. While the initial focus is opioids, this unsupervised learning AI could, in subsequent iterations, be used to identify and react to any behavior -- such as unsafe driving, binge eating, or anger management. Helping people identify the precursors to their behaviors could serve as a type of biofeedback that gives them and their support networks timely and individualized insights, preventions, and interventions, resulting in cost and health benefits across many populations. Project Narrative Behaivior is developing a system to predict and prevent opioid addiction relapses and overdoses using wearables and artificial intelligence for timely interventions. Our innovation lowers relapse and overdose rates and improves treatment adherence, which we anticipate will mitigate pain points such as higher treatment costs insurers currently pay from patient relapses, will reduce emergency room and first responder costs, and will ease (or alleviate) employers pain points such as poorer employee productivity and the added training and replacement costs. Through this program, Team Behavior will explore how to best tailor our technology for our likely first payers and validate the next potential customer segment we should pursue.","A Wearable, Biomarker-Tracking Device Platform Using Machine Learning and Predictive Technology for Positive Behavior Change.",10085849,R43DA046149,"['Alcohols ', ' Alcohol Chemical Class ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Behavior ', ' Biofeedback ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Costs and Benefits ', ' Dangerousness ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Family ', ' Health ', ' Human ', ' Modern Man ', ' Insurance Carriers ', ' Insurers ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Overdose ', ' Pain ', ' Painful ', ' Legal patent ', ' Patents ', ' Personal Satisfaction ', ' well-being ', ' wellbeing ', ' Productivity ', ' Relapse ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Safety ', ' Sodium Chloride ', ' salt ', ' Technology ', ' Time ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' Health Benefit ', ' Treatment Cost ', ' Custom ', ' improved ', ' Training ', ' Obsession ', ' insight ', ' Recovery ', ' sugar ', ' Opiates ', ' Opioid ', ' tool ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' programs ', ' compulsive eating ', ' compulsive feeding ', ' compulsive overeating ', ' Binge Eating ', ' System ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' behavior change ', ' anger management ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' Surgeon ', ' American ', ' success ', ' Employee ', ' hospital re-admission ', ' re-admission ', ' re-hospitalization ', ' readmission ', ' rehospitalization ', ' hospital readmission ', ' member ', ' sober ', ' sobriety ', ' Devices ', ' craving ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' preventing ', ' prevent ', ' global health ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' Pattern Recognition ', ' cost ', ' reincarceration ', ' rearrest ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' addictive disorder ', ' addiction ', ' high risk ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' treatment adherence ', ' support network ', ' I-Corps ', ' Innovation Corps ', ' opiate use disorder ', ' opioid use disorder ', ' relapse patients ', ' fitbit ', ' relapse risk ', ' opiate deaths ', ' opiate mortality ', ' opioid deaths ', ' opioid overdose death ', ' opioid related death ', ' opioid mortality ', ' unsupervised machine learning ', ' unsupervised learning ', ' unsafe driving ', ' first responder ', ' ']",NIDA,"BEHAIVIOR, LLC",R43,2020,55000,PA-18,0.10869629382033884
"A Chatbot Utilizing Machine Learning and Natural Language Processing to Implement the Brief Negotiation Interview to Improve Engagement in Buprenorphine Treatment among Justice-Involved Individuals PROJECT SUMMARY/ABSTRACT The people at greatest risk of dying from an opioid overdose are the least likely to get life-saving medication. Justice-involved individuals coming out of prison have the highest risk of death by overdose (8x greater than the general population), yet only 1 in 20 of these individuals receive buprenorphine (bup), a safe, effective medication that has been shown to reduce a persons risk of death by overdose by half. There is an urgent need to facilitate an increase in bup treatment engagement among these individuals. Two of the top barriers to receiving bup for these individuals are 1) system level barriers and, 2) low levels of individual motivation. Our prior research shows that delivering individual level treatment engagement interventions increase the rate at which individuals receive bup. Thus, our solution is to improve engagement in bup treatment among justice-involved individuals by 1) disrupting system level barriers by circumventing the pieces of the probation system that are stigmatizing and reduce the chances of a bup referral by using an artificial intelligence (AI)-based chatbot to make the referral, and 2) addressing low individual motivation by programming the chatbot to deliver the BNI itself, without the need for a trained professional. Aim 1: Design and develop a functional prototype chatbot to motivate bup engagement. Milestones: (a) human-centered design (including focus groups) with all stakeholders; and (b) creation of a functional chatbot using ML and NLP that is integrated with a mobile application, an application program interface server, and an administrator portal. Aim 2: Conduct a 4-week pilot study with 60 probationers randomly assigned to BNI Chatbot or Treatment-as-Usual (TAU). Hypothesis 1. The BNI Chatbot group will have a higher percentage of participants attending their first bup appointment than the TAU group at 4 weeks (Primary outcome). Hypothesis 2. The BNI Chatbot group will demonstrate higher ratings of readiness and intention to engage in bup treatment, and lower opioid use, as measured by urine toxicology tests, than the TAU group at 4 weeks (Secondary outcomes). Hypothesis 3. The BNI Chatbot group will demonstrate higher ratings of satisfaction than the TAU group. PROJECT NARRATIVE Justice-involved individuals with Opioid Use Disorder coming out of prison have the highest risk of death by overdose (8x greater than the general population), yet only 1 in 20 of these individuals receive buprenorphine, a safe, effective medication that has been shown to reduce a persons risk of overdose death by half. Prior research shows that focusing on evidence-based treatment engagement interventions leads to high rates of individuals receiving buprenorphine. Our solution is to deliver the Brief Negotiation Interview via an artificial intelligence-based chatbot that also connects users to a buprenorphine referral.",A Chatbot Utilizing Machine Learning and Natural Language Processing to Implement the Brief Negotiation Interview to Improve Engagement in Buprenorphine Treatment among Justice-Involved Individuals,10157712,R43DA051267,"['Appointment ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Buprenorphine ', ' Communities ', ' Continuity of Patient Care ', ' Continuity of Care ', ' Continuum of Care ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Focus Groups ', ' Health ', ' Human ', ' Modern Man ', ' Interview ', ' Justice ', ' Motivation ', ' Persons ', ' Natural Language Processing ', ' natural language understanding ', ' Pilot Projects ', ' pilot study ', ' Prisons ', ' Research ', ' Risk ', ' Savings ', ' Stigmatization ', ' Technology ', ' Testing ', ' Toxicology ', ' Urine ', ' Urine Urinary System ', ' Measures ', ' Administrator ', ' Caring ', ' Intention ', ' base ', ' improved ', ' Area ', ' Training ', ' Failure ', ' Individual ', ' satisfaction ', ' machine learned ', ' Machine Learning ', ' Research Priority ', ' Life ', ' System ', ' Participant ', ' Negotiating ', ' Negotiation ', ' Mediation ', ' General Public ', ' General Population ', ' probation ', ' Drug Courts ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Provider ', ' Preparedness ', ' Readiness ', ' Address ', ' Jail ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Process ', ' developmental ', ' Development ', ' Evidence based treatment ', ' digital ', ' designing ', ' design ', ' probationer ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' Evidence based intervention ', ' motivational intervention ', ' addictive disorder ', ' addiction ', ' prototype ', ' commercialization ', ' high risk ', ' evidence base ', ' primary outcome ', ' secondary outcome ', ' usual care ', ' treatment as usual ', ' brief motivational intervention ', ' overdose death ', ' Secure ', ' mobile app ', ' mobile application ', ' application program interface ', ' application programming interface ', ' opiate use disorder ', ' opioid use disorder ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' web application ', ' web app ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' system-level barriers ', ' overdose risk ', ' buprenorphine treatment ', ' death risk ', ' mortality risk ', ' chat bot ', ' chatbot ', ' ']",NIDA,"CENTER FOR PROGRESSIVE RECOVERY, LLC",R43,2020,251500,CT-03,-0.0008504893011024086
"Telemedicine for Treatment of Opioid Use Disorder PROJECT SUMMARY: A key challenge in combating the opioid epidemic has been connecting individuals with opioid use disorder to evidence-based treatments. The President's Commission on Combating Drug Addiction and the Opioid Crisis and others have suggested that telemedicine for substance use disorder (tele- SUD) may be part of the solution. In preliminary analyses, we have found that tele-SUD use is growing rapidly, and there is widespread policy interest in Congress and state legislatures in how to accelerate this growth. The SUPPORT for Patients and Communities Act, signed into law in October 2018, includes several provisions intended to reduce barriers to tele-SUD use and will likely increase the availability of and reimbursement for tele-SUD. However, despite the widespread interest and growing use, there has never been a rigorous assessment of tele-SUD. For example, what are the different tele-SUD models being used to treat opioid use disorder, what barriers exist to greater use of tele-SUD, and is tele-SUD use associated with improved (or potentially worse) quality of care for people with opioid use disorder? To fill this knowledge gap, we propose a comprehensive national evaluation of telemedicine for opioid use disorder using data through 2021 from Medicaid, Medicare, and commercial insurance as well as a series of qualitative interviews. Our Aims are to: (1) describe the different models of how tele-SUD is being incorporated into opioid use disorder care and how this is changing over time, (2) identify regional factors associated with greater tele-SUD use for opioid use disorder, (3) examine the association between tele-SUD use and quality of opioid use disorder care received and whether this varies by model, and (4) describe existing tele-SUD programs, and identify barriers and facilitators to tele-SUD adoption and sustainability. The proposed mixed-methods study will help providers interested in using tele-SUD and inform ongoing debates about regulations and reimbursement for tele-SUD in Congress and state legislatures. Our goal is to highlight policies and practices that drive greater use of tele-SUD and explore its potential role in improving access to, and quality of, care for individuals with opioid use disorder. Our research will help inform how tele- SUD may be leveraged to combat the opioid epidemic as well as other substance use disorders, such as alcohol and methamphetamine use disorders. PROJECT NARRATIVE: Many patients with opioid use disorder have great difficulty accessing substance use disorder (SUD) treatment. Telemedicine for SUD (tele-SUD) is one potential solution, and many states and the Congress are considering laws and regulations to encourage greater tele-SUD use. In this project, our goal is to understand how tele-SUD is being used for patients, what drives the variation in use, whether tele-SUD is associated with better care, and how some providers have successfully used tele-SUD.",Telemedicine for Treatment of Opioid Use Disorder,10169552,R01DA048533,"['Adoption ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Buprenorphine ', ' Communities ', ' Congresses ', ' meeting reports ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemic ', ' Goals ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Health ', ' Medicare ', ' Health Insurance for Aged and Disabled, Title 18 ', ' Health Insurance for Disabled Title 18 ', ' Title 18 ', ' health insurance for disabled ', ' Insurance ', ' Interview ', ' Laws ', ' Medicaid ', ' Methadone ', ' Adanon ', ' Althose ', ' Dolophine ', ' Methadose ', ' Methods ', ' Naltrexone ', ' Nalorex ', ' Nemexin ', ' ReVia ', ' Vivitrol ', ' Persons ', ' Patients ', ' Play ', ' Recommendation ', ' Research ', ' Role ', ' social role ', ' Substance Use Disorder ', ' Time ', ' Transportation ', ' United States Food and Drug Administration ', ' Food and Drug Administration ', ' USFDA ', ' Work ', ' Measures ', ' Privacy ', ' physical disability ', ' physically disabled ', ' physically handicapped ', ' Caring ', ' Telemedicine ', ' base ', ' rural region ', ' rural area ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Series ', ' Evaluation ', ' Individual ', ' Policies ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Treatment Period ', ' treatment days ', ' treatment duration ', ' interest ', ' Visit ', ' American ', ' Speed ', ' Structure ', ' disorder model ', ' Disease model ', ' Regulation ', ' Modeling ', ' QOC ', ' Quality of Care ', ' Provider ', ' Address ', ' Chemical Dependence ', ' Drug Dependence ', ' Drug Dependency ', ' Drug Addiction ', ' Data ', ' Improve Access ', ' enroll ', ' Enrollment ', ' Characteristics ', ' Evidence based treatment ', ' designing ', ' design ', ' intervention efficacy ', ' therapeutic efficacy ', ' therapeutically effective ', ' therapy efficacy ', ' Treatment Efficacy ', ' combat ', ' Randomization trial ', ' randomized trial ', ' screening ', ' METH use ', ' METH using ', ' methamphetamine using ', ' methamphetamine use ', ' opiate use disorder ', ' opioid use disorder ', ' improved outcome ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' opiate deaths ', ' opiate mortality ', ' opioid deaths ', ' opioid overdose death ', ' opioid related death ', ' opioid mortality ', ' machine learning method ', ' ']",NIDA,HARVARD MEDICAL SCHOOL,R01,2020,174599,MA-07,0.13030638033529468
"Great Lakes Node of the Drug Abuse Clinical Trials Network Project Summary/Abstract In alignment with RFA-DA-19-008, this application seeks to establish the Great Lakes Node (GLN) of the NIDA-supported Drug Abuse Clinical Trials Network (CTN). This node will draw on an experienced set of investigators who have active collaborations and represent all of the major academic medical centers in the Greater Chicago and Wisconsin areas. The node will serve as a vital Midwestern hub for the CTN and will expand on the success of the CTN approach. In addition, the GLN will bring substantial experience in adolescent/young adult research, seniors/aging research, digital & mobile technologies, opioid misuse, collaborative care/population health, telehealth, and electronic health record and systems-driven interventions and research methodologies. The GLN will support engagement with CTN protocols and also add the following: Aim 1: GLN will identify and recommend substance misuse research and intervention protocols focused on systems-based practice using hospital-based screening, collaborative care, and population approaches. Aim 2: We will establish a digital and computation health core that will leverage our expertise in these domains and serve as a conduit for studies in mHealth, eHealth, artificial intelligence, natural language processing, and telehealth interventions. Aim 3: Our node will bring substantial expertise with youth/adolescent health and seniors/aging that will enable us to recommend studies to the CTN that examine the genesis of substance misuse and the potential for prevention strategies to mitigate these life-course pathways. Aim 4: In alignment with our teams expertise, we plan to support work on substance and opioid misuse that focuses on health disparities including socioeconomic, geographic, sexual orientation, and gender identity. Aim 5: Leveraging our experience in professional education and practice-based learning, our node will rigorously test the impact of professional education on opioid and substance treatment. We have built on the ECHO model to develop methods to conduct high-quality distance education and supported training that are currently being trialed in Illinois with plans to expand these programs nationally. Aim 6: GLN will expand the pipeline of early investigators interested in substance misuse research. We will align this part of our program with our very successful CTSA-supported programs and build specific subprogramming that supports addiction and substance misuse research, training, and mentorship. Project Narrative This application will establish the Great Lakes Node of the Drug Abuse Clinical Trials Network. The creation of this node will help facilitate research on substance and opioid misuse which are key components of NIH and federal government strategy to reduce the mortality and morbidity associated with the current opioid and substance epidemics. This node will support clinical trials relevant to the epidemics and also advance research in novel models of care, data analytics, mobile interventions and training.",Great Lakes Node of the Drug Abuse Clinical Trials Network,9956715,UG1DA049467,"['Academic Medical Centers ', ' University Medical Centers ', ' Aging ', ' Opioid Analgesics ', ' opiate analgesia ', ' opiate analgesic ', ' opiate pain medication ', ' opiate pain reliever ', ' opioid analgesia ', ' opioid anesthetic ', ' opioid pain medication ', ' opioid pain reliever ', ' opioid painkiller ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Buprenorphine ', ' Chicago ', ' Cities ', ' Clinical Trials ', ' Communities ', ' Cessation of life ', ' Death ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Professional Education ', ' Epidemic ', ' Federal Government ', ' National Government ', ' Gender Identity ', ' Geography ', ' Health ', ' Hospitals ', ' Illinois ', ' Indiana ', ' Learning ', ' Life Cycle Stages ', ' Life Cycle ', ' life course ', ' Los Angeles ', ' Mentorship ', ' Methods ', ' Midwestern United States ', ' Midwest ', ' Midwest U.S. ', ' Midwest US ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Natural Language Processing ', ' natural language understanding ', ' New York ', ' Professional Practice ', ' health care professional practice ', ' healthcare professional practice ', ' Public Health ', ' Refugees ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Rest ', ' medical schools ', ' medical college ', ' school of medicine ', ' Testing ', ' Training Support ', ' Universities ', ' Veterans ', ' Wisconsin ', ' Work ', ' Asians ', ' oriental ', ' County ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Latino ', ' Research Methods ', ' Research Methodology ', ' Caring ', ' base ', ' rural region ', ' rural area ', ' suburban ', ' suburbia ', ' suburb ', ' urban area ', ' Area ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Sexual Orientation ', ' Sex Orientation ', ' Training ', ' homeless ', ' unhoused ', ' Homelessness ', ' Individual ', ' adult youth ', ' young adulthood ', ' young adult ', ' Rural ', ' Pacific Islander ', ' Pacific Islander American ', ' Pacific Island Americans ', ' Opiates ', ' Opioid ', ' Collaborations ', ' Native Americans ', ' cooking ', ' programs ', ' Side ', ' Home ', ' Home environment ', ' Protocol ', ' Protocols documentation ', ' System ', ' interest ', ' experience ', ' success ', ' metropolitan ', ' Distance Education ', ' novel ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' vulnerable group ', ' Vulnerable Populations ', ' disparity in health ', ' health disparity ', ' telehealth ', ' Health system ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Research Training ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' pathway ', ' Pathway interactions ', ' digital ', ' Clinical Trials Network ', ' Minority ', ' Population ', ' racial and ethnic ', ' collaborative care ', ' addictive disorder ', ' addiction ', ' overdose death ', ' population health ', ' waiver ', ' screening ', ' m-Health ', ' mobile health ', ' mHealth ', ' e-Health ', ' eHealth ', ' ED visit ', ' ER visit ', ' Emergency care visit ', ' Emergency hospital visit ', ' Emergency room visit ', ' Emergency department visit ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' Data Analytics ', ' adolescent health ', ' ethnically diverse ', ' ethnic diversity ', ' racially diverse ', ' racial diversity ', ' substance misuse ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' opioid treatment program ', ' non-medical opioid use ', ' nonmedical opioid use ', ' opiate misuse ', ' opioid misuse ', ' sexual identity ', ' ']",NIDA,RUSH UNIVERSITY MEDICAL CENTER,UG1,2020,422584,IL-07,0.06706860357750141
"Mining Social Media Big Data for Toxicovigilance: Automating the Monitoring of Prescription Medication Abuse via Natural Language Processing and Machine Learning Methods Project Summary The problem of prescription medication (PM) abuse has reached epidemic proportions in the United States. According to a 2014 report by the Director of the National Institute on Drug Abuse (NIDA), an estimated 52 million people, have been involved in the non-medical use of PMs a significant portion of which can be classified as abuse. PMs that are commonly abused include opioids, central nervous system depressants and stimulants, and the consequences of their abuse may be severe. Increases in PM misuse and abuse over the last 15 years have resulted in increased emergency department visits, rates of addiction and overdose deaths. Due to the rapidly escalating morbidity and mortality, it is now receiving national attention. The opioid crisis, which has its root in opioid-based PM abuse, has been declared a national emergency by the president of the United States. Despite the problems associated with PM abuse, surveillance programs such as prescription drug monitoring programs (PDMPs) are inadequate and suffer from numerous shortcomings, thus limiting their usefulness in real life. Studies evaluating the long-term effects of distinct classes of PMs on cohorts of abusers are scarce and expensive to conduct. To better characterize the problem and to monitor it in real-time, new sources of information need to be identified and novel monitoring techniques need to be developed. To address these problems, our project aims to utilize social media data for performing toxicovigilance. Social media encapsulates an abundance of knowledge about PM abuse and the abusers in the form of noisy natural language text. At the heart of the proposed approach is a machine learning system that can automatically distinguish between `abuse' and `non-abuse' indicating user posts collected from social media. Using this classification system, users will be categorized into multiple groups(i) abusers, (ii) medical users and (iii) non users. The developed system will collect longitudinal data for users exposed the selected PMs via periodic collection of their publicly available posts/discussions and automatically categorize them based on age, gender and additional demographic feature, when possible. This will enable the conducting of observational studies on targeted cohorts, involving hundreds of thousands of cohort members. The cohort studies will focus on analyzing the transition rates from medical use to abuse for distinct PMs and transition rates from abuse of PMs to illicit analogs. Implementation of this data-centric framework, which will be open source, will revolutionize the mechanism by which PM abuse monitoring is performed and enable the future development of intervention strategies targeted towards specific cohorts, at the most effective time periods. Narrative Prescription Medication (PM) abuse is a major epidemic in the United States, and monitoring and studying the characteristics of the PM abuse problem requires the development of novel approaches. Social media encapsulates an abundance of data about PM abuse from different demographics, but extracting that data and converting it to knowledge requires advanced natural language processing and data-centric artificial intelligence systems. Our proposed social media mining framework will automate the process of big data to knowledge conversion for PM abuse, providing crucial insights to toxicologists about targeted populations and enabling the future development of directed intervention strategies.",Mining Social Media Big Data for Toxicovigilance: Automating the Monitoring of Prescription Medication Abuse via Natural Language Processing and Machine Learning Methods,9933852,R01DA046619,"['Affect ', ' Age ', ' ages ', ' Algorithms ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Attention ', ' Automation ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Benzodiazepines ', ' Benzodiazepine Compounds ', ' Central Nervous System Depressants ', ' CNS Depressants ', ' Classification ', ' Systematics ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' Control Groups ', ' Data Collection ', ' Cessation of life ', ' Death ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Emergency Situation ', ' Emergencies ', ' Epidemic ', ' Expert Systems ', ' Intelligent systems ', ' Fentanyl ', ' Actiq ', ' Duragesic ', ' Fentanest ', ' Fentyl ', ' Phentanyl ', ' Forensic Medicine ', ' Forensics ', ' Future ', ' Geographic Locations ', ' Geographic Area ', ' Geographic Region ', ' Geographical Location ', ' geographic site ', ' Goals ', ' Health ', ' Heart ', ' Hospitalization ', ' Hospital Admission ', ' Long-Term Effects ', ' Longterm Effects ', ' Manuals ', ' Methods ', ' Mining ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Names ', ' Natural Language Processing ', ' natural language understanding ', ' Occupations ', ' Jobs ', ' Professional Positions ', ' Overdose ', ' Oxycodone ', ' Dihydrohydroxycodeinone ', ' Oxycodeinon ', ' Oxycodone SR ', ' Oxycontin ', ' Roxicodone ', ' Periodicity ', ' Cyclicity ', ' Rhythmicity ', ' Pilot Projects ', ' pilot study ', ' Population Characteristics ', ' Public Health ', ' Research ', ' Schools ', ' Supervision ', ' Surveys ', ' Survey Instrument ', ' Target Populations ', ' Time ', ' United States ', ' Work ', ' Gender ', ' Percocet ', ' quetiapine ', ' TimeLine ', ' Dataset ', ' Data Set ', ' Social Impacts ', ' Guidelines ', ' Natural History ', ' base ', ' Clinical ', ' Encapsulated ', ' Variation ', ' Variant ', ' Medical ', ' Training ', ' Ingestion ', ' insight ', ' Individual ', ' Opiates ', ' Opioid ', ' root ', ' Plant Roots ', ' analog ', ' Adderall XR ', ' Adderall ', ' Exposure to ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Investigation ', ' Event ', ' Source ', ' Pattern ', ' Techniques ', ' System ', ' Lorcet ', ' Vicodin ', ' spelling ', ' interest ', ' Prescription medication misuse ', ' non-medical prescription drug use ', ' nonmedical prescription drug use ', ' prescription drug misuse ', ' prescription misuse ', ' misuse of prescription only drugs ', ' age group ', ' cohort ', ' intervention program ', ' novel ', ' member ', ' Self-Report ', ' Patient Self-Report ', ' Categories ', ' Reporting ', ' prescription medication abuse ', ' prescription drug abuse ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Address ', ' Data ', ' Detection ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Surveillance Program ', ' Collection ', ' Observation research ', ' Observation study ', ' Observational research ', ' Observational Study ', ' Monitor ', ' Characteristics ', ' Process ', ' Text ', ' developmental ', ' Development ', ' study characteristics ', ' Health Care Professional ', ' Healthcare professional ', ' Health Professional ', ' meta data ', ' Metadata ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Outcome ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' open source ', ' demographics ', ' addictive disorder ', ' addiction ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' natural language ', ' non-medical use ', ' nonmedical use ', ' overdose death ', ' adverse consequence ', ' adverse outcome ', ' BigData ', ' Big Data ', ' ED visit ', ' ER visit ', ' Emergency care visit ', ' Emergency hospital visit ', ' Emergency room visit ', ' Emergency department visit ', ' social media ', ' BD2K ', ' Big Data to Knowledge ', ' medication misuse ', ' drug misuse ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' Prescription Drug Monitoring Program ', ' prescription monitoring program ', ' experimental group ', ' deep learning based neural network ', ' deep learning neural network ', ' deep neural net ', ' deep neural network ', ' Twitter ', ' Infrastructure ', ' supervised machine learning ', ' supervised learning ', ' social observations ', ' large data sets ', ' large datasets ', ' machine learning method ', ' ']",NIDA,EMORY UNIVERSITY,R01,2020,332269,GA-05,0.038403048372342284
"Mining Social Media Messages for HIV Testing and Prevention Communication PROJECT SUMMARY With the advent of Big Data methods, social media is the proverbial low-hanging fruit to disseminate HIV prevention and testing messages on a large scale 1,2. These media already transmit messages on condom use, HIV testing, and Pre-Exposure Prophylaxis (PrEP), from government institutions, NGOs, private citizens, and community groups, but it does so in an informal way. This real-time repository of real-world health messages, along with our ability to mine and pinpoint counties that need to engage in a conversation about HIV prevention and testing, offers a unique opportunity to develop Big Data methods for geographically targeted message dissemination. Despite some interventions designed for online delivery 319, the overall potential of social media and their most promising contents (e.g., actionable messages with behavioral instructions) have surprisingly not been established to date. Our project will focus on the disease-burdened population of Men Who Have Sex With Men (MSM), and will develop a highly significant computing infrastructure (Aim 1) to automatically and continuously input social media postings from Twitter, Facebook, and Instagram, behavioral data from the American Men Internet Survey (AMIS), and HIV prevalence data from AIDSVu.org, and using that triangulation, to target counties that need social media messages about condom use, HIV testing, and/or PrEP for MSM. Using machine learning methods, the same platform will then select actionable and acceptable messages to fill county gaps. Once the platform has been refined with input from research participants who are employees of health departments, it will be used to send experimental messages (Aim 2), selected to match county needs, and to be actionable and acceptable to a group of health departments randomized to the experimental condition. The success of the experimental messages will be gauged by the hallmarks of social media, repostings, Likes, Dislike, and comment favorability, compared with the success of a random selection of HIV-relevant messages sent to a different group of health departments randomized to the control condition. The project is innovative in several ways. First, the social media messages will involve diverse inputs (text, images, videos) never before brought together in this area. Second, we are not aware of the prior use of the proposed triangulation involving epidemiological, behavioral, and social media data. Third, a method of mining naturally accruing messages will be new and transformative, allowing for the generation of live campaigns with messages selected that remain current, sustainable, and community-based by design. Further, the use of an implementation-science experiment at a large, geographically distributed, scale is highly novel. These research aims are facilitated by unique team expertise about communication and persuasion, Big Data methods, public health, and Bayesian spatio-temporal modeling, and leading institutions in the areas of psychology, public health, and computer science. PROJECT NARRATIVE  This project is concerned with identifying a method to disseminate public health information through social media in an optimal way. Findings from this project will inform prevention efforts in this area as well as in fighting other diseases in which social influences are important.",Mining Social Media Messages for HIV Testing and Prevention Communication,9988534,R01MH114847,"['Algorithms ', ' Awareness ', ' Communication ', ' Communities ', ' Consultations ', ' Disease ', ' Disorder ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Geography ', ' Government ', ' Health ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' Human ', ' Modern Man ', ' Illinois ', ' Information Services ', ' men ', "" men's "", ' Methods ', ' Methodology ', ' Mining ', ' Mission ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Persuasive Communication ', ' Persuasion ', ' Privatization ', ' Psychology ', ' Public Health ', ' Random Allocation ', ' Random Selection ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Public Health Schools ', ' Silicon Dioxide ', ' Cristobalite ', ' Sand ', ' Silica ', ' Tridymite ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' World Health ', ' County ', ' Employee Health ', ' Generations ', ' Measures ', ' Administrator ', ' HIV Prevention ', ' HIV/AIDS prevention ', ' AIDS prevention ', ' base ', ' Prophylaxis ', ' Prophylactic treatment ', ' Area ', ' Link ', ' Ensure ', ' Fostering ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' Funding ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' Respondent ', ' Comment ', ' Commentary ', ' Editorial Comment ', ' Viewpoint ', ' Published Comment ', ' tool ', ' Research Priority ', ' fighting ', ' Techniques ', ' interest ', ' Services ', ' Needs Assessment ', ' American ', ' success ', ' computer science ', ' condoms ', ' novel ', ' Participant ', ' member ', ' Prevention ', ' social ', ' HIV risk ', ' Modeling ', ' depository ', ' repository ', ' Institution ', ' preventing ', ' prevent ', ' AIDS test ', ' AIDS/HIV test ', ' HIV test ', ' HIV-1 test ', ' HIV-2 test ', ' Human immunodeficiency virus test ', ' Data ', ' Harvest ', ' Health Sciences ', ' International ', ' NIAID ', ' National Institute of Allergy and Infectious Disease ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Training and Infrastructure ', ' sex ', ' Text ', ' Behavioral ', ' imaging ', ' Image ', ' Instruction ', ' burden of disease ', ' disease burden ', ' years of life lost to disability ', ' years of life lost to disease ', ' burden of illness ', ' MSM ', ' men who have sex with other men ', ' men who have sex with men ', ' Population ', ' Prevalence ', ' innovate ', ' innovative ', ' innovation ', ' community based design ', ' community based research ', ' participatory action research ', ' community based participatory research ', ' implementation science ', ' intervention design ', ' treatment design ', ' therapy design ', ' spatiotemporal ', ' evidence base ', ' infrastructure development ', ' BigData ', ' Big Data ', ' project dissemination ', ' program dissemination ', ' social media ', ' experiment ', ' experimental research ', ' experimental study ', ' PrEP ', ' pre-exposure prophylaxis ', ' Facebook ', ' Twitter ', ' Infrastructure ', ' Big Data Analytics ', ' Big Data Tools ', ' Big Data Methods ', ' anal intercourse without condom ', ' anal sex without condom ', ' condomless anal intercourse ', ' unprotected anal intercourse ', ' unprotected anal sex ', ' unsafe anal intercourse ', ' unsafe anal sex ', ' condomless anal sex ', ' machine learning method ', ' ']",NIMH,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,R01,2020,546504,IL-13,-0.04408191919491884
"iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Nave Individuals PROJECT SUMMARY The integrated research and training plans outlined in this K23 submission will prepare me for a career as a clinician-scientist conducting translational substance abuse research. My career goal is to perform hypothesis- driven original research investigations directed toward reducing morbidity and mortality from opioid overdose. In this proposal, I intend to deploy wearable biosensors (small devices that continuously record physiology) to study the effects of therapeutic administration of opioid analgesics. I have already studied wearable biosensors in individuals receiving opioids; my preliminary data demonstrates that opioid-tolerant individuals have different biometric signals than non-tolerant individuals. This observation suggests that biosensors can be used to identify the onset of tolerance, an important event that correlates with higher doses of opioid analgesics, and higher risk of death from opioid overdose. Biosensor data management and analysis requires signal processing, data analytic, and machine learning techniques; these approaches are beyond the areas of traditional medical training. My short-term goal is to utilize this K23 award to fill my knowledge gaps in wearable biosensing and advanced data analysis so that I can generate ever more innovative responses to the problem of opioid prescribing, tolerance, misuse, addiction, and overdose. To optimize this important line of investigation, I have developed a training plan that includes: 1) completing a PhD through the Millennium PhD program; 2) expanding my skills in wearable biosensing and behavioral health-based research; 3) developing an understanding of signal processing and machine learning; 4) developing data analytic and data science skills; and 5) expanding my research presentation and dissemination skills. I will achieve these goals through directed coursework, focused seminars, and practical experience. My mentorship team of expert investigators who will ensure my productivity and success includes E. Boyer (primary mentor), D. Smelson, J. Fang, and P. Indic (secondary mentors), and D. Ganesan (advisor) My research plan has three specific aims: 1) to deploy a wearable biosensor technology to detect digital biomarkers associated with the initiation of opioid analgesic therapy in an opioid nave population; 2) to use signal-processing analytics to identify transitions in digital biomarkers with progressive opioid use and to identify individual characteristics associated with this transition; and, 3) to apply and explore supervised learning algorithms that can predict transitions in digital biomarkers that herald the onset of opioid tolerance. To identify dynamic patterns in response to opioids, I will study the digital biomarkers of opioid-nave patients with acute fractures who are prescribed opioid analgesics. Results will be used to develop big data approaches to apply predictive algorithms to identify the onset of opioid tolerance. This work has the potential to prevent development of problematic opioid use and will provide the basis for subsequent R01 submissions to implement sensor-based interventions triggered by the onset of tolerance in individuals receiving opioid analgesics. PROJECT NARRATIVE Morbidity and mortality related to opioids (both prescription and illicit) has reached staggering proportions: more than half of individuals who currently abuse heroin report that opioid abuse began with a prescription opioid. Dr. Carreiro has demonstrated that wearable biosensors can discriminate between individuals who are nave to the effects of opioids from those who are opioid tolerant, a characteristic that increases risk for opioid-related death. This career development award will provide her with the training to use of wearable biosensors to identify the onset of opioid tolerance and the expertise to reach her ultimate goal of developing tools to prevent opioid-related death and increase the safety of opioid prescribing.",iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Nave Individuals,9889092,K23DA045242,"['Age ', ' ages ', ' Algorithms ', ' Analgesics ', ' Analgesic Agents ', ' Analgesic Drugs ', ' Analgesic Preparation ', ' Anodynes ', ' Antinociceptive Agents ', ' Antinociceptive Drugs ', ' pain killer ', ' pain medication ', ' pain reliever ', ' painkiller ', ' Opioid Analgesics ', ' opiate analgesia ', ' opiate analgesic ', ' opiate pain medication ', ' opiate pain reliever ', ' opioid analgesia ', ' opioid anesthetic ', ' opioid pain medication ', ' opioid pain reliever ', ' opioid painkiller ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Biosensing Techniques ', ' Biosensing Technics ', ' biosensing ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Data Collection ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Evolution ', ' Fracture ', ' bone fracture ', ' Galvanic Skin Response ', ' Electrodermal Response ', ' Psychogalvanic Reflex ', ' Skin Electric Conductance ', ' skin conductance ', ' Goals ', ' Italy ', ' Mentors ', ' Mentorship ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Motion ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' opioid abuse ', ' opiate abuse ', ' opiate drug abuse ', ' opioid drug abuse ', ' Overdose ', ' Pain ', ' Painful ', ' Patients ', ' Physiology ', ' Pilot Projects ', ' pilot study ', ' Productivity ', ' Public Health ', ' Records ', ' Relapse ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' Safety ', ' Science ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Skin Temperature ', ' Substance Use Disorder ', ' Technology ', ' Testing ', ' Time ', ' Work ', ' Wrist ', ' Gender ', ' Measures ', ' Dataset ', ' Data Set ', ' analytical method ', ' base ', ' career ', ' sensor ', ' Area ', ' Acute ', ' Physiologic ', ' Physiological ', ' Medical ', ' Ensure ', ' Evaluation ', ' Training ', ' Ingestion ', ' insight ', ' Individual ', ' Opiates ', ' Opioid ', ' Measurement ', ' Funding ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' Therapeutic ', ' Genetic ', ' tool ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Event ', ' Protocol ', ' Protocols documentation ', ' Source ', ' Pattern ', ' Techniques ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' data management ', ' experience ', ' success ', ' Heroin Abuse ', ' biological sensor ', ' Biosensor ', ' skills ', ' novel ', ' Participant ', ' Devices ', ' Reporting ', ' social ', ' abuse of substances ', ' substance abuse ', ' Substance abuse problem ', ' behavioral health ', ' response ', ' data integrity ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Therapeutic Uses ', ' preventing ', ' prevent ', ' Dose ', ' Consent ', ' Data ', ' Ph.D. ', ' PhD ', ' Doctor of Philosophy ', ' K23 Award ', ' K23 Mechanism ', ' K23 Program ', ' Mentored Patient-Oriented Research Career Development Award (K23) ', ' Mentored Patient-Oriented Research Career Development Award ', ' Career Development Awards ', ' Career Development Awards and Programs ', ' Career Development Programs K-Series ', ' K-Awards ', ' Research Career Program ', ' K-Series Research Career Programs ', ' Research Training ', ' Pattern Recognition ', ' Monitor ', ' Characteristics ', ' Therapeutic Effect ', ' developmental ', ' Development ', ' Behavioral ', ' digital ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' comparative ', ' addictive disorder ', ' addiction ', ' high risk ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' opioid habituation ', ' opioid tolerance ', ' tolerance to opiates ', ' opiate tolerance ', ' Faculty Education ', ' Faculty Training ', ' Teacher Education ', ' Teacher Educator ', ' Teacher Preparation ', ' Teacher Training ', ' faculty development ', ' faculty professional development ', ' instructor training ', ' teacher development ', ' Teacher Professional Development ', ' m-Health ', ' mobile health ', ' mHealth ', ' signal processing ', ' BigData ', ' Big Data ', ' Predictive Analytics ', ' Data Science ', ' Data Analytics ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' opiate therapy ', ' opioid therapy ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' opiate deaths ', ' opiate mortality ', ' opioid deaths ', ' opioid overdose death ', ' opioid related death ', ' opioid mortality ', ' recruit ', ' machine learned algorithm ', ' machine learning algorithm ', ' supervised machine learning ', ' supervised learning ', ' learning algorithm ', ' Immersion ', ' machine learning method ', ' ']",NIDA,UNIV OF MASSACHUSETTS MED SCH WORCESTER,K23,2020,188616,MA-02,0.15362055064930596
"Classifying addictions using machine learning analysis of multidimensional data ABSTRACT This Independent Scientist Award will significantly enhance my research capabilities, enabling me to become a leading quantitative investigator in the field of substance use disorders (SUDs). Specifically, it will allow me to increase my knowledge in the areas of SUD phenotypes, treatment and genetics. SUDs are clinically and etiologically heterogeneous and their classification has been difficult. This application reflects my ongoing commitment to developing an innovative and interdisciplinary research program on the classification of SUDs through quantitative analysis of multidimensional data. My extensive training in computational science and prior research on biomedical informatics have provided me with the skills to design, implement and evaluate advanced algorithms and sophisticated analyses to solve challenging problems in classifying SUDs. My ongoing NIDA-funded R01 employs a large (n=~12,000) sample aggregated from multiple genetic studies of cocaine, opioid, and alcohol dependence to develop and evaluate novel statistical models to generate clinical SUD subtypes that are optimized for gene finding. This K02 proposal extends that work to evaluate treatment outcome in refined subgroups of SUD populations using data from treatment studies for cocaine, opioid, alcohol and multiple substance dependence. This project will integrate data from diagnostic behavioral variables and genotypes, as well as biological/neurobiological features of the disorders and repeated measures of treatment outcome. The primary career development goals of this application are to: (1) understand the reliability, validity and functional mechanisms of various phenotyping methods; (2) to continue training in the genetics of addictions; and (3) to gain greater knowledge of different treatment approaches and their efficacy. A solid foundation in these areas will enhance my ability to realize the full potential of the data collected and aggregated from multiple dimensions, and to use the data to design the most clinically useful analysis and generate innovative solutions to diagnostic and predictive challenges in SUD research. Through formal coursework, directed readings, individual tutoring and intensive multidisciplinary collaboration with a diverse team of world-renowned researchers, I will receive training and collect pilot data for future R01 projects by examining (Aim I): whether clinically-defined highly heritable subtypes derived in my current R01 project predict differential treatment response; (Aim II) whether new statistical models that directly combine treatment data with behavioral, biological, and genomic data identify refined subtypes with confirmatory multilevel evidence; and (Aim III) whether there are genetic and social moderators of treatment outcome by subtype. The overall goal of this proposal is to further my independent and multidisciplinary research program in the development of statistical methods for refined classification of SUDs. The K02 award will provide me with the protected time necessary to fully engage in the training activities described that will enhance my knowledge and skills to enable me to make important, novel contributions to the genetics and treatment of SUD. PROJECT NARRATIVE This project will develop novel statistical and quantitative tools to identify homogeneous subtypes of substance use disorders (SUDs) and other complex diseases to enhance gene finding and treatment matching. The proposed project will perform secondary analyses of existing data from treatment studies of cocaine, opioid, alcohol, and mixed SUDs. The proposed novel approaches are expected to advance precision medicine approaches to SUDs by enabling treatment matching and a more refined SUD classification to gene finding.",Classifying addictions using machine learning analysis of multidimensional data,9851853,K02DA043063,"['Aftercare ', ' After Care ', ' After-Treatment ', ' post treatment ', ' alcohol use disorder ', ' ethanol use disorder ', ' Alcohols ', ' Alcohol Chemical Class ', ' Algorithms ', ' Classification ', ' Systematics ', ' Cluster Analysis ', ' Cluster Analyses ', ' Cocaine ', ' Combined Modality Therapy ', ' Multimodal Therapy ', ' Multimodal Treatment ', ' combination therapy ', ' combined modality treatment ', ' combined treatment ', ' multi-modal therapy ', ' multi-modal treatment ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Pharmacotherapy ', ' Drug Therapy ', ' drug treatment ', ' Drug Use Disorder ', ' Electroencephalography ', ' EEG ', ' Foundations ', ' Future ', ' Genes ', ' Genetic Markers ', ' genetic biomarker ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Joints ', ' Methods ', ' Statistical Models ', ' Probabilistic Models ', ' Probability Models ', ' statistical linear mixed models ', ' statistical linear models ', ' Neurobiology ', ' neurobiological ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Reading ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk Factors ', ' Signs and Symptoms ', ' Diagnostic Findings ', ' Substance Addiction ', ' Substance Dependence ', ' Substance Use Disorder ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Training Activity ', ' training module ', ' Work ', ' Measures ', ' Treatment outcome ', ' Dataset ', ' Data Set ', ' improved ', ' Area ', ' Solid ', ' Clinical ', ' Biological ', ' Training ', ' DSM-4 ', ' DSM4 ', ' Diagnostic and Statistical Manual of Mental Disorders, 4th edition ', ' Diagnostic and Statistical Manual of Mental Disorders-IV ', ' DSM-IV ', ' Individual ', ' Opiates ', ' Opioid ', ' Interdisciplinary Research ', ' Multidisciplinary Collaboration ', ' Multidisciplinary Research ', ' Interdisciplinary Study ', ' Measurement ', ' Funding ', ' Collaborations ', ' Genetic ', ' tool ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Functional MRI ', ' fMRI ', ' Functional Magnetic Resonance Imaging ', ' Knowledge ', ' programs ', ' Scientist ', ' Investigation ', ' Dimensions ', ' Complex ', ' Pattern ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' treatment planning ', ' biological sensor ', ' Biosensor ', ' Cocaine Addiction ', ' Cocaine Dependence ', ' skills ', ' novel ', ' disorder classification ', ' nosology ', ' disease classification ', ' contingency management ', ' social ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' career development ', ' disease subgroups ', ' disease subtype ', ' disorder subtype ', ' Genomics ', ' Diagnostic and Statistical Manual ', ' Diagnostic and Statistical Manual of Mental Disorders ', ' DSM-5 ', ' DSM5 ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' DSM-V ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' genetic association ', ' Symptoms ', ' Adherence ', ' Data ', ' K02 Award ', ' Independent Scientist Award ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Subgroup ', ' Characteristics ', ' developmental ', ' Development ', ' Behavioral ', ' biomed informatics ', ' biomedical informatics ', ' designing ', ' design ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Computational Science ', ' Population ', ' alcohol addiction ', ' alcohol dependency ', ' alcohol-dependent ', ' Alcohol dependence ', ' innovate ', ' innovative ', ' innovation ', ' Heritability ', ' endophenotype ', ' addictive disorder ', ' addiction ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' cocaine use ', ' precision-based medicine ', ' precision medicine ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' personalized medicine ', ' Genetic study ', ' neural correlate ', ' tutorial support ', ' tutoring ', ' opiate use disorder ', ' opioid use disorder ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' imaging genetics ', ' secondary analysis ', ' recruit ', ' biomarker utility ', ' biomarker performance ', ' high dimensional data ', ' multidimensional datasets ', ' multidimensional data ', ' ']",NIDA,UNIVERSITY OF CONNECTICUT STORRS,K02,2020,161422,CT-02,0.004427923360704689
"LEVERAGING PREDICTIVE ANALYTICS WITHIN SOCIAL NETWORKS TO MAXIMIZE DRUG ANDALCOHOL TREATMENT EFFICACY AND RELAPSE PREVENTION PROJECT SUMMARY/ABSTRACT Sober Grid has developed a smartphone-based mobile application currently in use by over 120,000 individuals worldwide who are in, or seeking, recovery from drug and alcohol addiction. The Grid, as it is known, is a mobile-based, social recovery community providing rapid context- specific peer support, efficient help seeking, motivational enhancement exercises, and member ratings of support content  all aimed to prevent relapse. The overarching goal of this phase II project is to extend the current capabilities of the Sober Grid app to achieve a comprehensive social recovery support app featuring intelligent, context appropriate resource matching and 24/7 rapid response peer-coaching that is effective in reducing disordered substance use and is cost effective. We hypothesize that providing this functionality to high-risk members will be acceptable, feasible, increase access to and engagement with resources, and have a positive effect in increasing time to relapse and days of consecutive abstinence. The companys priority commercial goal is to leverage the insights gained from its large database of information and behaviors recorded in its existing addiction recovery-focused social network, combined with its recently completed SBIR phase I work, to identify users at risk for relapse and deliver tailored lay and professional peer support, telehealth, and provider interventions prompted by near real-time automated risk indicators built into an Enhanced Sober Grid (ESG) solution. The specific goals of this proposed phase II project include: (1) implementing the relapse risk scoring algorithm successfully developed in phase I in a production environment, (2) developing a ML resource relevancy matching algorithm, and (3) using this system to pilot test the feasibility and acceptability as well as to estimate the effect on abstinence of providing peer-coaching and resource information to a national sample of Sober Grid members in recovery from non- alcohol/nicotine substances who are predicted to be at high risk for relapse. We will accomplish our objectives by: (Aim 1) Implementing an accurate, near real-time production risk prediction system; (Aim 2) Developing an enhanced, in-app substance-addiction recovery resource locator; and, (Aim 3) Determining the feasibility, acceptability and estimating the effect size of the proposed ESG among high relapse-risk participants in recovery from opioid, stimulant, or cannabis use. The expected impact of this project is to substantially enhance Sober Grid's ability to deliver effective and timely interventions to the right individuals, at the right time  including those high-need and underserved populations that would otherwise lack access to care and draw considerable resources from the healthcare system. This capability holds the promise to reduce drug and alcohol relapse and the associated negative health impacts at both an individual and societal level while reducing the total cost of providing treatment services. PROJECT NARRATIVE Sober Grid is combining near real-time risk prediction with automated phone-app messaging, peer-coaching, and resource visibility and transparency in order to dramatically improve support for recovery from substance abuse. The strategy is to provide continuously available responsive connection and support with simple and familiar ways to search, filter, sort, identify, and review/rate resource options in order to lower overall relapse rates within the population, enabling Sober Grid users to achieve improved health outcomes and institutional payers to reduce the total cost of achieving those outcomes. Over time, the innovations resulting from this project will significantly reduce costs for individuals, public and private payers, the healthcare system, and society at large.",LEVERAGING PREDICTIVE ANALYTICS WITHIN SOCIAL NETWORKS TO MAXIMIZE DRUG ANDALCOHOL TREATMENT EFFICACY AND RELAPSE PREVENTION,9897501,R44DA044062,"['Aftercare ', ' After Care ', ' After-Treatment ', ' post treatment ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Algorithms ', ' Back ', ' Dorsum ', ' Behavior ', ' Client ', ' Communities ', ' Cost Control ', ' Cost Containment ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Environment ', ' Exercise ', ' Foundations ', ' Goals ', ' Group Meetings ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' Insurance ', ' Intelligence ', ' Motivation ', ' Natural Language Processing ', ' natural language understanding ', ' Nicotine ', ' Patients ', ' Privatization ', ' Production ', ' Relapse ', ' Resources ', ' Research Resources ', ' Risk ', ' Support Groups ', ' Self-Help Groups ', ' self help organization ', ' Social support ', ' social support network ', ' Societies ', ' Substance Addiction ', ' Substance Dependence ', ' Substance Use Disorder ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Work ', ' Writing ', ' Caring ', ' Social Network ', ' base ', ' improved ', ' Clinical ', ' Phase ', ' insight ', ' Personality Traits ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Recovery ', ' Data Bases ', ' data base ', ' Databases ', ' Opiates ', ' Opioid ', ' satisfaction ', ' drug use ', ' Drug usage ', ' Comment ', ' Commentary ', ' Editorial Comment ', ' Viewpoint ', ' Published Comment ', ' tool ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Stream ', ' System ', ' Location ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' Services ', ' preference ', ' success ', ' Participant ', ' peer ', ' treatment program ', ' member ', ' sober ', ' sobriety ', ' help seeking ', ' help-seeking behavior ', ' novel technologies ', ' new technology ', ' Reporting ', ' social ', ' abuse of substances ', ' substance abuse ', ' Substance abuse problem ', ' disease recurrence prevention ', ' disorder recurrence prevention ', ' recurrence prevention ', ' relapse prevention ', ' disorder later incidence prevention ', ' Modeling ', ' Sampling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Cannabis ', ' Enhancement Technology ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' Provider ', ' preventing ', ' prevent ', ' telehealth ', ' Chemical Dependence ', ' Drug Dependence ', ' Drug Dependency ', ' Drug Addiction ', ' Data ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Monitor ', ' Characteristics ', ' Process ', ' Behavioral ', ' cost ', ' drug relapse ', ' ethanol relapse ', ' alcohol relapse ', ' treatment center ', ' under served population ', ' underserved people ', ' Underserved Population ', ' designing ', ' design ', ' intervention efficacy ', ' therapeutic efficacy ', ' therapeutically effective ', ' therapy efficacy ', ' Treatment Efficacy ', ' Outcome ', ' cost effective ', ' Population ', ' alcohol addiction ', ' alcohol dependency ', ' alcohol-dependent ', ' Alcohol dependence ', ' innovate ', ' innovative ', ' innovation ', ' Abstinence ', ' provider intervention ', ' addictive disorder ', ' addiction ', ' high risk ', ' effective treatment ', ' effective therapy ', ' phase II study ', ' phase 2 study ', ' mobile app ', ' mobile application ', ' cloud based ', ' THC co-use ', ' THC use ', ' Tetrahydrocannabinol co-use ', ' Tetrahydrocannabinol use ', ' cannabis use ', ' marijuana use ', ' peer instruction ', ' peer led team learning ', ' peer mentoring ', ' peer teaching ', ' peer coaching ', ' peer support ', ' social media ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' Predictive Analytics ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' medication-assisted treatment ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' Android ', ' relapse risk ', ' high risk group ', ' high risk population ', ' treatment services ', ' stimulant use ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NIDA,"SOBER GRID, INC.",R44,2020,471700,OH-11,0.06809592125678733
"Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention     DESCRIPTION (provided by applicant): In recent years in the U.S., problems associated with opioid prescriptions, including non-medical use and overdose, increased to historically unprecedented levels and represent a public health crisis. Emergency departments (EDs) play an important role in opioid prescribing, particularly to individuals at high risk for adverse opioi-related outcomes. Half of all ED visits are for a painful condition, and one third of all ED visits result in an opioid being prescribed. Moreover, in our pilot work, a quarter of patients surveyed at the ED study site reported non-medical opioid use in the prior three months. Despite the importance of this problem, strategies to reduce non-medical opioid use after an ED visit have not been well-studied. Our recent trial of a motivational intervention delivered to patients in the ED by a therapist resulted in modest reductions in non- medical use after the ED visit compared to a control condition. However, the intervention was unable to address the implications of opioids prescribed as a result of the ED encounter on post-ED opioid use behavior. This project will adapt the intervention for delivery after the ED visit through mobile technology in order to directly address the use of ED-provided opioids. Patients (n=600) will be recruited during an ED visit for a randomized controlled trial of the adapted intervention based on having used opioids non-medically in the prior three months and being given an opioid by an ED prescriber. In the intervention condition, interactive voice response calls will repeatedly assess non-medical opioid use and pain level and deliver intervention content. The intervention will include several potential actions that vary in intensity: assessment only, a brief message, extended messaging, or connection to a therapist by phone. Because the most helpful intensity of intervention is unknown and likely to vary between patients, the project will use an artificial intelligence stratey called reinforcement learning (RL). The RL system will continuously ""learn"" from the success of prior actions in similar situations with similar patients in order to select the action most likelyto reduce non-medical opioid use for each participant during each call. The RCT will be complemented by qualitative interviews to inform later implementation. The specific aims are to: (1) Adapt and enhance an existing motivational intervention to decrease non-medical opioid use after an ED visit by optimizing intervention intensity and duration through RL; (2) Examine the impact of the intervention on non-medical opioid use level during the six months post-ED visit; (3) Examine the impact of the intervention on driving after opioid use, overdose risk behaviors, and subsequent opioid-related ED visits. Secondary Aims are: (1) to examine differences in intervention effects between participants with high and low baseline levels of non-medical opioid use; and (2) to understand barriers and facilitators of implementation. This project will use a highly innovative strategy, artificial intelligence, to address a highly significant problem, non-medical opioid use. Ultimately, this study can lead to reductions in opioid- related harms and move forward the field of mobile health. PUBLIC HEALTH RELEVANCE: Non-medical use of opioid pain medications has increased substantially over the last decade, and ensuring the safe use of opioids prescribed as part of medical care has become a critical public health priority. Emergency Departments (EDs) are on the front lines of this emerging public health problem. This randomized controlled trial will test the impact of a mobile health intervention, which incorporates an innovative artificial intelligenc component to determine intervention duration and intensity, on non-medical opioid use and related harms for adult ED patients treated with opioids and who have a history of non-medical opioid use.",Reducing Non-Medical Opioid Use: An automatically adaptive mHealth Intervention,9869872,R01DA039159,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Opioid Analgesics ', ' opiate analgesia ', ' opiate analgesic ', ' opiate pain medication ', ' opiate pain reliever ', ' opioid analgesia ', ' opioid anesthetic ', ' opioid pain medication ', ' opioid pain reliever ', ' opioid painkiller ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Automobile Driving ', ' driving ', ' Behavior ', ' Complement ', ' Complement Proteins ', ' Future ', ' Recording of previous events ', ' History ', ' Interview ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' Methodology ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Outpatients ', ' Out-patients ', ' Overdose ', ' Pain ', ' Painful ', ' Patients ', ' Play ', ' Psychotherapy ', ' Public Health ', ' Psychological reinforcement ', ' Reinforcement ', ' Research ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Safety ', ' Surveys ', ' Survey Instrument ', ' Telephone ', ' Phone ', ' Testing ', ' Time ', ' Voice ', ' Work ', ' Research Methods ', ' Research Methodology ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' Caring ', ' Guidelines ', ' injuries ', ' Injury ', ' base ', ' improved ', ' Site ', ' Acute ', ' Medical ', ' Randomized Clinical Trials ', ' Ensure ', ' Individual ', ' Opiates ', ' Opioid ', ' Randomized Controlled Trials ', ' Therapeutic ', ' Severities ', ' System ', ' Co-ordination disorder ', ' Coordination Disorder ', ' Dyscoordination ', ' Incoordination ', ' Lack of Coordination ', ' Abnormal coordination ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' experience ', ' success ', ' skills ', ' Participant ', ' novel technologies ', ' new technology ', ' Reporting ', ' Health Care Technology ', ' Healthcare Technology ', ' Health Technology ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Address ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Monitor ', ' Process ', ' ED care ', ' ER care ', ' Emergency Department care ', ' Emergency Room care ', ' Emergency health care ', ' Emergency healthcare ', ' Emergency medical care ', ' Emergency Care ', ' post intervention ', ' drugged driving ', ' intervention efficacy ', ' therapeutic efficacy ', ' therapeutically effective ', ' therapy efficacy ', ' Treatment Efficacy ', ' Outcome ', ' innovate ', ' innovative ', ' innovation ', ' multidisciplinary ', ' motivational intervention ', ' high risk ', ' public health relevance ', ' usual care ', ' treatment as usual ', ' intervention effect ', ' brief motivational intervention ', ' clinical practice ', ' non-medical use ', ' nonmedical use ', ' public health priorities ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' adverse consequence ', ' adverse outcome ', ' screening ', ' m-Health ', ' mobile health ', ' mHealth ', ' ED patient ', ' ER patient ', ' Emergency Room patient ', ' Emergency Department patient ', ' ED visit ', ' ER visit ', ' Emergency care visit ', ' Emergency hospital visit ', ' Emergency room visit ', ' Emergency department visit ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' behavior outcome ', ' behavioral outcome ', ' continuous learning ', ' learning progression ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' opiate therapy ', ' opioid therapy ', ' recruit ', ' overdose risk ', ' non-medical opioid use ', ' nonmedical opioid use ', ' opiate misuse ', ' opioid misuse ', ' compare intervention ', ' comparison intervention ', ' clinical encounter ', ' ']",NIDA,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2020,547843,MI-12,0.11013675004649813
"Northeast Node of the National Drug Abuse Clinical Trials Network Project Summary/Abstract  This proposal is a competing renewal application of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN), which joined the CTN in 2015. The Northeast Node brought hundreds of community and healthcare partners across the states of New Hampshire, Vermont, and Maine to the CTN community for the first time. These states have among the very highest rates of substance use in the U.S., including opioid use, and they include some of the most rural communities in the U.S. The Node has brought significant expertise to the CTN in conducting practical, rigorous, innovative, and highly impactful trials focused on improving the treatment of substance use disorders (SUDs) in community systems in the Northeast and in partnership with other CTN Nodes across the nation. Node Investigators have extensive experience in leading national and multi-national clinical trials, digital technology; medication and behavioral treatments for opioid use disorder; co-occurring SUDs and mental health disorders; SUD and chronic pain; SUD in pregnant women; opioid, cannabis, tobacco, alcohol, stimulant, and polydrug treatment; SUD prevention and treatment among youth; and implementation science. The Northeast Node is embedded within the Center for Technology and Behavioral Health (CTBH), a NIDA-funded P30 Center of Excellence. The Node thus brings significant expertise in developing, evaluating, and implementing digital treatments for SUDs, with a focus on overcoming the striking disparities in treatment access and treatment quality evident in healthcare across the globe.  In the renewal period, the Node proposes to enhance its activities and contributions to the national CTN to embrace advances in scientific discovery and research innovations that offer great promise for increasing the reach and effectiveness of treatments for SUDs. The Node will engage a broader group of investigators that bring additional expertise in data science (bioinformatics, predictive modeling, artificial intelligence, social media, data privacy/security) and experimental design (micro-randomized trials, adaptive designs, and implementation/systems science). With this expanded group of partners, it will support and grow a productive research agenda in the CTN with a focus on (a) digital health and data analytics, including research focused on providing personalized, science-based resources to individuals with SUD via digital technology and (b) expanding low threshold access to science-based SUD care, particularly in rural contexts (e.g., general medical settings; pharmacies; and community organizations). And the Node will lead an expansion of CTN research on the (c) rapidly evolving landscape of cannabis use as well as (d) co-morbid SUD and mental health disorders. The Node will establish Community and Policy Advisory Boards to complement the existing communication infrastructure between Node investigators and their partners, with a focus on identifying the most significant and timely SUD needs in our communities and scaling-up and sustaining best practices. Project Narrative The proposed activities of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) embrace advances in scientific discovery and research innovations that offer great promise for increasing the reach and effectiveness of treatments for substance use disorders (SUD). These activities reflect a vision for the next iteration of the CTN in the next 5 years. This work will advance translational science in SUD research and markedly reduce the gap between SUD research and clinical practice -- with a focus on scaling-up and sustaining best practices.",Northeast Node of the National Drug Abuse Clinical Trials Network,10056244,UG1DA040309,"['Achievement ', ' Achievement Attainment ', ' Alcohols ', ' Alcohol Chemical Class ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Behavior ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Clinical Trials ', ' Communication ', ' Communities ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Complement ', ' Complement Proteins ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Experimental Designs ', ' Fire - disasters ', ' Fires ', ' fire ', ' Health ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' Justice ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Leadership ', ' Maine ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Persons ', ' New Hampshire ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Phenotype ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Science ', ' medical specialties ', ' Specialty ', ' Substance Use Disorder ', ' Technology ', ' Time ', ' Tobacco ', ' United States Food and Drug Administration ', ' Food and Drug Administration ', ' USFDA ', ' Vermont ', ' Vision ', ' Sight ', ' visual function ', ' Work ', ' ranpirnase ', ' P-30 Protein ', ' P30 ', ' P30 Protein ', ' Community Health Care ', ' Community Healthcare ', ' health care ', ' Healthcare ', ' Research Methods ', ' Research Methodology ', ' Rural Community ', ' Treatment Effectiveness ', ' Youth 10-21 ', ' Youth ', ' chronic pain ', ' Caring ', ' base ', ' improved ', ' Clinical ', ' Medical ', ' Series ', ' Link ', ' Training ', ' insight ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Rural ', ' Opiates ', ' Opioid ', ' Policies ', ' Funding ', ' Community Networks ', ' Therapeutic ', ' System ', ' meetings ', ' collegiate ', ' college ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' experience ', ' high school ', ' special interest group ', ' novel ', ' disease prevention ', ' disorder prevention ', ' member ', ' research study ', ' behavioral health ', ' Cannabis ', ' Provider ', ' Bio-Informatics ', ' Bioinformatics ', ' AIDS test ', ' AIDS/HIV test ', ' HIV test ', ' HIV-1 test ', ' HIV-2 test ', ' Human immunodeficiency virus test ', ' telehealth ', ' Data ', ' International ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' Research Infrastructure ', ' Strategic Planning ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Security ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Authorization ', ' Permission ', ' Authorization documentation ', ' Federally Qualified Health Center ', ' drug adherence ', ' drug compliance ', ' medication adherence ', ' medication compliance ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Clinical Trials Network ', ' designing ', ' design ', ' scale up ', ' innovate ', ' innovative ', ' innovation ', ' community organizations ', ' mobile device ', ' handheld mobile device ', ' implementation science ', ' addictive disorder ', ' addiction ', ' clinical practice ', ' flexible ', ' flexibility ', ' cocaine use ', ' Randomization trial ', ' randomized trial ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' screening ', ' NCI National Clinical Trials Network ', ' National Clinical Trials Network ', ' health data ', ' THC co-use ', ' THC use ', ' Tetrahydrocannabinol co-use ', ' Tetrahydrocannabinol use ', ' cannabis use ', ' marijuana use ', ' social media ', ' mobile platform ', ' mobile technology ', ' mobile computing ', ' Data Science ', ' Data Analytics ', ' opiate use disorder ', ' opioid use disorder ', ' personalized healthcare ', ' precision health care ', ' precision healthcare ', ' personalized health care ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' disparities in treatment ', ' treatment disparity ', ' high risk group ', ' high risk population ', ' rural locality ', ' rural place ', ' rural setting ', ' recruit ', ' smartwatch ', ' smart watch ', ' body sensor ', ' body worn sensor ', ' wearable sensor ', ' wearable system ', ' wireless sensor technology ', ' wearable sensor technology ', ' healthcare settings ', ' health care settings ', ' Infrastructure ', ' data privacy ', ' ']",NIDA,DARTMOUTH COLLEGE,UG1,2020,1022375,NH-02,0.04188694002548188
"Development of a scalable, portable device platform to help objectively monitor the treatment of substance abuse. Abstract Assessing the effectiveness of substance abuse rehabilitation, where high relapse rates create financial and social tolls, is a pressing clinical problem in need of better measurement tools. The ability to identify cognitive changes should improve outcomes but current intake into rehabilitation programs doesnt typically include cognitive tests. Simple, quick, cost-effective, and objective measures are needed. This is the problem this proposal seeks to address. This proposal utilizes the experience of Evolve Behavioral Health which serve 150 patients weekly, and WAVi, a commercialized brain-assessment platform that combines EEG evoked responses (ERP) with 5 other tests also sensitive to addiction (heart rate variability, physical reaction times, MoCA, Trail Making, and Flanker). This user-friendly platform focuses on minimizing testing times and cost while maximizing information. Our first premise is that adding these tests will help us identify those addicts whose cognitive state requires modified treatment approaches, and this will decrease relapse rates and recidivism rates. Our second premise is that we can create a dataset that can be trained to identify appropriate treatment regimens on an individual basis from the initial baseline test. To date, WAVi data have shown ERP to be highly sensitive to concussion (another cognitive issue) and that artificial intelligence on raw EEG can classify both PTSD and musculoskeletal pain with high sensitivities and specificities. The aims of this project are to develop a scalable EEG-based test for rehabilitation facilities that is readily accessible to clinicians and to create a dynamic data asset to help longitudinally predict outcomes. Accomplishing these aims will assist clinicians on the front lines of substance abuse assessment and treatment. Narrative This project will help create an objective and clinically accessible test to be used in substance-abuse rehabilitation programs to assist clinicians in making intervention choices as well as determining the timing of release from rehabilitation.","Development of a scalable, portable device platform to help objectively monitor the treatment of substance abuse.",10145897,R43DA053012,"['Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Autonomic nervous system ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Brain Concussion ', ' Cerebral Concussion ', ' Commotio Cerebri ', ' concussion ', ' Budgets ', ' Cognition ', ' Cognitive Therapy ', ' Cognition Therapy ', ' Cognitive Psychotherapy ', ' cognitive behavior intervention ', ' cognitive behavior modification ', ' cognitive behavior therapy ', ' cognitive behavioral intervention ', ' cognitive behavioral modification ', ' cognitive behavioral therapy ', ' cognitive behavioral treatment ', ' Electroencephalography ', ' EEG ', ' Future ', ' Goals ', ' Grant ', ' Inpatients ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Musculoskeletal Pain ', ' Patients ', ' Publishing ', ' Reaction Time ', ' Response RT ', ' Response Time ', ' psychomotor reaction time ', ' Rehabilitation therapy ', ' Medical Rehabilitation ', ' Rehabilitation ', ' rehab therapy ', ' rehabilitative ', ' rehabilitative therapy ', ' Rehabilitation Centers ', ' Relapse ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Rest ', ' Sensitivity and Specificity ', ' Post-Traumatic Stress Disorders ', ' PTSD ', ' Post-Traumatic Neuroses ', ' Posttraumatic Neuroses ', ' Posttraumatic Stress Disorders ', ' post-trauma stress disorder ', ' posttrauma stress disorder ', ' traumatic neurosis ', ' Technology ', ' Testing ', ' Time ', ' Treatment Protocols ', ' Treatment Regimen ', ' Treatment Schedule ', ' Measures ', ' Dataset ', ' Data Set ', ' Caring ', ' Public Domains ', ' Light Reflection Rheography ', ' Photoreflexometries ', ' Photoreflexometry ', ' Photoplethysmography ', ' base ', ' Clinical ', ' Phase ', ' Training ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Measurement ', ' Personal Medical History ', ' Personal Medical History Epidemiology ', ' Medical History ', ' event related potential ', ' Event-Related Potentials ', ' tool ', ' programs ', ' Frequencies ', ' Auditory ', ' Clinic ', ' Protocol ', ' Protocols documentation ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' experience ', ' treatment planning ', ' Rehabilitation Outcome ', ' Structure ', ' expectation ', ' recidivism ', ' Modality ', ' Devices ', ' social ', ' abuse of substances ', ' substance abuse ', ' Substance abuse problem ', ' behavioral health ', ' response ', ' portability ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Effectiveness ', ' cognitive change ', ' Address ', ' Consent ', ' Data ', ' Detection ', ' Intake ', ' Cognitive ', ' Monitor ', ' developmental ', ' Development ', ' point of care ', ' substance abuse therapy ', ' substance abuse treatment ', ' cost ', ' biopsychosocial ', ' cost effective ', ' Population ', ' user-friendly ', ' addictive disorder ', ' addiction ', ' multi-modality ', ' multimodality ', ' standard measure ', ' new marker ', ' novel biomarker ', ' novel marker ', ' heart rate variability ', ' phase II study ', ' phase 2 study ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' cognitive assessment ', ' cognitive testing ', ' open-source data ', ' open science ', ' open data ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' improved outcome ', ' substance abuse rehabilitation ', ' out-patient facility ', ' outpatient center ', ' outpatient facility ', ' ']",NIDA,WAVI COMPANY,R43,2020,221675,CO-01,0.007168925643631618
"Development of the Strength Band Platform, a Technology Assisted Therapy Platform to Aid with Opioid Abuse Treatment. PROJECT SUMMARY Opioid overdose rates have risen six-fold since the late 1990s and presently claim the lives of over 130 Americans each day. Amongst treatment options for opioid dependence, medication-assisted treatment (MAT) with opioid substitutes, such as methadone or buprenorphine maintenance, are the only treatments for which effectiveness has been confirmed by empirical study. While methadone maintenance is effective for reducing mortality over the course of treatment, individuals remain at significant risk of overdose death during the initial phase of treatment (methadone induction). On the other hand, although buprenorphine has lower risk of mortality, it is associated with greater risk of withdrawal and relapse. Therefore, patient monitoring is critical for effective MAT, improved treatment retention and reduced likelihood of overdose death. Yet, MAT is most commonly administered on an outpatient basis, limiting the time periods during which the patient can be actively assessed. OpiAID is developing the Strength Band Platform, a wearable device featuring a multi-sensor array and artificial intelligence to facilitate patient monitoring during MAT for opioid use disorder. This device will provide an expanded range of biometric variables enabling prediction of opioid use and withdrawal in real world settings. Real-time monitoring of patients will allow appropriate and timely interventions, directly improving the outcomes for the patients undergoing the treatment. There are currently no FDA approved, commercially available, wearable products for monitoring opioid use in real world settings. This Phase I SBIR program consists of two Specific Aims designed to develop the Strength Band Platform using a commercially available clinically validated armband. The first Specific Aim is to collect biometric variables from patients and develop prediction algorithms through supervised learning. In the second Specific Aim, barriers to end-user adoption, compliance and social stigma will be identified through focus groups and solutions based on the feedback will be incorporated into development frameworks. Completion of this Phase I project will produce a proof-of-concept platform which will undergo further development and evaluation for commercialization. Phase II research will focus on developing fully functional user and practitioner interfaces and completing multi-region clinical trials to demonstrate efficacy and effectiveness of the platform for improving patient outcomes. OpiAID will leverage extensive partnerships in the opioid dependence treatment community in Wilmington, NC to evaluate performance of the device and complete the clinical trials. Ultimately, identifying periods of increased risk of relapse will allow provision of just-in-time interventions. PROJECT NARRATIVE To address the opioid crisis, OpiAID is developing a wearable biometric device platform that will predict use and withdrawal in patients undergoing medication-assisted therapy for opioid use disorder. Using a wearable device for real-time monitoring with predictive capability will allow timely interventions resulting in fewer deaths and relapses.","Development of the Strength Band Platform, a Technology Assisted Therapy Platform to Aid with Opioid Abuse Treatment.",10138614,R43DA050399,"['Adoption ', ' Algorithms ', ' Ambulatory Care ', ' Outpatient Care ', ' outpatient treatment ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Buprenorphine ', ' Clinical Trials ', ' Communities ', ' Cessation of life ', ' Death ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Face ', ' faces ', ' facial ', ' Feedback ', ' Focus Groups ', ' Guns ', ' gun ', ' Maintenance ', ' Methadone ', ' Adanon ', ' Althose ', ' Dolophine ', ' Methadose ', ' mortality ', ' opioid abuse ', ' opiate abuse ', ' opiate drug abuse ', ' opioid drug abuse ', ' opioid withdrawal ', ' opiate withdrawal ', ' opioid detox ', ' opioid detoxification ', ' Outpatients ', ' Out-patients ', ' Patient Monitoring ', ' Patients ', ' Physicians ', ' Physiology ', ' Relapse ', ' Research ', ' Risk ', ' Safety ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Technology ', ' Testing ', ' Time ', ' Custom ', ' Light Reflection Rheography ', ' Photoreflexometries ', ' Photoreflexometry ', ' Photoplethysmography ', ' base ', ' sensor ', ' improved ', ' Acute ', ' Clinical ', ' Phase ', ' Evaluation ', ' Training ', ' Individual ', ' Withdrawal ', ' Opiates ', ' Opioid ', ' drug use ', ' Drug usage ', ' machine learned ', ' Machine Learning ', ' programs ', ' Hour ', ' Frequencies ', ' Clinic ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' American ', ' experience ', ' monitoring device ', ' Performance ', ' Self-Report ', ' Patient Self-Report ', ' contingency management ', ' Devices ', ' Sampling ', ' craving ', ' response ', ' stigma ', ' social stigma ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Drops ', ' Effectiveness ', ' Address ', ' Dose ', ' Data ', ' Collection ', ' Narcotic Rotation ', ' Narcotic Substitution ', ' Narcotic Switching ', ' Opioid Substitution ', ' Opioid Switching ', ' Opioid Rotation ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Monitor ', ' Process ', ' developmental ', ' Development ', ' designing ', ' design ', ' Abstinence ', ' commercialization ', ' high risk ', ' FDA approved ', ' overdose death ', ' flexible ', ' flexibility ', ' Regimen ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' arm ', ' opiate use disorder ', ' opioid use disorder ', ' accelerometry ', ' activity monitor ', ' activity tracker ', ' Accelerometer ', ' improved outcome ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' medication-assisted treatment ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' relapse risk ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' opiate therapy ', ' opioid therapy ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' illicit opiate ', ' illicit opioid ', ' wearable electronics ', ' wearable technology ', ' wearable device ', ' overdose risk ', ' Opiate replacement therapy ', ' Opiate substitution therapy ', ' Opiate substitution treatment ', ' Opioid maintenance therapy ', ' Opioid maintenance treatment ', ' Opioid replacement treatment ', ' Opioid substitution therapy ', ' Opioid substitution treatment ', ' Opioid replacement therapy ', ' methadone maintenance ', ' methadone maintenance program ', ' methadone maintenance therapy ', ' methadone maintenance treatment ', ' methadone treatment ', ' realtime monitoring ', ' real time monitoring ', ' supervised machine learning ', ' supervised learning ', ' death risk ', ' mortality risk ', ' ']",NIDA,"OPIAID, LLC",R43,2020,276533,NC-07,0.13771272192213038
"Survive-OUD: AI Platform to Integrate Complex Data Sources, Predict Relapse, and Recommend Interventions for Opioid Use Disorder The current opioid crisis is significantly impacting millions of lives, healthcare, social welfare, and the economy. Patient interactions with the treatment system coupled with results of completed studies create a wealth of data stored in disparate electronic sources. Therapists and health care providers with limited time and resources face challenges to access, integrate and monitor this vast data set for novel opportunities to improve care. Significant advances would include predicting when a patient will relapse out of a program, and also suggesting optimal personalized care strategies to reengage patients before this negative event occurs.  Survive-OUD will solve these challenges by providing a web-based therapist interface integrating survivor model artificial intelligence (AI) strategies. Based on multiple input data domains leveraged from existing electronic medical record sources, survivor recurrent neural networks will be trained to recognize when patients are likely to relapse or drop out of an OUD program. Examples of data domains that can be input to the network include patient demographics, medical and prescription data, engagement with therapy paradigms, and compliance with logistical program tasks. Furthermore, once a patient is noted as high risk, a second layer of algorithms will be developed to recommend a specific and personalized care strategy for retention based on existing best practices in the literature and clinical trials. Therefore, the Survive-OUD platform will also integrate with common literature database and clinical trial repositories. Utilizing an existing AI platform for searching, tagging, and extracting data from database sources, the innovative platform will close the loop on actionable results by recommending updated care options based on potential outcomes learned from best practices in existing literature. The AI architecture developed will greatly improve success rates in opioid addition programs and expand high quality healthcare.  While the commercialized Survive-OUD platform will integrate all features above, Phase I will target feasibility of data aggregation and AI algorithms to detect relapse and recommend intervention strategies. The innovative technical challenge in Phase I is to develop and validate targeted AI tools using data already being captured in patient workflow to allow early prediction of patient retention issues. More specifically, a prototype therapist interface and data network infrastructure will be developed to source personalized patient data as well as literature and clinical trial sources. Once the platform architecture has passed verification testing, it will be deployed in a field data collection study to determine usability and also provide a rich set of de-identified data for algorithm development. Collected data will then be used to train and test AI algorithms for early detection of patient dropout/relapse and appropriate treatment recommendation. The objective is to design, develop, and demonstrate feasibility of Survive-OUD, an artificial intelligence driven platform to integrate complex data sources, predict patient relapse, and recommend intervention strategies for individuals impacted by opioid use disorder. Currently millions of Americans suffer from an opioid use disorder (OUD) and program relapse rates are extremely high. Therefore, an advanced, bioinformatics platform that accurately predicts when OUD patients will drop out of programs and offers personalized prevention strategies would provide a novel clinical tool to help combat the opioid crisis in the U.S.","Survive-OUD: AI Platform to Integrate Complex Data Sources, Predict Relapse, and Recommend Interventions for Opioid Use Disorder",10133357,R43DA052916,"['Algorithms ', ' Appointment ', ' Architecture ', ' Engineering / Architecture ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Centers for Disease Control and Prevention (U.S.) ', ' CDC ', ' Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' United States Centers for Disease Control and Prevention ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Data Aggregation ', ' Aggregated Data ', ' Data Collection ', ' Data Sources ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Face ', ' faces ', ' facial ', ' Fentanyl ', ' Actiq ', ' Duragesic ', ' Fentanest ', ' Fentyl ', ' Phentanyl ', ' Foundations ', ' Geography ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Literature ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Patient Dropouts ', ' Patients ', ' Publishing ', ' health care quality ', ' healthcare quality ', ' Recommendation ', ' Relapse ', ' Resources ', ' Research Resources ', ' Sensitivity and Specificity ', ' Social Welfare ', ' Testing ', ' Time ', ' Toxicology ', ' Computerized Medical Record ', ' Electronic Medical Record ', ' Price ', ' pricing ', ' health care ', ' Healthcare ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' improved ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Medical ', ' Survivors ', ' Training ', ' Individual ', ' Recovery ', ' Data Bases ', ' data base ', ' Databases ', ' Opiates ', ' Opioid ', ' Logistics ', ' WWW ', ' web ', ' world wide web ', ' Internet ', ' tool ', ' programs ', ' Complex ', ' Event ', ' Source ', ' System ', ' American ', ' early detection ', ' Early Diagnosis ', ' success ', ' Transact ', ' novel ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' Sampling ', ' Connectionist Models ', ' Neural Network Models ', ' Perceptrons ', ' Neural Network Simulation ', ' depository ', ' repository ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Drops ', ' Provider ', ' Bio-Informatics ', ' Bioinformatics ', ' Data ', ' Economic Burden ', ' Update ', ' Monitor ', ' socio-economic ', ' socio-economically ', ' socioeconomically ', ' socioeconomics ', ' Behavioral ', ' cost ', ' anti-cancer research ', ' cancer research ', ' anticancer research ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' Coupled ', ' innovate ', ' innovative ', ' innovation ', ' usability ', ' demographics ', ' prototype ', ' high risk ', ' combat ', ' patient population ', ' effective treatment ', ' effective therapy ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' Secure ', ' personalized prevention ', ' precision prevention ', ' individualized prevention ', ' Precision care ', ' individualized care ', ' individualized patient care ', ' personalized patient care ', ' personalized care ', ' retention strategy ', ' student retention ', ' retention rate ', ' Network Infrastructure ', ' Data Analytics ', ' opiate use disorder ', ' opioid use disorder ', ' relapse patients ', ' individualized strategies ', ' personalized strategies ', ' software as a service ', ' predict relapse ', ' relapse prediction ', ' high dimensionality ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' Service model ', ' care delivery model ', ' health care delivery model ', ' healthcare delivery model ', ' Service delivery model ', ' patient engagement ', ' non-medical use of prescription opiates ', ' non-medical use of prescription opioids ', ' nonmedical use of prescription opiates ', ' nonmedical use of prescription opioids ', ' opioid analgesic misuse ', ' opioid medication misuse ', ' opioid prescription medication misuse ', ' prescription opiate misuse ', ' prescription opioid misuse ', ' recurrent neural network ', ' algorithm development ', ' smart algorithm ', ' intelligent algorithm ', ' complex data  ', ' data deidentification ', ' de-identified data ', ' deidentified data ', ' data de-identification ', ' ']",NIDA,"INSILICA, LLC",R43,2020,251348,MD-98,0.11687787415890823
"Social Media Use and Mechanisms of Suicide Risk in Adolescents Project Summary/Abstract Suicide rates have nearly doubled among adolescent girls over the past decade. During this same time period, social media sites (e.g., Instagram, Snapchat, Facebook) have become ubiquitous, with nearly 97% of youth now using social media. Social media offers both risks and benefits for adolescent development. However, there is likely a vulnerable subset of youth for whom social media use influences suicidal thoughts and behaviors (STBs). The primary goal of this study is to examine how and for whom social media use contributes risk for STBs, so that we may better identify and intervene with youth most at risk. A multi-method approach, integrating computational psychiatry and experimental techniques, will be used to investigate the specific mechanisms by which social media use affects STBs. Data will be collected from both an existing dataset (n ~ 2,000) and a recruited sample (n = 90 adolescent females, ages 14-17, with lifetime history of STBs). To identify specific, directly observable social media experiences that heighten risk for STBs, digital trace data (i.e., social media content and meta-data) will be collected directly from adolescents social media pages and analyzed using machine learning techniques. In addition, an innovative laboratory paradigm with eye- tracking/pupillometry will be used to examine cognitive and affective responses to social media use that increase vulnerability to STBs. Participant STBs will be assessed at baseline, 3-month-, and 6-month follow ups. The aims of the study are well-aligned with the candidates long-term career goal of becoming an independent investigator of adolescent social media use and mental health. To purse this research agenda going forward, the candidate proposes training in four key areas: (1) machine learning methods for analyzing digital trace data, (2) experimental eye tracking/pupillometry paradigms, (3) mechanism-based translational research in adolescent suicide risk, and (4) professional development, with an emphasis on training in effective interdisciplinary collaboration and the ethics of social media research. A team of mentors and consultants from multiple disciplines will facilitate the candidates training, including experts in youth suicide risk, machine learning and natural language processing, and experimental peer interaction paradigms. The diverse resources available at Brown University and Rhode Island Hospital will ensure successful completion of the project and foster the development of the candidates research program. The proposed study has the potential to contribute significantly to our understanding of the role of social media in adolescent suicide risk. Completion of the proposed research and training goals will uniquely position the candidate to become a leader in the field of adolescent social media use. Project Narrative Nearly all adolescents use social media sites, yet for a vulnerable subset of teens, social media use may increase risk for suicide. Given rising suicide rates among adolescent girls in recent years, it is critical to examine the reasons why social media use may be related to suicidal thoughts and attempts. Findings of this study will have the potential to inform future suicide intervention and prevention efforts that address the unique needs of adolescents in the digital age.",Social Media Use and Mechanisms of Suicide Risk in Adolescents,9951503,K23MH122669,"['Female Adolescents ', ' adolescent girl ', ' Affect ', ' Age ', ' ages ', ' Arousal ', ' Attention ', ' Clinical Research ', ' Clinical Study ', ' Disease ', ' Disorder ', ' Environment ', ' Ethics ', ' ethical ', ' Exhibits ', ' Eye ', ' Eyeball ', ' Feedback ', ' Female ', ' Future ', ' Goals ', ' Grant ', ' Recording of previous events ', ' History ', ' Hospitals ', ' indexing ', ' Interview ', ' Laboratories ', ' Linguistics ', ' Linguistic ', ' Literature ', ' Longitudinal Studies ', ' long-term study ', ' longitudinal outcome studies ', ' longterm study ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Mentors ', ' Methods ', ' National Institute of Mental Health ', ' NIMH ', ' Natural Language Processing ', ' natural language understanding ', ' Psychiatry ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Rhode Island ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Self Disclosure ', ' Social Environment ', ' social climate ', ' social context ', ' socioenvironment ', ' socioenvironmental ', ' Suicide ', ' fatal attempt ', ' fatal suicide ', ' intent to die ', ' suicidality ', ' Suicide attempt ', ' non fatal attempt ', ' nonfatal attempt ', ' suicidal attempt ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' Measures ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' Dataset ', ' Data Set ', ' base ', ' career ', ' Suicide precaution ', ' prevent suicidality ', ' prevent suicide ', ' suicidality prevention ', ' suicide intervention ', ' Suicide prevention ', ' Site ', ' Area ', ' Clinical ', ' Phase ', ' Physiologic ', ' Physiological ', ' Series ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Discipline ', ' Individual ', ' social norm ', ' Fostering ', ' Data Bases ', ' data base ', ' Databases ', ' machine learned ', ' Machine Learning ', ' programs ', ' Suicidal thoughts ', ' suicidal ideation ', ' suicidal thinking ', ' suicide ideation ', ' thoughts about suicide ', ' Feeling suicidal ', ' Frequencies ', ' Severities ', ' Techniques ', ' gaze ', ' suicide risk ', ' suicidal risk ', ' experience ', ' eye tracking ', ' visual tracking ', ' transdisciplinary collaboration ', ' interdisciplinary collaboration ', ' Participant ', ' peer ', ' Self-Report ', ' Patient Self-Report ', ' Benefits and Risks ', ' social ', ' Position ', ' Positioning Attribute ', ' Emotional ', ' Modeling ', ' Sampling ', ' Adolescent Development ', ' career development ', ' girls ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' preventing ', ' prevent ', ' Address ', ' Length ', ' Mechanisms of Behavior and Behavior Change ', ' behavior mechanism ', ' Behavioral Mechanisms ', ' Data ', ' Research Training ', ' Cognitive ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Teen ', ' teen years ', ' teenage ', ' Teenagers ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' meta data ', ' Metadata ', ' suicide behavior ', ' suicidal behavior ', ' suicide rate ', ' digital ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' Affective ', ' web interface ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' social media ', ' recruit ', ' adolescent suicide ', ' Facebook ', ' Twitter ', ' learning classifier ', ' machine learning method ', ' ']",NIMH,RHODE ISLAND HOSPITAL,K23,2020,195616,RI-01,0.02500356962594872
"Hematopoietic Stem Cell And Cord Blood Transplantation PROJECT SUMMARY/ABSTRACT Hematopoietic cell transplantation from unrelated donors, haploidentical related donors and cord blood units can cure life-threatening blood disorders; however, graft-versus-host disease (GVHD), relapse and survivorship disparities across different ancestries remain the major obstacles. When matched donors are not available, the properties of HLA mismatches that govern (non)-permissivity are not well-defined. Furthermore, the role of KIR/HLA interactions in modulating relapse remain to be clarified. These deficiencies have important implications for a large fraction of patients who lack HLA-matched donors, and for all patients at risk for disease relapse. We have demonstrated that HLA class I leader peptides, HLA-DP expression, and HLA/KIR interactions each contribute to GVHD, relapse and mortality. The unmet needs are to understand the mechanisms through which HLA and KIR genes modulate transplant risks, and a means to apply the research findings to clinical care. We propose to define the underlying mechanisms through which HLA and KIR genes and proteins function in transplantation, and develop tools for using HLA and KIR in the selection of the optimal transplant donor and cord blood unit. The specific aims are to: define the role of HLA-DP expression and peptide-binding groove pocket in GVHD; define NKG2/HLA-E interactions and HLA-G in GVHD and relapse; define the role for KIR and HLA interaction in relapse after HCT for acute leukemia, and design tools to evaluate gene features in clinical practice. The goals will be achieved through systemic analysis of individual gene variation, haplotypes of genes, and receptor/ligand recognition in large ethnically diverse transplant populations with complete clinical data. This proposal will fill the knowledge gap in the immunobiological basis of GVHD, relapse and survivorship disparities in transplantation. The information will increase the safety, efficacy and availability of transplantation for all patients in need of this life-saving therapy. Project Narrative We will study how immune system genes affect the success of transplantation for patients of diverse ancestries. This information will help to lower risks through individualized treatment options for future patients.",Hematopoietic Stem Cell And Cord Blood Transplantation,10007670,U01AI069197,"['personalized medicine ', ' GEM protein ', ' GTP-Binding Mitogen-Induced T-Cell Protein ', ' KIR gene ', ' KIR protein ', ' Kinase-Inducible RAS-like Protein ', ' GEM gene ', ' individual patient ', ' individualized strategies ', ' personalized strategies ', ' improved outcome ', ' ethnically diverse ', ' ethnic diversity ', ' Affect ', ' Alleles ', ' Allelomorphs ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Biology ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Donor person ', ' transplant donor ', ' Future ', ' Genes ', ' Genotype ', ' Goals ', ' graft vs host disease ', ' GvHD ', ' Homologous Wasting Disease ', ' Runt Disease ', ' graft versus host disease ', ' graft vs. host disease ', ' Haplotypes ', ' Health ', ' Hematological Disease ', ' Blood Diseases ', ' Hematologic Diseases ', ' Hematological Disorder ', ' blood disorder ', ' Hematopoietic stem cells ', ' Blood Precursor Cell ', ' Hematopoietic Progenitor Cells ', ' blood stem cell ', ' hematopoietic progenitor ', ' hematopoietic stem progenitor cell ', ' hemopoietic progenitor ', ' hemopoietic stem cell ', ' Histocompatibility ', ' Tissue Compatibility ', ' HLA-B Antigens ', ' HLA-B ', ' HLA-C Antigens ', ' HLA-C ', ' HLA-DP Antigens ', ' HLA-DP ', ' HLA-PL ', ' HLA-PL Antigens ', ' HLA-SB ', ' HLA-SB Antigens ', ' Immune system ', ' allergic/immunologic body system ', ' allergic/immunologic organ system ', ' Natural Killer Cells ', ' Cytotoxic cell ', ' K lymphocyte ', ' NK Cells ', ' leukemia ', ' Ligands ', ' Linkage Disequilibrium ', ' Methods ', ' mortality ', ' Patients ', ' Peptides ', ' Phenotype ', ' Genetic Polymorphism ', ' polymorphism ', ' Registries ', ' Relapse ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Safety ', ' Savings ', ' Survival Rate ', ' survivorship ', ' Testing ', ' Translating ', ' Transplantation ', ' transplant ', ' Caucasians ', ' Caucasian ', ' Caucasian Race ', ' Caucasoid ', ' Caucasoid Race ', ' Occidental ', ' white race ', ' Work ', ' Asians ', ' oriental ', ' Measures ', ' HLA G antigen ', ' HLA-G ', ' Acute leukemia ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Cord Blood ', ' fetal cord blood ', ' Umbilical Cord Blood ', ' base ', ' Clinical ', ' Variation ', ' Variant ', ' Ensure ', ' prognostic ', ' Failure ', ' Individual ', ' African ', ' Selection Criteria ', ' Funding ', ' Relapsed Disease ', ' Recurrent disease ', ' gene function ', ' Shapes ', ' tool ', ' Nature ', ' transplant patient ', ' Transplant Recipients ', ' Knowledge ', ' Life ', ' Frequencies ', ' Receptor Protein ', ' receptor ', ' success ', ' novel ', ' disease risk ', ' disorder risk ', ' Acute GVHD ', ' acute graft vs host disease ', ' acute graft vs. host disease ', ' Acute Graft Versus Host Disease ', ' Property ', ' Leader Peptide ', ' Leader Signal Peptide ', ' Peptide Leader Sequences ', ' Cord Blood Transplantation ', ' UCB transplantation ', ' Umbilical Cord Blood Transplantation ', ' Sentinel ', ' Molecular Interaction ', ' Binding ', ' Population Group ', ' HLA-A ', ' HLAA ', ' HLA-A gene ', ' HLA-DP1B ', ' HLA-DPB1 ', ' HLADPB1 ', ' HLA-DPB1 gene ', ' Affinity ', ' Data ', ' International ', ' Reproducibility ', ' Resolution ', ' Clinical Data ', ' Validation ', ' protein function ', ' work group ', ' working group ', ' designing ', ' design ', ' Outcome ', ' Population ', ' tumor ', ' high risk ', ' clinical care ', ' clinical practice ', ' Regimen ', ' clinical decision-making ', ' hematopoietic cell transplantation ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' personalization of treatment ', ' personalized therapy ', ' personalized treatment ', ' ']",NIAID,FRED HUTCHINSON CANCER RESEARCH CENTER,U01,2020,808331,WA-07,0.04699978453908585
"Leveraging Social Media for Substance Use Behavioral Insight  Project Summary Substance misuse places a tremendous burden on individuals and society and remains high because so many youth initiate substance use at an early age and progress to dependence. In one of my NIDA sponsored R01s, I am funded to examine the effects of school and state-level penalties on youth substance use behaviors while accounting for anti-tobacco/drug media campaigns (R01 DA032843). My research signals a health issue of increasing importance that is youth exposure to the promotion of alcohol, tobacco, and other drug-related content via advertisements, online social networking, and other normalizing and pro-use messages. There is potential for leveraging social media as a tool to understand, inform, and potentially dissuade harmful substance use behaviors. However, a critical and necessary first step is to better understand displayed substance use references on key social media sites and how these displays are associated with use. In my second NIDA-sponsored R01, I am funded to investigate the implications of social media content and engagement for alcohol and marijuana use (R01 DA039456). I am a newly tenured investigator who has already made important contributions to the study of substance use policy and social media research. I will investigate social media posts for novel insight into drug use, especially newly emerging drugs that are increasing in popularity. I also aim to generate a strong scientific base about social media as a potential medium for delivering anti-/pro- substance use messages to young people. At this juncture, it is critical for me to receive support from this Independent Scientist Award so that I can devote all of my efforts towards continuing to build my research program and to enhance my scientific skills and advance me to the next level of achievement. I will collaborate with investigators at Washington University and nationally in order to gain further experience in sophisticated and efficient data mining analysis. I will additionally achieve an improved ability to synthesize results across multiple studies into strategic and actionable recommendations for tailored prevention messages to deliver on social media. This award will also enable me to devote a substantial amount of time to mentorship and the development of the next generation of researchers. In summary, this Independent Scientist Award will enable me to expand my knowledge base in targeted areas to significantly enhance my research trajectory in ways that would not be otherwise feasible. Project Narrative This study is significant to the public health field because it will harness social media posts for novel insight into drug use, especially newly emerging drugs that are increasing in popularity. This application requests 5 years of funding to support protected research time for Dr. Cavazos to learn and apply new skills in state-of-the-art big data analysis and to synthesize her results across studies into strategic and actionable recommendations for tailored prevention messages to deliver on social media.",Leveraging Social Media for Substance Use Behavioral Insight ,10002211,K02DA043657,"['Accounting ', ' Achievement ', ' Achievement Attainment ', ' Age ', ' ages ', ' Alcohol consumption ', ' Alcohol Drinking ', ' EtOH drinking ', ' EtOH use ', ' alcohol ingestion ', ' alcohol intake ', ' alcohol product use ', ' alcohol use ', ' alcoholic beverage consumption ', ' alcoholic drink intake ', ' ethanol consumption ', ' ethanol drinking ', ' ethanol ingestion ', ' ethanol intake ', ' ethanol product use ', ' ethanol use ', ' Attitude ', ' Award ', ' Behavior ', ' Belief ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Data Sources ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Grant ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Health ', ' Influentials ', ' Leadership ', ' Learning ', ' Marijuana ', ' marihuana ', ' Mentors ', ' Mentorship ', ' Methods ', ' Minority Groups ', ' Mission ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Productivity ', ' Public Health ', ' Recommendation ', ' Research ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Role ', ' social role ', ' Wages ', ' Salaries ', ' Schools ', ' medical schools ', ' medical college ', ' school of medicine ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Societies ', ' Substance Addiction ', ' Substance Dependence ', ' Substance Use Disorder ', ' Survey Methodology ', ' Survey Method ', ' Educational process of instructing ', ' Teaching ', ' Technology ', ' Time ', ' Tobacco ', ' Universities ', ' Washington ', ' Work ', ' Cost Sharing ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' analytical method ', ' base ', ' improved ', ' Site ', ' Area ', ' Clinical ', ' insight ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' adult youth ', ' young adulthood ', ' young adult ', ' Policies ', ' Research Activity ', ' drug use ', ' Drug usage ', ' Funding ', ' Exposure to ', ' Shapes ', ' tool ', ' Nature ', ' Research Priority ', ' programs ', ' Complex ', ' Dependence ', ' Source ', ' Pattern ', ' interest ', ' experience ', ' knowledgebase ', ' knowledge base ', ' skills ', ' expectation ', ' novel ', ' Media Campaign ', ' member ', ' narghile ', ' shisha ', ' water pipe ', ' waterpipe ', ' hookah ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Prevention ', ' Position ', ' Positioning Attribute ', ' career development ', ' Advertisements ', ' Latinas ', ' Latina ', ' disparity in health ', ' health disparity ', ' preventing ', ' prevent ', ' datamining ', ' data mining ', ' Address ', ' Data ', ' K02 Award ', ' Independent Scientist Award ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' NIH RFA ', ' Request for Applications ', ' Underrepresented Ethnic Minority ', ' under-representation of minorities ', ' underrepresentation of minorities ', ' Underrepresented Minority ', ' trend ', ' developmental ', ' Development ', ' Behavioral ', ' substance use among adolescents ', ' substance use among youth ', ' youth substance use ', ' adolescent substance use ', ' next generation ', ' addictive disorder ', ' addiction ', ' on-line social networking ', ' online social networking ', ' social networking site ', ' social networking web site ', ' web-based social networking ', ' social networking website ', ' social implication ', ' alcohol, tobacco, and other drug ', ' alcohol, tobacco, or other drug ', ' ATOD ', ' Secure ', ' BigData ', ' Big Data ', ' e-cig ', ' e-cigarette ', ' ecig ', ' ecigarette ', ' Electronic cigarette ', ' THC co-use ', ' THC use ', ' Tetrahydrocannabinol co-use ', ' Tetrahydrocannabinol use ', ' cannabis use ', ' marijuana use ', ' associate faculty ', ' associate professor ', ' midcareer faculty ', ' mid-career faculty ', ' social media ', ' Data Analytics ', ' substance misuse ', ' Twitter ', ' Big Data Analytics ', ' Big Data Tools ', ' Big Data Methods ', ' social factors ', ' machine learning method ', ' ']",NIDA,WASHINGTON UNIVERSITY,K02,2020,118137,MO-01,0.042549820513271
"Online Evidence of Withdrawal Self-Medication PROJECT SUMMARY/ABSTRACT Withdrawal symptoms from opioid use can be severe and are major contributing factors to relapse and continuing misuse. Many opioid users are actively experimenting with remedies that can alleviate withdrawal, and they are discussing their effectiveness in blogs and forums. In this pilot study we will use Natural Language Processing (NLP) and human expertise to examine over 50,000 recent posts in two Reddit forums OpiatesRecovery and Opiates to assess systematically which remedies are being used, how they are being used, and what are the reported consequences of such self-help experimentation. We will create a curated database of user-reported remedies. Information will be semiautomatically extracted from the online, self-reported use of alternative treatments (i.e., other prescription drugs, over the counter medications, food supplements, activities such as meditation and yoga). A team of a pharmacologist, physician, and ethnographer will evaluate database entries to uncover (1) potential harm associated with uncontrolled and unsupervised experimentation, (2) potentially effective available treatments (e.g., traditional medicine), (3) potentially promising compound leads, and (4) patients' needs and issues that are most important to them. Aim 1. To assemble an extensive database of opioid withdrawal and remedy-associated terminology from posts on OpiatesRecovery and Opiates Reddit communities. NLP will be used to build a language model that understands how words are used in context (word2vec). Aim 2. To develop a dataset of instances of self-reported remedy use from Reddit and conduct a bipartite network analysis of remedies and users. Using NLP tools and the word embedding model we will develop an exclusive dataset containing extracted information associated with remedies targeting withdrawal and craving. This aim will use elements of artificial intelligence and close human supervision to extract remedies, including variations of spelling, from the texts. The result of this aim will be a remedy database that includes spelling variations and slang references and a network analysis linking remedies and users. Aim 3. To organize, aggregate, and systematically assess information from mentions of remedy use. Potential compounds and other remedies will be classified to provide an initial assessment of their potential relevance to the opioid treatment process. This process will require the most human oversight and assessment. Network analysis tools will be used to assess and identify the relationships between the types of remedies and potential therapeutic effect and will create the benchmarks for similar future studies. PROJECT NARRATIVE Withdrawal symptoms from opioid use can be severe and are major contributing factors to relapse and continuing misuse. Many opioid users are actively experimenting with remedies that can alleviate withdrawal, and they are discussing their effectiveness in blogs and forums. In this pilot study we will use Natural Language Processing and human expertise to examine over 50,000 recent posts in two Reddit forums OpiatesRecovery and Opiatesto assess systematically which remedies are being used, how they are being used, and what are the reported consequences of such self-help experimentation.",Online Evidence of Withdrawal Self-Medication,9979829,R21DA048739,"['Acupuncture Therapy ', ' Acupuncture procedure ', ' acupuncture ', ' Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Automation ', ' Belief ', ' Cluster Analysis ', ' Cluster Analyses ', ' Communities ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Non-Prescription Drugs ', ' Nonprescription Drugs ', ' OTC Drugs ', ' Over-the-Counter Drugs ', ' Patent Medicines ', ' Elements ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Food ', ' Food or Food Product ', ' Food Additives ', ' Future ', ' Habits ', ' Herb ', ' Human ', ' Modern Man ', ' Language ', ' Marijuana ', ' marihuana ', ' Herbal Medicine ', ' Traditional Medicine ', ' Methods ', ' Methodology ', ' Natural Language Processing ', ' natural language understanding ', ' Terminology ', ' opioid withdrawal ', ' opiate withdrawal ', ' opioid detox ', ' opioid detoxification ', ' Patients ', ' Physicians ', ' Pilot Projects ', ' pilot study ', ' Drug Prescriptions ', ' Drug Prescribing ', ' Relapse ', ' Research ', ' Resources ', ' Research Resources ', ' Self Medication ', ' Supervision ', ' United States Food and Drug Administration ', ' Food and Drug Administration ', ' USFDA ', ' Vitamins ', ' Yoga ', ' Information Retrieval ', ' Information extraction ', ' Withdrawal Symptom ', ' Dataset ', ' Data Set ', ' Meditation ', ' Variation ', ' Variant ', ' Medical ', ' Link ', ' Withdrawal ', ' diet supplement ', ' nutritional supplement ', ' dietary supplements ', ' Data Bases ', ' data base ', ' Databases ', ' Opiates ', ' Opioid ', ' Nonnarcotic Analgesics ', ' Nonopioid Analgesics ', ' non-narcotic analgesic ', ' non-opiate analgesic ', ' non-opioid ', ' nonopiate analgesic ', ' nonopioid ', ' non-opioid analgesic ', ' Collaborations ', ' Comment ', ' Commentary ', ' Editorial Comment ', ' Viewpoint ', ' Published Comment ', ' tool ', ' Knowledge ', ' Life ', ' Food Supplements ', ' Best Practice Analysis ', ' Benchmarking ', ' spelling ', ' interest ', ' experience ', ' self help ', ' novel ', ' Harm Minimization ', ' Harm Reduction ', ' Self-Report ', ' Patient Self-Report ', ' Categories ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Epidemiological Studies ', ' Epidemiology Research ', ' epidemiologic investigation ', ' epidemiology study ', ' Reporting ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' craving ', ' Effectiveness ', ' Data ', ' Epidemiologist ', ' trend ', ' Process ', ' Therapeutic Effect ', ' cost ', ' alternative treatment ', ' patient population ', ' on-line community ', ' virtual community ', ' online community ', ' social media ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' experiment ', ' experimental research ', ' experimental study ', ' Opiate user ', ' Opioid drug user ', ' PWUO ', ' patients who use opioids ', ' people who use opioids ', ' persons who use opioids ', ' opioid user ', ' non-medical opioid use ', ' nonmedical opioid use ', ' opiate misuse ', ' opioid misuse ', ' Twitter ', ' off-label medication ', ' off-label drug ', ' off-label application ', ' off-label prescribing ', ' off-label use ', ' ']",NIDA,RESEARCH TRIANGLE INSTITUTE,R21,2020,268226,NC-04,0.05194197963426062
"Reducing racial disparities in the treatment of opioid use disorder using machine learning-based causal analysis PROJECT SUMMARY  The opioid overdose crisis emerged in predominantly White communities, but the opioid-related mortality rate is increasing most rapidly in the Black population. A key driver of the crisis is opioid use disorder, which affects over 2 million Americans. Despite their effectiveness, medications for opioid use disorder remain underused, especially among Black Americans. Compared to White Americans, Black Americans have lower access to medications for opioid use disorder, are one-third as likely to initiate treatment, and have lower retention in care. Black Americans face unique structural obstacles to care, such as mistrust of the health care system, lack of representation among medical providers, and racially-biased providers perceptions. There is a critical gap in our understanding of the structural factors associated with treatment initiation and retention in care for Black patients with OUD. The scientific objective of this research plan is to identify modifiable structural factors at the community, provider, and facility levels that affect treatment initiation and retention in care for opioid use disorder in the Black population. This innovative project proposes to leverage machine learning-based causal inference methods with a combination of large national electronic medical records, corporate data warehouses, and publicly available data. By combining multiple data sources, this project will empirically evaluate modifiable factors such as provider characteristics (e.g., years of experience, patient satisfaction scores), facility characteristics (e.g., mental health staffing to patient ratios, number of buprenorphine-eligible prescribers), and patient-provider characteristics (e.g., number of previous visits or interactions). While focused on promoting equitable access to treatment for opioid use disorder in Black Americans, the public health implications of this proposal are expected to apply broadly to ameliorate the overall health burden of substance use disorders and reduce health disparities. This research plan is complemented by a career development plan that builds on the applicants background in epidemiology and biostatistics. Specifically, this career development plan outlines new training in three areas: (1) the clinical treatment of opioid use disorder, (2) analysis of the massive data of electronic medical records, and (3) machine learning-based causal inference methods. The combined research and training plan will prepare the applicant for a successful independent research career identifying, evaluating, and implementing multilevel interventions to reduce racial/ethnic inequalities in treatment for substance use disorders. PROJECT NARRATIVE  Opioid use disorder is a key driver of the U.S. opioid overdose crisis, yet treatment remains both underused and unequal. The proposed research is relevant to public health because it focuses on identifying modifiable structural predictors of treatment initiation and retention in care for opioid use disorder. The results of this project are expected to inform multilevel interventions equitably deliver treatment for opioid use disorder, ameliorate the overall health burden of substance use disorders, and reduce health disparities.",Reducing racial disparities in the treatment of opioid use disorder using machine learning-based causal analysis,10039535,K99DA051534,"['Affect ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Buprenorphine ', ' Communities ', ' Community Surveys ', ' Complement ', ' Complement Proteins ', ' Critical Care ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Ethnic group ', ' ethnicity group ', ' Face ', ' faces ', ' facial ', ' Foundations ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Health Resources ', ' Health Services Accessibility ', ' Access to Care ', ' access to health services ', ' access to services ', ' access to treatment ', ' accessibility to health services ', ' availability of services ', ' care access ', ' health service access ', ' health services availability ', ' service availability ', ' treatment access ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Mentorship ', ' Methods ', ' mortality ', ' Client satisfaction ', ' Patient Satisfaction ', ' Patients ', ' Perception ', ' Public Health ', ' Race ', ' Racial Group ', ' Racial Stocks ', ' Research ', ' Substance Use Disorder ', ' Veterans ', ' Work ', ' Computerized Medical Record ', ' Electronic Medical Record ', ' Measures ', ' Treatment outcome ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' forest ', ' Specialist ', ' Caring ', ' base ', ' career ', ' health administration ', ' improved ', ' Area ', ' Phase ', ' Medical ', ' Training ', ' white American ', ' caucasian American ', ' Individual ', ' Data Bases ', ' data base ', ' Databases ', ' Opiates ', ' Opioid ', ' Development Plans ', ' Inequality ', ' Ethnicity ', ' Ethnic Origin ', ' Therapeutic ', ' machine learned ', ' Machine Learning ', ' Visit ', ' American ', ' experience ', ' success ', ' Structure ', ' skills ', ' social ', ' Modeling ', ' career development ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Provider ', ' disparity in health ', ' health disparity ', ' Effectiveness ', ' Address ', ' Data ', ' Research Training ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Characteristics ', ' electronic data ', ' designing ', ' design ', ' Minority ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Population ', ' Natural experiment ', ' innovate ', ' innovative ', ' innovation ', ' multidisciplinary ', ' racial and ethnic ', ' standard of care ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' BigData ', ' Big Data ', ' disparities in race ', ' race disparity ', ' racial disparity ', ' opiate use disorder ', ' opioid use disorder ', ' improved outcome ', ' race bias ', ' racial bias ', ' disparities in treatment ', ' treatment disparity ', ' Obamacare ', ' Affordable Care Act ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' barrier to health care ', ' barrier to healthcare ', ' barrier to treatment ', ' obstacle to care ', ' obstacle to healthcare ', ' barrier to care ', ' Data Banks ', ' Databanks ', ' data depository ', ' data repository ', ' data warehouse ', ' multiple data sources ', ' machine learning method ', ' ']",NIDA,STANFORD UNIVERSITY,K99,2020,179582,CA-18,0.1206430073625182
"The Ohio Valley Node of the Clinical Trials Network Project Summary (Abstract): Since its establishment in 2000, the Ohio Valley Node (OVN) has been one of the most productive of NIDA's Clinical Trials Network (CTN) nodes, both in leading and participating in multi-site trials. The OVN includes successful partnerships with four healthcare systems, two pharmacy networks, and six addiction specialty/ infectious disease programs. These collaborating sites span a seven-state region including some of the states most heavily impacted by opioid (Ohio, Kentucky, and West Virginia) and methamphetamine (Missouri, Kentucky, and North Dakota) use. The OVN includes Midwestern, Appalachian, Upper South, and Native American representation, which significantly enhances the geographical and cultural diversity of the CTN. The OVN Research Core is the driving force of the OVN and is led by Dr. Winhusen, one of the foremost experts in conducting multi-site addiction clinical trials in clinical practice settings. The OVN investigators have extensive expertise in substance use disorders (Winhusen, Brown, Burlew, Lyons, Montgomery, Lofwall, Walsh) and bioinformatics (Kaelber, Xu). The six members of the OVN research-implementation team bring > 60 years of combined experience conducting CTN clinical trials. If funded, our overall goal would be to utilize the wealth of experience and expertise gained over the past 19 years to conduct the research needed to address public health care crises, including the opioid use epidemic and the alarming increase in stimulant use. To this end, we would work with our healthcare partners to engage a diverse set of patients and service systems in areas highly impacted by substance use in CTN research. We would also contribute our expertise in conducting efficacy, effectiveness, and implementation trials testing the full range of interventions, from medications to behavioral interventions and health service innovations, for both opioid and stimulant use disorders. Moreover, we would contribute our expertise in the use of electronic health records for prospective and retrospective research studies, including the application of artificial intelligence to large healthcare datasets. In sum, we seek to continue providing scientific leadership, particularly on studies that could meaningfully impact clinical practice, and to effectively collaborate with a variety of professionals including treatment providers, investigators from diverse institutions, and staff of the Center for CTN (CCTN), clinical coordinating center (CCC) and data and statistics center (DSC) in support of the CTN mission. Project Narrative: Since its establishment in 2000, the Ohio Valley Node (OVN) has been one of the most productive of NIDA's Clinical Trials Network (CTN) nodes, both in leading and participating in multi-site trials. The OVN includes successful partnerships with four healthcare systems, two pharmacy networks, and six addiction specialty/ infectious disease programs spanning a seven-state region including some of the states most heavily impacted by opioid (Ohio, Kentucky, and West Virginia) and methamphetamine (Missouri, Kentucky, and North Dakota) use. Our overall goal is to utilize the wealth of experience and expertise gained over the past 19 years to conduct the research needed to address public health care crises, including the opioid use epidemic and the alarming increase in stimulant use.",The Ohio Valley Node of the Clinical Trials Network,10164515,UG1DA013732,"['Appalachian Region ', ' Appalachia ', ' Appalachian ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Behavior Therapy ', ' Behavior Conditioning Therapy ', ' Behavior Modification ', ' Behavior Treatment ', ' Behavioral Conditioning Therapy ', ' Behavioral Modification ', ' Behavioral Therapy ', ' Behavioral Treatment ', ' Conditioning Therapy ', ' behavior intervention ', ' behavioral intervention ', ' Buprenorphine ', ' Clinical Trials ', ' Communicable Diseases ', ' Infectious Disease Pathway ', ' Infectious Diseases ', ' Infectious Disorder ', ' Communities ', ' Disease ', ' Disorder ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Investigational Drugs ', ' Investigational New Drugs ', ' Epidemic ', ' Geography ', ' Goals ', ' Healthcare Systems ', ' Health Care Systems ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Health Services ', ' Recording of previous events ', ' History ', ' Hospitals ', ' Kentucky ', ' Leadership ', ' Methamphetamine ', ' Crystal Meth ', ' Deoxyephedrine ', ' Desoxyephedrine ', ' Methylamphetamine ', ' N-Methylamphetamine ', ' Mission ', ' Missouri ', ' North Dakota ', ' Ohio ', ' Patients ', ' Pharmacy facility ', ' Pharmacies ', ' Pharmacists ', ' Pregnant Women ', ' expectant mother ', ' expecting mother ', ' pregnant mothers ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Productivity ', ' Public Health ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Serine ', ' L-Serine ', ' medical specialties ', ' Specialty ', ' statistics ', ' Substance Use Disorder ', ' Technology ', ' Testing ', ' West Virginia ', ' Work ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' health care ', ' Healthcare ', ' Dataset ', ' Data Set ', ' base ', ' Peripartum ', ' Perinatal ', ' Site ', ' Area ', ' Clinical ', ' Ensure ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Data Bases ', ' data base ', ' Databases ', ' Opiates ', ' Opioid ', ' Funding ', ' Native Americans ', ' Multiculturalism ', ' Cultural Diversity ', ' programs ', ' South American ', ' Clinic ', ' System ', ' meetings ', ' Services ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' experience ', ' health care organization ', ' healthcare organization ', ' healthcare service organization ', ' health care service organization ', ' Performance ', ' Participant ', ' treatment program ', ' member ', ' research study ', ' validation studies ', ' behavioral health ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Bio-Informatics ', ' Bioinformatics ', ' Institution ', ' Address ', ' Data ', ' Multi-center clinical trial ', ' Multi-site clinical trial ', ' Multicenter clinical trial ', ' Multisite clinical trial ', ' Multi-Institutional Clinical Trial ', ' NIDA ', ' National Institute on Drug Abuse ', ' National Institute of Drug Abuse ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Sum ', ' trial regimen ', ' trial treatment ', ' Clinical Treatment ', ' Conduct Clinical Trials ', ' enroll ', ' Enrollment ', ' trend ', ' point of care ', ' electronic health care record ', ' electronic healthcare record ', ' Electronic Health Record ', ' implementation research ', ' Clinical Trials Network ', ' designing ', ' design ', ' prospective ', ' innovate ', ' innovative ', ' innovation ', ' driving force ', ' addictive disorder ', ' addiction ', ' FDA approved ', ' multisite trial ', ' multi-site trial ', ' clinical practice ', ' cocaine use ', ' retention strategy ', ' student retention ', ' retention rate ', ' support tools ', ' opiate use disorder ', ' opioid use disorder ', ' Formulation ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' racially diverse ', ' racial diversity ', ' substance misuse ', ' recruit ', ' practice setting ', ' Prescription Drug Monitoring Program ', ' prescription monitoring program ', ' stimulant use ', ' stimulant use disorder ', ' Infrastructure ', ' adverse event risk ', ' effectiveness implementation trial ', ' clinical trial participant ', ' clinical center ', ' ']",NIDA,UNIVERSITY OF CINCINNATI,UG1,2020,2424851,OH-01,0.09259162013583427
"Improving the Identification and Management of Suicide Risk among Patients Using Prescription Opioids ABSTRACT The opioid epidemic in the US, coupled with emerging data on the association between opioid use and suicidal behavior, highlights the urgent need for research that identifies patients at greatest risk and provides strategies to mitigate this risk. However, the development of risk algorithms that provide clinical guidance for providers with patients using opioids who may have underlying mental disorders or comorbid diagnoses has been nonexistent. Recent work has demonstrated the compelling need for a better understanding of, and clinical decision support tools to address, suicide risk among prescription opioid drug users. The proposed study provides an opportunity to address gaps in both the identification and clinical management of suicide risk in patients using prescription opioids. We propose to use transfer learning approaches to identify the clinical and demographic characteristics associated with elevated risk of suicidal behavior among prescription opioid users; to develop clinical phenotypes of patients with higher risk of suicidal behavior associated with prescription opioids, and to incorporate these phenotypes in a clinical decision support platform that can be used for identification and intervention at the point of care; and to conduct a pilot study implementing and evaluating the impact of the clinical decision support platform in the existing clinical workflow in 3 diverse clinical settings. Our approach is specifically designed to address the incomplete picture of patient risk in existing models due to the fragmentation of clinical care across settings. We do this by developing algorithms that can statistically borrow information from more comprehensive patient datasets and apply it to more limited datasets in a particular healthcare setting. The proposed work will draw on comprehensive clinical data from a mature health information exchange containing more than 2.3 million patients across the spectrum of clinical care to develop a statistically robust method to measure suicide risk associated with prescription opioid use. The clinical decision support tool developed under this proposal will provide a generalizable platform that could be extended to other opioid related risks, e.g., OUD and overdose. The potential public health significance of this study is substantial. The fragmentation of the healthcare system, particularly in relation to patients' behavioral health needs, highlights the critical need to cultivate comprehensive, system-wide approaches to identifying and managing at patients using prescription opioids who are at risk of suicide. Narrative Suicide and prescription opioid use are two of the most serious public health problems facing the United States. The proposed project will demonstrate an innovative method for identifying patients using prescription opioids who are at risk of suicidal behavior.",Improving the Identification and Management of Suicide Risk among Patients Using Prescription Opioids,10155895,R01MH112148,"['Algorithms ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Bipolar Disorder ', ' Bipolar Affective Psychosis ', ' Manic-Depressive Psychosis ', ' bipolar affective disorder ', ' bipolar disease ', ' bipolar illness ', ' manic depressive disorder ', ' manic depressive illness ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Mental Depression ', ' depression ', ' Diagnosis ', ' Health ', ' Healthcare Systems ', ' Health Care Systems ', ' Hospitals ', ' Methods ', ' Morphine ', ' Infumorph ', ' Kadian ', ' MS Contin ', ' MSir ', ' Morphia ', ' Oramorph ', ' Oramorph SR ', ' Roxanol ', ' Statex SR ', ' Overdose ', ' Patients ', ' Phenotype ', ' Physicians ', ' Pilot Projects ', ' pilot study ', ' Primary Health Care ', ' Primary Care ', ' Primary Healthcare ', ' Public Health ', ' Research ', ' Risk ', ' Risk Factors ', ' medical specialties ', ' Specialty ', ' Suicide ', ' fatal attempt ', ' fatal suicide ', ' intent to die ', ' suicidality ', ' Time ', ' Psychological Transfer ', ' learning transfer ', ' training transfer ', ' United States ', ' Work ', ' Measures ', ' Community Health Centers ', ' Satellite Centers ', ' Neighborhood Health Center ', ' chronic pain ', ' Dataset ', ' Data Set ', ' Caring ', ' base ', ' dosage ', ' improved ', ' Clinical ', ' Opiates ', ' Opioid ', ' machine learned ', ' Machine Learning ', ' suicidal ', ' milligram ', ' Complex ', ' Techniques ', ' System ', ' suicide risk ', ' suicidal risk ', ' Modeling ', ' behavioral health ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Provider ', ' Address ', ' Health system ', ' Data ', ' Clinical Data ', ' Clinical Management ', ' Characteristics ', ' developmental ', ' Development ', ' point of care ', ' Federally Qualified Health Center ', ' suicide behavior ', ' suicidal behavior ', ' clinical phenotype ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' Outcome ', ' Coupled ', ' innovate ', ' innovative ', ' innovation ', ' high risk ', ' clinical care ', ' clinical practice ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' urgent care ', ' Patient risk ', ' support tools ', ' opiate use disorder ', ' opioid use disorder ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' patient subgroups ', ' patient subpopulations ', ' patient subtypes ', ' patient subsets ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' healthcare settings ', ' health care settings ', ' clinical decision support ', ' Opiate user ', ' Opioid drug user ', ' PWUO ', ' patients who use opioids ', ' people who use opioids ', ' persons who use opioids ', ' opioid user ', ' data fusion ', ' ']",NIMH,UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,R01,2020,853369,CT-05,0.02995408438543516
"Predicting Post-treatment Relapse in Pediatric Acute Myeloid Leukemia Using Single-cell Proteomics Project Summary  Pediatric Acute Myeloid Leukemia (AML) is the most lethal hematologic malignancy in childhood, with a probability of 5-year survival at only 60%. Most children diagnosed with AML initially respond well to standard chemotherapy; however, nearly 40% eventually develop relapsed disease, which responds poorly to treatment and is fatal in the majority of patients. Although age at diagnosis, response to induction chemotherapy, and cytogenetic status have been identified as coarse prognostic factors in pediatric AML, it is still unclear what molecular features lead certain patients to relapse over others. Thus, developing an enhanced understanding of the mechanistic drivers underlying relapse in pediatric AML represents a significant area of clinical need.  Many reports indicate that there are rare, hematopoietic stem cell-like subpopulations in AML patients that resist chemotherapy and drive relapse. However, the exact characteristics of these relapse-associated cellsoften called leukemic stem cells (LSCs)are a matter of contention, with reported phenotypes spanning much of the known hematopoietic developmental continuum and differing significantly between patients and throughout the course of disease. As such, the identity and importance of these relapse-associated cells as well as their relationship to normal hematopoietic developmental processes remain mysterious.  The proposed project will examine the relationship between single-cell AML phenotypes, clinical outcomes, and normal myeloid development in 60 clinically-annotated primary samples from pediatric AML patients in order to identify relapse-associated cellular subtypes. To achieve this, we will leverage the versatility of mass cytometry, a 40-parameter single-cell proteomics platform, and machine learning in simultaneously studying the complex surface and signaling phenotypes of millions of leukemic cells from patients diagnostic and relapse bone marrow samples relative to healthy controls. Central hypothesis: We hypothesize that high-dimensional molecular profiling of primary AML cells will reveal consistent, functional phenotypes associated with relapse-driving subpopulations that computationally align with particular stages of healthy hematopoietic development and represent points of future therapeutic intervention. Aim 1: Develop methods to computationally align high-dimensional, single-cell AML phenotypes with their  most analogous developmental state along the healthy myeloid continuum. Aim 2: Utilize predictive modeling to determine the surface, signaling, and functional phenotype of AML  subpopulations predicting relapse and functionally validate these characteristics in vitro and in vivo. Project Narrative: For reasons that remain poorly understood, nearly 40% of the roughly 500 children diagnosed with acute myeloid leukemia (AML) each year in the United States will experience relapse after initially responding to treatment. To better characterize why some AML patients relapse while others do not, the proposed project will use state-of-the-art molecular profiling approaches to characterize millions of primary AML cells and their computational alignment with healthy hematopoietic development. These data will be used to construct a method of predicting at diagnosis which patients have a high risk of relapse in order to identify prognostically important cell populations that represent future therapeutic targets in the management of pediatric AML.",Predicting Post-treatment Relapse in Pediatric Acute Myeloid Leukemia Using Single-cell Proteomics,9994724,F31CA239365,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Aftercare ', ' After Care ', ' After-Treatment ', ' post treatment ', ' Age ', ' ages ', ' Algorithms ', ' Automobile Driving ', ' driving ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biology ', ' Bone Marrow ', ' Bone Marrow Reticuloendothelial System ', ' Cells ', ' Cell Body ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Cox Models ', ' Cytogenetics ', ' Cessation of life ', ' Death ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Future ', ' Hematopoietic stem cells ', ' Blood Precursor Cell ', ' Hematopoietic Progenitor Cells ', ' blood stem cell ', ' hematopoietic progenitor ', ' hematopoietic stem progenitor cell ', ' hemopoietic progenitor ', ' hemopoietic stem cell ', ' In Vitro ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' leukemia ', ' B-Cell Acute Lymphoblastic Leukemia ', ' Acute B-Lymphocytic Leukemia ', ' B cell progenitor acute lymphoblastic leukemia ', ' B-ALL ', ' B-Cell  Acute Lymphocytic Leukemia ', ' B-Cell Lymphoblastic Leukemia ', ' B-cell precursor acute lymphoblastic leukemia ', ' Pre-B-Cell Leukemia ', ' Precursor B Lymphoblastic Leukemia ', ' Acute Myelocytic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Acute Myeloblastic Leukemia ', ' Acute Myelogenous Leukemia ', ' acute granulocytic leukemia ', ' acute myeloid leukemia ', ' Myeloid Leukemia ', ' Granulocytic Leukemia ', ' Myelocytic Leukemia ', ' Myelogenous Leukemia ', ' Non-Lymphoblastic Leukemia ', ' Non-Lymphocytic Leukemia ', ' Nonlymphoblastic Leukemia ', ' Nonlymphocytic Leukemia ', ' myeloid granulocytic leukemia ', ' myelosis ', ' Light ', ' Photoradiation ', ' Maps ', ' Methods ', ' mortality ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Patients ', ' Phenotype ', ' Probability ', ' outcome forecast ', ' Prognosis ', ' Relapse ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Testing ', ' Time ', ' Treatment Protocols ', ' Treatment Regimen ', ' Treatment Schedule ', ' United States ', ' Work ', ' Fluorescence-Activated Cell Sorting ', ' Fluorescence Activated Cell Sorting Fractionation ', ' Fluorescence-Activated Cell Sortings ', ' Mediating ', ' base ', ' Area ', ' Surface ', ' Clinical ', ' Childhood AML ', ' Childhood Acute Granulocytic Leukemia ', ' Childhood Acute Myeloblastic Leukemia ', ' Childhood Acute Myelocytic Leukemia ', ' Childhood Acute Myelogeneous Leukemia ', ' Childhood Acute Myelogenous Leukemia ', ' Pediatric AML ', ' Pediatric Acute Myeloblastic Leukemia ', ' Pediatric Acute Myelocytic Leukemia ', ' Pediatric Acute Myelogeneous Leukemia ', ' Pediatric Acute Myelogenous Leukemia ', ' Pediatric Acute Myeloid Leukemia ', ' Childhood Acute Myeloid Leukemia ', ' prognostic ', ' hemopoietic ', ' Hematopoietic ', ' pediatric ', ' Childhood ', ' Individual ', ' Relapsed Disease ', ' Recurrent disease ', ' Malignant Cell ', ' cancer cell ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' Hematologic Cancer ', ' Hematologic Malignancies ', ' Hematological Malignancies ', ' Hematological Neoplasms ', ' Hematological Tumor ', ' Hematopoietic Cancer ', ' Malignant Hematologic Neoplasm ', ' Hematologic Neoplasms ', ' programs ', ' Myeloid ', ' Myelogenous ', ' Complex ', ' Event ', ' cell type ', ' Remission ', ' Disease remission ', ' experience ', ' Graph ', ' Reporting ', ' intervention therapy ', ' Therapeutic Intervention ', ' Cytometry ', ' Modeling ', ' Sampling ', ' Property ', ' response ', ' Proteomics ', ' Cell Cycle Control ', ' Cell Cycle Regulation ', ' STAT3 ', ' STAT3 gene ', ' leukemic stem cell ', ' Address ', ' Data ', ' Developmental Process ', ' Molecular Fingerprinting ', ' molecular profile ', ' molecular signature ', ' Molecular Profiling ', ' General Prognostic Factor ', ' Prognostic/Survival Factor ', ' Prognostic Factor ', ' in vivo ', ' Leukemic Cell ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Xenograft Model ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' meta data ', ' Metadata ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' designing ', ' design ', ' intervention efficacy ', ' therapeutic efficacy ', ' therapeutically effective ', ' therapy efficacy ', ' Treatment Efficacy ', ' Outcome ', ' Population ', ' resistant ', ' Resistance ', ' Cancerous ', ' chemotherapy ', ' self-renew ', ' self-renewal ', ' progenitor ', ' therapeutic target ', ' high risk ', ' child patients ', ' pediatric patients ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' individual patient ', ' relapse patients ', ' molecular targeted therapeutics ', ' molecular targeted treatment ', ' molecular targeted therapies ', ' expression subtypes ', ' molecular sub-types ', ' molecular subsets ', ' molecular subtypes ', ' predict relapse ', ' relapse prediction ', ' relapse risk ', ' high dimensionality ', ' stem-like cell ', ' acute granulocytic leukemia cell ', ' acute myeloblastic leukemia cell ', ' acute myelocytic leukemia cell ', ' acute myelogenous leukemia cell ', ' acute nonlymphocytic leukemia cell ', ' acute myeloid leukemia cell ', ' feature selection ', ' ']",NCI,STANFORD UNIVERSITY,F31,2020,39490,CA-18,0.038309014444542
"Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 - Clinical Trial Optional) R&R Other Project Information 7. Project Summary/Abstract Neurobiological changes caused by addiction impair behavioral control and increase relapse risk (Volkow, Koob, & McLellan, 2016), substantiating the need for long-term care coordination and recovery engagement for individuals with Substance Use Disorders (SUD) (Humphreys, Malenka, Knutson, & MacCoun, 2017). Because addiction creates stress and reward system dysregulation impairing emotional regulation and executive functioning capacities when experiencing intense craving (Volkow, Koob & McLellan, 2016), traditional didactic relapse prevention strategies may have limited efficacy for those in early recovery when they transition back to their natural communities post-discharge from treatment, where they will be exposed to SUD-related stimuli. New recovery support models that detect implicit cue-induced neurophysiological dysregulation and restore real-time regulatory capacity to decrease relapse risk are of clinical significance. This feasibility Phase I study will use Virtual Reality (VR) technology to 1) simulate a patient-specific drug cue-triggering experience (VR_drug) to calibrate a personalized neurophysiological relapse risk set-point, captured in-session using fNIRS (Functional Near-Infrared Spectroscopy) sensors, a portable alternative to fMRI which will be integrated into the VR HMD (Head Mounted Display), and physiological sensors (smartwatch Empatica E4) worn during the VR_drug scenario (Aim 1); and 2) simulate a recovery-regulation experience (VR_recovery) using patient-specific virtually-generated sober-supportive relationships, recovery-enhanced environmental conditions, and recovery-associated sensory cues, to calibrate a recovery-regulated neurophysiological set-point, captured by the same in-session neurophysiological sensors systems (Aim 2). If successful, in Phase II, a mobile recovery support system product will be developed to help individuals in SUD recovery modulate real-time craving by monitoring their personalized neurophysiological relapse risk and activating their recovery-regulation intervention (VR_recovery) to alter urge reactivity in real-time. This type of mobile intervention that is immediately available to individuals in recovery as they leave treatment institutions and transition back into their natural communities may help manage in-the-moment drug urges in ways that allow engagement in other recovery-related activities (e.g., calling a sponsor, getting to a meeting), decreasing real-time relapse risk (Matto,& Seshaiyer, 2018; Matto, 2015; Matto, et al, 2014). R&R Other Project Information 8. Project Narrative Addiction is a self-regulation disorder where chronic exposure to and compulsive consumption of the drug creates dysregulation in the reward, stress and executive functioning regions of the brain, intensifying emotional reactivity and impairing cognitive and behavioral control (Volkow, Koob, & McLellan, 2016). This study seeks to examine the utility of using Virtual Reality (VR) simulations to calibrate person-specific neurophysiological relapse-risk and recovery regulation set-points. Results may lead to the development of a non-pharmacological mobile recovery support system to help individuals in SUD recovery manage implicit craving reactivity in ways that reduce relapse risk.",Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 - Clinical Trial Optional),9898050,R41DA050225,"['Adult ', ' 21+ years old ', ' Adult Human ', ' adulthood ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Back ', ' Dorsum ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Clinical Trials ', ' Cocaine ', ' Communities ', ' Cues ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Euphoria ', ' Feedback ', ' Goals ', ' Intelligence ', ' Interview ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Long-Term Care ', ' extended care ', ' longterm care ', ' Motivation ', ' Persons ', ' Neurobiology ', ' neurobiological ', ' neurophysiology ', ' neurophysiological ', ' Patients ', ' Pilot Projects ', ' pilot study ', ' Play ', ' Research ', ' Rewards ', ' Risk ', ' Role ', ' social role ', ' Informal Social Control ', ' Self Regulation ', ' Stress ', ' Substance Use Disorder ', ' Technology ', ' Testing ', ' Time ', ' Imagery ', ' base ', ' sensor ', ' Area ', ' Chronic ', ' Phase ', ' Physiologic ', ' Physiological ', ' Stimulus ', ' Consciousness ', ' Conscious ', ' Individual ', ' Recovery ', ' Data Bases ', ' data base ', ' Databases ', ' Exposure to ', ' tool ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' Behavioral Manipulation ', ' behavioral control ', ' Behavior Control ', ' Functional MRI ', ' fMRI ', ' Functional Magnetic Resonance Imaging ', ' NIR Spectroscopy ', ' Near-Infrared Spectrometry ', ' Near-Infrared Spectroscopy ', ' Protocol ', ' Protocols documentation ', ' Sensory ', ' System ', ' meetings ', ' implicit memory ', ' experience ', ' Structure ', ' simulation ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' sober ', ' sobriety ', ' Social Support System ', ' Support System ', ' cue reactivity ', ' disease recurrence prevention ', ' disorder recurrence prevention ', ' recurrence prevention ', ' relapse prevention ', ' disorder later incidence prevention ', ' Emotional ', ' Regulation ', ' Modeling ', ' craving ', ' response ', ' virtual reality ', ' portability ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' executive control ', ' executive function ', ' DSM-5 ', ' DSM5 ', ' Diagnostic and Statistical Manual of Mental Disorders, 5th edition ', ' Diagnostic and Statistical Manual of Mental Disorders-V ', ' DSM-V ', ' Institution ', ' Brain region ', ' Address ', ' Chemical Dependence ', ' Drug Dependence ', ' Drug Dependency ', ' Drug Addiction ', ' Feeds ', ' Data ', ' Cognitive ', ' Monitor ', ' developmental ', ' Development ', ' Behavioral ', ' imaging ', ' Image ', ' Evidence based treatment ', ' virtual ', ' conditioning ', ' Consumption ', ' Impairment ', ' clinical significance ', ' clinically significant ', ' cognitive control ', ' emotional regulation ', ' emotion regulation ', ' addictive disorder ', ' addiction ', ' prototype ', ' impaired behavior ', ' behavioral impairment ', ' Phase I Study ', ' phase 1 study ', ' patient profile ', ' profiles in patients ', ' relapse risk ', ' smartwatch ', ' smart watch ', ' coordinating care ', ' care coordination ', ' virtual simulation ', ' virtual reality simulation ', ' head mounted device ', ' head mounted display ', ' ']",NIDA,"BRIGHTLINE INTERACTIVE, LLC",R41,2020,218097,VA-08,0.03700725770989218
"Leveraging Social Media Data and Machine Learning to Optimize Treatment Paradigms for Youth with Schizophrenia Abstract Schizophrenia constitutes a chronic and disabling illness. While patients show high rates of response to treatment after a rst-episode of schizophrenia, the long-term course of the illness is typically characterized by frequent re- lapses, persistence of symptoms, and enduring cognitive and functional decits. Despite the prioritization of relapse prevention as a treatment goal, about four out of ve patients experience a relapse within the rst ve years of treatment. Relapses are known to have serious psychosocial, educational, or vocational implications in young adultsa population at high risk of psychosis. However, current psychiatric ability to recognize indicators of relapse in order to prevent escalation of psychotic symptoms is markedly limited. Challenges stem from a lack of availability of comprehensive information about early warning signs, and reliance on xed time point sampling of cross-sectional data as well as patient or family reported observations, that is subject to recall bias, or on clin- ician sought information, that needs frequent and timely contact. The present proposal seeks to address these gaps in early psychosis treatment, by leveraging patient-generated and patient-volunteered social media data, and developing and validating machine learning approaches for digital phenotyping and relapse prediction. Our proposed work is founded on the observation that social media sites have emerged as prominent platforms of emotional and linguistic expressionyoung adults are among the heaviest users of social media. The work signif- icantly advances the research agenda and extensive pilot investigations of the team, who a) have demonstrated that social media data of individuals can serve as a powerful lens toward understanding and inferring mental health state, illness course, and likelihood of relapse, including among young adults with early psychosis; and b) have been involved in examining the role of emergent technologies, like social media, in improving access to and delivery of psychiatric care. Aim 1 will provide theoretically-grounded and clinically meaningful methods for extracting and modeling digital phenotypes and symptoms from social media data of young adult early psychosis patients. Then in Aim 2, we will develop and evaluate machine learning methods that will utilize the extracted social media digital phenotypes to infer patient-specic personalized risk of relapse, and identify its antecedents. Finally, Aim 3 will develop a two-faceted validation framework, to assess the statistical and clinical efcacy and utility of the social media derived inferences of psychosis and relapse in inuencing clinical outcomes and in facilitating evidence-based treatment. To accomplish these aims, the project brings together a strong multidisci- plinary team, combining expertise in social media analytics, psychiatry, psychology, natural language analysis, machine learning, information privacy, and research ethics. Our novel approach offers unprecedented opportuni- ties to initiate the adoption of personalized, responsive, and preemptive evidence-based strategies in treatment of psychosis. The knowledge will set the stage for future research on launching large-scale trials aimed to develop interventions that diminish the severity of relapses, or prevent their occurrence altogether. Project Narrative Timely monitoring of symptoms and preventing relapse after an initial psychotic episode are essential component of early intervention programs and have a critical impact on long term outcome in individuals with psychotic dis- orders. Employing patient-contributed social media data as a viable source of collateral information, this proposal provides a suite of robust, scalable, and eld evaluated machine learning methods to facilitate early and precise identication of digital phenotypes, symptomatic exacerbation, and risk of psychotic relapse in early psychosis patients. The knowledge would provide the necessary opportunity to initiate personalized, adaptive, and proac- tive illness management strategies, inform better nosology, and assist the adoption of improved evidence-based care approaches to diminish the severity of relapses, or prevent their occurrence altogether.",Leveraging Social Media Data and Machine Learning to Optimize Treatment Paradigms for Youth with Schizophrenia,9914128,R01MH117172,"['Adoption ', ' Affect ', ' Aftercare ', ' After Care ', ' After-Treatment ', ' post treatment ', ' Behavior ', ' Mental disorders ', ' Mental health disorders ', ' Psychiatric Disease ', ' Psychiatric Disorder ', ' mental illness ', ' psychiatric illness ', ' psychological disorder ', ' Biometry ', ' Biometrics ', ' Biostatistics ', ' Circadian Rhythms ', ' Nyctohemeral Rhythm ', ' Twenty-Four Hour Rhythm ', ' circadian process ', ' daily biorhythm ', ' Clinical Research ', ' Clinical Study ', ' Clinical Trials ', ' Cognition ', ' Computers ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Data Collection ', ' Mental Depression ', ' depression ', ' Family ', ' Feedback ', ' Foundations ', ' Goals ', ' Health ', ' Hospitalization ', ' Hospital Admission ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' Linguistics ', ' Linguistic ', ' Mental Health ', ' Mental Hygiene ', ' Psychological Health ', ' Methods ', ' Theoretical model ', ' Theoretic Models ', ' Moods ', ' National Institute of Mental Health ', ' NIMH ', ' Patients ', ' Phenotype ', ' Psychiatry ', ' Psychology ', ' Clinical Psychology ', ' Social Psychology ', ' Psychotic Disorders ', ' Psychoses ', ' psychotic illness ', ' Relapse ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Schizophrenia ', ' Schizophrenic Disorders ', ' dementia praecox ', ' schizophrenic ', ' Stigmatization ', ' Suicide ', ' fatal attempt ', ' fatal suicide ', ' intent to die ', ' suicidality ', ' Testing ', ' Texas ', ' Time ', ' Universities ', ' Violence ', ' violent ', ' violent behavior ', ' Work ', ' Privacy ', ' Research Methods ', ' Research Methodology ', ' Youth 10-21 ', ' Youth ', ' Caring ', ' base ', ' improved ', ' psychiatric care ', ' psychiatric therapy ', ' psychiatric treatment ', ' Psychiatric therapeutic procedure ', ' Site ', ' Surface ', ' Chronic ', ' Clinical ', ' Phase ', ' Evaluation ', ' medical complication ', ' disability ', ' Disorientation ', ' Individual ', ' adult youth ', ' young adulthood ', ' young adult ', ' Early Intervention ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Scientist ', ' Adopted ', ' Investigation ', ' Severities ', ' Source ', ' Techniques ', ' psychosocial ', ' innovative technologies ', ' early detection ', ' Early Diagnosis ', ' experience ', ' cohort ', ' intervention program ', ' novel ', ' peer ', ' disorder classification ', ' nosology ', ' disease classification ', ' Reporting ', ' social ', ' disease recurrence prevention ', ' disorder recurrence prevention ', ' recurrence prevention ', ' relapse prevention ', ' disorder later incidence prevention ', ' Research Ethics ', ' Emotional ', ' Deterioration ', ' Sampling ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' preventing ', ' prevent ', ' Address ', ' Symptoms ', ' Data ', ' Ph.D. ', ' PhD ', ' Doctor of Philosophy ', ' Improve Access ', ' Strategic Planning ', ' Clinical Data ', ' Cognitive ', ' Computational Technique ', ' Emergent Technologies ', ' Emerging Technologies ', ' Patient outcome ', ' Patient-Centered Outcomes ', ' Patient-Focused Outcomes ', ' Validation ', ' Monitor ', ' developmental ', ' Development ', ' Behavioral ', ' Evidence based treatment ', ' digital ', ' Social Functioning ', ' clinical efficacy ', ' willingness ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' first episode schizophrenia ', ' Outcome ', ' Population ', ' prospective ', ' biological research ', ' multidisciplinary ', ' volunteer ', ' stem ', ' digital models ', ' lenses ', ' lens ', ' high risk ', ' evidence base ', ' response to treatment ', ' therapeutic response ', ' treatment response ', ' treatment strategy ', ' natural language ', ' psychotic symptoms ', ' Adolescent and Young Adult ', ' BigData ', ' Big Data ', ' precision interventions ', ' personalized intervention ', ' social media ', ' support tools ', ' digital media ', ' biomarker development ', ' relapse patients ', ' predict relapse ', ' relapse prediction ', ' relapse risk ', ' recruit ', ' clinical decision support ', ' clinical heterogeneity ', ' therapy optimization ', ' treatment optimization ', ' deep learning ', ' computational basis ', ' social observations ', ' machine learning method ', ' burden on families ', ' burden to families ', ' familial burden ', ' family burden ', ' ']",NIMH,GEORGIA INSTITUTE OF TECHNOLOGY,R01,2020,640014,GA-05,0.10502751397856458
"Social Processing Deficits in Remitted Adolescent Depression Major depressive disorder (MDD) is a leading cause of disability worldwide and has a peak onset during adolescence. While interventions are moderately effective for many adolescents, 40 to 70% will relapse within 5 years. Further, MDD relapse predicts academic difficulties, risky behaviors, and suicide. Thus, identifying mechanisms of MDD relapse is critical to clarify intervention targets for this significant public health problem.  During adolescence, social processes and dynamics (especially with peers) are particularly significant, although it is unclear which social processes are most critical to MDD relapse. The present study focuses on the role of social communication, a set of mechanisms involving the receiving and delivery of socially relevant information. Social communication is especially significant to adolescents, as maladaptive social communication can negatively impact the establishment and maintenance of relationships, thus increasing risk for MDD relapse.  For the proposed study, we will employ an NIMHs Research Domain Criteria (RDoC) lens and use multiple measures (behavior, event-related potentials [ERPs], eye tracking) to compare adolescents (aged 14-17 years) with remitted depression (remMDD; N=200) to healthy controls (HC; N=100) on deficits in several aspects of social communication, including: (i) processing of nonverbal social information, (ii) processing of socioemotional feedback, and (iii) digital communication. First, Aim 1 will test whether remMDD adolescents abnormally process two types of nonverbal social informationfacial expressions (as indexed by reduced accuracy and abnormal ERPs [i.e., the N170]) and hand gesturing behaviors (assessed via eye-tracking). Second, Aim 2 will test whether remMDD adolescents abnormally process socioemotional feedback (being accepted versus rejected by same-aged peers), a well-established trigger of adolescent MDD. Specifically, Aim 2 will test whether remMDD adolescents exhibit a reduced Late Positive Potential [LPP]), an ERP indexing emotional encoding, following positive social feedback from faux peers during a peer evaluation task. Third, using an innovative smartphone app, Aim 3 will collect multiple indicators of digital communication regarding the structure of adolescents digital social network (i.e., size of the network; frequency of communication) and sentiment of the communication with their digital social network (i.e., coding sentiment from their texts, social media posts); allowing us to test whether remMDD adolescents exhibit abnormal digital communication. Last, we will follow adolescents for 1-year to determine whether processing of nonverbal information, social feedback, and digital communication predict the escalation of depression symptoms and MDD relapse. Further, supervised machine learning will explore which social communication deficit(s) predict symptoms or MDD relapse, and whether these social processes predict outcomes independent of (or interaction with) other established predictors of relapse (e.g., stressful life events). In summary, the project has the promise to identify social process that contribute to recurrent depression, which, ultimately, will lead to innovative treatment approaches. Project Narrative Depression in adolescence is common and recurrent. While social processes and dynamics are particularly significant in adolescence, it is unclear which social processes are most critical to depression relapse. The present study uses an RDoC lens to examine the role of multiple aspects of social communication to determine which social communication deficit predicts the escalation of depression symptoms and relapse during a 1-year follow-up period.",Social Processing Deficits in Remitted Adolescent Depression,9908456,R01MH119771,"['Adolescence ', ' 12-20 years old ', ' adolescence (12-20) ', ' Attention ', ' Behavior ', ' Communication ', ' Mental Depression ', ' depression ', ' Exhibits ', ' Face ', ' faces ', ' facial ', ' Facial Expression ', ' face expression ', ' Feedback ', ' Gestures ', ' Hand ', ' indexing ', ' Laboratories ', ' Maintenance ', ' National Institute of Mental Health ', ' NIMH ', ' neurophysiology ', ' neurophysiological ', ' Public Health ', ' Recurrence ', ' Recurrent ', ' Relapse ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Suicide ', ' fatal attempt ', ' fatal suicide ', ' intent to die ', ' suicidality ', ' Testing ', ' Time ', ' Measures ', ' Emotional Depression ', ' depression symptom ', ' depressive ', ' depressive symptoms ', ' Process Measure ', ' Risky Behavior ', ' at risk behavior ', ' Risk Behaviors ', ' Youth 10-21 ', ' Youth ', ' Social Network ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Evaluation ', ' recurrent depression ', ' disability ', ' Individual ', ' event related potential ', ' Event-Related Potentials ', ' depressed ', ' sadness ', ' Depressed mood ', ' Life ', ' Adopted ', ' Frequencies ', ' Event ', ' emotional expression ', ' expression of emotion ', ' showing emotion ', ' eye tracking ', ' visual tracking ', ' Structure ', ' peer ', ' social ', ' Coding System ', ' Code ', ' Emotional ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' clinical depression ', ' major depression ', ' major depression disorder ', ' Major Depressive Disorder ', ' Symptoms ', ' Data ', ' Process ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' digital ', ' facial processing ', ' Face Processing ', ' adolescent depression ', ' adolescents with depression ', ' childhood depression ', ' childhood onset depression ', ' depressed adolescents ', ' depression in adolescence ', ' pediatric depression ', ' youth depression ', ' child depression ', ' aged ', ' Individual Differences ', ' social communication ', ' innovate ', ' innovative ', ' innovation ', ' stem ', ' lenses ', ' lens ', ' information processing ', ' RDoC ', ' Research Domain Criteria ', ' Social Processes ', ' social media ', ' predictive outcomes ', ' predictors of outcomes ', ' outcome prediction ', ' negative affectivity ', ' negative affect ', ' predict relapse ', ' relapse prediction ', ' relapse risk ', ' Android App ', ' Android Application ', ' Cell Phone Application ', ' Cell phone App ', ' Cellular Phone App ', ' Cellular Phone Application ', ' Smart Phone App ', ' Smart Phone Application ', ' Smartphone App ', ' iOS app ', ' iOS application ', ' iPhone App ', ' iPhone Application ', ' smartphone Application ', ' short message service ', ' texting ', ' Text Messaging ', ' supervised machine learning ', ' supervised learning ', ' ']",NIMH,NEW YORK STATE PSYCHIATRIC INSTITUTE,R01,2020,814533,NY-13,-0.004785377329462429
"AI-powered social entrepreneurship training and community-opportunities matching platform for women enrolled in drug treatment programs. The Opioid drug crisis in US increases at an alarming rate with 68% of the more than 70,200 drug overdose deaths in 2017 involved an opioid, averaging 130 Americans dying every day from opioid overdose (CDC, 2013). Remarkably, between 1999 and 2010, overdose deaths from prescription painkillers increased more than 400% among women, astonishing 1.7 times higher than that of men; and heroin use among women between 2002 and 2013 increased 100%, 2 times higher than among men (CDC, 2013). There is a call for gender-focused drug abuse interventions (OWH, 2016; NIH, 2018). Adverse social conditions, including economic insecurity, have been identified as risk factors for opioid use among women and reasons for relapse. Addressing addiction problems in conjunction with vocational rehabilitation and, specifically, entrepreneurial skills training has been suggested (SAMHSA, 2000). Furthermore, a good behavioral strategy should include community involvement, as it helps to maintain successful addictive behavioral change (NDCI, 2014). Unfortunately, only a handful of recovery centers offer entrepreneurial skills training and help women to engage in volunteer work or offer them employment opportunities, due to the lack of financial and human resources (SAHMSA, 2000). The objective of this Phase I grant application is to establish technical and commercial feasibility of Gooddler AI-powered, online social entrepreneurship training platform that aims to provide recovery centers with a cost-effective option that will address entrepreneurial skills training and match women with open job or volunteer opportunities at local non-profit organizations. To accomplish this objective, we plan to execute the following specific aims: 1) demonstrate commercial feasibility of Gooddler social entrepreneurship training curriculum with three recovery centers in San Francisco Bay Area; and 2) demonstrate the technical feasibility of Gooddler platform to match women in recovery with appropriate volunteering and/job opportunities at local non-profit organizations. We will establish the technical feasibility by developing community-opportunities matching model that will address the specifications of the Minimum Viable Product (MVP). The commercial feasibility will be demonstrated by helping women to gain skills and knowledge for meaningful engagement (job, volunteering, entrepreneurship). Success will move us closer to our long-term goal of providing drug recovery centers with a tool to help 430,000 women, entering US drug treatment programs every year, to get on the path of productive social involvement in communities of their choice. Gooddler, Inc. proposes to develop and validate an AI-powered social entrepreneurship training and community-opportunities matching platform, targeting 430,000 women in US enrolled in drug treatment programs annually, to give them the necessary knowledge and skills to ensure a productive social involvement in chosen communities after they complete the treatment. Our highly experienced team will be able to successfully execute the project in this $100M market and expand the offering to other settings. It can be easily adapted to be included in programs for incarcerated women, extended to be offered to men and/or to be offered as a stand-alone vocational skills training course.",AI-powered social entrepreneurship training and community-opportunities matching platform for women enrolled in drug treatment programs.,9985318,R43DA051061,"['Aftercare ', ' After Care ', ' After-Treatment ', ' post treatment ', ' Analgesics ', ' Analgesic Agents ', ' Analgesic Drugs ', ' Analgesic Preparation ', ' Anodynes ', ' Antinociceptive Agents ', ' Antinociceptive Drugs ', ' pain killer ', ' pain medication ', ' pain reliever ', ' painkiller ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Budgets ', ' Centers for Disease Control and Prevention (U.S.) ', ' CDC ', ' Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' United States Centers for Disease Control and Prevention ', ' Communities ', ' Educational Curriculum ', ' Curriculum ', ' lesson plans ', ' Drug abuse ', ' abuse of drugs ', ' abuses drugs ', ' Pharmacotherapy ', ' Drug Therapy ', ' drug treatment ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Economics ', ' Feedback ', ' Goals ', ' Grant ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' men ', "" men's "", ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Occupations ', ' Jobs ', ' Professional Positions ', ' Nonprofit Organizations ', ' Non-Profit Organizations ', ' Overdose ', ' Vocational rehabilitation ', ' Relapse ', ' Research ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Risk Factors ', ' San Francisco ', ' Social Conditions ', ' Societal Conditions ', ' Surveys ', ' Survey Instrument ', ' Time ', ' United States Substance Abuse and Mental Health Services Administration ', ' SAMHSA ', ' Substance Abuse and Mental Health Services Administration ', ' Weight ', ' Woman ', ' Work ', ' Gender ', ' Research Subjects ', ' Entrepreneurship ', ' Entrepreneurial Skill ', ' base ', ' Label ', ' Area ', ' incarcerated ', ' incarceration ', ' Imprisonment ', ' Phase ', ' Ensure ', ' Evaluation ', ' Training ', ' Recovery ', ' Opiates ', ' Opioid ', ' Policies ', ' drug use ', ' Drug usage ', ' tool ', ' Knowledge ', ' programs ', ' skills training ', ' Emergency Department ', ' Emergency room ', ' Accident and Emergency department ', ' American ', ' experience ', ' success ', ' skills ', ' treatment program ', ' Manpower ', ' personnel ', ' Human Resources ', ' social ', ' Modeling ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Effectiveness ', ' Address ', ' Drug Abuse Treatment Centers ', ' Drug Treatment Centers ', ' Drug Rehabilitation Centers ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' International ', ' Employment Opportunities ', ' enroll ', ' Enrollment ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Behavioral ', ' treatment center ', ' designing ', ' design ', ' Outcome ', ' cost effective ', ' volunteer ', ' addictive disorder ', ' addiction ', ' overdose death ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' social involvement ', ' social participation ', ' social engagement ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' heroin intake ', ' heroin use ', ' community involvement ', ' ']",NIDA,"GOODDLER, INC",R43,2020,225000,CA-14,0.033189984116706976
"Project Motivate: A digital motivation and prediction platform to improve treatment retention and reduce relapse in opioid use disorder PROJECT SUMMARY/ABSTRACT The opioid crisis is the deadliest drug epidemic in American history and new approaches are needed. One novel approach includes predicting likelihood of opioid use disorder (OUD) treatment retention by assessing someones risk of early departure from treatment. Current methods to improve treatment retention rely on providers using their intuition to identify when an individual is at risk of leaving treatment early in order to intervene, which often happens too late. Mobile health and machine learning predictive analytics offer a new opportunity to personalize OUD treatment, improve retention in OUD care, and mitigate the risk of relapse and overdose episodes. Project Motivate will combine physiological and behavioral data from disparate sources in order to predict when an individual is at risk of early departure from OUD treatment. This data will be displayed in a user-friendly manner so that providers can more effectively support patients to remain in treatment with timely intervention and responses. PROJECT NARRATIVE Early departure from opioid use disorder treatment programs is common, with early termination rates over 50% for many opioid use disorder treatments, putting individuals at an increased risk of relapsing, overdose and death. Using physiological monitoring tools to predict the likelihood that someone is at risk of early departure from opioid use disorder treatment due to worsening symptoms and/or cravings will allow for proactive interventions that will improve treatment retention. Making an impact here will not only save lives, but it will also lower medical costs, municipal emergency response costs, recidivism, workplace accidents, lost workplace productivity and costs to families.",Project Motivate: A digital motivation and prediction platform to improve treatment retention and reduce relapse in opioid use disorder,10013066,R43DA051279,"['Accidents ', ' Algorithms ', ' Beds ', ' Computer Vision Systems ', ' computer vision ', ' Professional counselor ', ' Counselor ', ' Data Collection ', ' Data Reporting ', ' data representation ', ' Cessation of life ', ' Death ', ' Heroin ', ' Diacetylmorphine ', ' Diamorphine ', ' Disadvantaged ', ' Dropout ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemic ', ' Family ', ' Feedback ', ' Future ', ' Goals ', ' Health ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Heart Rate ', ' Cardiac Chronotropism ', ' Recording of previous events ', ' History ', ' Inpatients ', ' Methods ', ' Methodology ', ' Physiologic Monitoring ', ' Physiological Monitoring ', ' Moods ', ' Motion ', ' Motivation ', ' Overdose ', ' Patients ', ' Productivity ', ' Program Development ', ' Public Health ', ' Relapse ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Residential Treatment ', ' residential care ', ' Risk ', ' Running ', ' Sleep ', ' Computer software ', ' Software ', ' Stress ', ' Surveys ', ' Survey Instrument ', ' Technology ', ' Testing ', ' Time ', ' United States ', ' Weather ', ' Wrist ', ' medical costs ', ' Medical Care Costs ', ' Caring ', ' Job Location ', ' Job Place ', ' Job Setting ', ' Job Site ', ' Work Location ', ' Work Place ', ' Work-Site ', ' Worksite ', ' work setting ', ' Workplace ', ' base ', ' sensor ', ' improved ', ' Clinical ', ' prematurity ', ' premature ', ' Phase ', ' Physiologic ', ' Physiological ', ' Medical ', ' Ensure ', ' Intuition ', ' Individual ', ' tool ', ' machine learned ', ' Machine Learning ', ' Clinic ', ' Source ', ' Pattern ', ' System ', ' meetings ', ' American ', ' experience ', ' Municipalities ', ' novel ', ' Participant ', ' treatment program ', ' member ', ' recidivism ', ' validation studies ', ' Self-Report ', ' Patient Self-Report ', ' General Public ', ' General Population ', ' Reporting ', ' Thorace ', ' Thoracic ', ' Thorax ', ' Chest ', ' Modeling ', ' craving ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Cell Phone ', ' Cellular Telephone ', ' iPhone ', ' smart phone ', ' smartphone ', ' Cellular Phone ', ' Provider ', ' preventing ', ' prevent ', ' Symptoms ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' Regulatory Pathway ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Monitor ', ' Behavioral ', ' imaging ', ' Image ', ' early onset ', ' cost ', ' digital ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' visualization tool ', ' Visualization software ', ' cost effective ', ' Imaging technology ', ' early therapy ', ' Early treatment ', ' user-friendly ', ' motivational intervention ', ' prototype ', ' heart rate variability ', ' overdose death ', ' m-Health ', ' mobile health ', ' mHealth ', ' Emergency response ', ' precision interventions ', ' personalized intervention ', ' data visualization ', ' Predictive Analytics ', ' opiate use disorder ', ' opioid use disorder ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' relapse risk ', ' dashboard ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' wearable electronics ', ' wearable technology ', ' wearable device ', ' patient engagement ', ' clinical decision support ', ' quality of sleep ', ' sleep quality ', ' Prescription overdose ', ' Prescription drug overdose ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NIDA,"BIOMOTIVATE, LLC",R43,2020,251492,PA-18,0.1599528883743135
"Real-time fMRI neurofeedback of large-scale network dynamics in opioid use disorder PROJECT SUMMARY The misuse of opioids, opioid addiction and overdose are a serious national public health crisisthe opioid epidemicthat despite increased scientific, clinical and government attention, continues to grow. Methadone is a generally effective treatment for opioid use disorder, however relapse rates remain high, and risk of overdose is greatest during relapse. There is a need for improved mechanistic understanding of the factors that contribute to opioid relapse to improve our understanding of opioid use disorder and its treatment. Using connectome-based methods (i.e., functional connectivity) in functional magnetic resonance imaging (fMRI), we recently identified a large-scale brain network that predicted opioid relapse from both resting and task states. Connectome-based methods enable data-driven characterization of whole brain networks related to behavior that might be better suited to describe complex clinical phenomena (e.g., opioid relapse). Building on prior work indicating the utility of real-time fMRI neurofeedback to test brain activation patterns related to specific functions and individual abilities to regulate these functions, the proposed project will use connectome-based neurofeedback to target patterns of functional connectivity within our recently identified opioid abstinence network. This information is critical to improve understanding of mechanisms of opioid relapse. Individuals on methadone will be randomized to receive either active (n=12) or sham (n=12) connectome-based neurofeedback at 3 weekly scanning sessions including feedback and transfer runs. Additional baseline and follow-up scans will include resting state and reward and cognitive task runs. Craving, negative affect and opioid use will be measured weekly and at 1-mo follow-up. Based on our pilot data, connectome-based feedback will be targeted at the opioid abstinence network and we hypothesize that increased connectivity in this network will be associated with improved clinical outcomes. Aim 1 will test the hypothesis that active feedback is associated with reduced opioid use from baseline to follow-up scans (Aim 1a) and at 1-mo follow- up (Aim 1b). Aim 2 will test the hypothesis that active feedback is associated with increased opioid abstinence network connectivity in resting state (Aim 2a) and task (reward, cognitive) state (Aim 2b) versus sham feedback, as in our pilot work. Aim 3 will test the hypothesis that active feedback is associated with greater improvements in clinical features of opioid use disorder (craving, negative affect) than sham feedback (Aim 3a) and that increased opioid abstinence network connectivity will correlate with these improvements (Aim 3b). Overall, this project tests a potentially transformative hypothesis relating large-scale brain network dynamics to outcomes in opioid use disorder, and tests a highly innovative method for real-time fMRI neurofeedback from the opioid abstinence network to improve clinical features of opioid use disorder. This project will provide unprecedented insight into the functional neurobiology of opioid relapse and more generally has the potential to transform existing real-time fMRI paradigms in addictions. PROJECT NARRATIVE This project leverages advances in real-time fMRI neurofeedback and machine learning to test whether methadone-treated individuals with opioid use disorder can increase functional connectivity within an empirically-derived opioid abstinence network that has previously been identified to predict opioid relapse. This project will provide critical data and information to improve our understanding of opioid relapse and may transform existing real-time fMRI paradigms in addictions more generally. Findings should contribute to the scientific and clinical response to the growing opioid epidemic and be used to inform treatment development.",Real-time fMRI neurofeedback of large-scale network dynamics in opioid use disorder,10025590,R21DA049583,"['Attention ', ' Behavior ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Feedback ', ' Government ', ' Learning ', ' Methadone ', ' Adanon ', ' Althose ', ' Dolophine ', ' Methadose ', ' Methods ', ' Neurobiology ', ' neurobiological ', ' Public Health ', ' Relapse ', ' Research ', ' Rest ', ' Rewards ', ' Running ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Testing ', ' Time ', ' Work ', ' Measures ', ' base ', ' improved ', ' Clinical ', ' Refractory ', ' Link ', ' Training ', ' insight ', ' AOD use ', ' substance use ', ' substance using ', ' using substances ', ' Alcohol or Other Drugs use ', ' Individual ', ' Opiates ', ' Opioid ', ' Therapeutic ', ' tool ', ' machine learned ', ' Machine Learning ', ' Functional MRI ', ' fMRI ', ' Functional Magnetic Resonance Imaging ', ' Complex ', ' Scanning ', ' Pattern ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' neural ', ' relating to nervous system ', ' novel ', ' Reporting ', ' Modeling ', ' craving ', ' response ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Brain region ', ' Dose ', ' Symptoms ', ' Data ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Cognitive ', ' Characteristics ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' designing ', ' design ', ' Outcome ', ' Population ', ' innovate ', ' innovative ', ' innovation ', ' Abstinence ', ' brain behavior ', ' addictive disorder ', ' addiction ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' high risk ', ' effective treatment ', ' effective therapy ', ' neural patterning ', ' neurofeedback ', ' licit opioid ', ' opiate medication ', ' opioid medication ', ' prescribed opiate ', ' prescribed opioid ', ' prescription opiate ', ' prescription opioid ', ' cognitive task ', ' cognitive process ', ' Data Analytics ', ' opiate use disorder ', ' opioid use disorder ', ' improved outcome ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' connectome ', ' negative affectivity ', ' negative affect ', ' imaging study ', ' opiate crisis ', ' opioid crisis ', ' opioid epidemic ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' overdose risk ', ' methadone maintenance ', ' methadone maintenance program ', ' methadone maintenance therapy ', ' methadone maintenance treatment ', ' methadone treatment ', ' non-medical opioid use ', ' nonmedical opioid use ', ' opiate misuse ', ' opioid misuse ', ' neural network ', ' ']",NIDA,YALE UNIVERSITY,R21,2020,209375,CT-03,0.18870195215849425
